Page last updated: 2024-11-04

penicillin g

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Penicillin G: A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

benzylpenicillin : A penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5904
CHEMBL ID29
CHEBI ID18208
SCHEMBL ID3783
MeSH IDM0016133

Synonyms (143)

Synonym
BRD-K55191674-236-03-7
BRD-K55191674-237-02-7
free penicillin ii
liquacillin
cilloral
penicillin, (phenylmethyl)-
cilopen
pradupen
nsc-193396
cosmopen
free benzylpenicillin
benzylpenicillinic acid
penicillinic acid, (phenylmethyl)-
specilline g
gelacillin
pharmacillin
free penicillin g
dropcillin
benzylpenicillin g
CHEBI:18208 ,
benzylpenicillinum
2,2-dimethyl-6beta-(phenylacetamido)penam-3alpha-carboxylic acid
(2s,5r,6r)-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
bensylpenicillin
bencilpenicilina
6-(2-phenylacetamido)penicillanic acid
benzyl benicillin
benzylpenicilline
DIVK1C_000316
KBIO1_000316
SPECTRUM_000933
BSPBIO_001096
SPECTRUM5_001108
BSPBIO_002183
PRESTWICK3_001078
PRESTWICK2_001078
phenylacetyl-6-aminopenicillanic acid
ursopen
4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- [2s-(2alpha,5alpha,6beta)]-
4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-, (2s,5r,6r)-
cillora
4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-
(5r,6r)-benzylpenicillin
C05551
61-33-6
benzylpenicillin
penicillin g
bicillin (*benzathine salt, tetrahydrate*)
penicillin-g potassium
benzyl penicillin
4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- (2s,5r,6r)-
(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
DB01053
NCGC00159348-02
D02336
benzylpenicillin (inn)
IDI1_000316
benzylpenicillin [inn:ban]
(2s,5r,6r)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
brn 0044740
4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-, (2s-(2alpha,5alpha,6beta))-
nsc 193396
4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6- (2-phenylacetamido)-
pencillin g
benzylpenicillinum [latin]
hsdb 3166
benzylpenicilline [french]
einecs 200-506-3
4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)- (2s-(2alpha,5alpha,6beta))-
bencilpenicilina [spanish]
4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-
KBIO3_001683
KBIO2_001413
KBIO2_006549
KBIOSS_001413
KBIOGR_000942
KBIO2_003981
SPBIO_002998
SPECTRUM2_000518
SPECTRUM4_000471
PRESTWICK1_001078
SPECTRUM3_000542
PRESTWICK0_001078
NINDS_000316
SPBIO_000475
BPBIO1_001206
smr000538912
MLS001173382
PENICILLIN-G ,
MLS000766897
MLS001032123
CHEMBL29
j01ce01
3,3-dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid(penicillin g)
(2s,5r,6r)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid
3,3-dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid anion (penicillin g)
bdbm50022787
(+)-3,3-dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid(penicillin g)
(2s,5r,6r)-3,3-dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid
3,3-dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid
(2s,5r,6r)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
A833169
NCGC00159348-03
HMS2875L09
AKOS005203091
unii-q42t66vg0c
q42t66vg0c ,
4-27-00-05861 (beilstein handbook reference)
phenoxymethylpenicillin (benzathine) tetrahydrate impurity a [ep impurity]
phenoxymethylpenicillin impurity a [ep impurity]
penicillin g [mi]
benzylpenicillin [inn]
benzylpenicillin [who-dd]
penicillin g [vandf]
penicillin g [hsdb]
phenoxymethylpenicillin potassium impurity a [ep impurity]
benzylpenicillin [mart.]
EPITOPE ID:114070
gtpl4796
SCHEMBL3783
penicilling
JGSARLDLIJGVTE-MBNYWOFBSA-N
DTXSID5046934 ,
W-109262
benzylpenicillin, antibiotic for culture media use only
SBI-0051476.P003
(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2s,5r,6r)-3,3-dimethyl-7-oxo-6-
(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]
penicillin,(s)
Q258450
BRD-K55191674-237-12-6
(2s,5r,6r)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid
EN300-19631164
4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2s,5r,6r)-
CS-0013727
HY-N7139
dtxcid3026934
benzylpenicillinum (latin)
benzylpenicillin (mart.)
phenoxymethylpenicillin impurity a (ep impurity)
GLXC-25718
benzylpenicillin 1000 microg/ml in acetonitrile:water

Research Excerpts

Overview

Penicillin G is an unstable thioether that degrades in a range of pathways. It is one of the most predominant drug residues in animal-derived food products.

ExcerptReferenceRelevance
"Penicillin G is an unstable thioether that degrades in a range of pathways."( Reactions of cisplatin and oxaliplatin with penicillin G: implications for drug inactivation and biological activity.
Prokes, I; Sadler, PJ; Shi, H; Song, L; Wang, FX, 2022
)
1.7
"Penicillin G is a widely used antimicrobial in food-producing animals, and one of the most predominant drug residues in animal-derived food products. "( Development and application of a population physiologically based pharmacokinetic model for penicillin G in swine and cattle for food safety assessment.
Gehring, R; Li, M; Lin, Z; Riviere, JE, 2017
)
2.12
"Penicillin G (PEN) is a widely used antibiotic whose mechanism of action is related to the interference with the synthesis of bacteria cell wall. "( Interaction of penicillin G with the human erythrocyte membrane and models.
Aguilar, F; Sotomayor, CP; Suwalsky, M; Villena, F,
)
1.93

Effects

Pencillin G has little effect on the SAD process. Penicillin G (PNG) has been demonstrated to elicit T-cell responsiveness in vitro in allergic patients by means of a lymphocyte transformation test (LTT)

ExcerptReferenceRelevance
"Penicillin G has little effect on the SAD process."( Simultaneous ANAMMOX and denitrification (SAD) process in batch tests.
Jia, XS; Zhong, YM, 2013
)
1.11
"Penicillin G (PenG) has successfully been used for therapy of dermal fibrosis in patients suffering from systemic sclerosis (SSc). "( Penicillin G does not alter collagen type I metabolism of dermal fibroblasts in culture.
Anderegg, U; Haustein, UF; Wilczek, A, 2000
)
3.19
"Penicillin G (PNG) has been demonstrated to elicit T-cell responsiveness in vitro in allergic patients by means of a lymphocyte transformation test (LTT). "( Penicillin-allergic patients react to penicillin-modified "self".
Bell, SJ; Pichler, WJ, 1989
)
1.72

Treatment

Pencillin G treatment slightly diminished the local tissue metabolic deterioration and significantly reduced the amount of debrided tissue as compared to untreated animals. In penicillin G-treated animals, the dermal lesions became smaller as early as day 3 of treatment and almost disappeared during the therapy.

ExcerptReferenceRelevance
"Penicillin G successfully treated 82% (126/154) of the study group and improvement was marked on the first day of treatment."( Outcome of children hospitalized with community-acquired pneumonia treated with aqueous penicillin G.
Araújo, M; Nascimento-Carvalho, CM; Simbalista, R, 2011
)
2.03
"Penicillin G treatment slightly diminished the local tissue metabolic deterioration and significantly reduced the amount of debrided tissue as compared to untreated animals."( Effects of penicillin G on local metabolic changes in skeletal muscle following high velocity missile injury.
Almskog, BA; Haljamäe, H; Nordström, G; Seeman, T, 1984
)
1.38
"Penicillin G treatment of seeds did not reduce seed germination or root tip growth, or affect seedling development."( Enhanced attachment of Bradyrhizobium japonicum to soybean through reduced root colonization of internally seedborne microorganisms.
Emerich, DW; Karr, DB; Kremer, RJ; Oehrle, NW, 2000
)
1.03
"In penicillin G-treated animals, the dermal lesions became smaller as early as day 3 of treatment and almost disappeared during the therapy."( Lack of effectiveness of ofloxacin against experimental syphilis in rabbits.
Katami, K; Nakajima, R; Osada, Y; Otani, M; Otani, T; Une, T, 1987
)
0.79
"penicillin G treatment (i.v."( Tick-borne Borrelia-meningitis in children. An outbreak in the Kalmar area during the summer of 1984.
Gustafsson, PM; Jörbeck, HJ; Lind, HC; Stiernstedt, GT, 1987
)
0.99
"Treatment with penicillin G and IM streptomycin for 14 days was reserved for severe cases or cases that responded poorly to treatment."( Whipple's disease: report of cases diagnosed in our hospital.
Cordero Fernández, C; Márquez Galán, JL; Reina Campos, FR; Reyes Martínez, C; Sánchez Agüera, M; Torronteras Santiago, R, 2003
)
0.66
"Treatment with Penicillin G was curative."( [Disseminated actinomycosis presenting with multiple subcutaneous abscesses (author's transl)].
Auffret, N; Bertail, MA; Brion, N; Civatte, J; Denis, C, 1981
)
0.6
"Treatment with penicillin G or ampicillin was equally effective."( Hemophilus influenzae type b pneumonia in 43 children.
Asmar, BI; Dajani, AS; Reed, JO; Slovis, TL, 1978
)
0.6
"Treatment with penicillin G and streptomycin was successful in the first patient, whereas ampicillin alone resulted in clinical cure in the second case."( Kingella denitrificans prosthetic endocarditis.
Brewer, J; Khan, JA; Mann, KR; Sharp, S, 1986
)
0.61

Toxicity

Less toxic TunR1 and TunR2 both enhance the antibacterial activity of β-lactams: oxacillin by 32- to 64-fold. Extralabel use of penicillin G is common, which may lead to violative residues in edible tissues.

ExcerptReferenceRelevance
" Both biotin and sulfathiazole are shown to be promising candidates for use in the suppression of the adverse effects of cisplatin, and other sulfur-containing compounds currently in clinical use may have equivalent or superior properties in this respect."( Control of the nephrotoxicity of cisplatin by clinically used sulfur-containing compounds.
Basinger, MA; Holscher, MA; Jones, MM, 1992
)
0.28
"PENICILLIN TOXICITY IN THE GUINEA PIG MAY BE MANIFESTED IN SEVERAL DIFFERENT WAYS, AND IT IS PROPOSED THAT THESE TOXIC EFFECTS BE CATEGORIZED INTO THREE SYNDROMES: (1) toxic syndrome, characterized by acute fatal illness; (2) hemorrhagic syndrome, characterized by delayed illness with leukopenia and thrombocytopenia, and culminating in massive visceral hemorrhages; (3) chronic syndrome, characterized by retardation of growth and alopecia, a condition somewhat resembling "runt disease."( The association of viral activation with penicillin toxicity in guinea pigs and hamsters.
Green, RH, 1974
)
0.25
"Prevention of cephalosporin nephrotoxicity in animal models by probenecid or p-aminohippurate requires treatment regimen that produce sustained inhibition of cortical accumulation of the toxic antibiotic."( Prevention of cephalosporin nephrotoxicity by other cephalosporins and by penicillins without significant inhibition of renal cortical uptake.
Browning, MC; Fravert, D; Hsu, CY; Tune, BM, 1982
)
0.26
" These cells were exposed to antibiotics for 24 hr and subsequently toxic effects on cells were evaluated by three different assays."( Cytotoxic effects of four antibiotics on endothelial cells.
Lanbeck, P; Paulsen, O, 1995
)
0.29
"Determination of potential drug toxicity and side effect in early stages of drug development is important in reducing the cost and time of drug discovery."( Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach.
Chen, YZ; Ung, CY, 2001
)
0.31
" Patients can then be advised to undergo a tolerance test with safe penicillins instead of provocation with culprit penicillins for confirmation of penicillin allergy."( Combined in vivo and in vitro approach for the characterization of penicillin-specific polyclonal lymphocyte reactivity: tolerance tests with safe penicillins instead of challenge with culprit drugs.
Al Masaoudi, T; Erdmann, S; Merk, HF; Sachs, B, 2004
)
0.32
" Four patients showed a side chain-specific sensitization to amino-penicillins in vivo and in vitro and were advised to undergo tolerance tests with safe penicillins."( Combined in vivo and in vitro approach for the characterization of penicillin-specific polyclonal lymphocyte reactivity: tolerance tests with safe penicillins instead of challenge with culprit drugs.
Al Masaoudi, T; Erdmann, S; Merk, HF; Sachs, B, 2004
)
0.32
" Patients with such sensitization are very likely to tolerate safe penicillins, thereby expanding their therapeutic options when antibiotic treatment is required."( Combined in vivo and in vitro approach for the characterization of penicillin-specific polyclonal lymphocyte reactivity: tolerance tests with safe penicillins instead of challenge with culprit drugs.
Al Masaoudi, T; Erdmann, S; Merk, HF; Sachs, B, 2004
)
0.32
" Administration of studied antidotes without alpha-AMA, was not associated with any adverse effects in hepatocytes."( Failure of benzylpenicillin, N-acetylcysteine and silibinin to reduce alpha-amanitin hepatotoxicity.
Dziegiel, P; Izykowska, I; Magdalan, J; Nowak, M; Ostrowska, A; Piotrowska, A; Szelag, A,
)
0.13
" In the present study, novel methods to screen toxic chemicals during the developmental process were evaluated using undifferentiated human embryonic stem (hES) cells."( Evaluation of developmental toxicity using undifferentiated human embryonic stem cells.
An, BS; Choi, KH; Choi, YU; Hong, EJ; Jeung, EB; Jung, EM; Kang, HS; Yang, H; Yang, JY, 2015
)
0.42
"Children (<18 years) with a history of penicillin allergy were evaluated with penicillin skin tests and were reviewed for basic demographics, penicillin skin test results, adverse drug reaction to penicillin after penicillin skin test, and adverse reaction to penicillin skin test."( Penicillin skin testing is a safe and effective tool for evaluating penicillin allergy in the pediatric population.
Fox, SJ; Park, MA,
)
0.13
"8%) had an adverse drug reaction."( Penicillin skin testing is a safe and effective tool for evaluating penicillin allergy in the pediatric population.
Fox, SJ; Park, MA,
)
0.13
"Penicillin skin testing was safe and effective in the evaluation of children with a history of penicillin allergy."( Penicillin skin testing is a safe and effective tool for evaluating penicillin allergy in the pediatric population.
Fox, SJ; Park, MA,
)
0.13
" The goal of this study was to validate spheroid contraction as a cytotoxic endpoint using 3T3 fibroblasts in response to 5 toxic compounds (all-trans retinoic acid, dexamethasone, doxorubicin, 5'-fluorouracil, forskolin), sodium dodecyl sulfate (+control), and penicillin-G (-control)."( A spheroid toxicity assay using magnetic 3D bioprinting and real-time mobile device-based imaging.
Becker, JL; Chen, J; Desai, PK; Gage, JA; Haisler, WL; Hebel, C; Liao, A; Neeley, SK; Raphael, RM; Shen, T; Shiao, S; Souza, GR; Tseng, H, 2015
)
0.42
" Therefore, we compared parenteral benzylpenicillin plus gentamicin with ceftriaxone as first-line treatment, assessing outcome and adverse events."( The Treatment of Possible Severe Infection in Infants: An Open Randomized Safety Trial of Parenteral Benzylpenicillin and Gentamicin Versus Ceftriaxone in Infants <60 days of Age in Malawi.
Banda, FM; Chiume, M; Dube, Q; Heyderman, RS; Mallewa, M; Molyneux, EM; Schwalbe, EC; Singini, I, 2017
)
0.46
" Adverse events and outcomes were recorded until 6 months post discharge."( The Treatment of Possible Severe Infection in Infants: An Open Randomized Safety Trial of Parenteral Benzylpenicillin and Gentamicin Versus Ceftriaxone in Infants <60 days of Age in Malawi.
Banda, FM; Chiume, M; Dube, Q; Heyderman, RS; Mallewa, M; Molyneux, EM; Schwalbe, EC; Singini, I, 2017
)
0.46
"Ceftriaxone and gentamicin are safe for infants in our setting."( The Treatment of Possible Severe Infection in Infants: An Open Randomized Safety Trial of Parenteral Benzylpenicillin and Gentamicin Versus Ceftriaxone in Infants <60 days of Age in Malawi.
Banda, FM; Chiume, M; Dube, Q; Heyderman, RS; Mallewa, M; Molyneux, EM; Schwalbe, EC; Singini, I, 2017
)
0.46
" Due to reduced sensitivity of bacteria to penicillin, extralabel use of penicillin G is common, which may lead to violative residues in edible tissues and cause adverse reactions in consumers."( Development and application of a population physiologically based pharmacokinetic model for penicillin G in swine and cattle for food safety assessment.
Gehring, R; Li, M; Lin, Z; Riviere, JE, 2017
)
0.91
" acnes is not significantly chondrotoxic and may be safe for intrawound application."( Exploring Penicillin G as an Intrawound Antibiotic Powder for Prevention of Postoperative Shoulder Infections: Does It Exhibit In Vitro Chondrotoxicity?
Nadig, NS; Parada, SA; Shaw, KA, 2020
)
0.96
" Secondary outcomes were lung function, muscle strength, plasma creatinine, clinical stage, gastrostomy placement, quality of life and occurrence of adverse of events."( A placebo-controlled trial to investigate the safety and efficacy of Penicillin G/Hydrocortisone in patients with ALS (PHALS trial).
Bunte, TM; Van Den Berg, LH; Van Eijk, RPA; Van Es, MA, 2020
)
0.79
" The hiPSC-EST also discerned adverse developmental outcomes driven by novel environmental toxicants."( An Evaluation of Human Induced Pluripotent Stem Cells to Test for Cardiac Developmental Toxicity.
Puig-Sanvicens, V; Rodrigues, B; Sparks, NRL; Walker, LM; Zur Nieden, NI, 2021
)
0.62

Pharmacokinetics

Mean values for elimination half-life and mean residence time of penicillin G were significantly higher in emus than in ostriches. No significant differences in antipyrine pharmacokinetics between species were demonstrated. Pharmacokinetic analysis determined that the disposition of peniillin G was best described by a two-compartment open model.

ExcerptReferenceRelevance
" The biological half-life of SBPC in the serum was shortened in pretreatment with GM and prolonged in posttreatment with GM, while that of GM did not vary in pre- or post-treatment with SBPC."( [Fundamental studies on combination of antibiotics; especially on pharmacokinetics. I. Combination of gentamicin with sulbenicillin or cephacetrile (author's transl)].
Aratani, H; Nakatsuka, M, 1976
)
0.26
" In the case of sulbenicillin, the mean serum concentration at 1 hr was 157 plus or minus 25 mug/ml, the mean serum half-life was 70 plus or minus 10 min, the renal clearance was 95 plus or minus 25 ml/min, and the total urinary recovery after 24 hr was about 80% of the dose."( Pharmacokinetics of sulbenicillin, a new broad-spectrum semisynthetic penicillin.
Hansen, IB; Jacobsen, E; Weis, J, 1975
)
0.25
" Furthermore, pharmacokinetic analysis of the data obtained from in vivo and in vitro experiments indicated that PCG reduced the permeability of [14C]CDZM across the sinusoidal and bile canalicular membranes to 32% and 40% of the control value, respectively."( Effect of benzylpenicillin on the disposition of cefodizime in rats: no net effect on total clearance due to decreased hepatobiliary clearance and increased renal clearance.
Hanano, M; Iga, T; Kawaguchi, Y; Matsushita, H; Sawada, Y; Sugiyama, Y; Suzuki, H, 1992
)
0.28
"01) in Cmax and AUC occurred."( Effects of experimentally induced Streptococcus suis infection on the pharmacokinetics of penicillin G in pigs.
Fung, KF; Zeng, ZL, 1990
)
0.5
" There was a significant difference between the areas under the curve with change of posture but not between any of the other pharmacokinetic variables."( The effects of posture on the pharmacokinetics of intramuscular benzylpenicillin.
Roberts, MS; Rumble, RH; Scott, AR, 1988
)
0.27
"In order to assess pharmacokinetic differences between sulbenicillin (S) and piperacillin (P), two penicillin derivatives, 24 in-patients, 12 males and 12 females mean age 59."( Comparison between sulbenicillin and piperacillin levels in serum and in bronchial secretions--a pharmacokinetic study.
Bichisao, E; Fraschini, F; Gaffuri Riva, V; Marchi, E; Scaglione, F; Scarpazza, G; Scarpazza, P, 1987
)
0.27
" There were no significant differences between any of these pharmacokinetic variables with the change in posture."( The effect of posture on the pharmacokinetics of intravenous benzylpenicillin.
Roberts, MS; Rumble, RH; Scott, AR, 1986
)
0.27
" The mean penicillin plasma peak concentration and bioavailability were highest after the drug was injected in the neck and biceps musculature."( Effect of the injection site on the pharmacokinetics of procaine penicillin G in horses.
Driessens, F; Firth, EC; Klein, WR; Nouws, JF; Peperkamp, K; Schmaetz, P, 1986
)
0.51
"Sulbactam, a new beta-lactamase inhibitor, has pharmacokinetic characteristics in humans similar to those of ampicillin and amoxicillin."( Pharmacokinetics of sulbactam in humans.
Foulds, G; Hayes, SL; Marshall, DC; McMahon, FG; O'Brien, MM; Stankewich, JP; Weidler, DJ, 1983
)
0.27
" The half-life (t1/2 beta), however, did not change significantly over the 15-day period of the study."( Clearance of penicillin G in the newborn calf.
Powers, JD; Powers, TE; Short, CR; Varma, KJ; White, MB, 1984
)
0.64
" The aim of the present study was to establish the pharmacokinetic parameters of benzylpenicillin and cloxacillin administration in patients receiving high-dose benzylpenicillin or cloxacillin therapy by continuous infusion."( Clinical pharmacokinetics of continuous intravenous administration of penicillins.
Arnouts, P; Mattie, H; van den Broek, PJ; van Furth, R; Visser, LG, 1993
)
0.29
" Pharmacokinetic analysis determined that the disposition of penicillin G was best described by a two-compartment open model with penicillin concentrations in plasma (Cp) defined by two biexponential equations, Cp = 170."( Pharmacokinetics of penicillin G in plasma and interstitial fluid collected with dialysis fiber bundles in sheep.
Bevill, RP; Cooke, IM; Koritz, GD; Nelson, DR, 1996
)
0.86
"The pharmacodynamic effects of benzylpenicillin against Streptococcus pyogenes were studied in a new in vitro kinetic model in which bacterial outflow was prevented by a filter membrane."( Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.
Bengtsson, S; Cars, O; Löwdin, E; Odenholt, I, 1996
)
0.29
" Penicillin-G in serum was analysed by a microbiological method and pharmacokinetic parameters were calculated by model-independent methods."( Pharmacokinetics of penicillin-G in ewes and cows in late pregnancy and in early lactation.
Bengtsson, B; Franklin, A; Jacobsson, SO; Luthman, J, 1997
)
0.3
"The correlation between pharmacokinetic parameters and the in-vivo effect of antibiotics in relation to bacterial growth phases was evaluated using the mouse peritonitis model with a penicillin-resistant pneumococcus."( Pharmacodynamics of penicillin are unaffected by bacterial growth phases of Streptococcus pneumoniae in the mouse peritonitis model.
Espersen, F; Frimodt-Møller, N; Knudsen, JD, 1998
)
0.3
" The pharmaceutic and pharmacokinetic relevance of the chemical and physical factors as well as the influence of the particle size of the active principle were demonstrated with benzylpenicillin potassium in the in vitro model of the isolated perfused bovine udder."( [Pharmacokinetic aspects of mastitis therapy].
Ehinger, AM; Kietzmann, M, 1998
)
0.3
" Mean values for elimination half-life and mean residence time of penicillin G were significantly higher in emus than in ostriches; no significant differences in antipyrine pharmacokinetics between species were demonstrated."( Intravenous pharmacokinetics of penicillin G and antipyrine in ostriches (Struthio camelus) and emus (Dromaius novaehollandiae).
Clarke, CR; Cudd, LA; Kocan, AA; Wang, Z; Webb, AI, 2001
)
0.83
"7%) and a prolongation of the elimination half-life of penicillin (17."( Effect of Tomanol on the pharmacokinetics and tissue distribution of penicillin G in dairy cows.
Hekman, P; Nouws, JF; van Ginneken, CA, 1982
)
0.5
" The aim of the present study was to develop a semimechanistic pharmacokinetic (PK)/pharmacodynamic (PD) model characterizing the events seen in a bacterial system when it is exposed to antibacterial agents with different mechanisms of action."( Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments.
Cars, O; Karlsson, MO; Löwdin, E; Nielsen, EI; Sandström, M; Viberg, A, 2007
)
0.34
" The pharmacokinetics of penicillin G were best described by a two-compartment pharmacokinetic model."( Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.
Bult, Y; Danhof, M; DeJongh, J; Goessens, WH; Mouton, JW; Muller, AE; van den Anker, JN, 2007
)
0.97
" pharmacokinetic data on 670 drugs representing, to our knowledge, the largest publicly available set of human clinical pharmacokinetic data."( Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Lombardo, F; Obach, RS; Waters, NJ, 2008
)
0.35
" The sigmoid maximum-threshold-of-efficacy (E(max)) model fit the survival data, in which the free-drug area under the concentration-time curve (fAUC)/MIC ratio, the maximum concentration of free drug in plasma (fC(max))/MIC ratio, and the cumulative percentage of a 24-h period that the free-drug concentration exceeds the MIC under steady-state pharmacokinetic conditions (f %T(MIC)) were each evaluated."( Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
Ambrose, PG; Bassett, J; Beaudry, A; Bhavnani, SM; Critchley, I; Gill, SC; Heine, HS; Janjic, N; Li, J; Miller, L; Rubino, CM; Stone, KC, 2010
)
0.36
"We performed a post-hoc analysis of a pharmacokinetic (PK) study of penicillin-G, enrolling 18 neonates with a birth weight of <1,200 g, gestational age of <28 weeks and postnatal age of <5 days, with a risk of early onset sepsis."( Blood loss related to participation in pharmacokinetic study in preterm neonates.
Heidmets, LT; Ilmoja, ML; Lutsar, I; Metsvaht, T; Oselin, K; Pisarev, H, 2011
)
0.37
" Pharmacokinetic parameters were comparable to those reported for eutherians of equivalent size and suggest that the practice of adjusting allometrically scaled doses to account for the lower metabolic rate of marsupials may not be valid."( Single-dose pharmacokinetics of oxytetracycline and penicillin G in tammar wallabies (Macropus eugenii).
Barker, IK; Crawshaw, G; Hinds, LA; Johnson, R; McLelland, DJ; Spilsbury, L, 2011
)
0.62
" There are, however, no population pharmacokinetic studies of penicillin G for food animals."( Interspecies mixed-effect pharmacokinetic modeling of penicillin G in cattle and swine.
Baynes, R; Gehring, R; Huang, Q; Li, M; Riviere, JE; Tell, L, 2014
)
0.89
" Pharmacodynamic models describing the relationship between the concentration of antimicrobials and the minimum growth rate of the bacteria provide more detailed information than the MIC only."( Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae.
Althaus, CL; Foerster, S; Hathaway, LJ; Low, N; Unemo, M, 2016
)
0.43
" The experimental time-kill curves were analysed and quantified with a previously established pharmacodynamic model."( Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae.
Althaus, CL; Foerster, S; Hathaway, LJ; Low, N; Unemo, M, 2016
)
0.43
" gonorrhoeae time-kill curve experiments analysed with a pharmacodynamic model have potential for in vitro evaluation of new and existing antimicrobials."( Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae.
Althaus, CL; Foerster, S; Hathaway, LJ; Low, N; Unemo, M, 2016
)
0.43
"Organic anion transporters (OATs) are important in the renal secretion, and thus, the clearance, of many drugs; and their functional change can result in pharmacokinetic variability."( Quantitative Prediction of Human Renal Clearance and Drug-Drug Interactions of Organic Anion Transporter Substrates Using In Vitro Transport Data: A Relative Activity Factor Approach.
Feng, B; Litchfield, J; Mathialagan, S; Piotrowski, MA; Tess, DA; Varma, MV, 2017
)
0.46
" This study aimed to develop a physiologically based pharmacokinetic (PBPK) model to predict drug residues in edible tissues and estimate extended withdrawal intervals for penicillin G in swine and cattle."( Development and application of a population physiologically based pharmacokinetic model for penicillin G in swine and cattle for food safety assessment.
Gehring, R; Li, M; Lin, Z; Riviere, JE, 2017
)
0.87
" Modern pediatric pharmacokinetic study protocols frequently favor opportunistic, "scavenged" sampling."( Development of a Novel Multipenicillin Assay and Assessment of the Impact of Analyte Degradation: Lessons for Scavenged Sampling in Antimicrobial Pharmacokinetic Study Design.
Barker, CIS; Johnston, A; Kipper, K; Sharland, M; Standing, JF, 2018
)
0.48
" Pharmacokinetic data for non-ICU hospitalized populations are lacking."( Pharmacokinetics and Pharmacodynamic Target Attainment of Benzylpenicillin in an Adult Severely Ill Sub-Saharan African Patient Population.
Beirão, JC; Bos, JC; Lang, CN; Mathôt, RAA; Mistício, MC; Nunguiane, G; Prins, JM; van Hest, RM, 2018
)
0.48
"We performed a population pharmacokinetic (PPK) study in an adult Mozambican hospital population treated intravenously with PEN from October 2014 through November 2015."( Pharmacokinetics and Pharmacodynamic Target Attainment of Benzylpenicillin in an Adult Severely Ill Sub-Saharan African Patient Population.
Beirão, JC; Bos, JC; Lang, CN; Mathôt, RAA; Mistício, MC; Nunguiane, G; Prins, JM; van Hest, RM, 2018
)
0.48
" Physiologically based pharmacokinetic (PBPK) models are useful tools to predict withdrawal intervals and tissue residues of drugs in food animals to ensure food safety, especially for extralabel drug use due to the scarcity of experimental data after extralabel administrations."( Probabilistic Physiologically Based Pharmacokinetic Model for Penicillin G in Milk From Dairy Cows Following Intramammary or Intramuscular Administrations.
Gehring, R; Li, M; Lin, Z; Riviere, JE, 2018
)
0.72
" The collected new data and other available data from the literature were used to develop a population physiologically based pharmacokinetic (PBPK) model for penicillin G in heavy sows."( An integrated experimental and physiologically based pharmacokinetic modeling study of penicillin G in heavy sows.
Coetzee, JF; Gehring, R; Karriker, LA; Li, M; Lin, Z; Mainquist-Whigham, C; Riviere, JE; Wulf, LW; Zeng, D, 2019
)
0.93
" Great efforts have been made to develop physiologically based pharmacokinetic (PBPK) models for estimating withdrawal intervals (WDIs) for extralabel prescribed drugs in food animals."( An Interactive Generic Physiologically Based Pharmacokinetic (igPBPK) Modeling Platform to Predict Drug Withdrawal Intervals in Cattle and Swine: A Case Study on Flunixin, Florfenicol, and Penicillin G.
Baynes, RE; Chou, WC; Davis, JL; Lin, Z; Maunsell, FP; Riviere, JE; Tell, LA, 2022
)
0.91

Compound-Compound Interactions

When administered with penicillin G, tobramycin given once daily was as efficacious and safe as tobramYcin given three times daily in patients with febrile neutropenia.

ExcerptReferenceRelevance
"An experimental dog model was used to reproduce the clinical picture of bilateral arteriole and choriocapillaris occlusion from a unilateral intracarotid injection of long-acting corticosteroids combined with other drugs including lidocaine, epinephrine, and penicillin."( Bilateral retinal artery and choriocapillaris occlusion following the injection of long-acting corticosteroid suspensions in combination with other drugs: II. Animal experimental studies.
McGrew, RN; White, HJ; Wilson, RS, 1978
)
0.26
"The dynamics of penicillin concentrations in the blood and lung tissue of animals with chronic experimental pneumonia after its repeated administration in combination with prednisolone was studied."( [Penicillin distribution in the body of animals with experimental chronic pneumonia when administered repeatedly in combination with prednisolone].
Sazonov, VF, 1976
)
0.26
"Fifteen strains of Enterococcus faecalis, all clinical blood culture isolates from patients with endocarditis, were studied by kill-kinetic experiments using penicillin G, ampicillin and amoxicillin alone and in combination with tobramycin."( Bactericidal effect of penicillin, ampicillin, and amoxicillin alone and in combination with tobramycin against Enterococcus faecalis as determined by kill-kinetic studies.
Frimodt-Møller, N; Gutschik, E; Westh, H,
)
0.33
"In this study penicillin alone versus penicillin combined with anti-anthrax serum were compared in the treatment of experimental anthrax of mice."( [Evaluation of penicillin alone and penicillin combined with anti-anthrax serum in experimental anthrax in mice].
Doğanay, M; Hanağasi, R; Zora, A, 1985
)
0.27
"If a bactericidal drug is combined with an agent which is only bacteristatic, the killing effect may be antagonized, since many bactericidal drugs only kill rapidly multiplying cells."( Drug combinations in antibacterial chemotherapy.
Barber, M, 1965
)
0.24
"The in vitro bactericidal interactions of penicillin G, cefotaxime, or vancomycin in combination with gentamicin were compared against 20 group G streptococci by the timed kill curve method."( In vitro bactericidal synergy of gentamicin combined with penicillin G, vancomycin, or cefotaxime against group G streptococci.
Bayer, AS; Lam, K, 1984
)
0.78
"The activities of moxalactam and cefotaxime, alone and combined with ampicillin or penicillin, against 40 isolates of group B streptococci were assessed by using the microtiter broth dilution, checkerboard, and time-kill techniques."( Activity of moxalactam and cefotaxime alone and in combination with ampicillin or penicillin against group B streptococci.
Cherubin, CE; Corrado, ML; Landesman, SH; Sierra, MF, 1981
)
0.26
" This study demonstrated the efficacy of penicillin and clavulanic acid in the treatment of infections caused by Bacteroides fragilis alone or in combination with beta-lactamase-producing aerobic bacteria."( Antibiotic and clavulanic acid treatment of subcutaneous abscesses caused by Bacteroides fragilis alone or in combination with aerobic bacteria.
Brook, I; Coolbaugh, JC; Walker, RI, 1983
)
0.27
"Since the optimal antimicrobial therapy for infections caused by Listeria monocytogenes, particularly in patients allergic to penicillin, is uncertain, we investigated the in vitro effects of erythromycin, alone and in combination with other antibiotics, on listeriae."( Effects of erythromycin in combination with penicillin, ampicillin, or gentamicin on the growth of Listeria monocytogenes.
Penn, RL; Steigbigel, RT; Ward, TT, 1982
)
0.26
" The clinical picture was markedly mitigated by the early initiation of silybin therapy, in combination with penicillin and cortisone."( [Treatment of Amanita phalloides poisoning with silybin in combination with penicillin and cortisone].
Egermann, G; Hofer, JF; Mach, K; Sommer, K, 1983
)
0.27
"For the individual determination of residual drug concentrations in meat when using penicillin-G (PC-G) in combination with one of the aminoglycoside antibiotics, the differentiation of PC-G and the aminoglycoside groups was easily accomplished by incubation of the individual drug with penicillinase (PCase)."( Simple bacteriological and thin-layer chromatographic methods for determination of individual drug concentrations treated with penicillin-G in combination with one of the aminoglycosides.
Kondo, F; Lin, SY, 1994
)
0.29
"We examined the efficacy of gentamicin combined with beta-lactam antibiotics against penicillin-resistant Streptococcus pneumoniae (PRSP) in a noncompromised mouse model of pneumonia."( Efficacy of beta-lactam antibiotics combined with gentamicin against penicillin-resistant pneumococcal pneumonia in CBA/J mice.
Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K, 1999
)
0.3
"The objective of the present study was to evaluate the therapeutic potential of bovine lactoferrin or lactoferricin in combination with penicillin G against Staphylococcus aureus."( Effect of lactoferrin in combination with penicillin on the morphology and the physiology of Staphylococcus aureus isolated from bovine mastitis.
Diarra, MS; Lacasse, P; Petitclerc, D, 2002
)
0.52
"Convulsant activity of pazufloxacin mesilate (PZFX mesilate), a new quinolone antibacterial agent for intravenous use, in combination with nonsteroidal anti-inflammatory drug (NSAID) was investigated in mice after intravenous or intracerebroventricular administration."( [Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
Fukuda, H; Kawamura, Y, 2002
)
0.31
" In this study, we have investigated the effects of bovine lactoferrin alone or in combination with penicillin G on the phagocytic activity of bovine polymorphonuclear leukocytes against Staphylococcus aureus."( Lactoferrin against Staphylococcus aureus Mastitis. Lactoferrin alone or in combination with penicillin G on bovine polymorphonuclear function and mammary epithelial cells colonisation by Staphylococcus aureus.
Deschênes, E; Diarra, MS; Grondin, G; Lacasse, P; Lessard, N; Petitclerc, D; Talbot, BG, 2003
)
0.75
" After the short-term treatment of low dose of corticosteroid combined with continuous antibiotics, high fever and renal insufficiency were dramatically improved."( Successful recovery of infective endocarditis-induced rapidly progressive glomerulonephritis by steroid therapy combined with antibiotics: a case report.
Haneda, M; Kikkawa, R; Koya, D; Shibuya, K, 2004
)
0.32
" Although the participation of the particular transporters in observed drug-drug interactions can be difficult to confirm in humans, this review focuses mainly on pharmacokinetic interactions of clinically important drugs."( Transporter-mediated Drug Interactions.
Tsuji, A, 2002
)
0.31
"When administered with penicillin G, tobramycin given once daily was as efficacious and safe as tobramycin given three times daily in cancer patients with febrile neutropenia in Norway, provided the regimen was modified according to the clinical response."( Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial.
Bø, K; Grøttum, K; Holte, H; Høiby, EA; Jacobsen, AB; Kvaløy, S; Lauritzsen, GF; Meyer, P; Olsen, H; Sandstad, B; Tangen, JM; Torfoss, D; Weyde, K, 2007
)
0.9
"The hepatic organic anion transporting polypeptides (OATPs) influence the pharmacokinetics of several drug classes and are involved in many clinical drug-drug interactions."( Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR, 2012
)
0.38
" Synergism was reported and therapeutic efficacy was significantly enhanced when DM3 was formulated in combination with penicillin (PEN)."( In vivo efficacy and molecular docking of designed peptide that exhibits potent antipneumococcal activity and synergises in combination with penicillin.
Hassan, MA; Isa, DM; Le, CF; Lee, VS; Sekaran, SD; Yusof, MY, 2015
)
0.42
" This mechanistic static approach was further applied to quantitatively predict renal drug-drug interactions (AFE ∼1."( Quantitative Prediction of Human Renal Clearance and Drug-Drug Interactions of Organic Anion Transporter Substrates Using In Vitro Transport Data: A Relative Activity Factor Approach.
Feng, B; Litchfield, J; Mathialagan, S; Piotrowski, MA; Tess, DA; Varma, MV, 2017
)
0.46
" Continuous-infusion benzylpenicillin via a 24 h elastomeric infusor, combined with either once-daily gentamicin or ceftriaxone, requires only one nursing encounter daily and is commonly used in New Zealand."( Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal endocarditis.
Bhally, H; Briggs, S; Broom, M; Duffy, E; Everts, G; Everts, R; Lowe, B; McBride, S, 2021
)
0.62
"A retrospective observational case series from multiple hospitals of patients aged 15 years or over with enterococcal endocarditis diagnosed between July 2013 and June 2019 who received at least 14 days of outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for synergy."( Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal endocarditis.
Bhally, H; Briggs, S; Broom, M; Duffy, E; Everts, G; Everts, R; Lowe, B; McBride, S, 2021
)
0.62
"Outpatient treatment of enterococcal endocarditis with continuous-infusion benzylpenicillin combined with either once-daily gentamicin or ceftriaxone following a period of inpatient treatment is usually effective."( Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal endocarditis.
Bhally, H; Briggs, S; Broom, M; Duffy, E; Everts, G; Everts, R; Lowe, B; McBride, S, 2021
)
0.62

Bioavailability

ExcerptReferenceRelevance
"Intestinal absorption rate constants of amoxicillin, ampicillin, epicillin, cyclacillin and azidocillin, by means of a static in situ intestinal perfusion method has been estimated."( Intestinal absorption kinetics of a series of aminopenicillins and azidocillin. A comparative study in the rat.
Margarit, F; Moreno-Dalmau, J; Obach, R; Peraire, C; Plá-Delfina, JM, 1991
)
0.28
" The mean penicillin plasma peak concentration and bioavailability were highest after the drug was injected in the neck and biceps musculature."( Effect of the injection site on the pharmacokinetics of procaine penicillin G in horses.
Driessens, F; Firth, EC; Klein, WR; Nouws, JF; Peperkamp, K; Schmaetz, P, 1986
)
0.51
"In a comparative kinetic study of the serum concentrations of two penicillin complexes--medium-long-acting (benethamine penicillin) and long-acting (benzathine bipenicillin)--after a single injection in young adults and elderly people, the following results were confirmed statistically: (a) age was a major factor in the variations in serum penicillin concentrations and in their persistence in the serum; (b) the penicillin was absorbed faster in young than in elderly subjects even when a long-acting complex was used; (c) serum concentrations below the level regarded as lethal for treponemes appeared much earlier and more frequently in young than in old people; and (d) the bioequivalence between penicillin preparations could not be estimated solely for the number of units of the agent used but from the bioavailability of the chosen formulation."( Kinetic study of serum penicillin concentrations after single doses of benzathine and benethamine penicillins in young and old people.
Collart, P; Durel, J; Herlin, A; Milovanovic, A; Poitevin, M, 1980
)
0.26
" The absorption rate for benzylpenicillin from the mammary gland was reduced by probenecid, as measured by the ratio of benzylpenicillin to urea absorption half-life, which was increased by 40-50% in the presence of probenecid."( Active transport of benzylpenicillin across the blood-milk barrier.
Frey, HH; Merck, CC; Nielsen, P; Rasmussen, F; Schadewinkel-Scherkl, AM, 1993
)
0.29
" The rate of absorption (t1/2ab and Tmax) was slower after subcutaneous compared to intramuscular injection, but the extent of absorption (AUC) was similar for both routes of administration."( Influence of injection site on the absorption of benzylpenicillin sodium in the dromedary.
Oukessou, M, 1995
)
0.29
" The success of systemic treatment is influenced by the bioavailability of the chemotherapeutic agent."( [Pharmacokinetic aspects of mastitis therapy].
Ehinger, AM; Kietzmann, M, 1998
)
0.3
"Many beta lactams are well absorbed by the small intestine, although the reasons for this are poorly understood."( Characterisation of penicillin G uptake in human small intestinal brush border membrane vesicles.
Fairclough, PD; Hammond, SM; Poschet, JF, 1999
)
0.63
" Bioavailability was 10."( Bioavailability and disposition of sodium and procaine penicillin G (benzylpenicillin) administered orally with milk to calves.
Anderson, KL; Musser, JM, 2001
)
0.56
"The utilization of the membrane transport protein PEPT1 as a drug delivery system is a promising strategy to enhance the oral bioavailability of drugs."( Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I, 2005
)
0.33
" Human oral bioavailability is an important pharmacokinetic property, which is directly related to the amount of drug available in the systemic circulation to exert pharmacological and therapeutic effects."( Hologram QSAR model for the prediction of human oral bioavailability.
Andricopulo, AD; Moda, TL; Montanari, CA, 2007
)
0.34
" The poor intracellular bioavailability of antibiotics reduces the efficency of many treatments and thereby promotes resistances."( An efficient system for intracellular delivery of beta-lactam antibiotics to overcome bacterial resistance.
Abed, N; Couvreur, P; Desmaële, D; Gref, R; Mougin, J; Nicolas, V; Saïd-Hassane, F; Zouhiri, F, 2015
)
0.42

Dosage Studied

The daily dosage of penicillin G ranged from 110,000 to 165,000 U/kg. The dosage of ampicillin varied from 77 to 110 mg/kg (35-50 mg/lb) Addition of peniillin G-resistant microorganisms together with the antibiotic dosage into the wild culture prevented death.

ExcerptRelevanceReference
" Rosaramicin at 100 mg/kg per day intramuscularly for 5 days cured only 5 of 15 rabbits with meningitis, but a higher dosage regimen of that drug (250 mg/kg per day intramuscularly) produced acute, fulminant enterocecitis and death within 48 h in seven of eight rabbits."( Rosaramicin versus penicillin G in experimental Pneumococcal meningitis.
Monson, TP; Nolan, CM; Ulmer, WC, 1979
)
0.59
" Failure to suppress allergic manifestations was reported in 11 cases, among which some may have been due to insufficient dosage of inhibiting hapten."( Clinical trial of Ro 6-0787, a monovalent specific hapten inhibitor of penicillin allergy.
De Weck, AL; Girard, JP; Grilliat, JP; Jeunet, F; Juhlin, L; Louis, P; Moneret-Vautrin, D; Scheiffarth, F; Schulz, KH; Spengler, H; Storck, H; Virgaay, SR; Warnatz, H; Wortmann, F; Wuthrich, B, 1975
)
0.25
" The penicillin type shows almost no improvement in bactericidal activity despite increasing the dosage above a certain level."( [Bactericidal dosie-activity relationships with E. coli, K. pneumoniae and Staph. aureus (author's transl)].
Shah, PM; Stille, W, 1976
)
0.26
" In a comprehensive series of experiments, various dosage schedules were explored."( Cytochrome C as antidote in mice poisoned with the mushroom toxin alpha-amanitin.
Floersheim, GL, 1977
)
0.26
" Bacterial lysis by penicillin was concentration-dependent and showed an optimal dosage effect which was very marked for one of the strains."( The response of Staphylococcus aureus to benzylpenicillin.
Elliott, TS; Greenwood, D; O'Grady, F; Rodgers, FG, 1979
)
0.26
" The daily dosage of penicillin G ranged from 110,000 to 165,000 U/kg (50,000-75,000 U/lb), and the dosage of ampicillin varied from 77 to 110 mg/kg (35-50 mg/lb)."( Penicillin G or ampicillin for oral treatment of canine urinary tract infections.
Gilmore, CJ; Ling, GV, 1977
)
2.02
" It is pointed out, that in a modern treatment there must be given Penicillin-G-Natrium in high dosage as early as possible, also in cases of questionableness."( [Mushroom poisoning in childhood].
Gudowski, G; Koloc, C; Rechlin, R, 1979
)
0.26
"Five patients suffering from dementia paralytica who failed to improve or deteriorated after one or several high dosage courses of penicillin, had pneumoencephalographic patterns suggesting communicating hydrocephalus."( Dementia paralytica: deterioration from communicating hydrocephalus.
Benito, C; Giménez-Roldán, S; Martin, M, 1979
)
0.26
" The present observations and those of other authors working in this area are discussed and an approach to drug dosage of renally excreted drugs in kwashiorkor has been proposed."( Penicillin pharmacokinetics in kwashiorkor.
Buchanan, N; Eyberg, C; Koornhof, HJ; Robinson, R, 1979
)
0.26
"A novel computerized automated system is described which conforms to the basic requirements set forth in the compendia for testing the dissolution characteristics of solid dosage forms."( ADS-12: an automated programmable 12-tablet dissolution testing system.
Bendrot, H; Cioffi, FJ; Martynovych, S, 1979
)
0.26
" Daily dosage of SBPC was 10g in two divided doses in most cases given by the intravenous infusion."( [Chemotherapy of peritonitis with particular reference to concentrations of sulbenicillin in human ascites (author's transl)].
Fujii, K; Hikasa, Y; Honda, K; Izukura, T; Jujo, H; Kobayashi, N; Maruyama, K; Nishijima, Y; Nomoto, S; Okabayashi, H; Sekiya, T; Setoyama, M; Tanimura, H; Yasumoto, H, 1978
)
0.26
" Penicillin was given at a daily intramuscular dosage of 40,000 units procaine penicillin G beginning 2 days prior to exposure and continuing through the third day after exposure."( Protective effect of prophylactic penicillin on splenectomized mice exposed to an aerosolized suspension of type III Streptococcus pneumoniae.
Bolton, E; Chalmer, BJ; Coil, JA; Dickerman, JD; Jakab, GJ, 1979
)
0.49
"The alterations of early syphilitic infection occuring in the course of high dosage penicillin (120 mega IU, 36 h) as clinical experimental trial has been studied both from the clinical and the electron microscopical views."( Treponema pallidum in early syphilitic lesions in humans during high-dosage penicillin therapy. An electron microscopical study.
Bartunek, J; Stüttgen, G; Wecke, J, 1976
)
0.26
"Data on 40 patients with Staphylococcus aureus endocarditis treated with appropriate antibiotics in adequate dosage at the University of Cincinnati Medical Center hospitals between January 1961 and June 1975 were analyzed."( Prognostic factors in Staphylococcus aureus endocarditis and results of therapy with a penicillin and gentamicin.
Baird, IM; Watanakunakorn, C,
)
0.13
" Penicillin G in the dosage studied is adequate therapy for most streptococcal and meningococcal meningitis in children; an increased dosage may be necessary when the minimal inhibitory concentration of penicillin to the etiologic agent is unusually high."( A pharmacologic evaluation of penicillin in children with purulent meningitis.
Hieber, JP; Nelson, JD, 1977
)
1.17
"Prophylactic (preventive) antibiotic therapy initiated preoperatively, with antibiotics administered in moderately high dosage for short periods, is recommended on the basis of experimental and prospective, randomized clinical trials for patients who require surgery that is likely to expose tissue planes to contamination."( Prophylactic antibiotic therapy in surgery.
MacLean, LD, 1975
)
0.25
" Both these antimicrobials seem appropriate for the treatment of meningitis caused by penicillin G-resistant pneumococci provided their dosage is adjusted to achieve adequate drug levels in the cerebrospinal fluid."( [Bacteriostatic activity and killing curves of eight antibiotics against seven strains of penicillin G-resistant pneumococci].
Barakett, V; Burghoffer, B; Delisle, F; Guidet, B; Lesage, D; Offenstadt, G; Petit, JC; Richard, G; Vergez, P, 1992
)
0.73
"The aqueous suspensions for intramuscular administration belong to the group of the dosage forms, that have a sustained release behaviour."( In vitro evaluation of the dissolution rate of crystalline suspensions destined to intramuscular administration.
Burgos, ML; Cadorniga, R; Molina, IT; Negro, S; Nernanez, MT; Pastoriza, P, 1991
)
0.28
" The study presented here was designed to compare cefotaxime at a dosage of 2 x 3 g/day with penicillin G at a dosage of 2 x 10 megaunits/day, for ten days in a prospective randomized trial."( Cefotaxime versus penicillin in the late stage of Lyme disease--prospective, randomized therapeutic study.
Hassler, D; Haude, M; Heinrich, F; Hufnagel, HD; Sonntag, HG; Zöller, L,
)
0.35
" It was concluded that benzylpenicillin elimination occurs more slowly in the dromedary than in sheep and that use of the same dosage regimen for the two ruminant species may lead to significant differences in plasma concentrations and therapeutic efficacy."( Comparative benzylpenicillin pharmacokinetics in the dromedary Camelus dromedarius and in sheep.
Hossaini, J; Oukessou, M; Toutain, PL; Zine-Filali, R, 1990
)
0.28
" These modifications in benzylpenicillin kinetics were explained in terms of fluid balance adjustments and renal function adaptation observed during pregnancy and lactation, and it is suggested that an appropriate dosage regimen for benzylpenicillin should take into account the physiological status of the animal."( Benzylpenicillin kinetics in the ewe: influence of pregnancy and lactation.
Benlamlih, S; Oukessou, M; Toutain, PL, 1990
)
0.28
" If a PAE is present in vivo, antibiotic levels in tissue at the site of infection may decrease below the MIC without bacterial regrowth in the latter portion of the dosing interval."( Postantibiotic effect of penicillin plus gentamicin versus Enterococcus faecalis in vitro and in vivo.
Hessen, MT; Levison, ME; Pitsakis, PG, 1989
)
0.28
" Addition of penicillin G-resistant microorganisms together with the antibiotic dosage into the wild culture prevented death."( Growth kinetics of Streptococcus thermophilus at subbacteriostatic penicillin G concentrations.
Bozoglu, TF; Ozilgen, M; Yöndem, F, 1989
)
0.88
" Each antimicrobial agent was diluted with sterile water for injection to a concentration representative of the most common dosage when administered via a portable infusion pump."( Stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirs.
Allen, LV; Stiles, ML; Tu, YH, 1989
)
0.51
" The effects of subinhibitory concentrations on streptococci previously exposed to penicillin may therefore be a more important factor in determining dosage intervals than the PAE."( Effects of benzylpenicillin on Streptococcus pyogenes during the postantibiotic phase in vitro.
Cars, O; Holm, SE; Odenholt, I, 1989
)
0.28
" In contrast, clindamycin was highly effective over a broad dosing range (8."( Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens.
Laine, BM; Maier, KA; Mitten, JE; Stevens, DL, 1987
)
0.27
" There was a striking association between tolerance and Eagle's optimum dosage effect, particularly among strains that displayed tolerance in both the stationary and the logarithmic growth phases."( Tolerance to penicillin in streptococci of viridans group.
Greenwood, D; Meeson, J; Powley, L, 1989
)
0.28
" Antibiotic therapy initially at a high dosage followed by prolonged oral therapy is generally recommended."( Ureteric obstruction secondary to pelvic actinomycosis.
Jackson, AE; Parry, JR; Shah, PJ, 1988
)
0.27
"2 million U intramuscularly daily for 20 days is as effective as a dosage schedule which requires admission to hospital for intravenous administration."( Treatment of neurosyphilis. A comparison of penicillin regimens.
Callanan, JJ; Forder, AA; Philcox, DV, 1987
)
0.27
" Conformity to Beer's law enabled the assay of dosage forms of these drugs."( Utility of chloranil in assay of naphazoline, clemizole, penicillin G sodium, and piperazine.
Abdel-Hamid, ME; Abdine, H; Belal, S; Elsayed, MA, 1981
)
0.51
"We introduce a kinetic method for determining whether the descending limb of a biphasic histamine release dose-response curve is the result of insufficient cross-linking, and delineate conditions under which it is applicable."( A method for determining whether the descending limb of a biphasic histamine release curve reflects insufficient cross-linking.
Delisi, C; Perelson, AS; Siraganian, RP, 1982
)
0.26
" A significant relationship was observed between tolerance and Eagle's optimum dosage effect: 71% of tolerant strains examined displayed the Eagle effect, whereas only 17% of non-tolerant strains exhibited the effect."( Detection of penicillin tolerance in streptococci.
Greenwood, D; Slater, GJ, 1983
)
0.27
"This review considers the five major principles governing optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis: off the entry of passage of antibiotics into CSF, (2) the antimicrobial activity of beta-lactams within the purulent CSF in vivo, (3) the bactericidal activity within the CSF, (4) the route and mode of drug administration together with the postantibiotic effect, and (5) the duration of therapy."( Rationale for optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis.
Scheld, WM, 1984
)
0.27
"Twenty-one adult horses were randomly assigned into 7 groups of 3 and were treated for 5 days with procaine penicillin G, benzathine penicillin , or phenylbutazone in various combinations and dosage schedules."( Serum concentration of penicillin in the horse after repeated intramuscular injections of procaine penicillin G alone or in combination with benzathine penicillin and/or phenylbutazone.
Messer, NT; Nelson, L; Sullins, KE, 1984
)
0.7
"3%; when the dosage was increased to 600,000 U/day, the mortality ws 37."( Is penicillin alone effective in enterococcal endocarditis? An experimental study in rabbits.
Bach, VT; Mandal, AK; Rambhatla, K; Thadepalli, H, 1981
)
0.26
" As a result of the experiments the following dosage regimes could be recommended for each drug."( Serum concentrations of penicillin in the horse after administration of a variety of penicillin preparations.
Bailey, M; Love, DN; Martin, IC; Rose, RJ, 1983
)
0.27
" dosage were 57-60% for the tablets and 64% for the suspension."( Pharmacokinetics of azidocillin in healthy adults.
Bergan, T; Sørensen, G, 1980
)
0.26
" Of the 493 women in the study, 254 received dosed of 2 million IU of penicillin G intermuscularly 1/2 hour before and 3 hours after the procedure, followed by 350 mg of pivampicillin 3 times daily for 4 days, and 239 women received corresponding doses of placebo."( Prophylactic antibiotics in first-trimester abortions: a clinical, controlled trial.
Andersen, JT; Dyring-Andersen, K; Hebjøorn, S; Heisterberg, L; Hejl, BL; Sonne-Holm, S, 1981
)
0.5
" Combination of spore treatment with antibiotic chemotherapy in dosage able to prevent oncolysis or in dosage to reduce them corresponds with loss of clostridial multiplication or with reduced vegetative multiplication respectively."( Measurement of specific multiplication of an oncolytic and a nononcolytic strain of Clostridium butyricum inside the tumour UVT 15264 of the mouse.
Bräuniger, H; Mehnert, WH; Schlechte, H; Schulze, B; Schwabe, K, 1981
)
0.26
" The usually recommended dosage schedule is 1 g every 6 hours."( The influence of renal function on the elimination kinetics of sulbenicillin in man.
Borghetti, A; Borghi, L; Canali, M; Coruzzi, P; Montanari, A; Novarini, A, 1980
)
0.26
" Thus a uniform and standard penicillin dosage allowing no safety margin may help in the superficial healing of a syphilitic chancre or the resolution of a roseola but it will certainly be insufficient to kill Treponema pallidum."( Kinetic study of serum penicillin concentrations after single doses of benzathine and benethamine penicillins in young and old people.
Collart, P; Durel, J; Herlin, A; Milovanovic, A; Poitevin, M, 1980
)
0.26
" The enchancement of killing by pretreatment with cell wall-active antibiotics was present in a dose-response fashion to 1/16th the MIC."( Interactions between antibiotics and human neutrophils in the killing of staphylococci.
Isturiz, R; Malech, HL; Metcalf, JA; Molavi, A; Root, RK, 1981
)
0.26
" The in-vitro activities, indications, side effects and dosage recommendations of the first choice (clindamycin, metronidazole and ornidazole, cefoxitin, penicillin G) and second choice antibiotics (chloramphenicol, ticarcillin) are discussed."( [Therapy of anaerobic infections].
Eijsten, A; Lüthy, R, 1980
)
0.46
"5 min, respectively) and a dosage interval of 6-8 h would be suitable to treat infections caused by susceptible bacteria."( Disposition of penicillin G sodium following intravenous and oral administration to Equidae.
Horspool, LJ; McKellar, QA,
)
0.48
" The presence of the postantibiotic sub-MIC effect may be an important factor in determining the dosing regimen for infective endocarditis."( Postantibiotic effects and postantibiotic sub-MIC effects of benzylpenicillin on viridans streptococci isolated from patients with infective endocarditis.
Enari, T; Haruki, K; Hasegawa, H; Katahira, J; Kikuchi, K; Minami, S; Shibata, Y; Shimizu, K; Totsuka, K, 1994
)
0.29
" The dosage of 360 units/mL penicillin-G had only a modest effect on the growth of the microorganism."( Penicillin-G enhanced production of thuringiensin by Bacillus thuringiensis sp. darmstadiensis.
Tzeng, YM; Young, YH,
)
0.13
"Plasma concentration of penicillin G was evaluated in beef steers after administration of either a combination of benzathine penicillin G and procaine penicillin G in a 1:1 mixture at a dosage of 9,000 U/kg of body weight, IM (n = 5), 24,000 U/kg, IM (n = 5), or 8,800 U/kg, SC (n = 5), or benzathine penicillin G alone at a dosage of 12,000 U/kg, IM (n = 7)."( Disposition of penicillin G after administration of benzathine penicillin G, or a combination of benzathine penicillin G and procaine penicillin G in cattle.
Boison, JO; Janzen, ED; Korsrud, GO; Landry, DA; MacNeil, JD; McKinnon, JJ; Papich, MG; Yates, WD, 1994
)
0.95
" The dose-response curve for GABA in the presence of 10(-3) M PC-G was shifted rightward and there was a decrease in maximum response."( Effect of penicillin on GABA-gated chloride ion influx.
Ito, M; Kishi, K; Mori, C; Shiraishi, H; Tsuda, A; Tsuda, H, 1994
)
0.29
" Aqueous penicillin G (A-PEN), 100,000 U/kg per day, was used in 23 infant, and a dosage of 200,000 U/kg per day was used in 40 patients; procaine penicillin G (P-PEN), 50,000 U/kg per day, was used in 100 children."( Concentrations of procaine and aqueous penicillin in the cerebrospinal fluid of infants treated for congenital syphilis.
Azimi, PH; Berman, SM; Berne, P; Franklin, L; Fulroth, R; Janner, D; Lvoff, V, 1994
)
0.71
" After operation the patient became asymptomatic on treatment with low dosage pyridostigmine (3 x 30 mg)."( [Myasthenia gravis in AIDS and neurosyphilis].
Hagenah, R; Schneider, U; Wüllenweber, M, 1993
)
0.29
" For each drug, 13-18 groups (n = 5-10 individuals/group) of the dosed animals were killed at different post-dosing times."( Comparative plasma and tissue pharmacokinetics and drug residue profiles of different chemotherapeutants in fowls and rabbits.
Guo, WX; Hu, GZ; Li, SF; Li, SY; Li, T; Meng, FD; Qiao, GL; Qiu, YS; Yie, HL; Zhang, XY, 1995
)
0.29
" Thirty -six pigs were treated with trimethoprim/sulfatroxazole IM in the nec k at a dosage of 16 mg/kg body weight for five days."( [Study of the elimination of residues and local tissue injury following intramuscular injection of a solution of the combination trimethoprim/sulfatroxazole in pigs].
Edwards, HJ; Kissmeyer, AM; Pott, JM; Skov, B; Szancer, J, 1996
)
0.29
" The method was further validated on kidney, liver, and muscle tissues from 2 sheep dosed with Aquacaine G suspension (containing benzylpenicillin)."( Liquid chromatographic determination of benzylpenicillin and cloxacillin in animal tissues and its application to a study of the stability at -20 degrees C of spiked and incurred residues of benzylpenicillin in ovine liver.
Gee, HE; Ho, KB; Toothill, J,
)
0.13
" Once-daily dosing (ODD) of aminoglycosides can be recommended in penicillin-sensitive streptococcal endocarditis."( [Aminoglycosides in the treatment of infectious endocarditis].
Malinverni, R, 1996
)
0.29
" Our results suggest that, if the label withdrawal period of 10 days is observed, an increase in the dosage of up to three times the recommended rate is unlikely to increase significantly the risk that residues would occur in the tissues of treated hogs at concentrations which exceed MRLs."( Residue depletion in tissues and fluids from swine fed sulfamethazine, chlortetracycline and penicillin G in combination.
Fesser, AC; Korsrud, GO; MacNeil, JD; Papich, MG; Salisbury, CD, 1996
)
0.51
" The sheep were then dosed intravenously with 26."( Pharmacokinetics of penicillin G in plasma and interstitial fluid collected with dialysis fiber bundles in sheep.
Bevill, RP; Cooke, IM; Koritz, GD; Nelson, DR, 1996
)
0.62
" three times daily) and tobramycin (80 mg three times daily) for two weeks, followed by penicillin G in the same dosage for four more weeks."( [Infectious thyroiditis as initial manifestation of embolizing endocarditis of the aortic valve].
Heufelder, AE; Hofbauer, LC; Spitzweg, C; Tammen, AR, 1996
)
0.52
" Yield increases have been achieved by increasing the dosage of the biosynthetic genes cefEF (deacetoxycephalosporin C expandase/hydroxylase) and cefG (deacetylcephalosporin C acetyltransferase) or enhancing the oxygen uptake by expressing a bacterial oxygen-binding heme protein (Vitreoscilla hemoglobin)."( Recombinant Acremonium chrysogenum strains for the industrial production of cephalosporin.
Barredo, JL; Díez, B; Fouces, R; Mellado, E; Rodríguez, M, 1996
)
0.29
" The PME may prove to be a more reliable factor than the in vitro postantibiotic effect or postantibiotic sub-MIC effect for the design of optimal dosing schedules, since the PME, like the in vivo postantibiotic effect, includes the effects of subinhibitory concentrations and therefore better reflects the clinical situation with fluctuating antibiotic concentrations."( Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.
Bengtsson, S; Cars, O; Löwdin, E; Odenholt, I, 1996
)
0.29
" Concentrations in TCF remained above the minimum inhibitory concentration of Streptococcus zooepidemicus for the proposed dosing intervals of 8, 12 and 24 h for ampicillin sodium, pivampicillin and procaine penicillin G respectively."( Distribution of penicillins into subcutaneous tissue chambers in ponies.
Barneveld, A; Ensink, JM; Klein, WR; Tukker, JJ; Van Miert, AS; Vulto, AG, 1996
)
0.48
" It is concluded that in both ewes and cows pharmacokinetic parameters of penicillin-G are altered from late pregnancy to early lactation but that these changes have little practical impact and do not call for a revised dosage regime of the studied drug."( Pharmacokinetics of penicillin-G in ewes and cows in late pregnancy and in early lactation.
Bengtsson, B; Franklin, A; Jacobsson, SO; Luthman, J, 1997
)
0.3
" A third explanation for the infrequent use of penicillin is lack of clear consensus dosing guidelines."( Penicillin dosing for pneumococcal pneumonia.
Bryan, CS; Stinson, MS; Talwani, R, 1997
)
0.3
" The dosage of beta-lactamase during the exponential growth phase has revealed that the strain BS3 produces a maximal amount of this enzyme."( [Thermophilic bacteria resistant to antibiotics in traditional public baths].
Filali, FR; Frere, JM; Zaid, A; Zekhnini, Z, 1997
)
0.3
" Different 8 h dosing regimens were applied, with different total doses and initiated at different times during the bacterial growth phase."( Pharmacodynamics of penicillin are unaffected by bacterial growth phases of Streptococcus pneumoniae in the mouse peritonitis model.
Espersen, F; Frimodt-Møller, N; Knudsen, JD, 1998
)
0.3
"Direct current and differential pulse polarography DPP were used for the determination of three penicillins, namely, ampicillin, benzylpenicillin and carbenicillin, in pure form and in their dosage forms."( Polarographic determination of some penicillins through nitrosation.
Belal, F; Eid, M; Rizk, MS, 1998
)
0.3
" A dose-response profile for penicillin G was constructed by analysis of spiked milk samples."( A novel rapid enzyme immunoassay (Fluorophos BetaScreen) for detection of beta-lactam residues in ex-farm raw milk.
Johnsson, G; Sternesjö, A, 1998
)
0.59
" Group 2 received placebo in a similar dosing schedule."( Antibiotic prophylaxis in orthognathic surgery: a 1-day versus 5-day regimen.
Aiello, GA; Bentley, KC; Head, TW, 1999
)
0.3
" Although the appropriate selection of mouse strains and drug dosage levels has to be considered, these results suggest that the PLNA may be an appropriate screening system for prediction of the allergic or autoimmunity-inducing potentials of low-molecular-weight drugs."( Mouse popliteal lymph node assay for assessment of allergic and autoimmunity-inducing potentials of low-molecular-weight drugs.
Iwaki, Y; Kamimura, Y; Kuninishi, Y; Maki, E; Nakamura, K; Nishida, H; Shinkai, K; Suzuki, R; Takahashi, K; Takahashi, M; Tsutsui, N; Vohr, HW, 1999
)
0.3
"PenG did not alter the expression of the investigated mRNA, independently of the dosage and the incubation times used."( Penicillin G does not alter collagen type I metabolism of dermal fibroblasts in culture.
Anderegg, U; Haustein, UF; Wilczek, A, 2000
)
1.75
"Although the efficacy of penicillin treatment for syphilis has been amply demonstrated, the optimal, curative dosage is still undefined."( Treatment of latent and tertiary syphilis.
Augenbraun, M, 2000
)
0.31
" The dosing interval should be 4 hours to ensure anti-GBS activity in all patients."( Optimal dosing of penicillin G in the third trimester of pregnancy for prophylaxis against group B Streptococcus.
Cho, E; Colombo, DF; Fan-Havard, P; Gardner, D; Johnson, JR; Shellhaas, CS, 2001
)
0.64
" In addition, concurrent dosing of BPAA (1 microgram/body) did not reduce the convulsion-inducing dose of PZFX mesilate."( [Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
Fukuda, H; Kawamura, Y, 2002
)
0.31
"Optimizing pharmacokinetic/pharmacodynamic indices of antibiotics to obtain clinical and microbiological efficacy is essential, but dosing regimens must also be tailored to minimize the risk for emergence of resistance."( Suboptimal antibiotic dosage as a risk factor for selection of penicillin-resistant Streptococcus pneumoniae: in vitro kinetic model.
Cars, O; Gustafsson, I; Löwdin, E; Odenholt, I, 2003
)
0.32
" In the control group, 20 sows were intramuscularly injected with a standard dosage of penicillin G (400,000 IU/head) once a day for 3 consecutive days."( Therapeutic effect of bee venom in sows with hypogalactia syndrome postpartum.
Choi, SH; Kang, SS, 2001
)
0.53
" Rabbits were immunosuppressed with cyclosporin A (CsA) at a dosage of 15 mg/kg/day, decreased to 10 mg/kg/day after the fourth week."( Efficacy of five human melanocytic cell lines in experimental rabbit choroidal melanoma.
Almaraz, A; Blanco, G; Fernández, N; López-Velasco, R; Morilla-Grasa, A; Ordóñez, JL; Rábano, G; Saornil-Alvarez, MA, 2005
)
0.33
" These methods were applied to the analysis of plasma, urine, and kidney biopsy samples taken from standing animals that had been dosed with penicillin."( LC/MS/MS measurement of penicillin G in bovine plasma, urine, and biopsy samples taken from kidneys of standing animals.
Chiesa, OA; Heller, DN; Smith, ML, 2006
)
0.64
" The semimechanistic model that was developed might, after further refinement, serve as a tool for the development of optimal dosing strategies for antibacterial agents."( Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments.
Cars, O; Karlsson, MO; Löwdin, E; Nielsen, EI; Sandström, M; Viberg, A, 2007
)
0.34
" Repeated dosing was administered intraperitoneally every 4 to 6 hours for 48 hours."( Comparative treatment of alpha-amanitin poisoning with N-acetylcysteine, benzylpenicillin, cimetidine, thioctic acid, and silybin in a murine model.
Betten, DP; Clark, RF; Favata, M; Hernandez, M; Richardson, WH; Riffenburgh, RH; Tanen, DA; Tong, TC, 2007
)
0.34
" Regardless of the response to penicillin skin testing, patients received the usual 1-day dosage of penicillin and amoxicillin, on 2 separate occasions."( Skin testing and oral penicillin challenge in patients with a history of remote penicillin allergy.
Confino-Cohen, R; Goldberg, A, 2008
)
0.35
"This study was designed to evaluate the penicillin-induced epilepsy model in terms of dose-response relationship of penicillin used to induce epilepsy seizure on hippocampal neuron number and hippocampal volume in Sprague-Dawley rats."( Penicillin-induced epilepsy model in rats: dose-dependant effect on hippocampal volume and neuron number.
Adiguzel, E; Akdogan, I; Ozdemir, MB; Sahiner, M; Tufan, AC; Yilmaz, I, 2008
)
0.35
" The results demonstrated that simultaneous administration of α-AMA and each of tested antidotes (BPCN, CEFT, RIFSV) effectively protected human hepatocytes; however, in the group dosed with BPCN, the highest hepatocyte viability was observed."( Comparative antidotal efficacy of benzylpenicillin, ceftazidime and rifamycin in cultured human hepatocytes intoxicated with α-amanitin.
Dziędgiel, P; Gomułkiewicz, A; Magdalan, J; Ostrowska, A; Piotrowska, A; Szeląg, A, 2009
)
0.35
" In both man and rabbit, penicillin X provided higher and more sustained blood levels than did penicillins F or G similarly administered in equal dosage (0."( THE VARYING BLOOD LEVELS AFFORDED BY PENICILLINS F, G, K, AND X IN RABBITS AND MAN.
Eagle, H, 1947
)
0.23
" To determine if antibiotic residue levels are dependent upon muscle type, seven culled dairy cows were dosed with penicillin G (Pen G) from 1 to 3 days and then sacrificed on day 1, 2, or 5 of withdrawal."( Distribution of penicillin G residues in culled dairy cow muscles: implications for residue monitoring.
Mastovska, K; Schneider, MJ; Solomon, MB, 2010
)
0.92
"Streptomycin has been available for over 60 years, yet optimal dosing in hemodialysis (HD) patients is not well defined."( A successful strategy for the use of synergistic intravenous streptomycin in a hemodialysis patient with refractory Enterococcus faecalis bacteremia.
Belknap, R; Jenkins, TC; Swartwood, CJ; Young, H, 2011
)
0.37
" The selection and magnitude of the PK/PD index were, however, shown to be sensitive to differences in PK in subpopulations, uncertainty in MICs, and investigated dosing intervals."( Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.
Cars, O; Friberg, LE; Nielsen, EI, 2011
)
0.37
" Results of the part I (internal) and part II (independent laboratory) dose-response studies employing spiked samples were in close agreement."( Validation study of the BetaStar plus lateral flow assay for detection of beta-lactam antibiotics in milk.
Abouzied, M; Ankrapp, D; Driksna, D; Klein, F; Mozola, M; Rice, J; Sarzynski, M; Walsh, A; Walsh, C,
)
0.13
"The results achieved with 80% reduction in the incidence of early-onset neonatal group B streptococcal (GBS) sepsis following the implementation of the preliminary (1996, 2002) and subsequently the revised (2010) guidelines for intrapartum antibiotic prophylaxis imposed the discussion on a large scale of the updated:--algorithms for GBS screening (35-37 weeks of gestation) with the recommended dosage of penicillin-G for intrapartum antibiotic prophylaxis for women having normal labor and delivery;--algorithms for GBS screening and intrapartum antibiotic prophylaxis for women with preterm labor (PPROM) or premature rupture of membranes (PROM);--intrapartum antibiotic prophylaxis regimens for women with penicillin allergy;--algorithm for management of newborns with respect to risk of early-onset GBS disease."( [A study on early-onset group "B" streptococcal neonatal infection].
Decheva, A; Dimitrova, N; Dobreva, A; Kraleva, I; Takova, Ts; Todorova, M; Vacheva, R; Yarakova, N, 2012
)
0.38
" When treating enterococci, therapeutic drug monitoring should be applied to optimize penicillin G dosing and exposure."( Penicillin G Treatment in Infective Endocarditis Patients - Does Standard Dosing Result in Therapeutic Plasma Concentrations?
Bibby, BM; Brock, B; Hardlei, TF; Jensen, K; Kragh Thomsen, M; Öbrink-Hansen, K; Petersen, E; Wiggers, H, 2017
)
2.12
" The pharmacodynamic parameters based on a wide range of concentrations below and above the MIC provide information that could support improving future dosing strategies to treat gonorrhoea."( Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae.
Althaus, CL; Foerster, S; Hathaway, LJ; Low, N; Unemo, M, 2016
)
0.43
" Beta-lactam chemical instability in plasma can cause misleading pharmacokinetic modeling results, which could impact upon model-based dosing recommendations and the forthcoming era of beta-lactam therapeutic drug monitoring."( Development of a Novel Multipenicillin Assay and Assessment of the Impact of Analyte Degradation: Lessons for Scavenged Sampling in Antimicrobial Pharmacokinetic Study Design.
Barker, CIS; Johnston, A; Kipper, K; Sharland, M; Standing, JF, 2018
)
0.48
"1% would have a PENu concentration greater than the MIC during half of the dosing interval (fT > MIC = 50%), whereas this was 24."( Pharmacokinetics and Pharmacodynamic Target Attainment of Benzylpenicillin in an Adult Severely Ill Sub-Saharan African Patient Population.
Beirão, JC; Bos, JC; Lang, CN; Mathôt, RAA; Mistício, MC; Nunguiane, G; Prins, JM; van Hest, RM, 2018
)
0.48
" In this setting, dosing data for antibiotics like benzylpenicillin are lacking."( Pharmacokinetics of Benzylpenicillin (Penicillin G) during Prolonged Intermittent Renal Replacement Therapy.
Allen, C; Chang, T; Cheng, V; Dyer, J; Fox, E; Hoad, K; Litton, E; Page, MM; Rawlins, M; Roberts, JA, 2019
)
0.78
" We determined that when mice were administered intermittent subtherapeutic dosing of benzylpenicillin, the strain with a Pro601Leu amino acid replacement in PBP2X that confers reduced β-lactam susceptibility in vitro was more fit, as assessed by the magnitude of colony-forming units recovered from disease tissue."( A Single Amino Acid Replacement in Penicillin-Binding Protein 2X in Streptococcus pyogenes Significantly Increases Fitness on Subtherapeutic Benzylpenicillin Treatment in a Mouse Model of Necrotizing Myositis.
Musser, JM; Olsen, RJ; Zhu, L, 2020
)
0.56
"Adequate dosage recommendations are imperative for successful treatment of invasive infections."( Benzylpenicillin Serum Concentrations in Neonates With Group B Streptococci Sepsis or Meningitis: A Descriptive Cohort Study.
Bekker, V; Bredius, RGM; Jansen, SJ; Lopriore, E; Moes, DJAR; van der Beek, MT, 2021
)
0.62
" Outcomes included numbers of sub- and supratherapeutic concentrations, and dose adjustments, clinical evolution, and dosing recommendations from six pediatric reference sources."( Benzylpenicillin Serum Concentrations in Neonates With Group B Streptococci Sepsis or Meningitis: A Descriptive Cohort Study.
Bekker, V; Bredius, RGM; Jansen, SJ; Lopriore, E; Moes, DJAR; van der Beek, MT, 2021
)
0.62
" Substantial variation in dosing recommendations (50,000-400,000 IE/kg/d) was present between reference sources."( Benzylpenicillin Serum Concentrations in Neonates With Group B Streptococci Sepsis or Meningitis: A Descriptive Cohort Study.
Bekker, V; Bredius, RGM; Jansen, SJ; Lopriore, E; Moes, DJAR; van der Beek, MT, 2021
)
0.62
"Our data reveal that under current dosage recommendations, the predefined target serum or CSF concentrations of BPEN are not achieved in all children."( Benzylpenicillin Serum Concentrations in Neonates With Group B Streptococci Sepsis or Meningitis: A Descriptive Cohort Study.
Bekker, V; Bredius, RGM; Jansen, SJ; Lopriore, E; Moes, DJAR; van der Beek, MT, 2021
)
0.62
"Treatment regimens requiring multiple daily dosing for enterococcal endocarditis are challenging to deliver in the outpatient setting."( Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal endocarditis.
Bhally, H; Briggs, S; Broom, M; Duffy, E; Everts, G; Everts, R; Lowe, B; McBride, S, 2021
)
0.62
" The doses or dosing intervals of antimicrobials administered to horses undergoing anesthesia may need to be adjusted to ensure maintenance of safe and effective plasma concentrations."( Potassium penicillin and gentamicin pharmacokinetics in healthy conscious and anesthetized horses.
Bogers, SH; Council-Troche, RM; Davis, JL; Wilson, KE, 2023
)
0.91
" Each participant's penicillin pharmacokinetic parameters will be established prior to the challenge, to ensure accurate dosing for the continuous infusion."( Study protocol for controlled human infection for penicillin G against
Barr, R; Batty, KT; Carapetis, J; Enkel, SL; Hla, TK; Kado, J; Manning, L; Marsh, JA; McCarthy, J; Osowicki, J; Salman, S; Snelling, TL; Steer, AC, 2022
)
0.97
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
antibacterial drugA drug used to treat or prevent bacterial infections.
epitopeThe biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
drug allergenAny drug which causes the onset of an allergic reaction.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
penicillinAny member of the group of substituted penams containing two methyl substituents at position 2, a carboxylate substituent at position 3 and a carboxamido group at position 6.
penicillin allergenAny penicillin which causes the onset of an allergic reaction.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (67)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Guanine nucleotide-binding protein GHomo sapiens (human)Potency44.66841.995325.532750.1187AID624287
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Solute carrier family 22 member 6Rattus norvegicus (Norway rat)Ki1,049.00001.60005.744010.0000AID678786; AID679489
Solute carrier family 22 member 8Mus musculus (house mouse)IC50 (µMol)89.40003.02003.02003.0200AID1209730
Bile salt export pumpHomo sapiens (human)IC50 (µMol)10.00000.11007.190310.0000AID1449628
Solute carrier family 15 member 1Homo sapiens (human)Ki30,000.00000.18003.39339.8000AID238858; AID681115
Beta-lactamase TEMEscherichia coliKi20.00000.02701.82347.3000AID43582
Solute carrier family 15 member 2Homo sapiens (human)Ki10,982.39990.79434.22108.0000AID612540
Solute carrier family 15 member 2Rattus norvegicus (Norway rat)Ki11,100.00003.00006.47788.5000AID681114
Solute carrier family 22 member 8Homo sapiens (human)Ki97.60000.04004.22979.0000AID681372
Solute carrier family 22 member 8Rattus norvegicus (Norway rat)Ki52.80003.09005.54009.1000AID679175
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
streptokinase A precursorStreptococcus pyogenes M1 GASEC50 (µMol)0.06000.06008.9128130.5170AID1902
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Beta-lactamase Citrobacter freundiiKm16.00005.00007.00009.0000AID405084
Beta-lactamase Citrobacter gilleniiKm51.000010.000010.000010.0000AID285442
Beta-lactamase Escherichia coliKm3.80001.10004.76679.4000AID394487
Beta-lactamase Aeromonas caviaeKm206.00007.00007.00007.0000AID374363
Beta-lactamase Shouchella clausiiKm12.00000.01003.00506.0000AID373209
Beta-lactamase Acinetobacter baumanniiKm3.00003.00005.66679.0000AID567279
Beta-lactamase Burkholderia cenocepaciaKm25.000010.000010.000010.0000AID541022
Metallo-beta-lactamase type 2Klebsiella pneumoniaeKm16.00008.00009.333310.0000AID563972
Metallo-beta-lactamase VIM-11 Pseudomonas aeruginosaKm15.30004.50007.00009.4000AID520385
Beta-lactamase Klebsiella pneumoniaeKm4.90003.20005.825010.0000AID562754
Metallo-beta-lactamase VIM-2Pseudomonas aeruginosaKm19.10005.50007.87509.9000AID520386
Beta-lactamase Pseudomonas aeruginosaKm4.00000.30002.00638.0000AID495661
Beta-lactamase Aeromonas allosaccharophilaKm200.00001.50006.300010.0000AID584846
Metallo-beta-lactamaseStutzerimonas stutzeriKm90.00003.50004.75006.0000AID518728
Beta-lactamase Acinetobacter baumanniiKm12.00006.00007.666710.0000AID567280
Solute carrier family 22 member 8Mus musculus (house mouse)Km40.00000.05392.40655.5000AID681168
Beta-lactamaseStaphylococcus aureusKm7.70001.00002.20003.4000AID368313; AID44042
Beta-lactamaseEnterobacter cloacaeKm5.92502.90006.43649.8000AID368498; AID368523; AID368527; AID495693
Beta-lactamase SHV-1Klebsiella pneumoniaeKm19.50004.20004.25004.3000AID368307; AID495687; AID519746; AID519983
Beta-lactamase OXA-10Pseudomonas aeruginosaKm7.90007.90007.90007.9000AID495694
Beta-lactamaseSerratia marcescensKm2.10002.10002.10002.1000AID368725
Beta-lactamasePseudomonas aeruginosa PAO1Km18.48330.50004.24448.0000AID368539; AID368543; AID368547; AID368729; AID495692; AID546426
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)Km51.000010.000010.000010.0000AID285442
Beta-lactamase TEMEscherichia coliKm33.00005.40006.30007.2000AID238095; AID368309; AID495686
Beta-lactamaseMorganella morganiiKm7.90007.90007.90007.9000AID368531
B2 metallo-beta-lactamase Chryseobacterium indologenesKm20.00003.00003.00003.0000AID562337
Beta-lactamase Klebsiella pneumoniaeKm8.70008.70008.70008.7000AID562755
Beta-lactamase Salmonella enterica subsp. enterica serovar WesthamptonKm10.000010.000010.000010.0000AID556340
Efflux transporter Salmonella enterica subsp. enterica serovar NewportKm0.30000.10003.875010.0000AID540966
Metallo-beta-lactamase VIM-2Klebsiella pneumoniaeKm49.00005.00007.500010.0000AID563976
Beta-lactamase Klebsiella pneumoniaeKm0.30000.10003.02507.3000AID540967
Beta-lactamase Klebsiella pneumoniaeKm5.00005.00007.166710.0000AID519982
Beta-lactamase Escherichia coliKm2.20000.00461.41494.5000AID495691
Beta-lactamase Pseudomonas luteolaKm8.00007.00007.50008.0000AID495635
Beta-lactamase Serratia marcescensKm2.20002.20004.60008.2000AID368509; AID495696
Beta-lactamase Klebsiella pneumoniaeKm700.00001.00004.45007.9000AID1320835
Beta-lactamase IMP-1 Pseudomonas aeruginosaKm550.00006.50006.50006.5000AID495698
BlaVIM-1 Escherichia coliKm850.00001.50001.50001.5000AID495914
Beta-lactamase Pseudomonas aeruginosaKm35.00000.50002.75005.0000AID546429
Beta-lactamase Escherichia coliKm8.70007.10008.16678.7000AID368492; AID495688
Carbapenem-hydrolyzing beta-lactamase KPCKlebsiella pneumoniaeKm30.00001.60003.80006.0000AID495695
Beta-lactamase class B VIM-2 Pseudomonas aeruginosaKm130.00002.00006.65009.4000AID368514; AID495697; AID529659; AID531315
Beta-lactamase Acinetobacter baumanniiKm20.00001.30003.80009.6000AID495699; AID495700
Solute carrier family 22 member 8Rattus norvegicus (Norway rat)Km82.60000.73901.53952.3400AID681390
Beta-lactamase VIM-1 Pseudomonas aeruginosaKm1,303.00004.00004.00004.0000AID530340
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (44)

Processvia Protein(s)Taxonomy
fatty acid metabolic processBile salt export pumpHomo sapiens (human)
bile acid biosynthetic processBile salt export pumpHomo sapiens (human)
xenobiotic metabolic processBile salt export pumpHomo sapiens (human)
xenobiotic transmembrane transportBile salt export pumpHomo sapiens (human)
response to oxidative stressBile salt export pumpHomo sapiens (human)
bile acid metabolic processBile salt export pumpHomo sapiens (human)
response to organic cyclic compoundBile salt export pumpHomo sapiens (human)
bile acid and bile salt transportBile salt export pumpHomo sapiens (human)
canalicular bile acid transportBile salt export pumpHomo sapiens (human)
protein ubiquitinationBile salt export pumpHomo sapiens (human)
regulation of fatty acid beta-oxidationBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transportBile salt export pumpHomo sapiens (human)
bile acid signaling pathwayBile salt export pumpHomo sapiens (human)
cholesterol homeostasisBile salt export pumpHomo sapiens (human)
response to estrogenBile salt export pumpHomo sapiens (human)
response to ethanolBile salt export pumpHomo sapiens (human)
xenobiotic export from cellBile salt export pumpHomo sapiens (human)
lipid homeostasisBile salt export pumpHomo sapiens (human)
phospholipid homeostasisBile salt export pumpHomo sapiens (human)
positive regulation of bile acid secretionBile salt export pumpHomo sapiens (human)
regulation of bile acid metabolic processBile salt export pumpHomo sapiens (human)
transmembrane transportBile salt export pumpHomo sapiens (human)
monoatomic ion transportSolute carrier family 15 member 1Homo sapiens (human)
protein transportSolute carrier family 15 member 1Homo sapiens (human)
peptide transportSolute carrier family 15 member 1Homo sapiens (human)
dipeptide import across plasma membraneSolute carrier family 15 member 1Homo sapiens (human)
tripeptide import across plasma membraneSolute carrier family 15 member 1Homo sapiens (human)
proton transmembrane transportSolute carrier family 15 member 1Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
renal water homeostasisGuanine nucleotide-binding protein GHomo sapiens (human)
G protein-coupled receptor signaling pathwayGuanine nucleotide-binding protein GHomo sapiens (human)
regulation of insulin secretionGuanine nucleotide-binding protein GHomo sapiens (human)
cellular response to glucagon stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
monoatomic ion transportSolute carrier family 15 member 2Homo sapiens (human)
protein transportSolute carrier family 15 member 2Homo sapiens (human)
peptide transportSolute carrier family 15 member 2Homo sapiens (human)
peptidoglycan transportSolute carrier family 15 member 2Homo sapiens (human)
xenobiotic transportSolute carrier family 15 member 2Homo sapiens (human)
dipeptide transportSolute carrier family 15 member 2Homo sapiens (human)
renal absorptionSolute carrier family 15 member 2Homo sapiens (human)
regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathwaySolute carrier family 15 member 2Homo sapiens (human)
dipeptide import across plasma membraneSolute carrier family 15 member 2Homo sapiens (human)
tripeptide import across plasma membraneSolute carrier family 15 member 2Homo sapiens (human)
antibacterial innate immune responseSolute carrier family 15 member 2Homo sapiens (human)
transport across blood-brain barrierSolute carrier family 15 member 2Homo sapiens (human)
proton transmembrane transportSolute carrier family 15 member 2Homo sapiens (human)
xenobiotic detoxification by transmembrane export across the plasma membraneSolute carrier family 15 member 2Homo sapiens (human)
monoatomic ion transportSolute carrier family 22 member 8Homo sapiens (human)
response to toxic substanceSolute carrier family 22 member 8Homo sapiens (human)
inorganic anion transportSolute carrier family 22 member 8Homo sapiens (human)
prostaglandin transportSolute carrier family 22 member 8Homo sapiens (human)
xenobiotic transportSolute carrier family 22 member 8Homo sapiens (human)
transmembrane transportSolute carrier family 22 member 8Homo sapiens (human)
transport across blood-brain barrierSolute carrier family 22 member 8Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (18)

Processvia Protein(s)Taxonomy
organic anion transmembrane transporter activitySolute carrier family 22 member 8Mus musculus (house mouse)
protein bindingBile salt export pumpHomo sapiens (human)
ATP bindingBile salt export pumpHomo sapiens (human)
ABC-type xenobiotic transporter activityBile salt export pumpHomo sapiens (human)
bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
canalicular bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transporter activityBile salt export pumpHomo sapiens (human)
ABC-type bile acid transporter activityBile salt export pumpHomo sapiens (human)
ATP hydrolysis activityBile salt export pumpHomo sapiens (human)
proton-dependent oligopeptide secondary active transmembrane transporter activitySolute carrier family 15 member 1Homo sapiens (human)
peptide:proton symporter activitySolute carrier family 15 member 1Homo sapiens (human)
tripeptide transmembrane transporter activitySolute carrier family 15 member 1Homo sapiens (human)
dipeptide transmembrane transporter activitySolute carrier family 15 member 1Homo sapiens (human)
G protein activityGuanine nucleotide-binding protein GHomo sapiens (human)
adenylate cyclase activator activityGuanine nucleotide-binding protein GHomo sapiens (human)
protein bindingSolute carrier family 15 member 2Homo sapiens (human)
peptide:proton symporter activitySolute carrier family 15 member 2Homo sapiens (human)
tripeptide transmembrane transporter activitySolute carrier family 15 member 2Homo sapiens (human)
dipeptide transmembrane transporter activitySolute carrier family 15 member 2Homo sapiens (human)
solute:inorganic anion antiporter activitySolute carrier family 22 member 8Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier family 22 member 8Homo sapiens (human)
prostaglandin transmembrane transporter activitySolute carrier family 22 member 8Homo sapiens (human)
xenobiotic transmembrane transporter activitySolute carrier family 22 member 8Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (14)

Processvia Protein(s)Taxonomy
basolateral plasma membraneSolute carrier family 22 member 8Mus musculus (house mouse)
basolateral plasma membraneBile salt export pumpHomo sapiens (human)
Golgi membraneBile salt export pumpHomo sapiens (human)
endosomeBile salt export pumpHomo sapiens (human)
plasma membraneBile salt export pumpHomo sapiens (human)
cell surfaceBile salt export pumpHomo sapiens (human)
apical plasma membraneBile salt export pumpHomo sapiens (human)
intercellular canaliculusBile salt export pumpHomo sapiens (human)
intracellular canaliculusBile salt export pumpHomo sapiens (human)
recycling endosomeBile salt export pumpHomo sapiens (human)
recycling endosome membraneBile salt export pumpHomo sapiens (human)
extracellular exosomeBile salt export pumpHomo sapiens (human)
membraneBile salt export pumpHomo sapiens (human)
plasma membraneSolute carrier family 15 member 1Homo sapiens (human)
brush borderSolute carrier family 15 member 1Homo sapiens (human)
membraneSolute carrier family 15 member 1Homo sapiens (human)
apical plasma membraneSolute carrier family 15 member 1Homo sapiens (human)
plasma membraneSolute carrier family 15 member 1Homo sapiens (human)
apical plasma membraneSolute carrier family 15 member 1Homo sapiens (human)
plasma membraneGuanine nucleotide-binding protein GHomo sapiens (human)
phagocytic vesicle membraneSolute carrier family 15 member 2Homo sapiens (human)
plasma membraneSolute carrier family 15 member 2Homo sapiens (human)
membraneSolute carrier family 15 member 2Homo sapiens (human)
apical plasma membraneSolute carrier family 15 member 2Homo sapiens (human)
extracellular exosomeSolute carrier family 15 member 2Homo sapiens (human)
apical plasma membraneSolute carrier family 15 member 2Homo sapiens (human)
plasma membraneSolute carrier family 15 member 2Homo sapiens (human)
plasma membraneSolute carrier family 22 member 8Homo sapiens (human)
basolateral plasma membraneSolute carrier family 22 member 8Homo sapiens (human)
apical plasma membraneSolute carrier family 22 member 8Homo sapiens (human)
extracellular exosomeSolute carrier family 22 member 8Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2661)

Assay IDTitleYearJournalArticle
AID562610Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID278681Antibacterial activity against Enterococcus faecium isolate 57522007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID495693Activity of Enterobacter cloacae AmpC2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID573583Antibacterial activity against beta-lactamase producing Bacteroides caccae assessed as resistant isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID1054741Antibacterial activity against Pseudomonas aeruginosa ATCC 13525 assessed as growth inhibition after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
Schiff's base derivatives bearing nitroimidazole moiety: new class of antibacterial, anticancer agents and potential EGFR tyrosine kinase inhibitors.
AID511291Activity of Pseudomonas aeruginosa GES-13 beta lactamase assessed as hydrolysis by spectrometry2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
AID528730Antibacterial activity against penicillin resistant Streptococcus pneumoniae clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID587963Activity of Escherichia coli beta-lactamase Toho-1 D240S mutant assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID770972Antibacterial activity against Staphylococcus epidermidis MTCC 435 by broth dilution method2013European journal of medicinal chemistry, Oct, Volume: 68Demonic axe-like conjugated alkynes in combating microbes.
AID588119Antimicrobial activity against Neisseria gonorrhoeae clinical isolates after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID150757P-gp activity was measured by a direct transport assay, using polarized LLC-MDR1 epithelial cells2003Journal of medicinal chemistry, Apr-24, Volume: 46, Issue:9
Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery.
AID559057Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID418560Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 700221 by NCCLS method2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
AID1287890Antimicrobial activity against Bacillus sphaericus MTCC 11 after 24 hrs by serial two-fold broth dilution method2016European journal of medicinal chemistry, May-04, Volume: 113Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids.
AID418557Antibacterial activity against methicillin-resistant Staphylococcus epidermidis ATCC 51625 by NCCLS method2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
AID573138Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID524881Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA, penB, ponA and mtrR mutant gene assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID542628Antimicrobial activity against streptomycin-resistant Streptococcus pneumoniae R6 harboring PBP2x2349 mutant gene and Janus disruption at PBP1a and aad9 disruption in CiaR gene after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID569342Antibacterial activity against methicillin-susceptible Staphylococcus aureus by agar dilution method2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
AID522643Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis Sterne by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID399188Antibacterial activity against Staphylococcus aureus ATCC 6538 P at below 625 ug/mL after 24 hrs by broth microdilution method2004Journal of natural products, Jan, Volume: 67, Issue:1
Africane-type sesquiterpenoids from the Argentine liverwort Porella swartziana and their antibacterial activity.
AID379709Antibacterial activity against Bacillus cereus by modified microtiter plate assay2006Journal of natural products, Feb, Volume: 69, Issue:2
Bioactive natural and semisynthetic latrunculins.
AID557489Displacement of Biocillin FL from Streptococcus pneumoniae 1077 PBP1B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID520725Activity of Acinetobacter baumannii MAD beta-lactamase assessed per mg of protein at 100 uM2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97.
AID531452Antibacterial activity against Streptococcus pneumoniae serotype 22 assessed as percent susceptible isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID531315Activity of Pseudomonas aeruginosa beta-lactamase VIM-2 by spectrophotometry2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
AID509630Antimicrobial activity against Staphylococcus aureus RN4220 by broth microdilution method2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Identification of a plasmid-borne resistance gene cluster comprising the resistance genes erm(T), dfrK, and tet(L) in a porcine methicillin-resistant Staphylococcus aureus ST398 strain.
AID335712Antibacterial activity against Bacillus subtilis ATCC 9372 after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID559058Antibacterial activity against levofloxacin-susceptible Streptococcus pneumoniae by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID575946Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae assessed as susceptible isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.
AID609860Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Unprecedented C-2 arylation of indole with diazonium salts: Syntheses of 2,3-disubstituted indoles and their antimicrobial activity.
AID557514Displacement of Biocillin FL from Streptococcus pneumoniae 3009 PBP2B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID340769Increase in pbp1B gene expression in penicillin-resistant Streptococcus gordonii with penicillin binding protein PR1_2 evolved mutation assessed as relative luciferase units relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii.
AID625530Antimicrobial activity against Pseudomonas aeruginosa MTCC 741 by broth dilution method2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Iodine-catalyzed conjugate addition of indoles onto en-1,4-dione: a novel synthesis of 3-(1-(1H-indol-3-yl)-2-oxo-2-phenylethyl)indolin-2-ones as antibacterial and antifungal agents.
AID529663Activity of Pseudomonas aeruginosa 166301 beta-lactamase VIM-16 relative to cephaloridine2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID573594Antibacterial activity against Fusobacterium varium assessed as susceptible isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID520392Antibacterial activity against mef and erm(B) positive Streptococcus pneumoniae isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).
AID528523Antimicrobial activity against penicillin-resistant Streptococcus agalactiae ATCC 12403 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID531313Activity of Pseudomonas aeruginosa beta-lactamase VIM-7 by spectrophotometry2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
AID572273Antimicrobial activity against Streptococcus pneumoniae ATCC 6303 by broth microdilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models.
AID679518TP_TRANSPORTER: inhibition of PAH uptake (PAH: 2 uM, PCG: 2000 uM) in Xenopus laevis oocytes1999The American journal of physiology, 01, Volume: 276, Issue:1
Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney.
AID1565596Antibacterial activity against Bacillus subtilis ATCC 23857 after 18 hrs by CLSI based broth microdilution method2019European journal of medicinal chemistry, Nov-15, Volume: 182Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity.
AID269445Antibacterial activity against MRSA Staphylococcus aureus 134/93 by agar diffusion assay2006Bioorganic & medicinal chemistry letters, Aug-01, Volume: 16, Issue:15
The synthesis and in vitro testing of structurally novel antibiotics derived from acylnitroso Diels-Alder adducts.
AID573152Antibacterial activity against vancomycin-resistant Enterococcus faecalis by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID545144Activity of CMY-2 by spectrophotometry2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids.
AID508382Antibacterial activity against Streptococcus pyogenes harboring erm(B) gene after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID372626Ratio of Kcat/Km for Escherichia coli DH5alpha beta-lactamase TEM-12 to Kcat/Km for Escherichia coli DH5alpha beta-lactamase TEM-1582007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
AID495694Activity of Pseudomonas aeruginosa OXA-102010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID562411Antimicrobial activity against erythromycin-susceptible Streptococcus Group G clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID341522Antimicrobial activity against Neisseria meningitidis isolates harboring penA 52 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID279187Ratio of kcat to Km of Enterobacter cloacae S3 isolate beta lactamase LAP1 expressed in Escherichia coli DH10B2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Novel Ambler class A beta-lactamase LAP-1 and its association with the plasmid-mediated quinolone resistance determinant QnrS1.
AID295110Antibacterial activity against Bacillus cereus ATCC 7064 at 10 ug after 24 hrs by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID322511AUC (0 to 12) in human adults at 600 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID368507Ratio of Kcat to Km of Escherichia coli KPC2 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID519995Antimicrobial activity against Streptococcus pneumoniae harboring erm(B) and mef(A) gene2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.
AID625282Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID587733Ratio of Kcat to Km for Pseudomonas aeruginosa strain PS 297 metallo-beta-lactamase IMP-1 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis using 100 uM nitrocefin2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States.
AID573149Antibacterial activity against vancomycin-susceptible Enterococcus faecalis by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID770969Antibacterial activity against Klebsiella pneumoniae MTCC 618 by broth dilution method2013European journal of medicinal chemistry, Oct, Volume: 68Demonic axe-like conjugated alkynes in combating microbes.
AID1548179Anti-chlamydial activity against Chlamydia trachomatis Serovar LGV-L2 infected in Hep2 cells assessed as reduction in chlamydial inclusion growth by measuring appearance of small and irregular inclusions at 3 ug/ml treated at 8 hrs post-infection and 24 h2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
Synthesis and Antichlamydial Activity of Molecules Based on Dysregulators of Cylindrical Proteases.
AID341347Antimicrobial activity against Neisseria meningitidis isolates harboring penA 1 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID368515Ratio of Kcat to Km of Pseudomonas aeruginosa IMP1 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID531565Antibacterial activity against Enterococcus faecalis obtained from complicated skin and skin structure infections by agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
AID322496Cmin in human very low birth weight preterm neonates at 28 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID528728Antibacterial activity against Streptococcus pyogenes group A clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID558536Antibacterial activity against bla gene-negative and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P854 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID351189Apparent peripheral volume of distribution in preterm neonates with septicemia or invasive infections with gestational age of less than 32 weeks at 50000 U/kg, iv administered every 12 hrs2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.
AID94369In vitro antimicrobial activity against Klebsiella pneumoniae NCTC 418 was determined2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Design, synthesis, and SAR of novel carbapenem antibiotics with high stability to Xanthomonas maltophilia oxyiminocephalosporinase type II.
AID558325Antibacterial activity against bla gene-negative and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni isolate P850 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID584846Activity at Aeromonas allosaccharophila AL-1 beta-lactamase PER62010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila.
AID557268Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae 3413 by CLSI method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID531458Antibacterial activity against Streptococcus pneumoniae serotype 23A assessed as percent resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID565734Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group C clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID531573Antibacterial activity against Staphylococcus intermedius obtained from complicated skin and skin structure infections by agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
AID1279016Antibacterial activity against Escherichia coli CCM 4517 after 48 hrs by microbroth dilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
AID332339Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 375 after 18 hrs by microbroth dilution method2003Journal of natural products, Feb, Volume: 66, Issue:2
Antibacterial diterpenes from Calceolaria pinifolia.
AID528729Antibacterial activity against multidrug-resistant Streptococcus pneumoniae clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID561513Antibacterial activity against Beta-hemolytic Streptococcus group B by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID372617Activity of Escherichia coli CF0042 beta-lactamase TEM-35 by microacidimetric method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
AID368725Activity of Serratia marcescens AmpC assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID535762Antimicrobial activity against penicillin-producing Neisseria gonorrhoeae NGON 05-042 expressing beta-lactamase TEM-1, MLST type ST-1588 and MAST type ST-4012 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Identification of TEM-135 beta-lactamase in penicillinase-producing Neisseria gonorrhoeae strains in Japan.
AID542621Antimicrobial activity against Streptococcus pneumoniae R6 harboring wild type PBP2x, disruption in PBP1a and aad9 disruption in CiaR gene after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID1601847Antibacterial activity against Escherichia coli CMCC 25922 measured after 24 hrs by ELISA2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety.
AID573581Antibacterial activity against beta-lactamase producing Bacteroides caccae by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID625280Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID524042Antibacterial activity against methicillin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 1287 by macrodilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID341523Antimicrobial activity against Neisseria meningitidis isolates harboring penA 15 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID1191511Antibacterial activity against Staphylococcus aureus CCM 4516/08 after 24 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID451352Antimicrobial activity against Escherichia coli ATCC 11775 after 24 hrs by broth dilution method2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Synthesis and evaluation of bioactive naphthoquinones from the Brazilian medicinal plant, Tabebuia avellanedae.
AID535647Antimicrobial activity against Group B Streptococcus serotype V 2603 V/R harboring E63K mutation in PBP 2A and L41S mutation in PBP 1B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID368531Activity of Morganella morganii AmpC assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID564229Ratio of Kcat to Km for Escherichia coli TOP10 beta-lactamase OXA-1432009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.
AID1755807Antibacterial activity against Bacillus subtilis ATCC 6633 incubated for 24 hrs by two fold serial dilution method2021European journal of medicinal chemistry, Jan-15, Volume: 210Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
AID573397Antibacterial activity against beta-lactamase producing Bacteroides thetaiotaomicron by by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID558535Antibacterial activity against bla gene-negative and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P843 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID561342Antibacterial activity against Beta-hemolytic Streptococcus group A by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID437461Antimicrobial activity Streptococcus faecalis ATCC 9790 by MTT assay2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
AID531578Antibacterial activity against Lactococcus lactis obtained from complicated skin and skin structure infections by agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
AID543284Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 3191 pbp2x, pbp2b, murM and Streptococcus pneumoniae 72521 pbp1a genes by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID532677Antimicrobial activity against ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates assessed as intermediate resistant isolates by agar dilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
AID1072983Antimicrobial activity against Escherichia coli MB 5746 harboring envA/tolC gene after 20 hrs by 2-fold serial broth dilution method2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Isolation, structure elucidation, and biological activity of altersolanol P using Staphylococcus aureus fitness test based genome-wide screening.
AID1647684Antibacterial activity against Staphylococcus aureus ATCC 12600 assessed as reduction in microbial growth after 24 hrs by agar well diffusion assay2020Journal of natural products, 02-28, Volume: 83, Issue:2
Isolation, Identification, and Decomposition of Antibacterial Dialkylresorcinols from a Chinese
AID508302Inhibition of PBP1 in wild type Enterococcus faecium D63 membranes assessed as inhibition of fluorescent ampicillin binding after 20 mins at 37 degC2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID1191528Selectivity index, ratio of IC50 for human HepG2 cells to MIC for Staphylococcus aureus CCM 4516/082015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID531445Antibacterial activity against Streptococcus pneumoniae serotype 6A/C assessed as percent susceptible isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID562375Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID585178Activity of Beta-lactamase GES-5 E104, S170 mutant2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
AID1870129Antibacterial activity against antibiotic resistant Staphylococcus aureus 4461/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID522661Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis K1938 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID511443Antimicrobial activity against Streptococcus uberis ATCC 8749 harboring PAP1A R273H, PBP2B N366I/T402I and PBP2X E381K/Q554E mutation after 16 passages assessed as inhibition of visible growth by broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID559704Antimicrobial activity against Pseudomonas aeruginosa AB92037 by microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.
AID529319Antibacterial activity against multidrug resistant Streptococcus pneumoniae serotype 23 URA3558 harboring mutant PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID524065Binding affinity to methicillin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 1287 PBP3 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID278560Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium bifidum BB12 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID528727Antibacterial activity against Streptococcus agalactiae group B clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID558338Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P1730 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID554876Antimicrobial activity against Streptococcus pneumoniae serotype 4 ST 205 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID559517Antibacterial activity against Streptococcus bovis assessed as percent susceptible isolates by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID572271Antimicrobial activity against methicillin-resistant Staphylococcus aureus NB01021 by broth microdilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models.
AID531569Antibacterial activity against Streptococcus sp. 'group C' obtained from complicated skin and skin structure infections by agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
AID588118Antimicrobial activity against Neisseria gonorrhoeae clinical isolates harboring porB G120K, A121D mutant gene, PBP2 XXXVI pattern, deletion of nucleotide A from mtrA promoter, MAST 3596 after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID322506Volume of distribution at steady state in human term neonates at 15 mg/kg, im administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID295098Antibacterial activity against Staphylococcus aureus ATCC 6538 at 10 ug after 24 hrs by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID559076Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID560702Activity of Escherichia coli MC4100 Beta-Lactamase CMY-22009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.
AID599147Antibacterial activity against Escherichia coli after 24 hrs by MTT assay2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Synthesis, crystal structure and antimicrobial activity of deoxybenzoin derivatives from genistein.
AID634232Antibacterial activity against Fusobacterium nucleatum ATCC 25586 assessed as growth inhibition at 0.00625 to 2.5 ug/ml ug/ml after 24 hrs by microplate dilution assay2011Journal of natural products, Dec-27, Volume: 74, Issue:12
Isoflavonoids and coumarins from Glycyrrhiza uralensis: antibacterial activity against oral pathogens and conversion of isoflavans into isoflavan-quinones during purification.
AID679174TP_TRANSPORTER: uptake in OATP-D-expressing HEK293 cells2000Biochemical and biophysical research communications, Jun-24, Volume: 273, Issue:1
Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.
AID373210Ratio of Kcat to Km for Bacillus clausii NR beta-lactamase BCL1 expressed in Escherichia coli BL21 (DE3)2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
AID535642Antimicrobial activity against Group B streptococcus serotype VI N4 harboring E63K mutation in PBP 2A and L41S mutation in PBP 1B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID335713Antibacterial activity against Brevibacterium ammoniagenes ATCC 6872 after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID573823Antibacterial activity against beta-lactamase producing Clostridium paraputrificum by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID1254302Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 24 hrs by microdilution broth method2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
AID681035TP_TRANSPORTER: inhibition of Ochratoxin A uptake (OTA: 1 uM, PCG: 200 uM) in OAT3-expressing S2 cells2001Life sciences, Sep-21, Volume: 69, Issue:18
Characterization of ochratoxin A transport by human organic anion transporters.
AID493654Antimicrobial activity against Staphylococcus aureus ATCC 6538 by MTT assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
AID531446Antibacterial activity against Streptococcus pneumoniae serotype 3 assessed as percent susceptible isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID1511410Antibacterial activity against Staphylococcus aureus assessed as reduction in bacterial cell growth incubated for 24 hrs by filter paper assay2019Bioorganic & medicinal chemistry, 11-01, Volume: 27, Issue:21
Synthesis and biological evaluation of calycanthaceous alkaloid analogs.
AID558318Antibacterial activity against Campylobacter jejuni by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID219756In vitro antimicrobial activity against Xanthomonas maltophilia GN 12873 was determined2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Design, synthesis, and SAR of novel carbapenem antibiotics with high stability to Xanthomonas maltophilia oxyiminocephalosporinase type II.
AID619679Antimicrobial activity against Enterococcus faecalis ATCC 29212 by broth microdilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis, antimicrobial activity and possible mechanism of action of 9-bromo-substituted indolizinoquinoline-5,12-dione derivatives.
AID372900Antibacterial activity against Enterobacter cloacae ATCC 13047 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID1638906Antimicrobial activity against multidrug-resistant Pseudomonas aeruginosa ATCC BAA-2108 measured after 18 hrs by broth microdilution method2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
AID561254Antibacterial activity against Streptococcus pyogenes assessed as susceptible isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID521825Antimicrobial activity against beta-lactam resistant Streptococcus pneumoniae clinical isolate by broth dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Clonal spread of highly beta-lactam-resistant Streptococcus pneumoniae isolates in Taiwan.
AID1180452Antimicrobial activity against Enterococcus sp. J 14365/08 after 48 hrs by microdilution method2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
AID1180449Antimicrobial activity against Staphylococcus epidermidis H 6966/08 after 24 hrs by microdilution method2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
AID530510Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 6138-03 expressing pbp2x Q557E mutant and multilocus sequence type ST19 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID530512Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 8607-03 expressing pbp2x Q557E mutant and multilocus sequence type ST19 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID495708Kcat/Km ratio of Enterobacter cloacae AmpC2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID524984Antibacterial activity against penicillin susceptible Streptococcus pneumoniae clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
AID520414Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Antistreptococcal activity of AR-709 compared to that of other agents.
AID324848Antimicrobial activity against Neisseria gonorrhoeae 90 isolate2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
AID447053Antibacterial activity against Escherichia coli ATCC 11230 at 10 IU after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID1076534Cytotoxicity against human macrophages after 24 hrs by MTT assay2014European journal of medicinal chemistry, Mar-21, Volume: 75Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
AID287376Antibacterial activity against Proteus vulgaris after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID425867Antimicrobial activity against Carnobacterium divergens BM4490 expressing beta-lactamase CAD1 at 0.5 McFarland inoculum size by E-test2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
AID495718Activity of Escherichia coli CTX-M-15 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID559514Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae assessed as percent susceptible isolates by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID508383Antibacterial activity against Streptococcus pyogenes harboring mef(A) gene after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID573156Antibacterial activity against vancomycin-resistant Enterococcus faecium assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID587964Activity of Escherichia coli beta-lactamase Toho-1 D240A mutant assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID1237608Antibacterial activity against Pseudomonas aeruginosa ATCC2785 assessed as bacterial growth inhibition after 24 hrs by broth dilution method2015European journal of medicinal chemistry, Jul-15, Volume: 100Novel cajaninstilbene acid derivatives as antibacterial agents.
AID548534Antimicrobial activity against viridans group Streptococcus by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID574050Antibacterial activity against beta-lactamase producing Finegoldia magna by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID520883Activity of Achromobacter xylosoxidans CIP69598 beta-lactamase OXA-114a expressed in Escherichia coli TOP10 assessed as compound hydrolysis2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans.
AID171257Concentration of compound in rat liver after intravenous injection of 20 mg/kg benzyl-penicillin after 1 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID533929Antimicrobial activity against linezolid-resistant methicillin-resistant Staphylococcus aureus NRS127 by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID495714Kcat/Km ratio of Pseudomonas aeruginosa SPM-12010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID1347491Antibacterial activity against Escherichia coli assessed as zone of inhibition after 24 to 48 hrs by well diffusion method2018European journal of medicinal chemistry, Jan-01, Volume: 143Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
AID520385Activity at Pseudomonas aeruginosa M5109 metallo-beta-lactamase VIM-11 by spectrometry2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biochemical characterization of metallo-beta-lactamase VIM-11 from a Pseudomonas aeruginosa clinical strain.
AID666778Antibacterial activity against Escherichia coli at 0.05 mg by agar diffusion test2012Bioorganic & medicinal chemistry letters, Jul-01, Volume: 22, Issue:13
Bioactive briarane diterpenoids from the South China Sea gorgonian Dichotella gemmacea.
AID519631Activity of Brachyspira pilosicoli beta-lactamase OXA-63 expressed in Escherichia coli BL21 (DE3) assessed as compound hydrolysis by spectrophotometry2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
AID560703Ratio of Kcat to Km for Escherichia coli MC4100 Beta-Lactamase CMY-22009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.
AID278566Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium longum P/N 601377 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID522663Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis SPS 0053 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID585177Activity of Beta-lactamase GES-2 E104, N170 mutant2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
AID278684Antibacterial activity against Enterococcus faecalis isolate 57462007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID557524Displacement of Biocillin FL from Streptococcus pneumoniae 1076 PBP32009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID558323Antibacterial activity against Campylobacter jejuni isolate P270 harboring blaOXA-61::cat gene by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID625290Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID171110Concentration of compound in rat blood after intravenous injection of 20 mg/kg benzyl-penicillin after 3 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID559519Antibacterial activity against Streptococcus intermedius assessed as percent susceptible isolates by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID599148Antibacterial activity against Pseudomonas fluorescens after 24 hrs by MTT assay2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Synthesis, crystal structure and antimicrobial activity of deoxybenzoin derivatives from genistein.
AID494345Antibacterial activity against Bacillus subtilis by twofold serial dilution method2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis, characterization and antimicrobial studies of 2-(4-methoxy-phenyl)-5-methyl-4-(2-arylsulfanyl-ethyl)-2,4-dihydro-[1,2,4] triazolo-3-ones and their corresponding sulfones.
AID528608Ratio of Kcat to Km for Escherichia coli 2138 beta-lactamase KPC-2 by spectrophotometry2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France.
AID422496Activity of Carnobacterium divergens BM4489 penicillinase Cad-1 assessed as initial rate of hydrolysis by spectrophotometer2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
AID520723Activity of Acinetobacter baumannii phenotype 1 beta-lactamase assessed per mg of protein at 100 uM2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97.
AID573134Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID625289Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID569344Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis by agar dilution method2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
AID322517Effect on glomerular filtration in human very low birth weight preterm neonates urine assessed as drug clearance at 15 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID508369Antibacterial activity against Streptococcus pneumoniae harboring erm(B) gene after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID575146Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NRS123 by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
AID531424Antibacterial activity against Streptococcus pneumoniae serotype 33 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID587965Activity of Escherichia coli beta-lactamase Toho-1 C69A mutant assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID395345Antibacterial activity against Bacillus cereus ATCC 7064 at 10 units after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID524974Antibacterial activity against Streptococcus sp. Group C clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
AID381177Antibacterial activity against Escherichia coli after 24 to 72 hrs by disk diffusion method1999Journal of natural products, Sep, Volume: 62, Issue:9
Antimicrobial and antitumor activities of mycosporulone.
AID1565593Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 hrs by CLSI based broth microdilution method2019European journal of medicinal chemistry, Nov-15, Volume: 182Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity.
AID533880Antibacterial activity against cefotaxime-intermediate Streptococcus pneumoniae isolate by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
AID495687Activity of Klebsiella pneumoniae SHV-12010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID520408Antimicrobial activity against trimethoprim-sulfamethoxazole-resistant Streptococcus pneumoniae by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Antistreptococcal activity of AR-709 compared to that of other agents.
AID1870121Antibacterial activity against antibiotic resistant Staphylococcus aureus 4880/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID530517Antimicrobial activity against group B Streptococcus sp. 'group B' serotype V isolate 3386-05 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID559510Antibacterial activity against Lancefield Streptococcus sp. 'group C' assessed as percent susceptible isolates by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID368727Ratio of Kcat to Km of Serratia marcescens AmpC assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID577461Inhibition of Bocillin FL binding to PBP2b Thr446Ala mutant in laboratory-derived Streptococcus pneumoniae isolate R62010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Affinity of ceftobiprole for penicillin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin.
AID511533Antimicrobial activity against Streptococcus uberis isolate 20592 harboring and PBP2X E381K/Q554E mutation assessed as inhibition of visible growth after 24 hrs by broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID559059Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID495744Kcat/Km ratio of Pseudomonas aeruginosa SPM-1 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID69322MIC against aerobic organism Escherichia coli strain 28911982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
Quaternary heterocyclylamino beta-lactams: a generic alternative to the classical acylamino side chain.
AID562371Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group C clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID588105Antimicrobial activity against Neisseria gonorrhoeae clinical isolates harboring porB G120K, A121D mutant gene, PBP1 L421P mutant gene, PBP2 XXXVIII pattern, deletion of nucleotide A from mtrA promoter, MAST 3563 after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID285266Activity of Escherichia coli BL21(DE3) beta-lactamase TEM1512007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.
AID540209Volume of distribution at steady state in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID519012Activity of Beta-lactamase TEM-102008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates.
AID573783Antibacterial activity against Prevotella buccae by by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID278555Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium longum P/N 601377 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID324845Antimicrobial activity against Neisseria gonorrhoeae 59 isolate2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
AID340848Increase in pbp2X gene expression in penicillin-resistant Streptococcus gordonii with penicillin binding protein PR1_2 evolved mutation assessed as relative luciferase units relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii.
AID278432Antibacterial activity against Streptococcus pyogenes M12 by time-kill curve assay2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments.
AID495690Activity of Klebsiella pneumoniae Beta-lactamase TEM-262010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID1287891Antimicrobial activity against Staphylococcus aureus MTCC 96 after 24 hrs by serial two-fold broth dilution method2016European journal of medicinal chemistry, May-04, Volume: 113Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids.
AID1870125Antibacterial activity against antibiotic resistant Staphylococcus aureus 4566/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID368488Ratio of Kcat to Km of Escherichia coli TEM1 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID381181Antibacterial activity against Streptococcus faecalis after 24 to 72 hrs by disk diffusion method1999Journal of natural products, Sep, Volume: 62, Issue:9
Antimicrobial and antitumor activities of mycosporulone.
AID682277TP_TRANSPORTER: inhibition of Carnitine uptake (Carnitine: 0.02 uM, PCG: 2500 uM) in OCTN2-expressing HeLa cells2000The Journal of biological chemistry, Jan-21, Volume: 275, Issue:3
beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter.
AID529315Antibacterial activity against tetracycline- erythromycin- clindamycin-resistant Streptococcus pneumoniae serotype 6B URA4376 harboring mutant PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID278567Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium thermophilum ATCC 25866 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID483192Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 by microbroth dilution technique2010Bioorganic & medicinal chemistry letters, Jun-15, Volume: 20, Issue:12
Design, synthesis, and antibacterial activity of 2,5-dihydropyrrole formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
AID558626Antimicrobial activity against Streptococcus pneumoniae isolate 3481 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID1245117Antimicrobial activity against Pseudomonas aeruginosa ATCC 13525 after 18 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Sep-15, Volume: 23, Issue:18
Design, synthesis and molecular docking of salicylic acid derivatives containing metronidazole as a new class of antimicrobial agents.
AID571186Antibacterial activity against Neisseria gonorrhoeae harboring wild-type GA and wild-type penA genes by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID495843Ratio of Kcat to Km for Escherichia coli DH10B beta-lactamase VIM-2 by microacidimetric method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
AID575082Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A assessed as percent susceptible isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID524647Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA, penB and ponA mutant gene assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID405084Activity of Citrobacter freundii PER2 beta lactamase2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Biochemical characterization of PER-2 and genetic environment of blaPER-2.
AID561249Antibacterial activity against Streptococcus pneumoniae by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID495686Activity of Escherichia coli TEM-12010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID518728Activity of Pseudomonas stutzeri beta-lactamase DIM-1 by UV-spectrophotometry2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Characterization of DIM-1, an integron-encoded metallo-beta-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands.
AID573116Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID1243291Antimicrobial activity against Escherichia coli ATCC 25922 by standard broth microdilution method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.
AID540177Antibacterial activity against Bacillus subtilis NCIM 2439 after 24 hrs by twofold serial dilution method2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis and anti-tubercular and antimicrobial activities of some 2r,4c-diaryl-3-azabicyclo[3.3.1]nonan-9-one N-isonicotinoylhydrazone derivatives.
AID528705Antibacterial activity against Streptococcus mitis clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID661940Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 24 hrs by agar dilution method2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Synthesis and antimicrobial activities of structurally novel S,S'-bis(heterosubstituted) disulfides.
AID620346Antibacterial activity against Staphylococcus aureus RCMB 000106 at 30 ug/ml after 24 hrs by diffusion agar technique2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and anti-microbial activity of some 1- substituted amino-4,6-dimethyl-2-oxo-pyridine-3-carbonitrile derivatives.
AID625447Antimicrobial activity against Staphylococcus epidermidis by broth dilution method2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Iodine-catalyzed conjugate addition of indoles onto en-1,4-dione: a novel synthesis of 3-(1-(1H-indol-3-yl)-2-oxo-2-phenylethyl)indolin-2-ones as antibacterial and antifungal agents.
AID533934Antimicrobial activity against linezolid-resistant Staphylococcus aureus CM/05 3067 harboring chromosomal cfr gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID524662Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA mutant gene assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID285268Activity of Escherichia coli BL21(DE3) beta-lactamase TEM1522007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.
AID573819Antibacterial activity against Veillonella parvula by by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID588110Antimicrobial activity against Neisseria gonorrhoeae clinical isolates harboring porB G120K, A121D mutant gene, PBP2 XXXVIII pattern, deletion of nucleotide A from mtrA promoter, MAST 3158 after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID682061TP_TRANSPORTER: uptake in OATP-C-expressing HEK293 cells2000Biochemical and biophysical research communications, Jun-24, Volume: 273, Issue:1
Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.
AID1191512Antibacterial activity against Staphylococcus aureus CCM 4516/08 after 48 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID577452Antimicrobial activity against penicillin resistant Streptococcus pneumoniae isolate 8819 harboring PBP2b 443SSNA mutant by broth microdilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Affinity of ceftobiprole for penicillin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin.
AID1191514Antibacterial activity against methicillin-resistant Staphylococcus aureus H 5996/08 after 48 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID519203Antibacterial activity against Streptococcus pneumoniae assessed as susceptible isolates by microdilution method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
In vitro activity of AR-709 against Streptococcus pneumoniae.
AID1254311Antibacterial activity against ESBL-positive Klebsiella pneumoniae J 14368/08 after 48 hrs by microdilution broth method2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
AID533938Antimicrobial activity against linezolid-resistant Staphylococcus aureus 425 harboring G2447U in peptidyl transferase centre by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID634233Antibacterial activity against Porphyromonas gingivalis ATCC 33277 assessed as growth inhibition at 0.00625 to 2.5 ug/ml ug/ml after 24 hrs by microplate dilution assay2011Journal of natural products, Dec-27, Volume: 74, Issue:12
Isoflavonoids and coumarins from Glycyrrhiza uralensis: antibacterial activity against oral pathogens and conversion of isoflavans into isoflavan-quinones during purification.
AID524983Antibacterial activity against Streptococcus sp. clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
AID1546105Antimicrobial activity against Bacillus subtilis2019European journal of medicinal chemistry, Dec-15, Volume: 184Current scenario of tetrazole hybrids for antibacterial activity.
AID520729Activity of Acinetobacter baumannii CIP7010 beta-lactamase OXA-97 assessed per mg of protein at 100 uM2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97.
AID559083Antibacterial activity against Neisseria meningitidis by CLSI M7-A7 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID562755Activity of Klebsiella pneumoniae AH27 CTX-M-15 beta-lactamase2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
New variant of CTX-M-type extended-spectrum beta-lactamases, CTX-M-71, with a Gly238Cys substitution in a Klebsiella pneumoniae isolate from Bulgaria.
AID571179Antibacterial activity against Neisseria gonorrhoeae harboring wild-type GA gene by disk agar diffusion method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID245438Minimum inhibitory concentration against Bacillus subtilis (Gram-positive) was determined by by broth dilution method2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Synthesis and antibacterial activity of 2,4,6-tri substituted s-triazines.
AID561257Antibacterial activity against Streptococcus agalactiae by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID336566Antibacterial activity against penicillin-susceptible Staphylococcus aureus ATCC 12598 after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID341345Antimicrobial activity against Neisseria meningitidis isolates harboring penA 4 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID508384Antibacterial activity against Streptococcus pyogenes harboring erm(A) gene after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID545143Ratio of Kcat to Km for Klebsiella pneumoniae cephalosporinase CMY-36 by spectrophotometry2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids.
AID511441Antimicrobial activity against Streptococcus uberis ATCC 19436 harboring PAP1A A227T/G386R, PBP2B N366I/T402I and PBP2X E381K/D524A/Q554E mutation after 30 passages assessed as inhibition of visible growth by broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID1076536Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT assay2014European journal of medicinal chemistry, Mar-21, Volume: 75Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
AID520730Activity of Escherichia coli DH10B beta-lactamase assessed per mg of protein at 100 uM2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97.
AID559064Antibacterial activity against Streptococcus intermedius by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID546426Activity at Pseudomonas aeruginosa PDC-1 by spectrophotometer2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.
AID368509Activity of Serratia marcescens SME3 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID529575Activity of Erwinia carotovora subsp. atroseptica DSM 30184 beta-lactamase CAR-12008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Functional diversity among metallo-beta-lactamases: characterization of the CAR-1 enzyme of Erwinia carotovora.
AID278858Antiproliferative effect against MG63 cells assessed as BrdU incorporation into DNA after 48 hrs after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID658950Antibacterial activity against Staphylococcus aureus 155554A at 100 mg/ml after 24 hrs by agar-well diffusion technique2012European journal of medicinal chemistry, Jun, Volume: 522-Aminothiophenes as building blocks in heterocyclic synthesis: synthesis and antimicrobial evaluation of a new class of pyrido[1,2-a]thieno[3,2-e]pyrimidine, quinoline and pyridin-2-one derivatives.
AID573784Antibacterial activity against Prevotella bivia by by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID564228Activity of Escherichia coli TOP10 beta-lactamase OXA-1432009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.
AID625445Antimicrobial activity against Bacillus subtilis MTCC 441 by broth dilution method2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Iodine-catalyzed conjugate addition of indoles onto en-1,4-dione: a novel synthesis of 3-(1-(1H-indol-3-yl)-2-oxo-2-phenylethyl)indolin-2-ones as antibacterial and antifungal agents.
AID535765Antimicrobial activity against penicillin-producing Neisseria gonorrhoeae NGON 08-041 expressing beta-lactamase TEM-1, MLST type ST-1584 and MAST type ST-1478 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Identification of TEM-135 beta-lactamase in penicillinase-producing Neisseria gonorrhoeae strains in Japan.
AID171268Concentration of compound in rat lung after intravenous injection of 20 mg/kg benzyl-penicillin after 40 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID565728Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group F clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID728909Antibacterial activity against levofloxacin-intermediate and levofloxacin-resistant Streptococcus pneumoniae after 18 hrs by microbroth dilution method2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Design, synthesis, and biological evaluations of novel 7-[7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens.
AID1698705Antibacterial activity against genotype penicillin-resistant Streptococcus pneumoniae by CLSI method2020Bioorganic & medicinal chemistry, 11-15, Volume: 28, Issue:22
Lead optimization of 8-(methylamino)-2-oxo-1,2-dihydroquinolines as bacterial type II topoisomerase inhibitors.
AID573597Antibacterial activity against Fusobacterium necrophorum assessed as susceptible isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID322509AUC (0 to 12) in human very low birth weight preterm neonates at 14 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID368497Activity of Klebsiella oxytoca beta-lactamase K1assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID530505Antimicrobial activity against group B Streptococcus sp. 'group B' serotype II isolate 3776-04 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID1601841Antibacterial activity against Staphylococcus aureus CMCC(B) 26003 measured after 24 hrs by ELISA2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety.
AID1546168Antimicrobial activity against Streptococcus pneumoniae2019European journal of medicinal chemistry, Dec-15, Volume: 184Current scenario of tetrazole hybrids for antibacterial activity.
AID495735Kcat/Km ratio of Klebsiella pneumoniae Beta-lactamase TEM-26 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID559054Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID574949Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID372613Activity of Escherichia coli DH5alpha beta-lactamase TEM-158 by microacidimetric method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
AID368548Activity of Pseudomonas aeruginosa MK-1184 AmpC assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID681168TP_TRANSPORTER: uptake in Oat3-expressing oocyte cells2004The Journal of pharmacology and experimental therapeutics, Jun, Volume: 309, Issue:3
Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier.
AID373055Antimicrobial activity against Escherichia coli BL21(DE3) by agar-dilution technique2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
AID511442Antimicrobial activity against Streptococcus uberis ATCC 8749 harboring PBP2B N366I/T402I/V570A/P575S and PBP2X A492E mutation assessed as inhibition of visible growth by broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID573591Antibacterial activity against Fusobacterium nucleatum by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID558645Antimicrobial activity against compound-intermediate Streptococcus pneumoniae by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID542626Antimicrobial activity against Streptococcus pneumoniae R6 harboring PBP2x T338G and PBP1a2349 mutant gene and aad9 disruption in CiaR gene after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID511536Antimicrobial activity against Streptococcus uberis ATCC 9529 harboring PAP1A R273P, PBP2B N366I/T402I and PBP2X E381K/Q554E mutation after 28 passages assessed as inhibition of visible growth by broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID565741Antimicrobial activity against erythromycin-susceptible Streptococcus agalactiae clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID1063962Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 48 hrs by broth microdilution method2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Salicylanilide diethyl phosphates: synthesis, antimicrobial activity and cytotoxicity.
AID1347487Antibacterial activity against Staphylococcus epidermidis assessed as zone of inhibition after 24 to 48 hrs by well diffusion method2018European journal of medicinal chemistry, Jan-01, Volume: 143Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
AID533875Antibacterial activity against penicillin-nonsusceptible Streptococcus pneumoniae assessed as percent susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
AID519980Ratio of Kcat to Km for Klebsiella pneumoniae Beta-Lactamase SHV-552008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Biochemical characterization of SHV-55, an extended-spectrum class A beta-lactamase from Klebsiella pneumoniae.
AID573802Antibacterial activity against Prevotella melaninogenica assessed as resistant isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID209571In vitro Minimum inhibitory concentration against Streptococcus faecium ATCC 8043-21981Journal of medicinal chemistry, Oct, Volume: 24, Issue:10
Synthesis and evaluation of ureido- and vinylureidopenicillins as inhibitors of intraruminal lactic acid production.
AID543276Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 pbp2x and pbp2b genes by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID496403Antimicrobial activity against Borrelia burgdorferi N402010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Ineffectiveness of tigecycline against persistent Borrelia burgdorferi.
AID529659Activity of Pseudomonas aeruginosa COL-1 beta-lactamase VIM-22008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID585175Activity of Beta-lactamase GES-1 E104, G170 mutant2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
AID1870131Antibacterial activity against antibiotic resistant Staphylococcus aureus 4502/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID418553Antibacterial activity against Staphylococcus aureus ATCC 29213 by NCCLS method2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
AID573786Antibacterial activity against Prevotella melaninogenica by by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID422493Antimicrobial activity against Carnobacterium divergens BM4490 expressing beta-lactamase CAD1 at 3 McFarland inoculum size by E-test2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
AID573118Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID511450Antimicrobial activity against Streptococcus uberis isolate BL246 harboring PBP2B N366I/T402I and PBP2X E381K/Q554E mutation assessed as inhibition of visible growth after 24 hrs by broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID588111Antimicrobial activity against Neisseria gonorrhoeae clinical isolates harboring porB G120K, A121D mutant gene, PBP1 L421P mutant gene, PBP2 XXXIV pattern, deletion of nucleotide A from mtrA promoter, MAST 225 after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID1091741Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as growth arrest at 37 degC for 24 hr2009Chemical & pharmaceutical bulletin, Jul, Volume: 57, Issue:7
Synthesis, nematicidal and antimicrobial properties of Bis-[4-methoxy-3-[3-(4-fluorophenyl)-6-(4-methylphenyl)-2(aryl)-tetrahydro-2H-pyrazolo[3,4-d]thiazol-5-yl]phenyl]methanes.
AID1765579Antibacterial activity against Klebsiella pneumoniae ATCC 700603 incubated for 18 hrs by CLSI based broth dilution method2021Journal of medicinal chemistry, 08-12, Volume: 64, Issue:15
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
AID368547Activity of Pseudomonas aeruginosa MK-1184 AmpC assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID295095Antibacterial activity against Escherichia coli ATCC 11230 at 10 ug after 24 hrs by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID368308Ratio of Kcat to Km of Escherichia coli TEM1 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID617969Antibacterial activity against Pseudomonas aeruginosa ATCC 13525 after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea.
AID279186Activity of Enterobacter cloacae S3 isolate beta lactamase LAP1 expressed in Escherichia coli DH10B2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Novel Ambler class A beta-lactamase LAP-1 and its association with the plasmid-mediated quinolone resistance determinant QnrS1.
AID573122Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID565730Antimicrobial activity against Streptococcus Group F clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID278674Antibacterial activity against Enterococcus faecalis isolate 57442007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID300057Antibacterial activity against Staphylococcus aureus ATCC 25923 at 10U by disc diffusion method2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
Synthesis, characterization and antimicrobial activity of new aliphatic sulfonamide.
AID375921Antibacterial activity against Bacteroides fragilis ATCC 23745 by NCCLS method2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
AID585186Ratio of Kcat to Km for Beta-lactamase GES-13 K104, N170 mutant2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
AID556341Ratio of Kcat/Km for Salmonella enterica serotype Westhampton beta-lactamase CTX-M-532009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Novel plasmid-encoded ceftazidime-hydrolyzing CTX-M-53 extended-spectrum beta-lactamase from Salmonella enterica serotypes Westhampton and Senftenberg.
AID558327Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P285 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID531460Antibacterial activity against Streptococcus pneumoniae serotype 33 assessed as percent resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID438303Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 52592009Journal of medicinal chemistry, Oct-08, Volume: 52, Issue:19
Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening.
AID609855Antimicrobial activity against methicillin-resistant Staphylococcus aureus BAA-44 assessed as growth inhibition after 18 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Unprecedented C-2 arylation of indole with diazonium salts: Syntheses of 2,3-disubstituted indoles and their antimicrobial activity.
AID278551Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium infantis ATCC 15697 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID561736Antibacterial activity against Beta-hemolytic Streptococcus group B assessed as susceptible isolates by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID1180447Antimicrobial activity against methicillin-resistant Staphylococcus aureus H 5996/08 after 24 hrs by microdilution method2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
AID209756Minimum inhibitory concentration against aerobic organism Streptococcus pyogenes strain 31241982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
Quaternary heterocyclylamino beta-lactams: a generic alternative to the classical acylamino side chain.
AID562377Antimicrobial activity against erythromycin-nonsusceptible Streptococcus agalactiae clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID483193Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 by microbroth dilution technique2010Bioorganic & medicinal chemistry letters, Jun-15, Volume: 20, Issue:12
Design, synthesis, and antibacterial activity of 2,5-dihydropyrrole formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
AID1437662Antibacterial activity against Streptococcus pyogenes ATCC 19615 after 20 to 24 hrs by two-fold microdilution method
AID573563Antibacterial activity against beta-lactamase producing Bacteroides vulgatus by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID534086Antibacterial activity against levofloxacin-resistant Streptococcus pneumoniae isolate by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
AID757812Antibacterial activity against Pseudomonas aeruginosa ATCC 13525 after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
AID561738Antibacterial activity against Beta-hemolytic Streptococcus group A assessed as resistant isolates by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID324834Antimicrobial activity against Neisseria gonorrhoeae 119 isolate2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
AID522665Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis BA0018 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID1902630Antibacterial activity against Methicillin-drug resistant Staphylococcus aureus C0621 incubated for 18 hrs by by disc diffusion method2022ACS medicinal chemistry letters, Feb-10, Volume: 13, Issue:2
Antibacterial Activity of Metergoline Analogues: Revisiting the Ergot Alkaloid Scaffold for Antibiotic Discovery.
AID1428254Antibacterial activity against Pseudomonas aeruginosa RCMB 000103 assessed as zone of inhibition at 30 ug/ml2017European journal of medicinal chemistry, Jan-27, Volume: 126An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.
AID503223Antibacterial activity against penicillin-sensitive Streptococcus pneumoniae R6 by microscopy2007Nature chemical biology, Sep, Volume: 3, Issue:9
Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins.
AID556340Activity of Salmonella enterica serotype Westhampton beta-lactamase CTX-M-532009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Novel plasmid-encoded ceftazidime-hydrolyzing CTX-M-53 extended-spectrum beta-lactamase from Salmonella enterica serotypes Westhampton and Senftenberg.
AID378411Antimicrobial activity against Yarrowia lipolytica HT20after 24 hrs2006Journal of natural products, Aug, Volume: 69, Issue:8
Carneic acids A and B, chemotaxonomically significant antimicrobial agents from the xylariaceous ascomycete Hypoxylon carneum.
AID511440Antimicrobial activity against Streptococcus uberis ATCC 19436 harboring PAP1A A227T, PBP2B N366I/T402I and PBP2X E381K/D524A/Q554E mutation after 18 passages assessed as inhibition of visible growth by broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID519997Antimicrobial activity against Streptococcus pneumoniae ribosomal mutant2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.
AID519983Activity of Klebsiella pneumoniae Beta-Lactamase SHV-12008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Biochemical characterization of SHV-55, an extended-spectrum class A beta-lactamase from Klebsiella pneumoniae.
AID1437663Antibacterial activity against Streptococcus pneumoniae ATCC 6305 after 20 to 24 hrs by two-fold microdilution method
AID398237Antimicrobial activity against Bacillus subtilis 327 after 18 hrs by twofold serial microbroth dilution method2003Journal of natural products, Dec, Volume: 66, Issue:12
A novel antibacterial iridoid and triterpene from Caiophora coronata.
AID340736Activity of Chryseobacterium indologenes metallo-beta-lactamase IND-5 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes.
AID573137Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID665395Antibacterial activity against Bacillus subtilis MTCC 441 after 24 hrs by serial dilution technique2012European journal of medicinal chemistry, Jul, Volume: 53Synthesis, characterization, antimicrobial activities and QSAR studies of some 10a-phenylbenzo[b]indeno[1,2-e][1,4]thiazin-11(10aH)-ones.
AID531571Antibacterial activity against Streptococcus constellatus obtained from complicated skin and skin structure infections by agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
AID1402237Hemolytic activity in human erythrocytes at 10 to 200 ug/ml after 3 hrs relative to control2018European journal of medicinal chemistry, Jan-01, Volume: 143Hetero-Diels-Alder reactions of novel 3-triazolyl-nitrosoalkenes as an approach to functionalized 1,2,3-triazoles with antibacterial profile.
AID1601853Antibacterial activity against multidrug-resistant Escherichia coli ATCC BAA-196 measured after 24 hrs by ELISA2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety.
AID554673Antimicrobial activity against Streptococcus pneumoniae serotype 9V ST 156 harboring ERY-resistant erm(B) or mef(E) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID559708Antimicrobial activity against penicillin-resistant Staphylococcus epidermidis P1389 by microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.
AID1366138Antibacterial activity against Staphylococcus aureus assessed as diameter of inhibition zone at 1 mg/ml2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID495689Activity of Klebsiella oxytoca Beta-lactamase K12010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID559520Antibacterial activity against Streptococcus mitis assessed as percent susceptible isolates by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID586082Antimicrobial activity against multidrug-resistant Neisseria gonorrhoeae isolates harboring mosaic penicillin-binding protein 2 penA assessed as resistant isolates by disk susceptibility test2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Characteristics and dissemination of mosaic penicillin-binding protein 2-harboring multidrug-resistant Neisseria gonorrhoeae isolates with reduced cephalosporin susceptibility in northern Taiwan.
AID490132Antibacterial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT assay2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis of some N-alkyl substituted urea derivatives as antibacterial and antifungal agents.
AID562359Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID535635Antimicrobial activity against Group B streptococcus serotype VI R5 harboring F395L, V405A, R433H, H438Y, and G648A mutations in PBP 2X and T567I mutation in PBP 2B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID495736Kcat/Km ratio of Escherichia coli CMY-2 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID531576Antibacterial activity against Gemella morbillorum obtained from complicated skin and skin structure infections by RapID ANA system2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
AID368542Ratio of Kcat to Km of Pseudomonas aeruginosa 4352 AmpC assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID1091749Antibacterial activity against Bacillus subtilis MTCC 441 assessed as inhibition zones at 100 ug/disk at 37 degC for 24 hr2009Chemical & pharmaceutical bulletin, Jul, Volume: 57, Issue:7
Synthesis, nematicidal and antimicrobial properties of Bis-[4-methoxy-3-[3-(4-fluorophenyl)-6-(4-methylphenyl)-2(aryl)-tetrahydro-2H-pyrazolo[3,4-d]thiazol-5-yl]phenyl]methanes.
AID573599Antibacterial activity against Fusobacterium nucleatum assessed as resistant isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID559077Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID399189Antibacterial activity against Staphylococcus aureus F7 at below 625 ug/mL after 24 hrs by broth microdilution method2004Journal of natural products, Jan, Volume: 67, Issue:1
Africane-type sesquiterpenoids from the Argentine liverwort Porella swartziana and their antibacterial activity.
AID560497Activity of Escherichia coli MC4100 Beta-Lactamase CMY-30 harboring Val211?Gly211 mutation2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.
AID532984Antibacterial activity against Escherichia coli MG1655 in presence of 10 mM N-Acetylcysteine2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID1191517Antibacterial activity against Enterococcus sp. J 14365/08 after 24 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID524054Binding affinity to methicillin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 1287 PBP2 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID498369Antimicrobial activity against wild type streptomycin-susceptible Streptococcus gordonii harboring P438R mutation in ptsI assessed as bacterial count at 2 ug/ml after 24 hrs by macrodilution technique2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.
AID395347Antibacterial activity against Listeria monocytogenes ATCC 15313 at 10 units after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID171266Concentration of compound in rat lung after intravenous injection of 20 mg/kg benzyl-penicillin after 20 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID533931Antimicrobial activity against linezolid-resistant methicillin-resistant Staphylococcus aureus NRS120 harboring G2576U mutation in peptidyl transferase centre by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID519996Antimicrobial activity against Streptococcus pneumoniae harboring mef(A) gene2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.
AID587969Ratio of Kcat to Km for Escherichia coli beta-lactamase Toho-1 N104A mutant assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID661939Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 25923 after 24 hrs by agar dilution method2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Synthesis and antimicrobial activities of structurally novel S,S'-bis(heterosubstituted) disulfides.
AID373215Activity of Bacillus cereus beta-lactamase BcI2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
AID171112Concentration of compound in rat blood after intravenous injection of 20 mg/kg benzyl-penicillin after 5 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID612540Binding affinity to human PepT2 in SKTP cells2011Bioorganic & medicinal chemistry, Aug-01, Volume: 19, Issue:15
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
AID324837Antimicrobial activity against Neisseria gonorrhoeae 201 isolate2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
AID341342Antimicrobial activity against Neisseria meningitidis isolates harboring penA 34 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID1243286Antimicrobial activity against Streptococcus pneumoniae ATCC 49619 by standard broth microdilution method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.
AID542618Antimicrobial activity against streptomycin-resistant Streptococcus pneumoniae R6 harboring PBP2x T338G and PBP1a2349 mutant gene after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID529326Antibacterial activity against multidrug resistant Streptococcus pneumoniae serotype 15A URA5779 harboring mutant PBP2B PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID558611Antimicrobial activity against Streptococcus pneumoniae isolate 1564 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID573131Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID278680Antibacterial activity against Enterococcus faecium isolate 57512007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID521347Antimicrobial activity against Streptococcus pneumoniae isolate k-598 obtained from bronchoalveolar lavage fluid of patient2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20.
AID1063964Antibacterial activity against methicillin-resistant Staphylococcus aureus H 5996/08 after 48 hrs by broth microdilution method2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Salicylanilide diethyl phosphates: synthesis, antimicrobial activity and cytotoxicity.
AID565737Antimicrobial activity against erythromycin-nonsusceptible Streptococcus pyogenes clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID372615Activity of Escherichia coli DH5alpha beta-lactamase TEM-12 by microacidimetric method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
AID619675Antimicrobial activity against Salmonella paratyphi B CMCC 50094 by broth microdilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis, antimicrobial activity and possible mechanism of action of 9-bromo-substituted indolizinoquinoline-5,12-dione derivatives.
AID442479Antibacterial activity against Staphylococcus epidermidis MTCC 435 by broth dilution method2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Click chemistry: studies on the synthesis of novel fluorous tagged triazol-4-yl substituted quinazoline derivatives and their biological evaluation--theoretical and experimental validation.
AID508372Antibacterial activity against Streptococcus pneumoniae harboring erm(B) and mef(A) gene after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID558631Antimicrobial activity against Streptococcus pneumoniae isolate 4755 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID1659472Antimicrobial activity against Escherichia coli ATCC 25922 assessed as induction of changes in mass spectral profile of bacteria 1 times MIC uM by MALDI-TOF MS analysis2020Journal of medicinal chemistry, 08-27, Volume: 63, Issue:16
Machine Learning in Mass Spectrometry: A MALDI-TOF MS Approach to Phenotypic Antibacterial Screening.
AID524061Binding affinity to methicillin-, vancomycin-susceptible Staphylococcus aureus ATCC 29213 PBP3 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID528723Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID543278Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 3191 pbp2x and Streptococcus pneumoniae 72521 pbp2b genes by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID520726Activity of Escherichia coli TOP10 beta-lactamase OXA-58 assessed per mg of protein at 100 uM2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97.
AID495717Activity of Klebsiella pneumoniae SHV-1 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID532675Antimicrobial activity against ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates by agar dilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
AID573595Antibacterial activity against Fusobacterium nucleatum assessed as susceptible isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID1601852Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 measured after 24 hrs by ELISA2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety.
AID554864Antimicrobial activity against Streptococcus pneumoniae serotype 19F ST 271 harboring ERY-resistant erm(B) and mef(E) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID524972Antibacterial activity against Streptococcus pyogenes clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
AID535353Antimicrobial activity against Streptococcus pneumoniae clinical isolates assessed as susceptible isolates by by based on parenterally dosed broth dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
AID1193568Antibacterial activity against Enterococcus faecalis ATCC 14506 at 100 ug after 24 hrs2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities.
AID451354Antimicrobial activity against Salmonella enteritidis OPS10 after 24 hrs by broth dilution method2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Synthesis and evaluation of bioactive naphthoquinones from the Brazilian medicinal plant, Tabebuia avellanedae.
AID1076539Antibacterial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT assay2014European journal of medicinal chemistry, Mar-21, Volume: 75Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
AID322500Clearance in human very low birth weight preterm neonates at 28 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID573801Antibacterial activity against Prevotella intermedia assessed as resistant isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID1287893Antimicrobial activity against Klebsiella aerogenes MTCC 39 after 24 hrs by serial two-fold broth dilution method2016European journal of medicinal chemistry, May-04, Volume: 113Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids.
AID781325pKa (acid-base dissociation constant) as determined by Liao ref: J Chem Info Model 20092014Pharmaceutical research, Apr, Volume: 31, Issue:4
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
AID519632Activity of beta-lactamase FUS1 assessed as compound hydrolysis by spectrophotometry2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
AID524638Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID508370Antibacterial activity against Streptococcus pneumoniae harboring mef(A) gene after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID580180Antimicrobial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Mar-01, Volume: 19, Issue:5
Synthesis, structure, molecular docking, and structure-activity relationship analysis of enamines: 3-aryl-4-alkylaminofuran-2(5H)-ones as potential antibacterials.
AID533928Antimicrobial activity against linezolid-resistant Staphylococcus aureus 1652 harboring U2500A mutation in peptidyl transferase centre by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID373052Antimicrobial activity against Escherichia coli DH10B carrying pJIM2246 expressing Bacillus clausii NR beta-lactamase BCL1 by agar-dilution technique2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
AID531453Antibacterial activity against Streptococcus pneumoniae serotype 19A assessed as percent resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID1309202Antibacterial activity against Pseudomonas lachrymans by broth microdilution assay2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Four new minor brominated indole related alkaloids with antibacterial activities from Laurencia similis.
AID567279Activity of Acinetobacter baumannii ADC-33 beta-lactamase2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
Extended-spectrum cephalosporinase in Acinetobacter baumannii.
AID1128827Antibacterial activity against Bacillus subtilis SCSIO BS01 after 18 hrs by broth microdilution method2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Spiromastixones A-O, antibacterial chlorodepsidones from a deep-sea-derived Spiromastix sp. fungus.
AID425335Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococci.
AID559513Antibacterial activity against levofloxacin susceptible Streptococcus pneumoniae assessed as percent susceptible isolates by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID565732Antimicrobial activity against erythromycin-susceptible Streptococcus Group G clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID524066Binding affinity to against methicillin-, daptomycin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 25 PBP3 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID278538Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium breve R0070 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID611680Antifungal activity against Septoria tritici at 0.05 mg by agar diffusion method2011Journal of natural products, Jul-22, Volume: 74, Issue:7
Bioactive 11,20-epoxy-3,5(16)-diene briarane diterpenoids from the South China Sea gorgonian Dichotella gemmacea.
AID1245114Antimicrobial activity against Bacillus subtilis ATCC 6633 after 18 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Sep-15, Volume: 23, Issue:18
Design, synthesis and molecular docking of salicylic acid derivatives containing metronidazole as a new class of antimicrobial agents.
AID1882851Binding affinity to Staphylococcus aureus ATCC 43300 50S ribosomal subunit assessed as equilibrium dissociation constant by surface plasmon resonance analysis
AID278526Antimicrobial activity against Bifidobacterium infantis ATCC 156972007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID29160Dissociation constant of the compound1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. Synthesis and properties of some dihydropyridine and dihydroiosquinoline derivatives of benzylpenicillin.
AID522648Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis Africa 33 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID205978In Vitro minimal inhibitory concentration against Staphylococcus aureus (FDA 209P)1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
Syntheses of new isodethiaazacephems as potent antibacterial agents.
AID1191518Antibacterial activity against Enterococcus sp. J 14365/08 after 48 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID559056Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID770973Antibacterial activity against Staphylococcus aureus MTCC 96 by broth dilution method2013European journal of medicinal chemistry, Oct, Volume: 68Demonic axe-like conjugated alkynes in combating microbes.
AID520728Activity of Acinetobacter baumannii CIP7010 beta-lactamase assessed per mg of protein at 100 uM2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97.
AID573785Antibacterial activity against Prevotella intermedia by by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID508367Antibacterial activity against penicillin-resistant Streptococcus pneumoniae after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID528724Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID529655Activity of Pseudomonas aeruginosa 9551 beta-lactamase VIM-152008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID571175Antibacterial activity against Neisseria gonorrhoeae assessed as susceptible isolates by disk agar diffusion method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID495697Activity of Pseudomonas aeruginosa VIM-22010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID573825Antibacterial activity against beta-lactamase producing Clostridium tertium by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID508378Antibacterial activity against macrolide-resistant Streptococcus pneumoniae harboring mef(A) gene after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID532983Antibacterial activity against Escherichia coli W31102010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID1279009Antibacterial activity against methicillin-resistant Staphylococcus aureus H 5996/08 after 24 hrs by microbroth dilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
AID558537Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter coli isolate P321 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID1237617Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC510019 assessed as bacterial growth inhibition after 24 hrs by broth dilution method2015European journal of medicinal chemistry, Jul-15, Volume: 100Novel cajaninstilbene acid derivatives as antibacterial agents.
AID508373Antibacterial activity against Streptococcus pneumoniae harboring mutation in L4 ribosomal protein after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID524648Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA, penB, ponA and mtrR mutant gene assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID171115Concentration of compound in rat brain after intravenous injection of 20 mg/kg benzyl-penicillin after 10 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID534088Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae isolate by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
AID524257Ratio of Kcat to Km in Escherichia coli beta-lactamase SHV-12010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain.
AID1254301Antibacterial activity against methicillin-resistant Staphylococcus aureus H 5996/08 after 48 hrs by microdilution broth method2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
AID486256Antibacterial activity against Staphylococcus aureus NCIM 2120 after 24 hrs by disc diffusion method2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Synthesis and biological evaluation of beta-chloro vinyl chalcones as inhibitors of TNF-alpha and IL-6 with antimicrobial activity.
AID574948Antimicrobial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID1546647Antibacterial activity against Staphylococcus epidermidis assessed as reduction in microbial growth after 24 hrs by CLSI based microdilution method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
AID245519Minimum inhibitory concentration against Chromobacterium violaceum (Gram-negative) was determined by broth dilution method2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Synthesis and antibacterial activity of 2,4,6-tri substituted s-triazines.
AID542615Antimicrobial activity against Streptococcus pneumoniae R6 harboring PBP2x T338G mutant gene after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID524043Antibacterial activity against methicillin-, daptomycin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 25 by macrodilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID508375Antibacterial activity against quinolone-susceptible Streptococcus pneumoniae after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID356754Antimicrobial activity against methicillin-resistant Staphylococcus aureus 310 after 18 hrs by microbroth dilution method2001Journal of natural products, Jul, Volume: 64, Issue:7
Biological and mechanistic activities of xanthorrizol and 4-(1',5'-dimethylhex-4'-enyl)-2-methylphenol isolated from Iostephane heterophylla.
AID559060Antibacterial activity against Streptococcus pyogenes by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID1112105Antialgal activity against 'Chlorella' fusca by agar diffusion test2012Fitoterapia, Apr, Volume: 83, Issue:3
Pyrenocines J-M: four new pyrenocines from the endophytic fungus, Phomopsis sp.
AID524047Binding affinity to methicillin-, linezolid-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 2149A PBP1 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID373050Antimicrobial activity against Bacillus clausii NR expressing beta-lactamase BCL1 by agar-dilution technique2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
AID351193Clearance in iv dosed neonates with gestational age of 27 to 40 weeks2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.
AID558620Antimicrobial activity against Streptococcus pneumoniae isolate 3282 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID524875Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA and penB mutant gene assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID171261Concentration of compound in rat liver after intravenous injection of 20 mg/kg benzyl-penicillin after 40 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID520397Antibacterial activity against erm(B) and mef(E)-positive Streptococcus pneumoniae isolate Spain 6B by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).
AID1072989Antimicrobial activity against Staphylococcus aureus Smith MB 2865 after 20 hrs by 2-fold serial broth dilution method2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Isolation, structure elucidation, and biological activity of altersolanol P using Staphylococcus aureus fitness test based genome-wide screening.
AID679535TP_TRANSPORTER: inhibition of Ochratoxin A uptake (OTA: 1 uM, PCG: 200 uM) in OAT1-expressing S2 cells2001Life sciences, Sep-21, Volume: 69, Issue:18
Characterization of ochratoxin A transport by human organic anion transporters.
AID1072991Antibacterial activity against Streptococcus mutans ATCC 35668 after 24 hrs by microbroth dilution assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Pyrano-isoflavans from Glycyrrhiza uralensis with antibacterial activity against Streptococcus mutans and Porphyromonas gingivalis.
AID625284Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID70750In Vitro minimal inhibitory concentration against Escherichia coli (ATCC 39188)1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
Syntheses of new isodethiaazacephems as potent antibacterial agents.
AID498377Antimicrobial activity against penicillin- and streptomycin-resistant Streptococcus gordonii Tol1 harboring Tol1 mutation infected in Wistar rat assessed as protection against bacterial infection at 300000 U/kg, sc administered 16 hrs after infection ever2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.
AID573141Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID372895Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID341521Antimicrobial activity against Neisseria meningitidis isolates harboring penA 29 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID524663Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing mtrR mutant gene assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID529899Antimicrobial activity against Leptospira weilii isolate 8 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID322507Volume of distribution at steady state in human adults at 600 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID520396Antibacterial activity against mef(E) and mef(A)-positive Streptococcus pneumoniae isolate CC-6B by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).
AID529898Antimicrobial activity against Leptospira weilii isolate 6 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID561734Antibacterial activity against Beta-hemolytic Streptococcus group B assessed as resistant isolates by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID573120Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID654972Competitive inhibition of pig PAP using para-nitrophenol as substrate at pH 4.9 preincubated for 10 mins by UV-visible spectrophotometry2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Penicillin inhibitors of purple acid phosphatase.
AID658946Antibacterial activity against Escherichia coli 124300 at 100 mg/ml after 24 hrs by agar-well diffusion technique2012European journal of medicinal chemistry, Jun, Volume: 522-Aminothiophenes as building blocks in heterocyclic synthesis: synthesis and antimicrobial evaluation of a new class of pyrido[1,2-a]thieno[3,2-e]pyrimidine, quinoline and pyridin-2-one derivatives.
AID654973Uncompetitive inhibition of pig PAP using para-nitrophenol as substrate at pH 4.9 preincubated for 10 mins by UV-visible spectrophotometry2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Penicillin inhibitors of purple acid phosphatase.
AID533941Antimicrobial activity against linezolid-resistant Enterococcus faecalis 412 harboring G2576U mutation in peptidyl transferase centre by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID1348082Antimicrobial activity against Candida tropicalis ATCC 13803 assessed as zone of inhibition at 50 ug per disc after 48 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID210030Antibacterial activity was determined against clinically isolated penicillin resistant Streptococcus pneumoniae (PRSP) strains (50 strains); Range= 1-42003Journal of medicinal chemistry, Mar-13, Volume: 46, Issue:6
Synthesis and structure-activity relationships of 5-amino-6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-8-methylquinolonecarboxylic acid antibacterials having fluorinated 7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl] substituents.
AID554867Antimicrobial activity against Streptococcus pneumoniae serotype 19F ST 3245 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID1079941Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]
AID573119Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID520412Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Antistreptococcal activity of AR-709 compared to that of other agents.
AID490134Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT assay2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis of some N-alkyl substituted urea derivatives as antibacterial and antifungal agents.
AID1209731Drug uptake by mouse OAT3 expressed in CHO cells at 100 uM after 25 mins by HPLC/UV detection method2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
AID1128826Antibacterial activity against Bacillus thuringiensis SCSIO BT01 after 18 hrs by broth microdilution method2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Spiromastixones A-O, antibacterial chlorodepsidones from a deep-sea-derived Spiromastix sp. fungus.
AID520393Antibacterial activity against mef-positive Streptococcus pneumoniae isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).
AID1149038Antibacterial activity against Salmonella schottmuelleri assessed as growth inhibition incubated for 24 hrs using acid chloride1976Journal of medicinal chemistry, Feb, Volume: 19, Issue:2
Beta-lactam antibiotics with N-oxide side chains. 1. Quinoxaline N-oxides.
AID562361Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID1091746Antibacterial activity against Pseudomonas aeruginosa MTCC 741 assessed as inhibition zones at 100 ug/disk at 37 degC for 24 hr2009Chemical & pharmaceutical bulletin, Jul, Volume: 57, Issue:7
Synthesis, nematicidal and antimicrobial properties of Bis-[4-methoxy-3-[3-(4-fluorophenyl)-6-(4-methylphenyl)-2(aryl)-tetrahydro-2H-pyrazolo[3,4-d]thiazol-5-yl]phenyl]methanes.
AID322493Cmax in human very low birth weight preterm neonates at 14 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID529895Antimicrobial activity against Leptospira interrogans serovar Icterohaemorrhagiae isolate 3 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID351188Volume of distribution in central compartment in preterm neonates with septicemia or invasive infections with gestational age of less than 32 weeks at 50000 U/kg, iv administered every 12 hrs2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.
AID562583Antimicrobial activity against Streptococcus pyogenes clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID1161139Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by broth microdilution method2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
AID467612Fraction unbound in human plasma2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
AID557269Antimicrobial activity against Streptococcus pneumoniae 1394 by CLSI method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID591663Antimicrobial activity against multidrug-resistant Streptococcus pneumoniae after 18 hrs by agar dilution method2011Journal of medicinal chemistry, Apr-14, Volume: 54, Issue:7
A new DNA gyrase inhibitor subclass of the cyclothialidine family based on a bicyclic dilactam-lactone scaffold. Synthesis and antibacterial properties.
AID558627Antimicrobial activity against Streptococcus pneumoniae isolate 3587 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID557469Antimicrobial activity against penicillin-sensitive Streptococcus pneumoniae 3009 by CLSI method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID563976Activity of Klebsiella pneumoniae 05-560 beta-lactamase VIM2 by spectrophotometry2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
AID1079939Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]
AID1565590Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by CLSI based broth microdilution method2019European journal of medicinal chemistry, Nov-15, Volume: 182Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity.
AID1091739Antibacterial activity against Enterobacter aerogenes MTCC 39 assessed as growth arrest at 37 degC for 24 hr2009Chemical & pharmaceutical bulletin, Jul, Volume: 57, Issue:7
Synthesis, nematicidal and antimicrobial properties of Bis-[4-methoxy-3-[3-(4-fluorophenyl)-6-(4-methylphenyl)-2(aryl)-tetrahydro-2H-pyrazolo[3,4-d]thiazol-5-yl]phenyl]methanes.
AID200682In Vitro minimal inhibitory concentration against Salmonella typhi (O-901)1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
Syntheses of new isodethiaazacephems as potent antibacterial agents.
AID571185Antibacterial activity against Neisseria gonorrhoeae harboring KD gene by disk agar diffusion method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID1126515Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by two-fold serial dilution method2014Bioorganic & medicinal chemistry, Apr-15, Volume: 22, Issue:8
Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents.
AID666595Antibacterial activity against Escherichia coli after 16 hrs by broth dilution method2012European journal of medicinal chemistry, Aug, Volume: 54Facile synthesis, cytotoxic and antimicrobial activity studies of a new group of 6-aryl-3-[4-(methylsulfonyl)benzyl]-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines.
AID554871Antimicrobial activity against Streptococcus pneumoniae serotype 6B ST 90 harboring ERY-resistant erm(B) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID573574Antibacterial activity against beta-lactamase producing Bacteroides uniformis assessed as resistant isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID503226Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 38030509 by microscopy2007Nature chemical biology, Sep, Volume: 3, Issue:9
Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins.
AID573590Antibacterial activity against Fusobacterium varium by by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID521348Antimicrobial activity against Streptococcus pneumoniae isolate 187 obtained from bronchoalveolar lavage fluid of patient2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20.
AID575079Antimicrobial activity against Streptococcus pneumoniae serotype 7F assessed as percent susceptible isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID573824Antibacterial activity against beta-lactamase producing Clostridium septicum by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID1191513Antibacterial activity against methicillin-resistant Staphylococcus aureus H 5996/08 after 24 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID1254305Antibacterial activity against Enterococcus sp. J 14365/08 after 48 hrs by microdilution broth method2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
AID522649Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis Colorado by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID524689Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro antibacterial activity of CE-156811, a novel analog derived from hygromycin A.
AID591665Antimicrobial activity against multidrug-resistant Moraxella catarrhalis after 18 hrs by agar dilution method2011Journal of medicinal chemistry, Apr-14, Volume: 54, Issue:7
A new DNA gyrase inhibitor subclass of the cyclothialidine family based on a bicyclic dilactam-lactone scaffold. Synthesis and antibacterial properties.
AID524256Activity at Escherichia coli beta-lactamase SHV-12010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain.
AID522668Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis B126 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID519747Activity of Klebsiella pneumoniae Beta-Lactamase SHV-722008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
AID1191515Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 24 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID508376Antibacterial activity against quinolone-resistant Streptococcus pneumoniae after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID587967Activity of Escherichia coli beta-lactamase Toho-1 G232A mutant assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID1129598Antibacterial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT assay2014European journal of medicinal chemistry, Apr-09, Volume: 76Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents.
AID1601849Antibacterial activity against Pseudomonas aeruginosa CMCC 27853 measured after 24 hrs by ELISA2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety.
AID425339Antibacterial activity against azithromycin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococci.
AID451350Antimicrobial activity against Staphylococcus aureus NBRC13276 after 24 hrs by broth dilution method2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Synthesis and evaluation of bioactive naphthoquinones from the Brazilian medicinal plant, Tabebuia avellanedae.
AID559706Antimicrobial activity against methicillin-resistant Staphylococcus aureus P1374 by microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.
AID577451Antimicrobial activity against penicillin intermediate resistant Streptococcus pneumoniae isolate 8009 harboring PBP2b 443SSNA mutant by broth microdilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Affinity of ceftobiprole for penicillin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin.
AID335495Antimicrobial activity against Staphylococcus aureus 375 after 18 to 20 hrs by standard broth microdilution method2002Journal of natural products, Jun, Volume: 65, Issue:6
New antimicrobial cycloartane triterpenes from Acalypha communis.
AID395340Antibacterial activity against Escherichia coli ATCC 11230 at 10 units after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID1149036Antibacterial activity against Staphylococcus aureus assessed as growth inhibition incubated for 24 hrs using acid chloride1976Journal of medicinal chemistry, Feb, Volume: 19, Issue:2
Beta-lactam antibiotics with N-oxide side chains. 1. Quinoxaline N-oxides.
AID573797Antibacterial activity against Prevotella intermedia assessed as susceptible isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID573115Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID1237616Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC515992 assessed as bacterial growth inhibition after 24 hrs by broth dilution method2015European journal of medicinal chemistry, Jul-15, Volume: 100Novel cajaninstilbene acid derivatives as antibacterial agents.
AID368545Ratio of Kcat to Km of Pseudomonas aeruginosa 18SH AmpC assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID559522Antibacterial activity against Streptococcus salivarius assessed as percent susceptible isolates by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID495662Ratio of Kcat to Km for Pseudomonas aeruginosa 531 beta-lactamase BEL-22010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.
AID574950Antimicrobial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID559044Antibacterial activity against Listeria monocytogenes by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID522645Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis Texas by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID619775Antibacterial activity against Escherichia coli RCMB 000103 at 30 mg/ml after 24 hrs by agar well diffusion method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design and synthesis of some new thiophene, thienopyrimidine and thienothiadiazine derivatives of antipyrine as potential antimicrobial agents.
AID569260Antimicrobial activity against Staphylococcus aureus2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.
AID582967Antimicrobial activity against beta-lactamase B-deficient Yersinia enterocolitica GY5542 after 20 hrs by Etest2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Contribution of BlaA and BlaB beta-lactamases to antibiotic susceptibility of Yersinia enterocolitica biovar 1B.
AID587966Activity of Escherichia coli beta-lactamase Toho-1 F160T mutant assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID368493Activity of Escherichia coli CTX-M-15 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID322488Half life in human very low birth weight preterm neonates at 28 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID1237614Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC51033 assessed as bacterial growth inhibition after 24 hrs by broth dilution method2015European journal of medicinal chemistry, Jul-15, Volume: 100Novel cajaninstilbene acid derivatives as antibacterial agents.
AID531455Antibacterial activity against Streptococcus pneumoniae serotype 3 assessed as percent resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID530504Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IB isolate 5436-03 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID373054Antimicrobial activity against Escherichia coli BL21(DE3) carrying pET9a expressing Bacillus clausii beta-lactamase BCL1 by agar-dilution technique2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
AID431315Antibacterial activity against Bacillus cereus ATCC 117782009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
AID1079942Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]
AID368314Activity of Staphylococcus aureus betalactamase PC1 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID561099Antibacterial activity against Pasteurella multocida ATCC 43137 by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID1072982Antimicrobial activity against Haemophilus influenzae MB 4572 after 20 hrs by 2-fold serial broth dilution method2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Isolation, structure elucidation, and biological activity of altersolanol P using Staphylococcus aureus fitness test based genome-wide screening.
AID522667Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis K8091 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID378410Antimicrobial activity against Bacillus subtilis ATCC 6633 after 18 hrs2006Journal of natural products, Aug, Volume: 69, Issue:8
Carneic acids A and B, chemotaxonomically significant antimicrobial agents from the xylariaceous ascomycete Hypoxylon carneum.
AID559067Antibacterial activity against Streptococcus salivarius by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID1079947Comments (NB not yet translated). [column 'COMMENTAIRES' in source]
AID278521Antimicrobial activity against Bifidobacterium animalis ATCC 275362007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID368723Ratio of Kcat to Km of Pseudomonas aeruginosa MK-1184 AmpC assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID425341Antibacterial activity against quinolone-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococci.
AID577453Inhibition of Bocillin FL binding to Streptococcus pneumoniae isolate 8865 PBP2b2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Affinity of ceftobiprole for penicillin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin.
AID171258Concentration of compound in rat liver after intravenous injection of 20 mg/kg benzyl-penicillin after 10 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID574041Antibacterial activity against beta-lactamase producing Peptoniphilus asaccharolyticus by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID522662Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis K7038 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID569346Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae by agar dilution method2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
AID573593Antibacterial activity against Fusobacterium necrophorum by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID520388Ratio of Kcat to Km for Pseudomonas aeruginosa COL-1 metallo-beta lactamase VIM-22008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biochemical characterization of metallo-beta-lactamase VIM-11 from a Pseudomonas aeruginosa clinical strain.
AID533878Antibacterial activity against amoxicillin-resistant Streptococcus pneumoniae isolate by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
AID511449Antimicrobial activity against Streptococcus uberis isolate ALP 8144 harboring PBP2X E381K/Q554E mutation assessed as inhibition of visible growth after 24 hrs by broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID529657Activity of Pseudomonas aeruginosa 166301 beta-lactamase VIM-162008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID511532Antimicrobial activity against Streptococcus uberis isolate 20568 harboring PAP1A G386R, PBP2B N366I/T402I/V570A/P575S and PBP2X E381K/Q554E mutation assessed as inhibition of visible growth after 24 hrs by broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID425393Antibacterial activity against mucosa-associated Escherichia coli isolates isolated from patients with Crohn's disease by disk diffusion method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID531570Antibacterial activity against Streptococcus sp. 'group G' obtained from complicated skin and skin structure infections by agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
AID278677Antibacterial activity against Enterococcus faecium isolate 25472007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID493655Antimicrobial activity against Streptococcus faecalis ATCC 9790 by MTT assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
AID1079940Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]
AID1091743Antibacterial activity against Bacillus subtilis MTCC 441 assessed as growth arrest at 37 degC for 24 hr2009Chemical & pharmaceutical bulletin, Jul, Volume: 57, Issue:7
Synthesis, nematicidal and antimicrobial properties of Bis-[4-methoxy-3-[3-(4-fluorophenyl)-6-(4-methylphenyl)-2(aryl)-tetrahydro-2H-pyrazolo[3,4-d]thiazol-5-yl]phenyl]methanes.
AID524981Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
AID418563Antibacterial activity against Bacteroides fragilis ATCC 23745 by NCCLS method2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
AID525546Antimicrobial activity against Haemophilus influenzae Rd KW20 harboring with plasmid pB1000 bearing beta-lactamase ROB-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Haemophilus influenzae clinical isolates with plasmid pB1000 bearing blaROB-1: fitness cost and interspecies dissemination.
AID529321Antibacterial activity against multidrug resistant Streptococcus pneumoniae serotype 6B URA4566 harboring mutant PBP2B PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID531604Activity of Escherichia coli Inhibitor-resistant beta-lactamase SHV-562008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.
AID619681Antifungal activity against Candida albicans ATCC 10231 by broth microdilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis, antimicrobial activity and possible mechanism of action of 9-bromo-substituted indolizinoquinoline-5,12-dione derivatives.
AID573114Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID574023Antibacterial activity against beta-lactamase producing Peptostreptococcus anaerobius by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID508295Inhibition of PBP1 in penicillin-resistant Enterococcus faecium D63r membranes assessed as inhibition of fluorescent ampicillin binding after 20 mins at 37 degC2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID524977Antibacterial activity against Streptococcus bovis clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
AID1112107Antimicrobial activity against Bacillus megaterium by agar diffusion test2012Fitoterapia, Apr, Volume: 83, Issue:3
Pyrenocines J-M: four new pyrenocines from the endophytic fungus, Phomopsis sp.
AID562372Antimicrobial activity against erythromycin-susceptible Streptococcus Group C clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID546428Activity at Pseudomonas aeruginosa PDC-3 by spectrophotometer2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.
AID528725Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID372899Antibacterial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID498374Antimicrobial activity against wild type streptomycin-susceptible Streptococcus gordonii harboring P438R mutation in ptsI assessed as decrease in [14C]glucose uptake at 2 ug/ml after 60 mins by liquid scintillation counting2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.
AID591664Antimicrobial activity against multidrug-resistant Haemophilus influenzae after 18 hrs by agar dilution method2011Journal of medicinal chemistry, Apr-14, Volume: 54, Issue:7
A new DNA gyrase inhibitor subclass of the cyclothialidine family based on a bicyclic dilactam-lactone scaffold. Synthesis and antibacterial properties.
AID293929Inhibition of cell wall biosynthesis in Staphylococcus aureus assessed as cytoplasmic membrane rupture2007Bioorganic & medicinal chemistry, Mar-15, Volume: 15, Issue:6
N-thiolated beta-lactams: Studies on the mode of action and identification of a primary cellular target in Staphylococcus aureus.
AID573552Antibacterial activity against Bacteroides fragilis assessed as resistant isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID585179Activity of Beta-lactamase GES-6 K104, S170 mutant2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
AID557209Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis assessed as percent susceptible isolates by Etest method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
AID573143Antibacterial activity against penicillin-susceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID508365Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID522391Inhibition of Aeromonas enteropelogenes Beta-lactamase TRU12010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Genetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenes.
AID563972Activity of Klebsiella pneumoniae 05-560 beta-lactamase NDM-1 by spectrophotometry2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
AID562606Antimicrobial activity against Streptococcus pneumoniae clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID493653Antimicrobial activity against Bacillus subtilis ATCC 6633 by MTT assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
AID535763Antimicrobial activity against penicillin-producing Neisseria gonorrhoeae NGON 06-041 expressing beta-lactamase TEM-1, MLST type ST-1588 and MAST type ST-4012 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Identification of TEM-135 beta-lactamase in penicillinase-producing Neisseria gonorrhoeae strains in Japan.
AID546427Activity at Pseudomonas aeruginosa PDC-2 by spectrophotometer2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.
AID554858Antimicrobial activity against Streptococcus pneumoniae serotype 14 ST 2306 harboring ERY-resistant erm(B) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID557495Displacement of Biocillin FL from Streptococcus pneumoniae 3665 PBP2X2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID565739Antimicrobial activity against Streptococcus pyogenes clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID381180Antibacterial activity against Staphylococcus aureus after 24 to 72 hrs by disk diffusion method1999Journal of natural products, Sep, Volume: 62, Issue:9
Antimicrobial and antitumor activities of mycosporulone.
AID395341Antibacterial activity against Staphylococcus aureus ATCC 6538 at 10 units after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID565738Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID1079944Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]
AID542627Antimicrobial activity against streptomycin-resistant Streptococcus pneumoniae R6 harboring PBP2x T338G and PBP1a2349 mutant gene and aad9 disruption in CiaR gene after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID681415TP_TRANSPORTER: inhibition of Homovanillic acid uptake (HVA: 0.2 uM, PCG: 1000 uM) in Xenopus laevis oocytes2003Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, Apr, Volume: 23, Issue:4
Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells.
AID573155Antibacterial activity against vancomycin-resistant Enterococcus faecium by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID520404Antimicrobial activity against macrolide-resistant Streptococcus pneumoniae by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Antistreptococcal activity of AR-709 compared to that of other agents.
AID520405Antimicrobial activity against quinolone-susceptible Streptococcus pneumoniae by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Antistreptococcal activity of AR-709 compared to that of other agents.
AID1647683Antibacterial activity against Staphylococcus epidermidis ATCC 14990 assessed as reduction in microbial growth after 24 hrs by agar well diffusion assay2020Journal of natural products, 02-28, Volume: 83, Issue:2
Isolation, Identification, and Decomposition of Antibacterial Dialkylresorcinols from a Chinese
AID373209Activity of Bacillus clausii NR beta-lactamase BCL1 expressed in Escherichia coli BL21 (DE3)2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
AID573146Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID336568Antibacterial activity against Streptococcus mutans ATCC 25175 after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID557506Displacement of Biocillin FL from Streptococcus pneumoniae 1076 PBP2A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID374681Antimicrobial activity against kanamycin-resistant Escherichia coli K-12 M1 W3110 deltarapA mutant flow cell-generated 24 hrs biofilms at 350 ug/ml after 1 hr using BacLight staining by CSLM2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
AID508379Antibacterial activity against macrolide-resistant Streptococcus pneumoniae harboring erm(B) and mef(A) gene after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID559068Antibacterial activity against Streptococcus sanguinis by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID334154Antimicrobial activity against Staphylococcus aureus at 10 units by antimicrobial disk assay1997Journal of natural products, Nov, Volume: 60, Issue:11
New phomopsolides from a Penicillium sp.
AID486251Cytotoxicity against human CCK8 cells at 10 uM2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Synthesis and biological evaluation of beta-chloro vinyl chalcones as inhibitors of TNF-alpha and IL-6 with antimicrobial activity.
AID495721Activity of Escherichia coli CMY-2 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID278561Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium breve ATCC 15700 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID341527Antimicrobial activity against Neisseria meningitidis isolates harboring penA 42 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID534396Ratio of Kcat to Km for Escherichia coli JM109 harboring recombinant pKHM-1 Beta-lactamase KHM-1 assessed as compound hydrolysis by UV-visible spectrophotometry2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
AID559065Antibacterial activity against Streptococcus mitis by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID374685Antimicrobial activity against kanamycin-resistant Escherichia coli K-12 M2 W3110 deltayhcQ mutant 24 hrs biolflim at 350 ug/ml after 1 hr using BacLight staining2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
AID1546648Antibacterial activity against Bacillus subtilis MTCC 441 assessed as reduction in microbial growth after 24 hrs by CLSI based microdilution method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
AID575944Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae by broth microdilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.
AID585185Ratio of Kcat to Km for Beta-lactamase GES-6 K104, S170 mutant2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
AID394488Activity of Hafnia alvei beta-lactamase ACC-1 assessed as nmol of compound hydrolysis per ug of protein2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
AID557504Displacement of Biocillin FL from Streptococcus pneumoniae 3665 PBP2A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID1638895Antimicrobial activity against Staphylococcus aureus ATCC 25923 measured after 18 hrs by broth microdilution method2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
AID532987Antibacterial activity against Pseudomonas aeruginosa NCIM 5029 in presence of 10 mM N-Acetylcysteine2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID287375Antibacterial activity against Micrococcus luteus after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID1091748Antibacterial activity against Lysinibacillus sphaericus MTCC 11 assessed as inhibition zones at 100 ug/disk at 37 degC for 24 hr2009Chemical & pharmaceutical bulletin, Jul, Volume: 57, Issue:7
Synthesis, nematicidal and antimicrobial properties of Bis-[4-methoxy-3-[3-(4-fluorophenyl)-6-(4-methylphenyl)-2(aryl)-tetrahydro-2H-pyrazolo[3,4-d]thiazol-5-yl]phenyl]methanes.
AID398235Antimicrobial activity against methicillin-sensitive Staphylococcus aureus 375 after 18 hrs by twofold serial microbroth dilution method2003Journal of natural products, Dec, Volume: 66, Issue:12
A novel antibacterial iridoid and triterpene from Caiophora coronata.
AID322489Half life in human very low birth weight preterm neonates at 14.3 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID1601843Antibacterial activity against Streptococcus pyogenes CMCC 32067 measured after 24 hrs by ELISA2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety.
AID1279017Antibacterial activity against Klebsiella pneumoniae D 11750/08 after 24 hrs by microbroth dilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
AID557512Displacement of Biocillin FL from Streptococcus pneumoniae 3243 PBP2B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID351187Clearance in preterm neonates with septicemia or invasive infections with gestational age of less than 32 weeks at 50000 U/kg, iv administered every 12 hrs2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.
AID530339Activity of Pseudomonas aeruginosa VIM-13 beta-lactamase2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
AID1546640Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as diameter of zone of inhibition at 200 ug/ml after 24 hrs by agar well diffusion method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
AID522389Activity of Aeromonas caviae Beta-lactamase CAV12010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Genetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenes.
AID373051Antimicrobial activity against Bacillus clausii ATCC 21537 by agar-dilution technique2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
AID531423Antibacterial activity against Streptococcus pneumoniae serotype 15A by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID437460Antimicrobial activity Staphylococcus aureus ATCC 6538 by MTT assay2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
AID524640Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing mtrR mutant gene assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID524246Antimicrobial activity against Escherichia coli DH5alpha expressing SHV-842010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain.
AID558329Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P305 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID1638898Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 measured after 18 hrs by broth microdilution method2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
AID522656Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis 17T5 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID574032Antibacterial activity against beta-lactamase producing Micromonas micros by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID74714Inhibition of gram positive bacteria growth.1989Journal of medicinal chemistry, Jun, Volume: 32, Issue:6
Synthesis and antimicrobial properties of substituted beta-aminoxypropionyl penicillins and cephalosporins.
AID398236Antimicrobial activity against methicillin-resistant Staphylococcus aureus 310 after 18 hrs by twofold serial microbroth dilution method2003Journal of natural products, Dec, Volume: 66, Issue:12
A novel antibacterial iridoid and triterpene from Caiophora coronata.
AID529893Antimicrobial activity against Leptospira interrogans serovar Bataviae isolate 1 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID534084Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolate by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
AID543280Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 pbp2x, pbp2b and Streptococcus pneumoniae 3191 pbp1a genes by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID1546644Antibacterial activity against Pseudomonas aeruginosa MTCC 741 assessed as diameter of zone of inhibition at 200 ug/ml after 24 hrs by agar well diffusion method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
AID1449628Inhibition of human BSEP expressed in baculovirus transfected fall armyworm Sf21 cell membranes vesicles assessed as reduction in ATP-dependent [3H]-taurocholate transport into vesicles incubated for 5 mins by Topcount based rapid filtration method2012Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 40, Issue:12
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
AID531572Antibacterial activity against Streptococcus mitis obtained from complicated skin and skin structure infections by agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
AID573121Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID524980Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
AID529334Antibacterial activity against multidrug resistant Streptococcus pneumoniae serotype 14 URA4203 harboring mutant PBP2B PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID428134Antimicrobial activity against penicillin-resistant Streptococcus gordonii PR1_2 mutant assessed as logarithmic reduction in viability at stationary phase of growth after 70 hrs2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Fitness cost and impaired survival in penicillin-resistant Streptococcus gordonii isolates selected in the laboratory.
AID438297Inhibition of penicillin-sensitive Streptococcus pneumoniae R6 PBP2X preincubated for 1 hr before addition of substrate (R)-[2-(benzoylamino)propionylsulfanyl]acetic acid2009Journal of medicinal chemistry, Oct-08, Volume: 52, Issue:19
Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening.
AID530519Antimicrobial activity against group B Streptococcus sp. 'group B' serotype V isolate 5677-04 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID486727Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT assay2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Synthesis, structure and structure-activity relationship analysis of caffeic acid amides as potential antimicrobials.
AID1237609Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC43300 assessed as bacterial growth inhibition after 24 hrs by broth dilution method2015European journal of medicinal chemistry, Jul-15, Volume: 100Novel cajaninstilbene acid derivatives as antibacterial agents.
AID525547Antimicrobial activity against ampicillin resistant nontypeable Haemophilus influenzae isolate BB1050 harboring with plasmid pB1000 bearing beta-lactamase ROB-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Haemophilus influenzae clinical isolates with plasmid pB1000 bearing blaROB-1: fitness cost and interspecies dissemination.
AID531579Antibacterial activity against Micrococcus spp. obtained from complicated skin and skin structure infections by agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
AID565731Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group G clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID368546Ratio of Kcat to Km of Pseudomonas aeruginosa 18SH AmpC assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID1870120Antibacterial activity against antibiotic resistant Staphylococcus aureus 4883/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID1348089Antimicrobial activity against Bacillus subtilis subsp. subtilis ATCC 6051 assessed as zone of inhibition at 50 ug per disc after 24 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID559710Antimicrobial activity against methicillin-resistant Staphylococcus aureus P1386 at 500 ug/ml after 9 hrs by time-kill analysis2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.
AID565729Antimicrobial activity against erythromycin-susceptible Streptococcus Group F clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID285267Activity of Escherichia coli BL21(DE3) beta-lactamase TEM292007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.
AID341528Antimicrobial activity against Neisseria meningitidis isolates harboring penA 14 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID508304Inhibition of PBP3 in wild type Enterococcus faecium D63 membranes assessed as inhibition of fluorescent ampicillin binding after 20 mins at 37 degC2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID559532Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae assessed as percent susceptible isolates by CLSI M7-A7 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID524031Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 1564 by macrodilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID530340Activity of Pseudomonas aeruginosa VIM-1 beta-lactamase2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
AID368498Activity of Enterobacter cloacae 4092 AmpC (E2) assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID295119Antibacterial activity against Micrococcus luteus La 2971 at 10 ug by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID524976Antibacterial activity against Streptococcus sp. Group G clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
AID569340Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 by broth micro dilution technique2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
AID1852760Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 assessed as bacterial growth inhibition by broth microdilution assay2022RSC medicinal chemistry, Sep-21, Volume: 13, Issue:9
Design and evaluation of poly-nitrogenous adjuvants capable of potentiating antibiotics in Gram-negative bacteria.
AID307354Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth dilution assay2007Bioorganic & medicinal chemistry letters, Jun-15, Volume: 17, Issue:12
Penicillin-bound polyacrylate nanoparticles: restoring the activity of beta-lactam antibiotics against MRSA.
AID508294Antimicrobial activity against Enterococcus faecium D63 assessed as bacterial killing at 4 times MIC by time kill curve method2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID558319Antibacterial activity against Campylobacter coli by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID535632Antimicrobial activity against Group B streptococcus R8 harboring T77I, S353F and A514V in PBP 2X; V80A and G613R in PBP 2B; and L45P, N163K, N723S and G527V in PBP 1A by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID524258Activity at Escherichia coli beta-lactamase SHV-842010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain.
AID519981Ratio of Kcat to Km for Klebsiella pneumoniae Beta-Lactamase SHV-12008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Biochemical characterization of SHV-55, an extended-spectrum class A beta-lactamase from Klebsiella pneumoniae.
AID530518Antimicrobial activity against group B Streptococcus sp. 'group B' serotype V isolate 4857-03 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID574955Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID554862Antimicrobial activity against Streptococcus pneumoniae serotype 19F ST 671 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID522650Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis K7978 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID565740Antimicrobial activity against erythromycin-nonsusceptible Streptococcus agalactiae clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID495691Activity of Escherichia coli CMY-22010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID531314Ratio of Kcat to Km for Pseudomonas aeruginosa beta-lactamase VIM-7 by spectrophotometry2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
AID322492Cmax in human very low birth weight preterm neonates at 28 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID322490Half life in human term neonates at 15 mg/kg, im administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID575081Antimicrobial activity against Streptococcus pneumoniae serotype 6C assessed as percent susceptible isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID495661Activity at Pseudomonas aeruginosa 531 beta-lactamase BEL-22010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.
AID528731Antibacterial activity against penicillin intermediate Streptococcus pneumoniae clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID356755Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by microbroth dilution method2001Journal of natural products, Jul, Volume: 64, Issue:7
Biological and mechanistic activities of xanthorrizol and 4-(1',5'-dimethylhex-4'-enyl)-2-methylphenol isolated from Iostephane heterophylla.
AID620349Antibacterial activity against Escherichia coli RCMB 000103 at 30 ug/ml after 24 hrs by diffusion agar technique2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and anti-microbial activity of some 1- substituted amino-4,6-dimethyl-2-oxo-pyridine-3-carbonitrile derivatives.
AID634231Antibacterial activity against Streptococcus sobrinus ATCC 33478 assessed as growth inhibition at 0.00625 to 2.5 ug/ml after 24 hrs by microplate dilution assay2011Journal of natural products, Dec-27, Volume: 74, Issue:12
Isoflavonoids and coumarins from Glycyrrhiza uralensis: antibacterial activity against oral pathogens and conversion of isoflavans into isoflavan-quinones during purification.
AID554866Antimicrobial activity against Streptococcus pneumoniae serotype 19F ST 2917 harboring ERY-resistant erm(B) and mef(E) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID340766Antibacterial activity against wild type penicillin-susceptible Streptococcus gordonii at 2 times MIC2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii.
AID422497Ratio of Kcat to Km of Carnobacterium divergens BM4489 penicillinase Cad-12008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
AID757813Antibacterial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
AID1180448Antimicrobial activity against methicillin-resistant Staphylococcus aureus H 5996/08 after 48 hrs by microdilution method2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
AID530506Antimicrobial activity against group B Streptococcus sp. 'group B' serotype II isolate 9051-04 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID528722Antibacterial activity against Streptococcus viridans clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID524871Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID528521Antimicrobial activity against penicillin-resistant Streptococcus agalactiae ATCC BAA-611 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID534082Antibacterial activity against cefotaxime-resistant Streptococcus pneumoniae isolate by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
AID573394Antibacterial activity against Bacteroides fragilis by by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID524646Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA, ponA and mtrR mutant gene assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID528709Antibacterial activity against penicillin resistant Streptococcus pneumoniae clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID325444Antibacterial activity against Escherichia coli K12 after 14 to 16 hrs by broth dilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Polyamine effects on antibiotic susceptibility in bacteria.
AID611682Antifungal activity against Microbotryum violaceum at 0.05 mg by agar diffusion method2011Journal of natural products, Jul-22, Volume: 74, Issue:7
Bioactive 11,20-epoxy-3,5(16)-diene briarane diterpenoids from the South China Sea gorgonian Dichotella gemmacea.
AID576902Antimicrobial activity against Bacillus anthracis Sterne 7702 selected at 80 uM after 6 passages by macrodilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Oligochlorophens are potent inhibitors of Bacillus anthracis.
AID577450Antimicrobial activity against penicillin intermediate resistant Streptococcus pneumoniae isolate 8882 harboring PBP2b 443SSNA mutant by broth microdilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Affinity of ceftobiprole for penicillin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin.
AID1546641Antibacterial activity against Staphylococcus epidermidis assessed as diameter of zone of inhibition at 200 ug/ml after 24 hrs by agar well diffusion method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
AID534087Antibacterial activity against levofloxacin-resistant Streptococcus pneumoniae assessed as percent susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
AID1638896Antimicrobial activity against penicillin-resistant Staphylococcus aureus ATCC 29213 measured after 18 hrs by broth microdilution method2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
AID520406Antimicrobial activity against quinolone-resistant Streptococcus pneumoniae by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Antistreptococcal activity of AR-709 compared to that of other agents.
AID519627Antimicrobial activity against Brachyspira pilosicoli 80.10 without producing beta-lactamase OXA-63 by disc diffusion method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
AID278534Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium animalis ATCC 27536 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID529894Antimicrobial activity against Leptospira interrogans serovar Grippotyphosa isolate 2 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID557471Antimicrobial activity against penicillin-sensitive Streptococcus pneumoniae 1077 by CLSI method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID278675Antibacterial activity against Enterococcus faecalis isolate 57432007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID573385Antibacterial activity against beta lactamase-positive Moraxella catarrhalis by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID368307Activity of Klebsiella pneumoniae SHV1 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID495664Ratio of Kcat to Km for Pseudomonas aeruginosa 51170 beta-lactamase BEL-12010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.
AID554877Antimicrobial activity against Streptococcus pneumoniae serotype 6B ST 138 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID540968Ratio of Kcat to Km for Salmonella enterica serotype Newport AM17274 cephalosporinase CMY-31 by spectrophotometry2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids.
AID524046Binding affinity to methicillin-, vancomycin-resistant, beta-lactamase-positive Staphylococcus aureus 510 PBP1 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID530507Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 3444-99 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID531575Antibacterial activity against Bacillus spp. obtained from complicated skin and skin structure infections by agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
AID1072986Antimicrobial activity against Streptococcus pneumoniae CL 2883 grown in iso sensitet medium after 20 hrs by 2-fold serial broth dilution method2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Isolation, structure elucidation, and biological activity of altersolanol P using Staphylococcus aureus fitness test based genome-wide screening.
AID604261Antibacterial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT colorimetric method2011Bioorganic & medicinal chemistry, Jul-01, Volume: 19, Issue:13
4-alkoxy-3-arylfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
AID486254Antibacterial activity against Escherichia coli NCIM 2065 after 24 hrs by disc diffusion method2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Synthesis and biological evaluation of beta-chloro vinyl chalcones as inhibitors of TNF-alpha and IL-6 with antimicrobial activity.
AID495842Hydrolytic activity of Escherichia coli DH10B beta-lactamase VIM-2 by microacidimetric method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
AID210403In vitro Minimum inhibitory concentration against Streptococcus pyogenes ATCC 86681981Journal of medicinal chemistry, Oct, Volume: 24, Issue:10
Synthesis and evaluation of ureido- and vinylureidopenicillins as inhibitors of intraruminal lactic acid production.
AID1054742Antibacterial activity against Escherichia coli ATCC 35218 assessed as growth inhibition after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
Schiff's base derivatives bearing nitroimidazole moiety: new class of antibacterial, anticancer agents and potential EGFR tyrosine kinase inhibitors.
AID406553Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 24 hrs by serial dilution method2008Bioorganic & medicinal chemistry, Jul-01, Volume: 16, Issue:13
Unsymmetric aryl-alkyl disulfide growth inhibitors of methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
AID529327Antibacterial activity against multidrug resistant Streptococcus pneumoniae serotype 6B ATCC 700670 harboring mutant PBP2B PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID28559Concentration of compound in human blood tissues after intravenous administration of 2 g dose1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. Synthesis and properties of some dihydropyridine and dihydroiosquinoline derivatives of benzylpenicillin.
AID420258Inhibition of Streptococcus pneumoniae 5204 PBP2x assessed as residual activity at 100 uM after 16 hrs2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Large ring 1,3-bridged 2-azetidinones: experimental and theoretical studies.
AID619773Antibacterial activity against Pseudomonas aeruginosa RCMB 000102 at 30 mg/ml after 24 hrs by agar well diffusion method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design and synthesis of some new thiophene, thienopyrimidine and thienothiadiazine derivatives of antipyrine as potential antimicrobial agents.
AID524973Antibacterial activity against Streptococcus agalactiae clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
AID557394Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis assessed as percent resistant isolates by Etest method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
AID368525Ratio of Kcat to Km of Enterobacter cloacae 4080 AmpC (P99) assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID533930Antimicrobial activity against linezolid-resistant methicillin-resistant Staphylococcus aureus NRS119 harboring G2576U mutation in peptidyl transferase centre by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID554874Antimicrobial activity against Streptococcus pneumoniae serotype 14 ST 2678 harboring ERY-resistant erm(B) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID625446Antimicrobial activity against Staphylococcus aureus MTCC 96 by broth dilution method2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Iodine-catalyzed conjugate addition of indoles onto en-1,4-dione: a novel synthesis of 3-(1-(1H-indol-3-yl)-2-oxo-2-phenylethyl)indolin-2-ones as antibacterial and antifungal agents.
AID557267Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae 24 by CLSI method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID574951Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID587962Activity of Escherichia coli beta-lactamase Toho-1 N104A mutant assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID171270Concentration of compound in rat lung after intravenous injection of 20 mg/kg benzyl-penicillin after 60 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID1870119Antibacterial activity against antibiotic resistant Staphylococcus aureus 4862/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID562374Antimicrobial activity against erythromycin-nonsusceptible Streptococcus pyogenes clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID21916Relative hydrolysis rate (RHR) was evaluated against Staphylococcus aureus with the strain FS1081984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Dependence of beta-lactamase stability on substructures within beta-lactam antibiotics.
AID528704Antibacterial activity against Streptococcus intermedius clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID420256Inhibition of methicillin-resistant Staphylococcus aureus ATCC 433000 PBP2a assessed as residual activity at 100 uM after 16 hrs2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Large ring 1,3-bridged 2-azetidinones: experimental and theoretical studies.
AID495710Kcat/Km ratio of Klebsiella pneumoniae KPC-22010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID558616Antimicrobial activity against Streptococcus pneumoniae isolate 2880 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID776440Antibacterial activity against Bacillus cereus ATCC 14579 after 24 hrs by microdilution technique2013European journal of medicinal chemistry, Nov, Volume: 69Synthesis, antimicrobial, antioxidant activities of novel 6-aryl-5-cyano thiouracil derivatives.
AID278535Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium bifidum R0071 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID322505Volume of distribution at steady state in human very low birth weight preterm neonates at 14 mg/kg, iv2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID565815Antimicrobial activity against Neisseria gonorrhoeae assessed as resistant isolates by CLSI method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis.
AID558610Antimicrobial activity against Streptococcus pneumoniae isolate 1424 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID573124Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID524690Antibacterial activity against penicillin-nonsusceptible Streptococcus pneumoniae clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro antibacterial activity of CE-156811, a novel analog derived from hygromycin A.
AID451349Antimicrobial activity against Bacillus subtilis NBRC3134 after 24 hrs by broth dilution method2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Synthesis and evaluation of bioactive naphthoquinones from the Brazilian medicinal plant, Tabebuia avellanedae.
AID542613Antimicrobial activity against Streptococcus pneumoniae R6 harboring PBP2x T338A mutant gene after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID278922Antibacterial activity against penicillin-resistant Streptococcus pneumoniae2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
In vitro antibacterial activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
AID562586Antimicrobial activity against Streptococcus agalactiae clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID1321402Bactericidal activity against Staphylococcus aureus ATCC 29213 by broth microdilution method2016Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19
The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases.
AID278525Antimicrobial activity against Bifidobacterium breve ATCC 157002007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID524975Antibacterial activity against Streptococcus sp. Group F clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
AID207700In vitro antimicrobial activity against Staphylococcus aureus FDA 209P was determined2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Design, synthesis, and SAR of novel carbapenem antibiotics with high stability to Xanthomonas maltophilia oxyiminocephalosporinase type II.
AID278537Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium breve ATCC 15700 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID520407Antimicrobial activity against trimethoprim-sulfamethoxazole-susceptible Streptococcus pneumoniae by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Antistreptococcal activity of AR-709 compared to that of other agents.
AID540212Mean residence time in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID374669Antimicrobial activity against tetracycline-resistant Escherichia coli U1 rapA mutant grown as planktonic cells after 24 hrs by spectrophotometric method2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
AID520387Ratio of Kcat to Km for Pseudomonas aeruginosa M5109 metallo-beta-lactamase VIM-112008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biochemical characterization of metallo-beta-lactamase VIM-11 from a Pseudomonas aeruginosa clinical strain.
AID557492Displacement of Biocillin FL from Streptococcus pneumoniae 2527 PBP2X2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID573600Antibacterial activity against Fusobacterium mortiferum assessed as resistant isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID498378Antimicrobial activity against erythromycin- and streptomycin-resistant Streptococcus gordonii Tol1 harboring R483P mutation in ptsI infected in Wistar rat assessed as protection against bacterial infection at 300000 U/kg, sc administered 16 hrs after inf2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.
AID150758P-gp activity was measured by a direct transport assay, using polarized LLC-PK1 epithelial cells2003Journal of medicinal chemistry, Apr-24, Volume: 46, Issue:9
Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery.
AID576741Antimicrobial activity against Bacillus anthracis by Etest2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Oligochlorophens are potent inhibitors of Bacillus anthracis.
AID571189Antibacterial activity against Neisseria gonorrhoeae harboring Asp-345a insertion in penA and DA G101D mutant genes by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID1063966Antibacterial activity against Staphylococcus aureus CCM 4516/08 after 48 hrs by broth microdilution method2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Salicylanilide diethyl phosphates: synthesis, antimicrobial activity and cytotoxicity.
AID528606Activity of Escherichia coli 2138 beta-lactamase KPC-2 by spectrophotometry2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France.
AID520413Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Antistreptococcal activity of AR-709 compared to that of other agents.
AID541022Activity at Burkholderia cenocepacia 07-34 beta-lactamase PenB1 expressed in Escherichia coli Top10 by UV-spectrophotometry2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex.
AID565810Antimicrobial activity against Neisseria meningitidis by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
AID573132Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID163928In vitro antimicrobial activity against Pseudomonas aeruginosa 18S-H was determined2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Design, synthesis, and SAR of novel carbapenem antibiotics with high stability to Xanthomonas maltophilia oxyiminocephalosporinase type II.
AID369007Sensitivity of Staphylococcus aureus isolated from lactating Holstein bovine subclinical mastitis model at 10 ug/disk after 20 hrs2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Therapeutic effect of nisin Z on subclinical mastitis in lactating cows.
AID1309203Antibacterial activity against Ralstonia solanacearum by broth microdilution assay2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Four new minor brominated indole related alkaloids with antibacterial activities from Laurencia similis.
AID561253Antibacterial activity against Streptococcus pyogenes by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID770971Antibacterial activity against Escherichia coli MTCC 443 by broth dilution method2013European journal of medicinal chemistry, Oct, Volume: 68Demonic axe-like conjugated alkynes in combating microbes.
AID368729Activity of Pseudomonas aeruginosa AmpC assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID535643Antimicrobial activity against Group B streptococcus serotype III N3 by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID1237613Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC62202 assessed as bacterial growth inhibition after 24 hrs by broth dilution method2015European journal of medicinal chemistry, Jul-15, Volume: 100Novel cajaninstilbene acid derivatives as antibacterial agents.
AID562366Antimicrobial activity against erythromycin-susceptible Streptococcus Group F clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID557481Displacement of Biocillin FL from Streptococcus pneumoniae 24 PBP1B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID425336Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 by agar dilution method2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococci.
AID574952Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID287371Antibacterial activity against Escherichia coli after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID519008Activity of Beta-lactamase TEM-149 expressed in Escherichia coli HB1012008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates.
AID519994Antimicrobial activity against Streptococcus pneumoniae harboring erm(B) gene by broth microdilution method2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.
AID561106Antibacterial activity against Pasteurella multocida BB1040 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB9956 bearing tetH gene by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID531567Antibacterial activity against Streptococcus agalactiae obtained from complicated skin and skin structure infections by agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
AID278679Antibacterial activity against Enterococcus faecium isolate 57502007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID1237604Antibacterial activity against Staphylococcus epidermidis ATCC12228 assessed as bacterial growth inhibition after 24 hrs by broth dilution method2015European journal of medicinal chemistry, Jul-15, Volume: 100Novel cajaninstilbene acid derivatives as antibacterial agents.
AID1706286Protein binding in plasma (unknown origin)2020European journal of medicinal chemistry, Dec-15, Volume: 208β-lactam antibiotics: An overview from a medicinal chemistry perspective.
AID171113Concentration of compound in rat blood after intravenous injection of 20 mg/kg benzyl-penicillin after 60 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID575076Antimicrobial activity against Streptococcus pneumoniae serotype 19A assessed as percent susceptible isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID1348085Antimicrobial activity against Klebsiella oxytoca ATCC 8724 assessed as zone of inhibition at 50 ug per disc after 24 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID519013Ratio of Kcat to Km for Beta-lactamase TEM-102008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates.
AID666596Antibacterial activity against Staphylococcus aureus after 16 hrs by broth dilution method2012European journal of medicinal chemistry, Aug, Volume: 54Facile synthesis, cytotoxic and antimicrobial activity studies of a new group of 6-aryl-3-[4-(methylsulfonyl)benzyl]-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines.
AID394490Ratio of Vmax to Km for Hafnia alvei beta-lactamase ACC-12007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
AID776433Antibacterial activity against Staphylococcus aureus ATCC 12600 at 10 mg/ml after 48 hrs by disc-diffusion method2013European journal of medicinal chemistry, Nov, Volume: 69Synthesis, antimicrobial, antioxidant activities of novel 6-aryl-5-cyano thiouracil derivatives.
AID245437Minimum inhibitory concentration against Bacillus sphaericus (Gram-positive) was determined by broth dilution method2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Synthesis and antibacterial activity of 2,4,6-tri substituted s-triazines.
AID269450Antibacterial activity against ampC beta-lactamase Enterobacter cloacae P99 by agar diffusion assay2006Bioorganic & medicinal chemistry letters, Aug-01, Volume: 16, Issue:15
The synthesis and in vitro testing of structurally novel antibiotics derived from acylnitroso Diels-Alder adducts.
AID573592Antibacterial activity against Fusobacterium mortiferum by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID171114Concentration of compound in rat brain after intravenous injection of 20 mg/kg benzyl-penicillin after 1 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID540184Antibacterial activity against Pseudomonas aeruginosa NCIM 2035 after 24 hrs by twofold serial dilution method2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis and anti-tubercular and antimicrobial activities of some 2r,4c-diaryl-3-azabicyclo[3.3.1]nonan-9-one N-isonicotinoylhydrazone derivatives.
AID524661Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID561496Antibacterial activity against Moraxella catarrhalis by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID1279007Antibacterial activity against Staphylococcus aureus CCM 4516/08 after 24 hrs by microbroth dilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
AID520403Antimicrobial activity against macrolide-susceptible Streptococcus pneumoniae by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Antistreptococcal activity of AR-709 compared to that of other agents.
AID548746Antimicrobial activity against viridans group Streptococcus assessed as percent susceptible isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID585176Activity of Beta-lactamase GES-7 K104, G170 mutant2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
AID1765576Antibacterial activity against Staphylococcus epidermidis ATCC 12228 incubated for 18 hrs by CLSI based broth dilution method2021Journal of medicinal chemistry, 08-12, Volume: 64, Issue:15
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
AID540966Activity of Salmonella enterica serotype Newport AM17274 cephalosporinase CMY-31 by spectrophotometry2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids.
AID565735Antimicrobial activity against erythromycin-susceptible Streptococcus Group C clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID535636Antimicrobial activity against Group B streptococcus serotype VI R4 harboring Q557E mutation in PBP 2X and T567I, Y262N mutations in PBP 2B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID1354713Antimicrobial activity against Staphylococcus aureus subsp. aureus Rosenbach ATCC 25923 after 24 hrs by serial dilution method
AID341348Antimicrobial activity against Neisseria meningitidis isolates harboring penA 22 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID543275Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 3191 pbp2x and pbp1a genes by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID567281Ratio of Kcat to Km for Acinetobacter baumannii ADC-33 beta-lactamase2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
Extended-spectrum cephalosporinase in Acinetobacter baumannii.
AID543270Antimicrobial activity against Streptococcus pneumoniae by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID368526Ratio of Kcat to Km of Enterobacter cloacae 4080 AmpC (P99) assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID575338Antimicrobial activity against Listeria monocytogenes EGD-e at 5 ug after 16 hrs by disk diffusion assay2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID521352Antimicrobial activity against Streptococcus pneumoniae ATCC BAA-6122008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20.
AID521831Antimicrobial activity against Streptococcus pneumoniae isolated from meningitis patient assessed as percent resistant isolates by CLSI method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Clonal spread of highly beta-lactam-resistant Streptococcus pneumoniae isolates in Taiwan.
AID1193541Antibacterial activity against Escherichia coli ATCC 25922 at 100 ug after 24 hrs2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities.
AID285271Activity of Escherichia coli BL21(DE3) beta-lactamase TEM12007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.
AID511534Antimicrobial activity against Streptococcus uberis isolate 20618 harboring PAP1A G386R and PBP2X E381K/Q554E mutation assessed as inhibition of visible growth after 24 hrs by broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID571182Antibacterial activity against Neisseria gonorrhoeae harboring ponA L421P mutant gene by disk agar diffusion method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID495731Kcat/Km ratio of Escherichia coli TEM-1 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID574956Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID1437661Antibacterial activity against Staphylococcus haemolyticus CICC 10373 after 20 to 24 hrs by two-fold microdilution method
AID285442Activity of Citrobacter gillenii CIP 106783 Beta-lactamase GIL1 expressed in Escherichia coli DH10B2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii.
AID496405Antimicrobial activity against Borrelia burgdorferi B312010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Ineffectiveness of tigecycline against persistent Borrelia burgdorferi.
AID559859Antimicrobial activity against Streptococcus agalactiae clinical isolates by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections.
AID1157278Antibacterial activity against methicillin-sensitive Staphylococcus aureus by resazurin-based assay2014Journal of natural products, May-23, Volume: 77, Issue:5
Mahorones, highly brominated cyclopentenones from the red alga Asparagopsis taxiformis.
AID1601845Antibacterial activity against Enterococcus faecalis CMCC 29212 measured after 24 hrs by ELISA2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety.
AID428137Antimicrobial activity against penicillin-resistant Streptococcus gordonii PR1_2evolved mutant co-cultured with wild type Streptococcus gordoni assessed as loss of viability at stationary phase of growth at 0.5 ug/mL after 70 hrs relative to wild type2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Fitness cost and impaired survival in penicillin-resistant Streptococcus gordonii isolates selected in the laboratory.
AID341337Antimicrobial activity against Neisseria meningitidis isolates harboring penA 83 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID557487Displacement of Biocillin FL from Streptococcus pneumoniae 3009 PBP1B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID565813Antimicrobial activity against Neisseria gonorrhoeae assessed as susceptible isolates by CLSI method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis.
AID524665Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA and penB mutant gene assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID662526Antimicrobial activity against Escherichia coli ATCC 25922 after 18 to 20 hrs by spectrophotometry2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Discovery of potent antimicrobial peptide analogs of Ixosin-B.
AID534394Activity of Beta-lactamase KHM-1 in Escherichia coli JM109 harboring recombinant pKHM-1 assessed as compound hydrolysis by UV-visible spectrophotometry2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
AID542625Antimicrobial activity against Streptococcus pneumoniae R6 harboring PBP2x2349 mutant gene, disruption in PBP1a and aad9 disruption in CiaR gene after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID322513Effect on glomerular filtration in human very low birth weight preterm neonates urine assessed as creatinine excretion at 15 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID200524Minimum inhibitory concentration against aerobic organism Salmonella schottmuelleri 28371982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
Quaternary heterocyclylamino beta-lactams: a generic alternative to the classical acylamino side chain.
AID534154Antimicrobial activity against linezolid-resistant Enterococcus faecalis 3124 harboring G2576U mutation in peptidyl transferase centre by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID1454343Antibacterial activity Escherichia coli MTCC 443 by agar well method2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Synthesis and biological evaluation of 5-fatty-acylamido-1, 3, 4-thiadiazole-2-thioglycosides.
AID524048Binding affinity to methicillin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 1287 PBP1 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID532678Antimicrobial activity against ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates assessed as resistant isolates by agar dilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
AID285270Activity of Escherichia coli BL21(DE3) beta-lactamase TEM362007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.
AID428126Antimicrobial activity against wild type Streptococcus gordonii2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Fitness cost and impaired survival in penicillin-resistant Streptococcus gordonii isolates selected in the laboratory.
AID524641Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penB mutant gene assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID375920Antibacterial activity against Bacillus cereus ATCC 11778 by NCCLS method2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
AID486416Antibacterial activity against Proteus vulgaris NCIM 2813 after 24 hrs by disc diffusion method2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Synthesis and biological evaluation of beta-chloro vinyl chalcones as inhibitors of TNF-alpha and IL-6 with antimicrobial activity.
AID483191Antibacterial activity against Staphylococcus aureus ATCC 25923 by microbroth dilution technique2010Bioorganic & medicinal chemistry letters, Jun-15, Volume: 20, Issue:12
Design, synthesis, and antibacterial activity of 2,5-dihydropyrrole formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
AID368517Ratio of Kcat to Km of Pseudomonas aeruginosa VIM2 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID1237612Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC513045 assessed as bacterial growth inhibition after 24 hrs by broth dilution method2015European journal of medicinal chemistry, Jul-15, Volume: 100Novel cajaninstilbene acid derivatives as antibacterial agents.
AID378415Antimicrobial activity against Trichoderma harzianum ATCC 64870 after 24 hrs2006Journal of natural products, Aug, Volume: 69, Issue:8
Carneic acids A and B, chemotaxonomically significant antimicrobial agents from the xylariaceous ascomycete Hypoxylon carneum.
AID493656Antimicrobial activity against Pseudomonas aeruginosa ATCC 13525 by MTT assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
AID495703Kcat/Km ratio of Escherichia coli CTX-M-152010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID508387Antibacterial activity against macrolide-resistant Streptococcus pyogenes harboring mef(A) gene after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID368532Activity of Morganella morganii AmpC assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID1870124Antibacterial activity against antibiotic resistant Staphylococcus aureus 4482/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID619674Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 by broth microdilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis, antimicrobial activity and possible mechanism of action of 9-bromo-substituted indolizinoquinoline-5,12-dione derivatives.
AID324361Activity of Acinetobacter johnsonii SCO12007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina.
AID374363Activity of Aeromonas caviae A324R metallo-beta-lactamase IMP-19 expressed in Escherichia coli DH5alpha by computerized microacidimetric method2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
First occurrence of an IMP metallo-beta-lactamase in Aeromonas caviae: IMP-19 in an isolate from France.
AID495739Kcat/Km ratio of Pseudomonas aeruginosa OXA-10 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID1454342Antibacterial activity Staphylococcus epidermidis MTCC 9041 by agar well method2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Synthesis and biological evaluation of 5-fatty-acylamido-1, 3, 4-thiadiazole-2-thioglycosides.
AID529666Ratio of Kcat to Km for Pseudomonas aeruginosa COL-1 beta-lactamase VIM-2 relative to cephaloridine2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID548533Antimicrobial activity against Beta-hemolytic Streptococcus by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID278552Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium longum ATCC 15707 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID1279019Antibacterial activity against ESBL-positive Klebsiella pneumoniae J 14368/08 after 24 hrs by microbroth dilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
AID418564Antibacterial activity against Clostridium perfringens ATCC 10388 by NCCLS method2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
AID442478Antibacterial activity against Staphylococcus aureus MTCC 96 by broth dilution method2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Click chemistry: studies on the synthesis of novel fluorous tagged triazol-4-yl substituted quinazoline derivatives and their biological evaluation--theoretical and experimental validation.
AID368514Activity of Pseudomonas aeruginosa VIM2 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID207408Minimum protective concentration against beta-lactamase of Staphylococcus aureus 952000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Design, synthesis, and SAR of novel carbapenem antibiotics with high stability to Xanthomonas maltophilia oxyiminocephalosporinase type II.
AID68518Minimum inhibitory concentration against aerobic organism Enterobacter cloacae 26461982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
Quaternary heterocyclylamino beta-lactams: a generic alternative to the classical acylamino side chain.
AID322516Effect on glomerular filtration in human very low birth weight preterm neonates urine assessed as drug clearance at 30 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID1870126Antibacterial activity against antibiotic resistant Staphylococcus aureus 4504/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID368505Activity of Escherichia coli KPC2 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID519009Ratio of Kcat to Km for Beta-lactamase TEM-149 expressed in Escherichia coli HB1012008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates.
AID508380Antibacterial activity against macrolide-resistant Streptococcus pneumoniae harboring mutation in L4 ribosomal protein after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID575147Antimicrobial activity against vancomycin-resistant Staphylococcus aureus VRS1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
AID524642Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA and penB mutant gene assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID558324Antibacterial activity against bla gene-negative and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni isolate P835 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID573572Antibacterial activity against beta-lactamase producing Bacteroides uniformis by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID508388Antibacterial activity against macrolide-resistant Streptococcus pyogenes harboring erm(A) gene after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID543282Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 pbp2x, pbp1a, pbp2b genes and Streptococcus pneumoniae 3191 genomic DNA by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID368511Ratio of Kcat to Km of Serratia marcescens SME3 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID520383Antimicrobial activity Escherichia coli DH5alpha expressing metallo-beta-lactamase VIM-11 by agar macrodilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biochemical characterization of metallo-beta-lactamase VIM-11 from a Pseudomonas aeruginosa clinical strain.
AID559063Antibacterial activity against Streptococcus constellatus by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID1638907Antimicrobial activity against Ampc beta-lactamase expressing Enterobacter cloacae ATCC BAA-1143 measured after 18 hrs by broth microdilution method2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
AID508291Antimicrobial activity against Enterococcus faecium D63 by microdilution method2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID495724Activity of Pseudomonas aeruginosa OXA-10 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID372618Ratio of Kcat to Km for Escherichia coli CF0042 beta-lactamase TEM-352007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
AID524978Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
AID532986Antibacterial activity against Pseudomonas aeruginosa NCIM 50292010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID557499Displacement of Biocillin FL from Streptococcus pneumoniae 24 PBP2A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID533874Antibacterial activity against penicillin-nonsusceptible Streptococcus pneumoniae isolate by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
AID395402Antibacterial activity against Pseudomonas aeruginosa MTCC 1688 at 20 ug after 24 hrs by cup diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis of new series of 5,6-dihydro-4H-1,2-oxazines via hetero Diels-Alder reaction and evaluation of antimicrobial activity.
AID554865Antimicrobial activity against Streptococcus pneumoniae serotype 19F ST 2694 harboring ERY-resistant mef(E) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID524664Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penB mutant gene assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID546431Ratio of Kcat to Km for Pseudomonas aeruginosa PDC-2 by spectrophotometer2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.
AID495692Activity of Pseudomonas aeruginosa AmpC2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID519205Antibacterial activity against Streptococcus pneumoniae by microdilution method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
In vitro activity of AR-709 against Streptococcus pneumoniae.
AID1271949Antibacterial activity against Staphylococcus aureus assessed as growth inhibition at 10 mg/ml by drug sensitive assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel skeleton compound Allomyrinanoid A and two purine alkaloids from the adult of Allomyrina dichotoma L.
AID558614Antimicrobial activity against Streptococcus pneumoniae isolate 2688 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID1072980Antimicrobial activity against vancomycin-sensitive Enterococcus faecalis CL 8516 after 20 hrs by 2-fold serial broth dilution method2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Isolation, structure elucidation, and biological activity of altersolanol P using Staphylococcus aureus fitness test based genome-wide screening.
AID543274Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 3191 pbp2b, pbp1a and murM genes by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID539693Antifungal activity against Escherichia coli MTCC 443 by broth dilution method2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Indium(III) chloride catalyzed three-component coupling reaction: a novel synthesis of 2-substituted aryl(indolyl)kojic acid derivatives as potent antifungal and antibacterial agents.
AID558644Antimicrobial activity against compound-susceptible Streptococcus pneumoniae by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID558332Antibacterial activity against Campylobacter jejuni isolate P338 harboring blaOXA-61::cat gene by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID368312Ratio of Kcat to Km of Staphylococcus aureus betalactamase PC1 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID660261Ratio of MIC for wild type Escherichia coli JC7623 to MIC for acrAB-deficient Escherichia coli JZM1202012European journal of medicinal chemistry, Jun, Volume: 52Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
AID522654Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis K4539 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID1279011Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 24 hrs by microbroth dilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
AID557470Antimicrobial activity against penicillin-sensitive Streptococcus pneumoniae 1076 by CLSI method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID269455Antibacterial activity against Klebsiella pneumoniae ATCC 8308 by agar diffusion assay2006Bioorganic & medicinal chemistry letters, Aug-01, Volume: 16, Issue:15
The synthesis and in vitro testing of structurally novel antibiotics derived from acylnitroso Diels-Alder adducts.
AID554868Antimicrobial activity against Streptococcus pneumoniae serotype 23F ST 81 harboring ERY-resistant mef(E) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID543285Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 genomic DNA, pbp2x, pbp1a, pbp2b and Streptococcus pneumoniae 3191 pbp1a genes by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID534089Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae assessed as percent susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
AID451357Antimicrobial activity against Saccharomyces cerevisiae NBRC10114 after 24 hrs by broth dilution method2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Synthesis and evaluation of bioactive naphthoquinones from the Brazilian medicinal plant, Tabebuia avellanedae.
AID569345Antibacterial activity against methicillin-resistant Staphylococcus epidermidis by agar dilution method2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
AID520395Antibacterial activity against erm(B) and mef(E)-positive Streptococcus pneumoniae isolate Sweden 15A-25 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).
AID558333Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P790 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID1638903Antimicrobial activity against NDM1 beta -lactamse expressing Escherichia coli ATCC BAA-2469 measured after 18 hrs by broth microdilution method2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
AID529662Ratio of Kcat to Km for Pseudomonas aeruginosa 9551 beta-lactamase VIM-15 relative to cephaloridine2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID531568Antibacterial activity against Streptococcus pyogenes obtained from complicated skin and skin structure infections by agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
AID530500Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IA isolate 5662-05 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID340762Antibacterial activity against Streptococcus gordonii with non penicillin binding protein mutation2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii.
AID528534Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B503 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID746785Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 20 hrs by macrobroth dilution method2013Bioorganic & medicinal chemistry letters, May-15, Volume: 23, Issue:10
Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.
AID533881Antibacterial activity against cefotaxime-intermediate Streptococcus pneumoniae assessed as percent susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
AID535633Antimicrobial activity against Group B streptococcus serotype Ia R7 harboring T77I, F395V and S353F in PBP 2X; V80A and G613R in PBP 2B; and L45P, N163K, N723S and Y470F in PBP 1A by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID619677Antimicrobial activity against Staphylococcus aureus ATCC 25923 by broth microdilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis, antimicrobial activity and possible mechanism of action of 9-bromo-substituted indolizinoquinoline-5,12-dione derivatives.
AID1778126Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as microbial growth inhibition by CLSI-protocol based broth microdilution assay2021Journal of natural products, 04-23, Volume: 84, Issue:4
Opportunities and Limitations for Assigning Relative Configurations of Antibacterial Bislactones using GIAO NMR Shift Calculations.
AID495729Activity of Pseudomonas aeruginosa SPM-1 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID531450Antibacterial activity against Streptococcus pneumoniae serotype 15A assessed as percent susceptible isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID565811Antimicrobial activity against Neisseria meningitidis assessed as susceptible isolate by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
AID574953Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID557494Displacement of Biocillin FL from Streptococcus pneumoniae 3243 PBP2X2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID1870122Antibacterial activity against antibiotic resistant Staphylococcus aureus 4460/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID531574Antibacterial activity against Aerococcus viridans obtained from complicated skin and skin structure infections by agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
AID428131Ratio of generation time for wild type Streptococcus gordonii to generation time for penicillin-resistant Streptococcus gordonii PR1_2 mutant at mid-logarithmic phase of growth2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Fitness cost and impaired survival in penicillin-resistant Streptococcus gordonii isolates selected in the laboratory.
AID535646Antimicrobial activity against Group B Streptococcus serotype III NEM 316 by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID531456Antibacterial activity against Streptococcus pneumoniae serotype 19F assessed as percent resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID171263Concentration of compound in rat liver after intravenous injection of 20 mg/kg benzyl-penicillin after 60 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID278542Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium longum P/N 601377 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID1454344Antibacterial activity Pseudomonas aeruginosa MTCC 1688 by agar well method2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Synthesis and biological evaluation of 5-fatty-acylamido-1, 3, 4-thiadiazole-2-thioglycosides.
AID386908Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 13150 after 20 hrs by microdilution assay2008European journal of medicinal chemistry, Aug, Volume: 43, Issue:8
Functionalized chalcones with basic functionalities have antibacterial activity against drug sensitive Staphylococcus aureus.
AID368520Activity of Enterobacter cloacae 4092 AmpC (E2) assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID422494Antimicrobial activity against Escherichia coli BL21 (DE3) by E-test2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
AID524053Binding affinity to methicillin-, linezolid-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 2149A PBP2 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID210363In vitro antibacterial activity against the gram-positive bacteria, penicillin resistant Streptococcus pneumoniae (4630)1999Bioorganic & medicinal chemistry letters, Apr-05, Volume: 9, Issue:7
New N-substituted 7-aminocephalosporanic acid derivatives as potential agents against Streptococcus pneumoniae. Synthesis and in vitro activity.
AID325443Antibacterial activity against Escherichia coli K10 after 14 to 16 hrs by broth dilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Polyamine effects on antibiotic susceptibility in bacteria.
AID1054727Antibacterial activity against Staphylococcus aureus Rosenbach ATCC 9144 after overnight incubation by broth microdilution method2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
Pahangensin A and B, two new antibacterial diterpenes from the rhizomes of Alpinia pahangensis Ridley.
AID1245115Antimicrobial activity against Staphylococcus aureus ATCC 6538 after 18 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Sep-15, Volume: 23, Issue:18
Design, synthesis and molecular docking of salicylic acid derivatives containing metronidazole as a new class of antimicrobial agents.
AID340853Effect on pbp2X gene expression in penicillin-resistant Streptococcus gordonii with penicillin binding protein PR1_2 evolved mutation assessed as relative luciferase units relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii.
AID573150Antibacterial activity against vancomycin-susceptible Enterococcus faecalis assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID258714Antibacterial activity against gram negative Klebsiella aerogenes(MTCC 39)2006Bioorganic & medicinal chemistry letters, Jan-01, Volume: 16, Issue:1
Synthesis and biological evaluation of novel C (7) modified chrysin analogues as antibacterial agents.
AID372616Ratio of Kcat to Km for Escherichia coli DH5alpha beta-lactamase TEM-122007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
AID531566Antibacterial activity against Enterococcus faecium obtained from complicated skin and skin structure infections by agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
AID466788Antibacterial activity against Pseudomonas aeruginosa ATCC 27852010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents.
AID519011Ratio of Kcat to Km for Beta-lactamase TEM-149 T182M mutant expressed in Escherichia coli HB1012008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates.
AID588107Antimicrobial activity against Neisseria gonorrhoeae clinical isolates harboring porB G120K, A121D mutant gene, PBP1 L421P mutant gene, PBP2 XXXVIII pattern, deletion of nucleotide A from mtrA promoter, MAST 3158 after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID569261Antimicrobial activity against methicillin-resistant Staphylococcus aureus 8732011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.
AID206456In vitro antibacterial activity against the gram-positive bacteria, penicillin resistant Staphylococcus aureus (2619)1999Bioorganic & medicinal chemistry letters, Apr-05, Volume: 9, Issue:7
New N-substituted 7-aminocephalosporanic acid derivatives as potential agents against Streptococcus pneumoniae. Synthesis and in vitro activity.
AID1079931Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]
AID495701Kcat/Km ratio of Escherichia coli TEM-12010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID219758Minimum protective concentration against beta-lactamase of Xanthomonas maltophilia GN 12873 (CXase-II)2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Design, synthesis, and SAR of novel carbapenem antibiotics with high stability to Xanthomonas maltophilia oxyiminocephalosporinase type II.
AID395401Antibacterial activity against Escherichia coli MTCC 443 at 20 ug after 24 hrs by cup diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis of new series of 5,6-dihydro-4H-1,2-oxazines via hetero Diels-Alder reaction and evaluation of antimicrobial activity.
AID757810Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
AID1243288Antimicrobial activity against Streptococcus pyogenes ATCC 19615 by standard broth microdilution method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.
AID679543TP_TRANSPORTER: inhibition of MTX uptake (MTX: 1 uM, PCG: 1000 uM) in OAT1-expressing S2 cells2002The Journal of pharmacology and experimental therapeutics, Aug, Volume: 302, Issue:2
Characterization of methotrexate transport and its drug interactions with human organic anion transporters.
AID206460In vitro antibacterial activity against the gram-positive bacteria, penicillin sensitive Staphylococcus aureus (3849)1999Bioorganic & medicinal chemistry letters, Apr-05, Volume: 9, Issue:7
New N-substituted 7-aminocephalosporanic acid derivatives as potential agents against Streptococcus pneumoniae. Synthesis and in vitro activity.
AID558646Antimicrobial activity against compound-resistant Streptococcus pneumoniae by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID572269Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 49951 by broth microdilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models.
AID542614Antimicrobial activity against Streptococcus pneumoniae R6 harboring PBP2x T338P mutant gene after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID210362In vitro antibacterial activity against the gram-positive bacteria, penicillin resistant Streptococcus pneumoniae (4629)1999Bioorganic & medicinal chemistry letters, Apr-05, Volume: 9, Issue:7
New N-substituted 7-aminocephalosporanic acid derivatives as potential agents against Streptococcus pneumoniae. Synthesis and in vitro activity.
AID522653Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis K9724 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID530508Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 7037-99 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID524044Binding affinity to methicillin-, vancomycin-susceptible Staphylococcus aureus ATCC 29213 PBP1 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID529665Activity of Pseudomonas aeruginosa COL-1 beta-lactamase VIM-2 relative to cephaloridine2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID428129Antimicrobial activity against penicillin-resistant Streptococcus gordonii PR1_2 mutant assessed as generation time at mid-logarithmic phase of growth2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Fitness cost and impaired survival in penicillin-resistant Streptococcus gordonii isolates selected in the laboratory.
AID573157Antibacterial activity against vancomycin-resistant Enterococcus faecium assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID1054726Antibacterial activity against Bacillus subtilis (Ehrenberg) Cohn ATCC 6051 after overnight incubation by broth microdilution method2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
Pahangensin A and B, two new antibacterial diterpenes from the rhizomes of Alpinia pahangensis Ridley.
AID368528Activity of Enterobacter cloacae 908R AmpC assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID503228Ratio of MIC for penicillin-resistant Streptococcus pneumoniae 38040505 to MIC for penicillin-sensitive Streptococcus pneumoniae R62007Nature chemical biology, Sep, Volume: 3, Issue:9
Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins.
AID508374Antibacterial activity against Streptococcus pneumoniae harboring mutation in 23S rRNA after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID466786Antibacterial activity against Escherichia coli ATCC 352182010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents.
AID356760Antimicrobial activity against Escherichia coli 442 after 18 hrs by microbroth dilution method2001Journal of natural products, Jul, Volume: 64, Issue:7
Biological and mechanistic activities of xanthorrizol and 4-(1',5'-dimethylhex-4'-enyl)-2-methylphenol isolated from Iostephane heterophylla.
AID171254Concentration of compound in rat kidney after intravenous injection of 20 mg/kg benzyl-penicillin after 5 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID587960Activity of Escherichia coli beta-lactamase Toho-1 A237A mutant assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID528703Antibacterial activity against Streptococcus oralis clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID1054724Antibacterial activity against Salmonella sp. ATCC 700623 after overnight incubation by broth microdilution method2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
Pahangensin A and B, two new antibacterial diterpenes from the rhizomes of Alpinia pahangensis Ridley.
AID171111Concentration of compound in rat blood after intravenous injection of 20 mg/kg benzyl-penicillin after 40 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID503227Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 5204 by microscopy2007Nature chemical biology, Sep, Volume: 3, Issue:9
Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins.
AID531421Antibacterial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID568432Antimicrobial activity against Staphylococcus aureus MTCC 96 after 24 hrs by broth dilution method2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Stereoselective first total synthesis, confirmation of the absolute configuration and bioevaluation of botryolide-E.
AID518729Ratio of Kcat to Km for Pseudomonas stutzeri beta-lactamase DIM-1by UV-spectrophotometry2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Characterization of DIM-1, an integron-encoded metallo-beta-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands.
AID368513Activity of Pseudomonas aeruginosa VIM2 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID521350Antimicrobial activity against Streptococcus pneumoniae isolate 40 obtained from blood of patient2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20.
AID335496Antimicrobial activity against methicillin-resistant Staphylococcus aureus 310 after 18 to 20 hrs by standard broth microdilution method2002Journal of natural products, Jun, Volume: 65, Issue:6
New antimicrobial cycloartane triterpenes from Acalypha communis.
AID573564Antibacterial activity against beta-lactamase producing Bacteroides vulgatus assessed as susceptible isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID609856Antimicrobial activity against low-level vancomycin-resistant Enterococcus faecalis ATCC 51299 assessed as growth inhibition after 18 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Unprecedented C-2 arylation of indole with diazonium salts: Syntheses of 2,3-disubstituted indoles and their antimicrobial activity.
AID699541Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID1129597Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT assay2014European journal of medicinal chemistry, Apr-09, Volume: 76Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents.
AID150759P-gp activity was measured by a direct transport assay, using polarized LLC-mdr1a epithelial cells2003Journal of medicinal chemistry, Apr-24, Volume: 46, Issue:9
Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery.
AID368530Ratio of Kcat to Km of Enterobacter cloacae 908R AmpC assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID508366Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID572270Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 by broth microdilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models.
AID524880Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA, penB and ponA mutant gene assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID528528Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B10 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID522394Ratio of Kcat Km for Escherichia coli K-12 Beta-lactamase AmpC2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Genetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenes.
AID715625Antibacterial activity against Staphylococcus aureus MTCC 7443 after 24 hrs by serial dilution method2012European journal of medicinal chemistry, Nov, Volume: 57Synthesis, characterization, biological evaluation and QSAR studies of 11-p-substituted phenyl-12-phenyl-11a,12-dihydro-11H-indeno[2,1-c][1,5]benzothiazepines as potential antimicrobial agents.
AID529331Antibacterial activity against penicillin-cefotaxime- ceftriaxone-resistant Streptococcus pneumoniae serotype 14 URA3543 harboring mutant PBP2B PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID351195Half life in iv dosed neonates with gestational age of 27 to 40 weeks2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.
AID493657Antimicrobial activity against Escherichia coli ATCC 35218 by MTT assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
AID278556Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium pseudolongum ATCC 25562 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID532988Antibacterial activity against Klebsiella aerogenes NCIM 22812010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID368731Ratio of Kcat to Km of Pseudomonas aeruginosa AmpC assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID559531Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae assessed as percent susceptible isolates by CLSI M7-A7 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID448315Antibacterial activity against Staphylococcus aureus MTCC 11 by broth dilution method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, photochemical E (trans)-->Z (cis) isomerization and antimicrobial activity of 2-chloro-5-methylpyridine-3-olefin derivatives.
AID559518Antibacterial activity against Streptococcus constellatus assessed as percent susceptible isolates by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID524259Ratio of Kcat to Km in Escherichia coli beta-lactamase SHV-842010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain.
AID715627Antibacterial activity against Pseudomonas aeruginosa MTCC 7952 after 24 hrs by serial dilution method2012European journal of medicinal chemistry, Nov, Volume: 57Synthesis, characterization, biological evaluation and QSAR studies of 11-p-substituted phenyl-12-phenyl-11a,12-dihydro-11H-indeno[2,1-c][1,5]benzothiazepines as potential antimicrobial agents.
AID278562Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium breve R0070 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID369011Resistance of Staphylococcus aureus isolated from lactating Holstein bovine subclinical mastitis model at 10 ug/disk after 20 hrs2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Therapeutic effect of nisin Z on subclinical mastitis in lactating cows.
AID171269Concentration of compound in rat lung after intravenous injection of 20 mg/kg benzyl-penicillin after 5 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID245016Minimum inhibitory concentration against Klebsiella aerogenes (Gram-negative) in broth2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Synthesis and antibacterial activity of 2,4,6-tri substituted s-triazines.
AID1254304Antibacterial activity against Enterococcus sp. J 14365/08 after 24 hrs by microdilution broth method2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
AID1149037Antibacterial activity against Staphylococcus aureus assessed as growth inhibition incubated for 24 hrs using mixed anhydride1976Journal of medicinal chemistry, Feb, Volume: 19, Issue:2
Beta-lactam antibiotics with N-oxide side chains. 1. Quinoxaline N-oxides.
AID543271Antimicrobial activity against Streptococcus pneumoniae 3191 by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID678979TP_TRANSPORTER: uptake in OATP-E-expressing HEK293 cells2000Biochemical and biophysical research communications, Jun-24, Volume: 273, Issue:1
Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.
AID562365Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group F clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID573798Antibacterial activity against Prevotella melaninogenica assessed as susceptible isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID509631Antimicrobial activity against Staphylococcus aureus RN4220 transformant carrying plasmid pKKS25 and expressing erm(T), dfrK and tet(L) genes by broth microdilution method2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Identification of a plasmid-borne resistance gene cluster comprising the resistance genes erm(T), dfrK, and tet(L) in a porcine methicillin-resistant Staphylococcus aureus ST398 strain.
AID340768Increase in pbp1A gene expression in penicillin-resistant Streptococcus gordonii with penicillin binding protein PR1_2 evolved mutation assessed as relative luciferase units relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii.
AID529312Antibacterial activity against Streptococcus pneumoniae R62008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID335497Antimicrobial activity against vancomycin-resistant Enterococcus faecium 379 after 18 to 20 hrs by standard broth microdilution method2002Journal of natural products, Jun, Volume: 65, Issue:6
New antimicrobial cycloartane triterpenes from Acalypha communis.
AID368501Activity of Klebsiella pneumoniae TEM26 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID532981Antibacterial activity against Escherichia coli DH5alpha2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID495636Ratio of kcat/Km for Pseudomonas luteola LAM Beta-lactamase LUT-12010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.
AID558533Antibacterial activity against bla gene-positive and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni isolate P1698 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID368543Activity of Pseudomonas aeruginosa 18SH AmpC assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID565733Antimicrobial activity against Streptococcus Group G clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID573822Antibacterial activity against beta-lactamase producing Clostridium perfringens by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID562579Antimicrobial activity against erythromycin-susceptible Streptococcus Group C clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID1063965Antibacterial activity against methicillin-resistant Staphylococcus aureus H 5996/08 after 24 hrs by broth microdilution method2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Salicylanilide diethyl phosphates: synthesis, antimicrobial activity and cytotoxicity.
AID275134Antibacterial activity against Pseudomonas aeruginosa IAM10582007Journal of natural products, Jan, Volume: 70, Issue:1
Antimicrobial arylcoumarins from Asphodelus microcarpus.
AID522946Antibacterial activity against Streptococcus pneumoniae ATCC 49619 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone.
AID533936Antimicrobial activity against linezolid-resistant Staphylococcus aureus 131-6952X harboring plasmid borne cfr gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID529313Antibacterial activity against Streptococcus pneumoniae serotype 4 ATCC BAA-334 harboring mutant PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID540211Fraction unbound in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID447054Antibacterial activity against Staphylococcus aureus ATCC 6538 at 10 IU after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID573800Antibacterial activity against Prevotella bivia assessed as resistant isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID558609Antimicrobial activity against Streptococcus pneumoniae isolate 1397 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID533942Antimicrobial activity against linezolid-resistant Enterococcus faecalis 413 harboring G2576U mutation in peptidyl transferase centre by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID1076537Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT assay2014European journal of medicinal chemistry, Mar-21, Volume: 75Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
AID1778128Antimicrobial activity against Escherichia coli assessed as microbial growth inhibition by CLSI-protocol based broth microdilution assay2021Journal of natural products, 04-23, Volume: 84, Issue:4
Opportunities and Limitations for Assigning Relative Configurations of Antibacterial Bislactones using GIAO NMR Shift Calculations.
AID238095Binding affinity for TEM-1 beta-lactamase2005Journal of medicinal chemistry, Feb-10, Volume: 48, Issue:3
Molecular dynamics simulations of the TEM-1 beta-lactamase complexed with cephalothin.
AID436377Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT method2009European journal of medicinal chemistry, Oct, Volume: 44, Issue:10
Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents.
AID565742Antimicrobial activity against Streptococcus agalactiae clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID398240Antimicrobial activity against Escherichia coli 389 after 18 hrs by twofold serial microbroth dilution method2003Journal of natural products, Dec, Volume: 66, Issue:12
A novel antibacterial iridoid and triterpene from Caiophora coronata.
AID1254313Antibacterial activity against Pseudomonas aeruginosa CCM 1961 after 48 hrs by microdilution broth method2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
AID603189Antibacterial activity against Bacillus subtilis MTCC 441 by broth microdilution method2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Efficient synthesis, structural characterization and anti-microbial activity of chiral aryl boronate esters of 1,2-O-isopropylidene-α-D-xylofuranose.
AID699540Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID324835Antimicrobial activity against Neisseria gonorrhoeae 158 isolate2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
AID528526Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B7 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID543262Antimicrobial activity against Streptococcus pneumoniae R6 by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID1168787Cytotoxicity against human macrophages assessed as cell viability after 24 hrs by MTT assay2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Synthesis, molecular docking and biological evaluation of coumarin derivatives containing piperazine skeleton as potential antibacterial agents.
AID340765Antibacterial activity against wild type penicillin-susceptible Streptococcus gordonii at 4 times MIC2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii.
AID525548Antimicrobial activity against ampicillin resistant nontypeable Haemophilus influenzae isolate BB1051 harboring with plasmid pB1000 bearing beta-lactamase ROB-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Haemophilus influenzae clinical isolates with plasmid pB1000 bearing blaROB-1: fitness cost and interspecies dissemination.
AID585184Ratio of Kcat to Km for Beta-lactamase GES-5 E104, S170 mutant2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
AID563974Activity of Klebsiella pneumoniae 05-560 beta-lactamase IMP1 by spectrophotometry2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
AID1091742Antibacterial activity against Lysinibacillus sphaericus MTCC 11 assessed as growth arrest at 37 degC for 24 hr2009Chemical & pharmaceutical bulletin, Jul, Volume: 57, Issue:7
Synthesis, nematicidal and antimicrobial properties of Bis-[4-methoxy-3-[3-(4-fluorophenyl)-6-(4-methylphenyl)-2(aryl)-tetrahydro-2H-pyrazolo[3,4-d]thiazol-5-yl]phenyl]methanes.
AID431313Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 7002212009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
AID528535Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B513 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID558328Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P286 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID1279008Antibacterial activity against Staphylococcus aureus CCM 4516/08 after 48 hrs by microbroth dilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
AID519066Antibacterial activity against multidrug resistant Streptococcus pneumoniae ATCC 49619 by CLSI microdilution susceptibility testing method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Activity of the Diaminopyrimidine AR-709 against recently collected multidrug-resistant isolates of invasive Streptococcus pneumoniae from North America.
AID562376Antimicrobial activity against Streptococcus pyogenes clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID278530Antimicrobial activity against Bifidobacterium longum P/N 6013772007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID565736Antimicrobial activity against Streptococcus Group C clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID1870116Antibacterial activity against antibiotic resistant Staphylococcus aureus 4557/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID603193Antibacterial activity against Pseudomonas aeruginosa MTCC 741 by broth microdilution method2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Efficient synthesis, structural characterization and anti-microbial activity of chiral aryl boronate esters of 1,2-O-isopropylidene-α-D-xylofuranose.
AID559699Antimicrobial activity against Micrococcus luteus AB93113 by microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.
AID1279013Antibacterial activity against Enterococcus sp. J 14365/08 after 24 hrs by microbroth dilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
AID278539Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium infantis ATCC 15697 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID398241Antimicrobial activity against Candida albicans 54 after 18 hrs by agar diffusion method2003Journal of natural products, Dec, Volume: 66, Issue:12
A novel antibacterial iridoid and triterpene from Caiophora coronata.
AID378412Antimicrobial activity against Mucor hiemalis DSM 63298 after 24 hrs2006Journal of natural products, Aug, Volume: 69, Issue:8
Carneic acids A and B, chemotaxonomically significant antimicrobial agents from the xylariaceous ascomycete Hypoxylon carneum.
AID524667Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA, penB and mtrR mutant gene assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID565814Antimicrobial activity against Neisseria gonorrhoeae assessed as susceptible isolates by EUCAST method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis.
AID322497Cmin in human very low birth weight preterm neonates at 14 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID495712Kcat/Km ratio of Pseudomonas aeruginosa VIM-22010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID508293Antimicrobial activity against penicillin-resistant Enterococcus faecium D63r assessed as bacterial killing at 4 times MIC by time kill curve method2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID519628Antimicrobial activity against beta-lactamase OXA-63 producing Brachyspira pilosicoli isolate BM4442 isolated from feces of patient with diarrhea by disc diffusion method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
AID372896Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID486414Antibacterial activity against Klebsiella pneumoniae NCIM 5082 after 24 hrs by disc diffusion method2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Synthesis and biological evaluation of beta-chloro vinyl chalcones as inhibitors of TNF-alpha and IL-6 with antimicrobial activity.
AID776432Antibacterial activity against Bacillus cereus ATCC 14579 at 10 mg/ml after 48 hrs by disc-diffusion method2013European journal of medicinal chemistry, Nov, Volume: 69Synthesis, antimicrobial, antioxidant activities of novel 6-aryl-5-cyano thiouracil derivatives.
AID1428255Antibacterial activity against Escherichia coli RCMB 000106 assessed as zone of inhibition at 30 ug/ml2017European journal of medicinal chemistry, Jan-27, Volume: 126An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.
AID395403Antibacterial activity against Staphylococcus aureus MTCC 737 at 20 ug after 24 hrs by cup diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis of new series of 5,6-dihydro-4H-1,2-oxazines via hetero Diels-Alder reaction and evaluation of antimicrobial activity.
AID368489Activity of Klebsiella pneumoniae SHV1 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID372619Activity of Escherichia coli DH5alpha beta-lactamase TEM-1 by microacidimetric method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
AID559062Antibacterial activity against Streptococcus bovis by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID567280Activity of Acinetobacter baumannii ADC-11 beta-lactamase2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
Extended-spectrum cephalosporinase in Acinetobacter baumannii.
AID368503Ratio of Kcat to Km of Klebsiella pneumoniae TEM26 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID582268Ratio of MIC for Bacillus cereus ATCC 4342 selected after 20 daily cycles of drug selection followed by 5 days of nonselective growth to MIC for Bacillus cereus ATCC 43422008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax.
AID524045Binding affinity to methicillin-resistant, heteroresistant vancomycin-intermediate, beta-lactamase-negative Staphylococcus aureus 873 PBP1 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID558337Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P1650 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID269454Antibacterial activity against Salmonella enterica ATCC 13311 by agar diffusion assay2006Bioorganic & medicinal chemistry letters, Aug-01, Volume: 16, Issue:15
The synthesis and in vitro testing of structurally novel antibiotics derived from acylnitroso Diels-Alder adducts.
AID418555Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 by NCCLS method2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
AID451360Antimicrobial activity against Paecilomyces variotii NBRC4855 after 24 hrs by broth dilution method2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Synthesis and evaluation of bioactive naphthoquinones from the Brazilian medicinal plant, Tabebuia avellanedae.
AID278565Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium longum R0175 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID322491Half life in human adults at 600 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID535356Antimicrobial activity against Streptococcus pyogenes clinical isolates by broth dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
AID554873Antimicrobial activity against Streptococcus pneumoniae serotype 14 ST 13 harboring ERY-resistant mef(E) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID531316Ratio of Kcat to Km for Pseudomonas aeruginosa beta-lactamase VIM-2 by spectrophotometry2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
AID1437660Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 20 to 24 hrs by two-fold microdilution method
AID325446Antibacterial activity against Salmonella enterica serovar Typhimurium LT2 after 14 to 16 hrs by broth dilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Polyamine effects on antibiotic susceptibility in bacteria.
AID562368Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group G clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID524056Binding affinity to methicillin-resistant, heteroresistant vancomycin-intermediate, beta-lactamase-negative Staphylococcus aureus 873 PBP2a by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID322515Effect on glomerular filtration in human very low birth weight preterm neonates urine assessed as creatinine clearance at 15 mg/kg, iv administered every 12 hr after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID625286Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID368309Activity of Escherichia coli TEM1 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID557516Displacement of Biocillin FL from Streptococcus pneumoniae 1077 PBP2B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID548745Antimicrobial activity against Beta-hemolytic Streptococcus assessed as percent susceptible isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID425337Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococci.
AID1129599Antibacterial activity against Pseudomonas aeruginosa ATCC 13525 after 24 hrs by MTT assay2014European journal of medicinal chemistry, Apr-09, Volume: 76Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents.
AID524982Antibacterial activity against Streptococcus sanguinis clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
AID447060Antibacterial activity against Listeria monocytogenes ATCC 15313 at 10 IU after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID522390Activity of Escherichia coli K-12 Beta-lactamase AmpC2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Genetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenes.
AID558603Antimicrobial activity against Streptococcus pneumoniae isolate 37 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID1161141Antimicrobial activity against Escherichia coli isolate 1 after 24 hrs by broth microdilution method2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
AID1254310Antibacterial activity against ESBL-positive Klebsiella pneumoniae J 14368/08 after 24 hrs by microdilution broth method2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
AID558539Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter coli isolate P1826 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID1309198Antibacterial activity against Bacillus subtilis by broth microdilution assay2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Four new minor brominated indole related alkaloids with antibacterial activities from Laurencia similis.
AID1349908Antimicrobial activity against Bacillus subtilis DSM10 after 16 to 48 hrs by serial dilution method2018Journal of natural products, 02-23, Volume: 81, Issue:2
Cysteine-Derived Pleurotin Congeners from the Nematode-Trapping Basidiomycete Hohenbuehelia grisea.
AID356758Antimicrobial activity against Bacillus subtilis 327 after 18 hrs by microbroth dilution method2001Journal of natural products, Jul, Volume: 64, Issue:7
Biological and mechanistic activities of xanthorrizol and 4-(1',5'-dimethylhex-4'-enyl)-2-methylphenol isolated from Iostephane heterophylla.
AID425866Antimicrobial activity against Carnobacterium divergens BM4489 expressing beta-lactamase CAD1 at 3 McFarland inoculum size by E-test2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
AID575419Antimicrobial activity against Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID1063963Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 24 hrs by broth microdilution method2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Salicylanilide diethyl phosphates: synthesis, antimicrobial activity and cytotoxicity.
AID529896Antimicrobial activity against Leptospira interrogans serovar Pomona isolate 4 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID524039Antibacterial activity against methicillin-resistant, heteroresistant vancomycin-intermediate, beta-lactamase-negative Staphylococcus aureus 873 by macrodilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID1309204Antibacterial activity against Xanthomonas vesicatoria by broth microdilution assay2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Four new minor brominated indole related alkaloids with antibacterial activities from Laurencia similis.
AID495716Activity of Escherichia coli TEM-1 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID44042Stability against beta-lactamase of Staphylococcus aureus1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Dependence of beta-lactamase stability on substructures within beta-lactam antibiotics.
AID519288Activity of beta lactamase OXA23 in Acinetobacter baumannii Ab13 assessed as compound hydrolysis rate per mg of protein by spectrophotometry2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp.
AID278550Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium breve R0070 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID278678Antibacterial activity against Enterococcus faecium isolate 57492007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID242844Rate of catalysis against TEM-1 beta-lactamase2005Journal of medicinal chemistry, Feb-10, Volume: 48, Issue:3
Molecular dynamics simulations of the TEM-1 beta-lactamase complexed with cephalothin.
AID340849Increase in pbp1A gene expression in penicillin-resistant Streptococcus gordonii with penicillin binding protein PR1_2 evolved mutation at 1/2 times MIC assessed as relative luciferase units relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii.
AID425340Antibacterial activity against quinolone-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococci.
AID1437929Antibacterial activity against Streptococcus mutans ATCC 25175 after 24 hrs2017Journal of natural products, 01-27, Volume: 80, Issue:1
Dibenzofurans and Pseudodepsidones from the Lichen Stereocaulon paschale Collected in Northern Quebec.
AID1254307Antibacterial activity against Escherichia coli CCM4517 after 48 hrs by microdilution broth method2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
AID323866Antibacterial activity against methicillin-resistant Staphylococcus aureus 459 at pH 5.52007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Role of acidic pH in the susceptibility of intraphagocytic methicillin-resistant Staphylococcus aureus strains to meropenem and cloxacillin.
AID1210969Ratio of drug level in brain to plasma of 5/6 nephrectomized Sprague-Dawley rat chronic renal failure model at 1 mg/kg, im after 2 hrs by beta-counting method relative to control2012Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 40, Issue:1
Effects of chronic renal failure on brain drug transporters in rats.
AID625292Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1546111Antimicrobial activity against Salmonella typhimurium2019European journal of medicinal chemistry, Dec-15, Volume: 184Current scenario of tetrazole hybrids for antibacterial activity.
AID498375Antimicrobial activity against wild type streptomycin-susceptible Streptococcus gordonii infected in Wistar rat assessed as decrease in bacterial infection at 300000 U/kg, sc administered 16 hrs after infection every 12 hrs for 2 days measured within 3 da2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.
AID561108Antibacterial activity against Pasteurella multocida BB1042 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB9956 bearing tetH gene by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID374675Antimicrobial activity against tetracycline-resistant Escherichia coli U1 rapA mutant 24 hrs biofilms assessed as viability at 350 ug/ml after 1 hr by microtiter plate count method2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
AID495726Activity of Serratia marcescens SME-3 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID322498Cmin in human term neonates at 15 mg/kg, im administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID503224Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 38040505 by microscopy2007Nature chemical biology, Sep, Volume: 3, Issue:9
Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins.
AID508300Inhibition of low-affinity PBP5fm in penicillin-resistant Enterococcus faecium D63r membranes assessed as inhibition of fluorescent ampicillin binding after 20 mins at 37 degC2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID368512Ratio of Kcat to Km of Serratia marcescens SME3 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID530503Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IA isolate 9012-04 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID535764Antimicrobial activity against penicillin-producing Neisseria gonorrhoeae NGON 08-003 expressing beta-lactamase TEM-135, MLST type ST-7823 and MAST type ST-4013 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Identification of TEM-135 beta-lactamase in penicillinase-producing Neisseria gonorrhoeae strains in Japan.
AID442481Antibacterial activity against Pseudomonas aeruginosa MTCC 741 by broth dilution method2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Click chemistry: studies on the synthesis of novel fluorous tagged triazol-4-yl substituted quinazoline derivatives and their biological evaluation--theoretical and experimental validation.
AID521353Antimicrobial activity against Streptococcus pneumoniae isolate k-421 obtained from ear of patient2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20.
AID278554Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium longum R0175 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID562337Activity at Chryseobacterium indologenes 597 metallo-beta-lactamase IND-6 expressed in Escherichia coli DH5alpha by Michaelis-Menten equation2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso.
AID495723Activity of Enterobacter cloacae AmpC relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID557480Displacement of Biocillin FL from Streptococcus pneumoniae 1077 PBP1A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID520382Antimicrobial activity Escherichia coli DH5alpha harboring bacteriophage T4 plasmid alpha omega by agar macrodilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biochemical characterization of metallo-beta-lactamase VIM-11 from a Pseudomonas aeruginosa clinical strain.
AID324362Ratio of kcat to Km for Acinetobacter johnsonii SCO12007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina.
AID529314Antibacterial activity against Streptococcus pneumoniae serotype 9V URA4929 harboring mutant PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID557521Displacement of Biocillin FL from Streptococcus pneumoniae 3243 PBP32009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID524247Antimicrobial activity against Escherichia coli INSRA4590 expressing SHV-842010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain.
AID557523Displacement of Biocillin FL from Streptococcus pneumoniae 3009 PBP32009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID554869Antimicrobial activity against Streptococcus pneumoniae serotype 23F ST 961 harboring ERY-resistant erm(B) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID543273Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 3191 pbp2x gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID495688Activity of Escherichia coli CTX-M-152010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID278549Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium breve ATCC 15700 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID431311Antibacterial activity against Streptococcus pneumoniae ATCC 63012009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
AID535640Antimicrobial activity against Group B streptococcus serotype Ib C2 harboring E63K mutation in PBP 2A and L41S mutation in PBP 1B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID562402Antimicrobial activity against Streptococcus pneumoniae clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID529328Antibacterial activity against multidrug resistant Streptococcus pneumoniae serotype 19A ATCC 700673 harboring mutant PBP2B PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID542622Antimicrobial activity against Streptococcus pneumoniae R6 harboring PBP2x T338A mutant gene, disruption at PBP1a and aad9 disruption in CiaR gene after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID554675Antimicrobial activity against Streptococcus pneumoniae serotype 19F ST 156 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID561258Antibacterial activity against Streptococcus agalactiae assessed as susceptible isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID540967Activity of Klebsiella pneumoniae HP205 cephalosporinase CMY-36 by spectrophotometry2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids.
AID325445Antibacterial activity against Escherichia coli C921-61 after 14 to 16 hrs by broth dilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Polyamine effects on antibiotic susceptibility in bacteria.
AID368730Activity of Pseudomonas aeruginosa AmpC assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID495698Activity of Pseudomonas aeruginosa IMP-12010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID587732Activity of Pseudomonas aeruginosa strain PS 297 metallo-beta-lactamase IMP-1 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis using 100 uM nitrocefin2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States.
AID1638902Antimicrobial activity against Escherichia coli ATCC 25922 measured after 18 hrs by broth microdilution method2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
AID529316Antibacterial activity against Streptococcus pneumoniae serotype 3 URA3537 harboring mutant PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID1180455Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 24 hrs by MTS assay2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
AID587730Activity of Pseudomonas aeruginosa strain PS 297 metallo-beta-lactamase IMP-18 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis using 100 uM nitrocefin2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States.
AID1128825Antibacterial activity against Staphylococcus aureus ATCC 29213 after 18 hrs by broth microdilution method2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Spiromastixones A-O, antibacterial chlorodepsidones from a deep-sea-derived Spiromastix sp. fungus.
AID1366168Antibacterial activity against Staphylococcus aureus by agar dilution method2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID164883In Vitro minimal inhibitory concentration against Pseudomonas aeruginosa (1101-75)1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
Syntheses of new isodethiaazacephems as potent antibacterial agents.
AID278559Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium bifidum R0071 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID558326Antibacterial activity against bla gene-negative and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni isolate P1962 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID373053Antimicrobial activity against Escherichia coli DH10B by agar-dilution technique2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
AID171107Concentration of compound in rat blood after intravenous injection of 20 mg/kg benzyl-penicillin after 1 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID554879Antimicrobial activity against Streptococcus pneumoniae serotype 17 ST 3248 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID1183299Antibacterial activity against Pseudomonas aeruginosa2014European journal of medicinal chemistry, Sep-12, Volume: 84Design, synthesis and anti-mycobacterial activity of 1,2,3,5-tetrasubstituted pyrrolyl-N-acetic acid derivatives.
AID545508Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 34404 by microdilution method2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains.
AID448314Antibacterial activity against Bacillus subtilis MTCC 441 by broth dilution method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, photochemical E (trans)-->Z (cis) isomerization and antimicrobial activity of 2-chloro-5-methylpyridine-3-olefin derivatives.
AID565816Antimicrobial activity against Neisseria gonorrhoeae assessed as resistant isolates by EUCAST method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis.
AID557511Displacement of Biocillin FL from Streptococcus pneumoniae 3676 PBP2B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID577457Antimicrobial activity against laboratory-derived Streptococcus pneumoniae isolate R6 by broth microdilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Affinity of ceftobiprole for penicillin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin.
AID520731Activity of Escherichia coli DH10B beta-lactamase OXA-97 assessed per mg of protein at 100 uM2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97.
AID522658Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis V770-NP1-R by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID368724Ratio of Kcat to Km of Pseudomonas aeruginosa MK-1184 AmpC assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID324847Antimicrobial activity against Neisseria gonorrhoeae 82 isolate2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
AID1870128Antibacterial activity against antibiotic resistant Staphylococcus aureus 4738/B assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID522392Ratio of Kcat Km for Aeromonas enteropelogenes Beta-lactamase TRU12010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Genetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenes.
AID1193540Antibacterial activity against Staphylococcus aureus ATCC 25923 at 100 ug after 24 hrs2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities.
AID757811Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
AID569348Antibacterial activity against Haemophilus influenzae by agar dilution method2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
AID508298Inhibition of PBP4 in penicillin-resistant Enterococcus faecium D63r membranes assessed as inhibition of fluorescent ampicillin binding after 20 mins at 37 degC2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID559538Antibacterial activity against Neisseria meningitidis assessed as percent susceptible isolates by CLSI M7-A7 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID521354Antimicrobial activity against Streptococcus pneumoniae isolate 4134 obtained from sputum of patient2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20.
AID322502Clearance in human term neonates at 15 mg/kg, im administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID573113Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID557266Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae 2527 by CLSI method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID522651Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis K5926 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID374677Antimicrobial activity against tetracycline-resistant Escherichia coli U1 rapA mutant flow cell-generated 24 hrs biofilms using BacLight staining by CSLM2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
AID519635Activity of Brachyspira pilosicoli beta-lactamase OXA-63 expressed in Escherichia coli BL21 (DE3) assessed as compound hydrolysis by spectrophotometry relative to oxacillin2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
AID263113Antibacterial activity against methicillin-resistant Staphylococcus aureus USF658 by agar disk diffusion method2006Bioorganic & medicinal chemistry letters, Apr-15, Volume: 16, Issue:8
N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
AID373214Ratio of Kcat to Km for Bacillus clausii NR beta-lactamase BCL1 to ratio of Kcat/Km for Bacillus anthracis beta-lactamase Bla12007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
AID1161142Antimicrobial activity against Escherichia coli isolate 2 after 24 hrs by broth microdilution method2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
AID1250522Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hr by MTT assay2015European journal of medicinal chemistry, Sep-18, Volume: 102Synthesis and evaluation of new tyrosyl-tRNA synthetase inhibitors as antibacterial agents based on a N2-(arylacetyl)glycinanilide scaffold.
AID573799Antibacterial activity against Prevotella buccae assessed as resistant isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID1054723Antibacterial activity against Salmonella typhimurium (Loeffler) Castellani and Chalmers ATCC 14028 after overnight incubation by broth microdilution method2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
Pahangensin A and B, two new antibacterial diterpenes from the rhizomes of Alpinia pahangensis Ridley.
AID557477Displacement of Biocillin FL from Streptococcus pneumoniae 3665 PBP1A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID571191Antibacterial activity against Neisseria gonorrhoeae harboring wild-type penA and porB1a genes by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID522824Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis NH by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID425338Antibacterial activity against azithromycin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococci.
AID351196Volume of distribution in neonates2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.
AID522669Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis B133 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID524244Antimicrobial activity against Escherichia coli DH5alpha2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain.
AID336567Antibacterial activity against penicillin-resistant Staphylococcus aureus ATCC 29247 after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID528741Antimicrobial activity against penicillin-resistant Streptococcus agalactiae ATCC BAA-611 harboring PBP-2X V405A mutant gene by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID495700Activity of Acinetobacter baumannii OXA-232010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID495841Ratio of Kcat to Km for beta-lactamase VIM-1 in Escherichia coli DH5alpha expressing pBCLL/39H by microacidimetric method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
AID529897Antimicrobial activity against Leptospira interrogans serovar Pyrogenes isolate 5 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID562357Antimicrobial activity against Streptococcus pneumoniae clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID557488Displacement of Biocillin FL from Streptococcus pneumoniae 1076 PBP1B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID1279018Antibacterial activity against Klebsiella pneumoniae D 11750/08 after 48 hrs by microbroth dilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
AID1076535Inhibition of Escherichia coli N-terminal His-tagged FabH expressed in Escherichia coli BL21(DE3) using holo-acyl carrier protein as substrate preincubated for 1 min followed by acetyl-CoA addition measured after 25 mins by liquid scintillation counting a2014European journal of medicinal chemistry, Mar-21, Volume: 75Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
AID1180451Antimicrobial activity against Enterococcus sp. J 14365/08 after 24 hrs by microdilution method2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
AID529454Antibacterial activity against multidrug resistant Streptococcus pneumoniae serotype 19F URA3699 harboring mutant PBP2B PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID577449Antimicrobial activity against penicillin sensitive Streptococcus pneumoniae isolate 8865 by broth microdilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Affinity of ceftobiprole for penicillin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin.
AID528532Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B68 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID588109Antimicrobial activity against Neisseria gonorrhoeae clinical isolates harboring PBP2 XXXV pattern, deletion of nucleotide A from mtrA promoter, MAST 546 after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID508377Antibacterial activity against macrolide-resistant Streptococcus pneumoniae harboring erm(B) gene after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID406551Antibacterial activity against Bacillus anthracis assessed as inhibition zone diameter at 20 ug after 24 hrs by Kirby-Bauer test2008Bioorganic & medicinal chemistry, Jul-01, Volume: 16, Issue:13
Unsymmetric aryl-alkyl disulfide growth inhibitors of methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
AID263108Antibacterial activity against methicillin-resistant Staphylococcus aureus USF653 by agar disk diffusion method2006Bioorganic & medicinal chemistry letters, Apr-15, Volume: 16, Issue:8
N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
AID1209736Inhibition of human OAT3 expressed in CHO cells assessed as inhibition of fluorescein uptake at 500 uM over 20 mins relative to untreated-control2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
AID483195Antibacterial activity against Escherichia coli ATCC 25922 by microbroth dilution technique2010Bioorganic & medicinal chemistry letters, Jun-15, Volume: 20, Issue:12
Design, synthesis, and antibacterial activity of 2,5-dihydropyrrole formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
AID588113Antimicrobial activity against Neisseria gonorrhoeae clinical isolates assessed as percent resistant isolates after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID519010Activity of Beta-lactamase TEM-149 T182M mutant expressed in Escherichia coli HB1012008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates.
AID666779Antibacterial activity against Bacillus megaterium at 0.05 mg by agar diffusion test2012Bioorganic & medicinal chemistry letters, Jul-01, Volume: 22, Issue:13
Bioactive briarane diterpenoids from the South China Sea gorgonian Dichotella gemmacea.
AID534155Antimicrobial activity against linezolid-resistant Enterococcus faecalis 3128 harboring G2576U mutation in peptidyl transferase centre by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID498371Antimicrobial activity against wild type streptomycin-susceptible Streptococcus gordonii after 24 hrs by macrodilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.
AID1870138Antibacterial activity against wild type methicillin resistant Staphylococcus aureus 4968/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID1091738Antibacterial activity against Chromobacterium violaceum MTCC 2656 assessed as growth arrest at 37 degC for 24 hr2009Chemical & pharmaceutical bulletin, Jul, Volume: 57, Issue:7
Synthesis, nematicidal and antimicrobial properties of Bis-[4-methoxy-3-[3-(4-fluorophenyl)-6-(4-methylphenyl)-2(aryl)-tetrahydro-2H-pyrazolo[3,4-d]thiazol-5-yl]phenyl]methanes.
AID374679Antimicrobial activity against tetracycline-resistant Escherichia coli U1 rapA mutant nylon membrane cultivated 24 hrs biofilms at 350 ug/ml after 1 hr2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
AID428132Ratio of generation time for wild type Streptococcus gordonii to generation time for penicillin-resistant Streptococcus gordonii PR1_2evolved mutant at mid-logarithmic phase of growth2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Fitness cost and impaired survival in penicillin-resistant Streptococcus gordonii isolates selected in the laboratory.
AID447059Antibacterial activity against Mycobacterium smegmatis CCM 2067 at 10 IU after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID278861Inhibition of metabolic activity in HeLa cells assessed as MTT reduction after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID561740Antibacterial activity against Beta-hemolytic Streptococcus group A assessed as susceptible isolates by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID665396Antibacterial activity against Staphylococcus aureus MTCC 7443 after 24 hrs by serial dilution technique2012European journal of medicinal chemistry, Jul, Volume: 53Synthesis, characterization, antimicrobial activities and QSAR studies of some 10a-phenylbenzo[b]indeno[1,2-e][1,4]thiazin-11(10aH)-ones.
AID573388Antibacterial activity against Pasteurella multocida by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID451351Antimicrobial activity against Bacillus mycoides ATCC 11778 after 24 hrs by broth dilution method2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Synthesis and evaluation of bioactive naphthoquinones from the Brazilian medicinal plant, Tabebuia avellanedae.
AID341529Antimicrobial activity against Neisseria meningitidis isolates harboring penA 19 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID559055Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID531449Antibacterial activity against Streptococcus pneumoniae serotype 23A assessed as percent susceptible isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID625529Antimicrobial activity against Escherichia coli MTCC 443 by broth dilution method2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Iodine-catalyzed conjugate addition of indoles onto en-1,4-dione: a novel synthesis of 3-(1-(1H-indol-3-yl)-2-oxo-2-phenylethyl)indolin-2-ones as antibacterial and antifungal agents.
AID74719Inhibition of gram positive (resistant) bacteria growth.1989Journal of medicinal chemistry, Jun, Volume: 32, Issue:6
Synthesis and antimicrobial properties of substituted beta-aminoxypropionyl penicillins and cephalosporins.
AID335499Antimicrobial activity against Bacillus subtilis PY79 after 18 to 20 hrs by standard broth microdilution method2002Journal of natural products, Jun, Volume: 65, Issue:6
New antimicrobial cycloartane triterpenes from Acalypha communis.
AID368540Activity of Pseudomonas aeruginosa 4352 AmpC assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID285158Antimicrobial susceptibility of tetracycline-resistant Streptococcus pneumoniae from respiratory tract disease patient assessed as percent resistant isolates2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland.
AID557476Displacement of Biocillin FL from Streptococcus pneumoniae 3243 PBP1A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID1546170Antimicrobial activity against Rhodococcus equi2019European journal of medicinal chemistry, Dec-15, Volume: 184Current scenario of tetrazole hybrids for antibacterial activity.
AID620347Antibacterial activity against Bacillus subtilis RCMB 000107 at 30 ug/ml after 24 hrs by diffusion agar technique2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and anti-microbial activity of some 1- substituted amino-4,6-dimethyl-2-oxo-pyridine-3-carbonitrile derivatives.
AID368529Ratio of Kcat to Km of Enterobacter cloacae 908R AmpC assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID324841Antimicrobial activity against Neisseria gonorrhoeae 30 isolate2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
AID375911Antibacterial activity against Staphylococcus aureus ATCC 29213 by NCCLS method2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
AID322501Clearance in human very low birth weight preterm neonates at 14 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID495914Hydrolytic activity of beta-lactamase VIM-1 expressed in Escherichia coli TOP10 by spectrophotometry2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae.
AID562363Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID559061Antibacterial activity against Streptococcus anginosus by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID368311Ratio of Kcat to Km of Staphylococcus aureus betalactamase PC1 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID1347490Antibacterial activity against Pseudomonas aeruginosa assessed as zone of inhibition after 24 to 48 hrs by well diffusion method2018European journal of medicinal chemistry, Jan-01, Volume: 143Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
AID495711Kcat/Km ratio of Serratia marcescens SME-32010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID619676Antimicrobial activity against hemolytic Streptococcus Group B CMCC 32210 by broth microdilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis, antimicrobial activity and possible mechanism of action of 9-bromo-substituted indolizinoquinoline-5,12-dione derivatives.
AID1209732Drug uptake by mouse OAT3 expressed in CHO cells at 100 uM after 25 mins by HPLC/UV detection method in presence of probenecid2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
AID1354714Antimicrobial activity against Erysipelothrix rhusiopathiae ATCC 19414 after 24 hrs by serial dilution method
AID557208Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis by Etest method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
AID356756Antimicrobial activity against vancomycin-resistant Enterococcus faecium 379 after 18 hrs by microbroth dilution method2001Journal of natural products, Jul, Volume: 64, Issue:7
Biological and mechanistic activities of xanthorrizol and 4-(1',5'-dimethylhex-4'-enyl)-2-methylphenol isolated from Iostephane heterophylla.
AID1565594Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by CLSI based broth microdilution method2019European journal of medicinal chemistry, Nov-15, Volume: 182Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity.
AID269448Antibacterial activity against wild type Escherichia coli DC0 by agar diffusion assay2006Bioorganic & medicinal chemistry letters, Aug-01, Volume: 16, Issue:15
The synthesis and in vitro testing of structurally novel antibiotics derived from acylnitroso Diels-Alder adducts.
AID531318Ratio of Kcat to Km for Escherichia coli beta-lactamase VIM-1 by spectrophotometry2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
AID558613Antimicrobial activity against Streptococcus pneumoniae isolate 2686 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID495839Ratio of Kcat to Km for Escherichia coli BL21 DE3 beta-lactamase VIM-19 by microacidimetric method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
AID587968Ratio of Kcat to Km for Escherichia coli wild type beta-lactamase Toho-1 assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID559523Antibacterial activity against Streptococcus sanguinis assessed as percent susceptible isolates by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID1309199Antibacterial activity against Bacillus thuringiensis by broth microdilution assay2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Four new minor brominated indole related alkaloids with antibacterial activities from Laurencia similis.
AID278860Antiproliferative effect against HeLa cells after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID425653Renal clearance in human2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Physicochemical determinants of human renal clearance.
AID585183Ratio of Kcat to Km for Beta-lactamase GES-2 E104, N170 mutant2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
AID529324Antibacterial activity against penicillin-resistant Streptococcus pneumoniae serotype 14 URA4731 harboring mutant PBP2B PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID562339Ratio of Kcat to Km for Chryseobacterium indologenes 597 metallo-beta-lactamase IND-5 expressed in Escherichia coli DH5alpha by Michaelis-Menten equation2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso.
AID368728Ratio of Kcat to Km of Serratia marcescens AmpC assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID557483Displacement of Biocillin FL from Streptococcus pneumoniae 2527 PBP1B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID171252Concentration of compound in rat kidney after intravenous injection of 20 mg/kg benzyl-penicillin after 3 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID533876Antibacterial activity against amoxicillin-intermediate Streptococcus pneumoniae isolate by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
AID557519Displacement of Biocillin FL from Streptococcus pneumoniae 2527 PBP32009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID571180Antibacterial activity against Neisseria gonorrhoeae harboring porB1b and DA G101D mutant genes by disk agar diffusion method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID356762Antimicrobial activity against Klebsiella pneumoniae 425 after 18 hrs by microbroth dilution method2001Journal of natural products, Jul, Volume: 64, Issue:7
Biological and mechanistic activities of xanthorrizol and 4-(1',5'-dimethylhex-4'-enyl)-2-methylphenol isolated from Iostephane heterophylla.
AID619673Antimicrobial activity against Escherichia coli ATCC 25922 by broth microdilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis, antimicrobial activity and possible mechanism of action of 9-bromo-substituted indolizinoquinoline-5,12-dione derivatives.
AID508381Antibacterial activity against macrolide-susceptible Streptococcus pyogenes after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID571178Antibacterial activity against Neisseria gonorrhoeae harboring porB1a gene by disk agar diffusion method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID245455Minimum inhibitory concentration against Staphylococcus aureus (Gram-positive) was determined by broth dilution method2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Synthesis and antibacterial activity of 2,4,6-tri substituted s-triazines.
AID375913Antibacterial activity against methicillin-resistan Staphylococcus aureus ATCC 33591 by NCCLS method2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
AID543484Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 3191 pbp2x, pbp2b, pbp1a genes by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID533935Antimicrobial activity against linezolid-resistant Staphylococcus aureus 004-737X harboring plasmid borne cfr gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID574954Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID269447Antibacterial activity against wild type Mycobacterium vaccae IMET10670 by agar diffusion assay2006Bioorganic & medicinal chemistry letters, Aug-01, Volume: 16, Issue:15
The synthesis and in vitro testing of structurally novel antibiotics derived from acylnitroso Diels-Alder adducts.
AID535348Antimicrobial activity against Streptococcus pneumoniae clinical isolates by by based on po dosed broth dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
AID1243293Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 by standard broth microdilution method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.
AID486252Antibacterial activity against Bacillus subtilis NCIM 2546 after 24 hrs by disc diffusion method2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Synthesis and biological evaluation of beta-chloro vinyl chalcones as inhibitors of TNF-alpha and IL-6 with antimicrobial activity.
AID562404Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID1601844Antibacterial activity against Streptococcus pneumoniae CMCC 31968 measured after 24 hrs by ELISA2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety.
AID520394Antibacterial activity against mef(E)-positive Streptococcus pneumoniae isolate Spain 9V-3 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).
AID1287889Antimicrobial activity against Bacillus subtilis MTCC 441 after 24 hrs by serial two-fold broth dilution method2016European journal of medicinal chemistry, May-04, Volume: 113Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids.
AID524057Binding affinity to methicillin-, vancomycin-resistant, beta-lactamase-positive Staphylococcus aureus 510 PBP2a by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID575100Antimicrobial activity against Streptococcus pneumoniae serotype 22F assessed as percent susceptible isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID562582Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID557501Displacement of Biocillin FL from Streptococcus pneumoniae 2527 PBP2A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID524032Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 2688 by macrodilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID545510Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 700698 by microdilution method2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains.
AID599149Antibacterial activity against Staphylococcus aureus after 24 hrs by MTT assay2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Synthesis, crystal structure and antimicrobial activity of deoxybenzoin derivatives from genistein.
AID511447Antimicrobial activity against Streptococcus uberis ATCC 9529 harboring PAP1A A227T/G386R, PBP2B N366I/T402I and PBP2X E381K/D524A/Q554E mutation after 39 passages assessed as inhibition of visible growth by broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID554674Antimicrobial activity against Streptococcus pneumoniae serotype 14 ST 156 harboring ERY-resistant mef(E) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID680397TP_TRANSPORTER: inhibition of TEA uptake (TEA: 60 uM, PCG: 5000 uM) in Xenopus laevis oocytes1999The Journal of pharmacology and experimental therapeutics, May, Volume: 289, Issue:2
Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations.
AID368313Activity of Staphylococcus aureus betalactamase PC1 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID562412Antimicrobial activity against Streptococcus Group G clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID207407In vitro antimicrobial activity against Staphylococcus aureus 95 (methicillin-resistant strain) was determined2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Design, synthesis, and SAR of novel carbapenem antibiotics with high stability to Xanthomonas maltophilia oxyiminocephalosporinase type II.
AID322514Effect on glomerular filtration in human very low birth weight preterm neonates urine assessed as creatinine clearance at 30 mg/kg, iv administered every 12 hr after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID340737Ratio of Kcat to Km of Chryseobacterium indologenes metallo-beta-lactamase IND-5 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes.
AID1765578Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 18 hrs by CLSI based broth dilution method2021Journal of medicinal chemistry, 08-12, Volume: 64, Issue:15
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
AID508368Antibacterial activity against macrolide-susceptible Streptococcus pneumoniae after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID341526Antimicrobial activity against Neisseria meningitidis isolates harboring penA 23 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID364064Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT assay2008European journal of medicinal chemistry, Sep, Volume: 43, Issue:9
Enamines as novel antibacterials and their structure-activity relationships.
AID531448Antibacterial activity against Streptococcus pneumoniae serotype 35B assessed as percent susceptible isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID569343Antibacterial activity against methicillin-resistant Staphylococcus aureus by agar dilution method2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
AID269452Antibacterial activity against Escherichia coli X580 by agar diffusion assay2006Bioorganic & medicinal chemistry letters, Aug-01, Volume: 16, Issue:15
The synthesis and in vitro testing of structurally novel antibiotics derived from acylnitroso Diels-Alder adducts.
AID573135Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID438304Antibacterial activity against penicillin-resistant Streptococcus pneumoniae SP3282009Journal of medicinal chemistry, Oct-08, Volume: 52, Issue:19
Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening.
AID575149Antimicrobial activity against vancomycin-resistant Staphylococcus aureus VRS3 by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
AID375914Antibacterial activity against Staphylococcus epidermidis ATCC 12228 by NCCLS method2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
AID558336Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P1618 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID375918Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 700221 by NCCLS method2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
AID554880Antimicrobial activity against Streptococcus pneumoniae serotype 6B ST 3249 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID543065Antibacterial activity against methicillin-resistant Staphylococcus aureus ST3982009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Identification of a novel trimethoprim resistance gene, dfrK, in a methicillin-resistant Staphylococcus aureus ST398 strain and its physical linkage to the tetracycline resistance gene tet(L).
AID625283Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1511409Antibacterial activity against Bacillus cereus assessed as reduction in bacterial cell growth incubated for 24 hrs by filter paper assay2019Bioorganic & medicinal chemistry, 11-01, Volume: 27, Issue:21
Synthesis and biological evaluation of calycanthaceous alkaloid analogs.
AID495912Hydrolytic activity of beta-lactamase VIM-19 expressed in Escherichia coli TOP10 by spectrophotometry2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae.
AID498368Antimicrobial activity against penicillin- and streptomycin-resistant Streptococcus gordonii Tol1 harboring Tol1 mutation in ptsI assessed as bacterial count at 2 ug/ml after 24 hrs by macrodilution assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.
AID542617Antimicrobial activity against Streptococcus pneumoniae R6 harboring PBP2x2349 and PBP1a2349 mutant gene after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID561111Antibacterial activity against Pasteurella multocida BB1045 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB9956 bearing tetH gene by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID1638894Antibacterial activity against Bacillus subtilis 168 measured after 18 hrs by broth microdilution method2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
AID287373Antibacterial activity against Klebsiella pneumoniae after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID543281Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 genomic DNA, pbp2x, pbp1a and pbp2b genes by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID1064507Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 48 hrs by microdilution broth method2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Alkylamino derivatives of pyrazinamide: synthesis and antimycobacterial evaluation.
AID573154Antibacterial activity against vancomycin-resistant Enterococcus faecalis assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID1271947Antibacterial activity against Bacillus subtilis assessed as growth inhibition at 10 mg/ml by drug sensitive assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel skeleton compound Allomyrinanoid A and two purine alkaloids from the adult of Allomyrina dichotoma L.
AID278543Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium pseudolongum ATCC 25562 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID559700Antimicrobial activity against Bacillus thuringiensis AB93066 by microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.
AID301805Antibacterial activity against Staphylococcus aureus ATCC 292132007Bioorganic & medicinal chemistry, Dec-01, Volume: 15, Issue:23
Direct diazo-transfer reaction on beta-lactam: synthesis and preliminary biological activities of 6-triazolylpenicillanic acids.
AID515292Antibacterial activity against Staphylococcus aureus MTCC 96 by broth dilution method2010European journal of medicinal chemistry, Oct, Volume: 45, Issue:10
Stereoselective synthesis and biological evaluation of (R)-rugulactone, (6R)-((4R)-hydroxy-6-phenyl-hex-2-enyl)-5,6-dihydro-pyran-2-one and its 4S epimer.
AID1347486Antibacterial activity against Streptococcus pyogenes assessed as zone of inhibition after 24 to 48 hrs by well diffusion method2018European journal of medicinal chemistry, Jan-01, Volume: 143Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
AID746787Antimicrobial activity against Escherichia coli ATCC 25922 after 18 to 20 hrs by macrobroth dilution method2013Bioorganic & medicinal chemistry letters, May-15, Volume: 23, Issue:10
Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.
AID238858Binding affinity against membrane transport protein PEPT1 in human Caco-2 cells2005Journal of medicinal chemistry, Jun-30, Volume: 48, Issue:13
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
AID519633Ratio of Kcat to Km for Brachyspira pilosicoli beta-lactamase OXA-63 expressed in Escherichia coli BL21 (DE3) assessed as compound hydrolysis by spectrophotometry2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
AID368506Activity of Escherichia coli KPC2 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID368533Ratio of Kcat to Km of Morganella morganii AmpC assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID531457Antibacterial activity against Streptococcus pneumoniae serotype 35B assessed as percent resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID531447Antibacterial activity against Streptococcus pneumoniae serotype 19F assessed as percent susceptible isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID1191516Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 48 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID1755808Antibacterial activity against Staphylococcus aureus ATCC 6538 incubated for 24 hrs by two fold serial dilution method2021European journal of medicinal chemistry, Jan-15, Volume: 210Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
AID561109Antibacterial activity against Pasteurella multocida BB1043 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB9956 bearing tetH gene by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID495799Ratio of Kcat to Km of KPC-2 using nitrocefin hydrolysis2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.
AID523002Cytotoxicity against human 5637 cells assessed as mild induction of cell death by LDH release assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
AID575148Antimicrobial activity against vancomycin-resistant Staphylococcus aureus VRS2 by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
AID1091740Antibacterial activity against Pseudomonas aeruginosa MTCC 741 assessed as growth arrest at 37 degC for 24 hr2009Chemical & pharmaceutical bulletin, Jul, Volume: 57, Issue:7
Synthesis, nematicidal and antimicrobial properties of Bis-[4-methoxy-3-[3-(4-fluorophenyl)-6-(4-methylphenyl)-2(aryl)-tetrahydro-2H-pyrazolo[3,4-d]thiazol-5-yl]phenyl]methanes.
AID573153Antibacterial activity against vancomycin-resistant Enterococcus faecalis assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID368541Ratio of Kcat to Km of Pseudomonas aeruginosa 4352 AmpC assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID531577Antibacterial activity against Gemella spp. obtained from complicated skin and skin structure infections by agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
AID336569Antibacterial activity against Propionibacterium acnes ATCC 11827 after 2 days by twofold serial dilution method1992Journal of natural products, Oct, Volume: 55, Issue:10
Antibacterial activity of totarol and its potentiation.
AID368538Ratio of Kcat to Km of Providencia stuartii AmpC assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID1759748Binding affinity to Staphylococcus aureus ATCC 43300 50S ribosome assessed as association constant by SPR analysis2021Bioorganic & medicinal chemistry, 05-15, Volume: 38Design, synthesis and biological evaluation of novel pleuromutilin derivatives as potent anti-MRSA agents targeting the 50S ribosome.
AID1072987Antimicrobial activity against Streptococcus pneumoniae CL 2883 grown in 2.5 % lysed horse blood medium after 20 hrs by 2-fold serial broth dilution method2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Isolation, structure elucidation, and biological activity of altersolanol P using Staphylococcus aureus fitness test based genome-wide screening.
AID324842Antimicrobial activity against Neisseria gonorrhoeae 64 isolate2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
AID609857Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 assessed as growth inhibition after 18 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Unprecedented C-2 arylation of indole with diazonium salts: Syntheses of 2,3-disubstituted indoles and their antimicrobial activity.
AID519204Antibacterial activity against Streptococcus pneumoniae assessed as resistant isolates by microdilution method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
In vitro activity of AR-709 against Streptococcus pneumoniae.
AID658948Antibacterial activity against Serratia marcescens 155449 at 100 mg/ml after 24 hrs by agar-well diffusion technique2012European journal of medicinal chemistry, Jun, Volume: 522-Aminothiophenes as building blocks in heterocyclic synthesis: synthesis and antimicrobial evaluation of a new class of pyrido[1,2-a]thieno[3,2-e]pyrimidine, quinoline and pyridin-2-one derivatives.
AID495838Hydrolytic activity of Escherichia coli BL21 DE3 beta-lactamase VIM-19 by microacidimetric method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
AID582968Antimicrobial activity against beta-lactamase A and B-deficient Yersinia enterocolitica GY5718 after 20 hrs by Etest2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Contribution of BlaA and BlaB beta-lactamases to antibiotic susceptibility of Yersinia enterocolitica biovar 1B.
AID379710Antibacterial activity against Staphylococcus aureus ATCC 6535 by modified microtiter plate assay2006Journal of natural products, Feb, Volume: 69, Issue:2
Bioactive natural and semisynthetic latrunculins.
AID572274Antimicrobial activity against multiple drug-resistant Streptococcus pneumoniae ATCC 700677 by broth microdilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models.
AID557272Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae 3676 by CLSI method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID559509Antibacterial activity against Streptococcus agalactiae assessed as percent susceptible isolates by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID529900Antimicrobial activity against Leptospira interrogans serovar Icterohaemorrhagiae isolate 9 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID603192Antibacterial activity against Escherichia coli MTCC 443 by broth microdilution method2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Efficient synthesis, structural characterization and anti-microbial activity of chiral aryl boronate esters of 1,2-O-isopropylidene-α-D-xylofuranose.
AID508386Antibacterial activity against macrolide-resistant Streptococcus pyogenes harboring erm(B) gene after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID524671Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA, penB, ponA and mtrR mutant gene assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID746786Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 18 to 20 hrs by macrobroth dilution method2013Bioorganic & medicinal chemistry letters, May-15, Volume: 23, Issue:10
Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.
AID1366137Antibacterial activity against Escherichia coli assessed as diameter of inhibition zone at 1 mg/ml2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID486725Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT assay2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Synthesis, structure and structure-activity relationship analysis of caffeic acid amides as potential antimicrobials.
AID573796Antibacterial activity against Prevotella bivia assessed as susceptible isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID508292Antimicrobial activity against penicillin-resistant Enterococcus faecium D63r by microdilution method2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID372614Ratio of Kcat to Km for Escherichia coli DH5alpha beta-lactamase TEM-1582007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
AID520885Ratio of Kcat to Km for Achromobacter xylosoxidans CIP69598 beta-lactamase OXA-114a expressed in Escherichia coli TOP102008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans.
AID437464Antimicrobial activity Enterobacter cloacae ATCC 13047 by MTT assay2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
AID341534Antimicrobial activity against Neisseria meningitidis isolates harboring penA 9 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID431312Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 515752009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
AID531419Antibacterial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID558617Antimicrobial activity against Streptococcus pneumoniae isolate 3260 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID495738Kcat/Km ratio of Enterobacter cloacae AmpC relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID368500Ratio of Kcat to Km of Klebsiella oxytoca beta-lactamase K1 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID1647686Antibacterial activity against Streptococcus mutans ATCC 25175 assessed as reduction in microbial growth after 24 hrs by agar well diffusion assay2020Journal of natural products, 02-28, Volume: 83, Issue:2
Isolation, Identification, and Decomposition of Antibacterial Dialkylresorcinols from a Chinese
AID509632Antimicrobial activity against Staphylococcus aureus 25 transformant carrying plasmid pKKS25 and expressing erm(T), dfrKtet(L), tet(K), tet(M), mecA and blaZ genes by broth microdilution method2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Identification of a plasmid-borne resistance gene cluster comprising the resistance genes erm(T), dfrK, and tet(L) in a porcine methicillin-resistant Staphylococcus aureus ST398 strain.
AID533940Antimicrobial activity against linezolid-resistant Enterococcus faecalis 411 harboring G2576U mutation in peptidyl transferase centre by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID171253Concentration of compound in rat kidney after intravenous injection of 20 mg/kg benzyl-penicillin after 40 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID776431Antibacterial activity against Escherichia coli ATCC 11775 at 10 mg/ml after 48 hrs by disc-diffusion method2013European journal of medicinal chemistry, Nov, Volume: 69Synthesis, antimicrobial, antioxidant activities of novel 6-aryl-5-cyano thiouracil derivatives.
AID557478Displacement of Biocillin FL from Streptococcus pneumoniae 3009 PBP1A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID495720Activity of Klebsiella pneumoniae Beta-lactamase TEM-26 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID431316Antibacterial activity against Bacillus fragilis ATCC 237452009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
AID559066Antibacterial activity against Streptococcus oralis by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID368490Ratio of Kcat to Km of Klebsiella pneumoniae SHV1 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID1309200Antibacterial activity against Staphylococcus aureus by broth microdilution assay2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Four new minor brominated indole related alkaloids with antibacterial activities from Laurencia similis.
AID1161138Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by broth microdilution method2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
AID528524Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B1 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID524979Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
AID557522Displacement of Biocillin FL from Streptococcus pneumoniae 3665 PBP32009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID588104Antimicrobial activity against Neisseria gonorrhoeae clinical isolates harboring PBP2 XXXIV pattern, MAST 51 after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID1546110Antimicrobial activity against Proteus vulgaris2019European journal of medicinal chemistry, Dec-15, Volume: 184Current scenario of tetrazole hybrids for antibacterial activity.
AID535352Antimicrobial activity against Streptococcus pneumoniae clinical isolates by by based on parenterally dosed broth dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
AID285156Antimicrobial activity against Streptococcus pneumoniae ATCC 496192007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland.
AID1287892Antimicrobial activity against Pseudomonas aeruginosa MTCC 741 after 24 hrs by serial two-fold broth dilution method2016European journal of medicinal chemistry, May-04, Volume: 113Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids.
AID619680Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 by broth microdilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis, antimicrobial activity and possible mechanism of action of 9-bromo-substituted indolizinoquinoline-5,12-dione derivatives.
AID575101Antimicrobial activity against Streptococcus pneumoniae serotype 23B assessed as percent susceptible isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID535638Antimicrobial activity against Group B streptococcus serotype VI R2 harboring F395L, V405A, R433H, H438Y, and G648A mutations in PBP 2X and T567I mutation in PBP 2B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID523003Antibacterial activity against uropathogenic Escherichia coli UTI89 assessed as inhibition of biofilm formation after 24 hrs by microtiterplate-based assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
AID689076Antibacterial activity against Escherichia coli assessed as zone of inhibition at 0.05 mg by agar diffusion method2012Journal of natural products, Sep-28, Volume: 75, Issue:9
Sinularosides A and B, bioactive 9,11-secosteroidal glycosides from the South China Sea soft coral Sinularia humilis Ofwegen.
AID1126516Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by two-fold serial dilution method2014Bioorganic & medicinal chemistry, Apr-15, Volume: 22, Issue:8
Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents.
AID1072988Antimicrobial activity against Staphylococcus aureus Smith MB 2865 after 20 hrs by 2-fold serial broth dilution method in presence of 50 % human serum2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Isolation, structure elucidation, and biological activity of altersolanol P using Staphylococcus aureus fitness test based genome-wide screening.
AID573557Antibacterial activity against beta-lactamase producing Bacteroides thetaiotaomicron assessed as susceptible isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID324849Antimicrobial activity against Neisseria gonorrhoeae 91 isolate2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
AID558621Antimicrobial activity against Streptococcus pneumoniae isolate 3346 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID529335Antibacterial activity against penicillin-resistant Streptococcus pneumoniae serotype 14 URA5128 harboring mutant PBP2B PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID557271Antimicrobial activity against Streptococcus pneumoniae 2688 by CLSI method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1079949Proposed mechanism(s) of liver damage. [column 'MEC' in source]
AID666598Antibacterial activity against Bacillus cereus after 16 hrs by broth dilution method2012European journal of medicinal chemistry, Aug, Volume: 54Facile synthesis, cytotoxic and antimicrobial activity studies of a new group of 6-aryl-3-[4-(methylsulfonyl)benzyl]-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines.
AID562399Antimicrobial activity against Streptococcus Group F clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID557467Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae 3243 by CLSI method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID559511Antibacterial activity against Lancefield Streptococcus sp. group F assessed as percent susceptible isolates by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID495730Activity of Acinetobacter baumannii OXA-23 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID498373Antimicrobial activity against wild type streptomycin-susceptible Streptococcus gordonii assessed as decrease in [14C]glucose uptake at 2 ug/ml after 60 mins by liquid scintillation counting2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.
AID587959Activity of Escherichia coli beta-lactamase Toho-1 N104D mutant assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID535359Antimicrobial activity against Streptococcus pyogenes clinical isolates assessed as resistant isolates by broth dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
AID417433Antibacterial activity against Bacillus subtilis after 24 hrs by MTT method2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents.
AID1254309Antibacterial activity against Klebsiella pneumoniae D 11750/08 after 48 hrs by microdilution broth method2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
AID587971Ratio of Kcat to Km for Escherichia coli beta-lactamase Toho-1 A237A mutant assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID1882849Binding affinity to Staphylococcus aureus ATCC 43300 50S ribosomal subunit assessed as association rate constant by surface plasmon resonance analysis
AID540181Antibacterial activity against Escherichia coli NCIM 2345 after 24 hrs by twofold serial dilution method2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis and anti-tubercular and antimicrobial activities of some 2r,4c-diaryl-3-azabicyclo[3.3.1]nonan-9-one N-isonicotinoylhydrazone derivatives.
AID557518Displacement of Biocillin FL from Streptococcus pneumoniae 3413 PBP32009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID666597Antibacterial activity against Pseudomonas aeruginosa after 16 hrs by broth dilution method2012European journal of medicinal chemistry, Aug, Volume: 54Facile synthesis, cytotoxic and antimicrobial activity studies of a new group of 6-aryl-3-[4-(methylsulfonyl)benzyl]-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines.
AID1428253Antibacterial activity against Bacillus subtilis RCMB 000109 assessed as zone of inhibition at 30 ug/ml2017European journal of medicinal chemistry, Jan-27, Volume: 126An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.
AID575084Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B assessed as percent susceptible isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID210364In vitro antibacterial activity against the gram-positive bacteria, penicillin resistant Streptococcus pneumoniae (4635)1999Bioorganic & medicinal chemistry letters, Apr-05, Volume: 9, Issue:7
New N-substituted 7-aminocephalosporanic acid derivatives as potential agents against Streptococcus pneumoniae. Synthesis and in vitro activity.
AID524038Antibacterial activity against methicillin-, vancomycin-susceptible Staphylococcus aureus ATCC 29213 by macrodilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID689074Antifungal activity against Microbotryum violaceum assessed as zone of inhibition at 0.05 mg by agar diffusion method2012Journal of natural products, Sep-28, Volume: 75, Issue:9
Sinularosides A and B, bioactive 9,11-secosteroidal glycosides from the South China Sea soft coral Sinularia humilis Ofwegen.
AID428128Antimicrobial activity against wild type Streptococcus gordonii assessed as generation time at mid-logarithmic phase of growth2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Fitness cost and impaired survival in penicillin-resistant Streptococcus gordonii isolates selected in the laboratory.
AID207836Minimum inhibitory concentration against aerobic organism Staphylococcus aureus strain 28681982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
Quaternary heterocyclylamino beta-lactams: a generic alternative to the classical acylamino side chain.
AID1546164Antimicrobial activity against Staphylococcus aureus assessed as zone of inhibition at 5 mg/ml after 24 to 48 hrs by well diffusion method2019European journal of medicinal chemistry, Dec-15, Volume: 184Current scenario of tetrazole hybrids for antibacterial activity.
AID368518Ratio of Kcat to Km of Pseudomonas aeruginosa VIM2 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID1237605Antibacterial activity against Bacillus subtilis ATCC6633 assessed as bacterial growth inhibition after 24 hrs by broth dilution method2015European journal of medicinal chemistry, Jul-15, Volume: 100Novel cajaninstilbene acid derivatives as antibacterial agents.
AID495635Activity of Pseudomonas luteola LAM Beta-lactamase LUT-12010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.
AID1054744Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as growth inhibition after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
Schiff's base derivatives bearing nitroimidazole moiety: new class of antibacterial, anticancer agents and potential EGFR tyrosine kinase inhibitors.
AID529892Antimicrobial activity against Leptospira interrogans isolate 7 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID557515Displacement of Biocillin FL from Streptococcus pneumoniae 1076 PBP2B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID206457In vitro antibacterial activity against the gram-positive bacteria, penicillin resistant Staphylococcus aureus (2672)1999Bioorganic & medicinal chemistry letters, Apr-05, Volume: 9, Issue:7
New N-substituted 7-aminocephalosporanic acid derivatives as potential agents against Streptococcus pneumoniae. Synthesis and in vitro activity.
AID562378Antimicrobial activity against erythromycin-susceptible Streptococcus agalactiae clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID386910Toxicity in sheep erythrocytes assessed as hemolysis at 100 uM after 90 mins2008European journal of medicinal chemistry, Aug, Volume: 43, Issue:8
Functionalized chalcones with basic functionalities have antibacterial activity against drug sensitive Staphylococcus aureus.
AID171267Concentration of compound in rat lung after intravenous injection of 20 mg/kg benzyl-penicillin after 3 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID278557Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium thermophilum ATCC 25866 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID561101Antibacterial activity against Pasteurella multocida BB1035 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB1005 bearing strA, sul2 genes by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID437462Antimicrobial activity Escherichia coli ATCC 35218 by MTT assay2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
AID587731Ratio of Kcat to Km for Pseudomonas aeruginosa strain PS 297 metallo-beta-lactamase IMP18 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis using 100 uM nitrocefin2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States.
AID611681Antibacterial activity against Escherichia coli at 0.05 mg by agar diffusion method2011Journal of natural products, Jul-22, Volume: 74, Issue:7
Bioactive 11,20-epoxy-3,5(16)-diene briarane diterpenoids from the South China Sea gorgonian Dichotella gemmacea.
AID534156Antimicrobial activity against linezolid-resistant Enterococcus faecium 854 harboring G2576U mutation in peptidyl transferase centre by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID1870139Antibacterial activity against wild type methicillin resistant Staphylococcus aureus 5017/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID287379Antibacterial activity against Pseudomonas aeruginosa after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID573148Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID561251Antibacterial activity against Streptococcus pneumoniae assessed as intermediate isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID557498Displacement of Biocillin FL from Streptococcus pneumoniae 1077 PBP2X2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID531459Antibacterial activity against Streptococcus pneumoniae serotype 15A assessed as percent resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID263109Antibacterial activity against methicillin-resistant Staphylococcus aureus USF654 by agar disk diffusion method2006Bioorganic & medicinal chemistry letters, Apr-15, Volume: 16, Issue:8
N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
AID332341Antimicrobial activity against Escherichia coli imp 389 after 18 hrs by microbroth dilution method2003Journal of natural products, Feb, Volume: 66, Issue:2
Antibacterial diterpenes from Calceolaria pinifolia.
AID533939Antimicrobial activity against linezolid-resistant Staphylococcus aureus 480 harboring G2447U in peptidyl transferase centre by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID557475Displacement of Biocillin FL from Streptococcus pneumoniae 3676 PBP1A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID483196Antibacterial activity against Escherichia coli ATCC 35218 by microbroth dilution technique2010Bioorganic & medicinal chemistry letters, Jun-15, Volume: 20, Issue:12
Design, synthesis, and antibacterial activity of 2,5-dihydropyrrole formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
AID258712Antibacterial activity against gram positive Staphylococcus aureus(MTCC 96)2006Bioorganic & medicinal chemistry letters, Jan-01, Volume: 16, Issue:1
Synthesis and biological evaluation of novel C (7) modified chrysin analogues as antibacterial agents.
AID535760Antimicrobial activity against penicillin-producing Neisseria gonorrhoeae NGON 00-027 expressing beta-lactamase TEM-1, MLST type ST-1921 and MAST type ST-1817 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Identification of TEM-135 beta-lactamase in penicillinase-producing Neisseria gonorrhoeae strains in Japan.
AID530509Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 3789-04 expressing pbp2x Q557E mutant and multilocus sequence type ST19 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID533877Antibacterial activity against amoxicillin-intermediate Streptococcus pneumoniae assessed as percent susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
AID571192Antibacterial activity against Neisseria gonorrhoeae harboring Asp-345a insertion in penA and porB1a genes by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID1870137Antibacterial activity against wild type methicillin resistant Staphylococcus aureus 4561/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID534085Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
AID406552Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by serial dilution method2008Bioorganic & medicinal chemistry, Jul-01, Volume: 16, Issue:13
Unsymmetric aryl-alkyl disulfide growth inhibitors of methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
AID406554Antibacterial activity against Bacillus anthracis after 24 hrs by serial dilution method2008Bioorganic & medicinal chemistry, Jul-01, Volume: 16, Issue:13
Unsymmetric aryl-alkyl disulfide growth inhibitors of methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
AID528701Antibacterial activity against Streptococcus viridans clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID395344Antibacterial activity against Proteus vulgaris ATCC 8427 at 10 units after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID587961Activity of Escherichia coli wild type beta-lactamase Toho-1 assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID325447Antibacterial activity against Staphylococcus aureus N315 after 14 to 16 hrs by broth dilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Polyamine effects on antibiotic susceptibility in bacteria.
AID561100Antibacterial activity against Pasteurella multocida BB1034 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB1001 bearing tetB gene by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID557502Displacement of Biocillin FL from Streptococcus pneumoniae 3676 PBP2A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID436379Antibacterial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT method2009European journal of medicinal chemistry, Oct, Volume: 44, Issue:10
Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents.
AID278548Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium bifidum BB12 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID573144Antibacterial activity against penicillin-susceptible Streptococcus viridans assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID356753Antimicrobial activity against methicillin-sensitive Staphylococcus aureus 375 after 18 hrs by microbroth dilution method2001Journal of natural products, Jul, Volume: 64, Issue:7
Biological and mechanistic activities of xanthorrizol and 4-(1',5'-dimethylhex-4'-enyl)-2-methylphenol isolated from Iostephane heterophylla.
AID378414Antimicrobial activity against Stachybotrys chartarum DSM 2144 after 24 hrs2006Journal of natural products, Aug, Volume: 69, Issue:8
Carneic acids A and B, chemotaxonomically significant antimicrobial agents from the xylariaceous ascomycete Hypoxylon carneum.
AID524059Binding affinity to methicillin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 1287 PBP2a by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID1112106Antimicrobial activity against Escherichia coli by agar diffusion test2012Fitoterapia, Apr, Volume: 83, Issue:3
Pyrenocines J-M: four new pyrenocines from the endophytic fungus, Phomopsis sp.
AID571181Antibacterial activity against Neisseria gonorrhoeae harboring GS A102S mutant gene by disk agar diffusion method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID634230Antibacterial activity against Streptococcus mutans ATCC 25175 assessed as growth inhibition at 0.00625 to 2.5 ug/ml after 24 hrs by microplate dilution assay2011Journal of natural products, Dec-27, Volume: 74, Issue:12
Isoflavonoids and coumarins from Glycyrrhiza uralensis: antibacterial activity against oral pathogens and conversion of isoflavans into isoflavan-quinones during purification.
AID340763Antibacterial activity against Streptococcus gordonii with penicillin binding protein mutation2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii.
AID163929Minimum protective concentration against beta-lactamase of Pseudomonas aeruginosa 18S-H2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Design, synthesis, and SAR of novel carbapenem antibiotics with high stability to Xanthomonas maltophilia oxyiminocephalosporinase type II.
AID515293Antibacterial activity against Staphylococcus epidermidis MTCC 437 by broth dilution method2010European journal of medicinal chemistry, Oct, Volume: 45, Issue:10
Stereoselective synthesis and biological evaluation of (R)-rugulactone, (6R)-((4R)-hydroxy-6-phenyl-hex-2-enyl)-5,6-dihydro-pyran-2-one and its 4S epimer.
AID1271946Antibacterial activity against Bacillus subtilis assessed as growth inhibition at 1 mg/ml by drug sensitive assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel skeleton compound Allomyrinanoid A and two purine alkaloids from the adult of Allomyrina dichotoma L.
AID206458In vitro antibacterial activity against the gram-positive bacteria, penicillin resistant Staphylococcus aureus (853)1999Bioorganic & medicinal chemistry letters, Apr-05, Volume: 9, Issue:7
New N-substituted 7-aminocephalosporanic acid derivatives as potential agents against Streptococcus pneumoniae. Synthesis and in vitro activity.
AID374671Antimicrobial activity against wild type Escherichia coli isolate AMG1 grown as biofilms after 24 hrs by spectrophotometric method2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
AID451358Antimicrobial activity against Aspergillus fumigatus NBRC4400 after 24 hrs by broth dilution method2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Synthesis and evaluation of bioactive naphthoquinones from the Brazilian medicinal plant, Tabebuia avellanedae.
AID573117Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID1720710Antibacterial activity against Pseudomonas aeruginosa GKCW120 harboring P6 deletion mutant assessed as growth inhibition incubated for 24 hrs by micro dilution assay2020Bioorganic & medicinal chemistry letters, 08-15, Volume: 30, Issue:16
Short chain α-pyrones capable of potentiating penicillin G against Pseudomonas aeruginosa.
AID278857Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID495699Activity of Pseudomonas aeruginosa SPM-12010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID372897Antibacterial activity against Streptococcus faecalis ATCC 9790 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID1720709Antibacterial activity against Pseudomonas aeruginosa GKCW120 harboring P6 deletion mutant assessed as growth inhibition incubated for 8 hrs by micro dilution assay2020Bioorganic & medicinal chemistry letters, 08-15, Volume: 30, Issue:16
Short chain α-pyrones capable of potentiating penicillin G against Pseudomonas aeruginosa.
AID351190Intercompartmental clearance in preterm neonates with septicemia or invasive infections with gestational age of less than 32 weeks at 50000 U/kg, iv administered every 12 hrs2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.
AID364061Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT assay2008European journal of medicinal chemistry, Sep, Volume: 43, Issue:9
Enamines as novel antibacterials and their structure-activity relationships.
AID1653059Antibacterial activity against Pseudomonas aeruginosa2019European journal of medicinal chemistry, Feb-15, Volume: 164Isatin derivatives and their anti-bacterial activities.
AID558624Antimicrobial activity against Streptococcus pneumoniae isolate 3455 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID575144Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NRS1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
AID1870127Antibacterial activity against antibiotic resistant Staphylococcus aureus 4717/B assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID1168781Antibacterial against Bacillus subtilis ATCC 530 after 24 hrs by two-fold serial dilution method2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Synthesis, molecular docking and biological evaluation of coumarin derivatives containing piperazine skeleton as potential antibacterial agents.
AID356764Antimicrobial activity against Candida albicans 54 after 18 hrs by microbroth dilution method2001Journal of natural products, Jul, Volume: 64, Issue:7
Biological and mechanistic activities of xanthorrizol and 4-(1',5'-dimethylhex-4'-enyl)-2-methylphenol isolated from Iostephane heterophylla.
AID436380Antibacterial activity against Pseudomonas aeruginosa ATCC 13525 after 24 hrs by MTT method2009European journal of medicinal chemistry, Oct, Volume: 44, Issue:10
Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents.
AID522646Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis Ohio by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID323867Antibacterial activity against methicillin-resistant Staphylococcus aureus 459 at pH 7.42007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Role of acidic pH in the susceptibility of intraphagocytic methicillin-resistant Staphylococcus aureus strains to meropenem and cloxacillin.
AID532985Antibacterial activity against Escherichia coli MG16552010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID577458Antimicrobial activity against laboratory-derived Streptococcus pneumoniae isolate R6 harboring Thr446Ala mutant gene by broth microdilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Affinity of ceftobiprole for penicillin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin.
AID297186Antibacterial activity against multidrug resistant Staphylococcus aureus 495892007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
AID395348Antibacterial activity against Micrococcus luteus La 2971 at 10 units after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID1079937Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]
AID647399Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by serial broth microdilution susceptibility test2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
Novel dendrimeric lipopeptides with antifungal activity.
AID1870135Antibacterial activity against antibiotic resistant Staphylococcus aureus 78/CF assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID662527Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 18 to 20 hrs by spectrophotometry2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Discovery of potent antimicrobial peptide analogs of Ixosin-B.
AID278532Antimicrobial activity against Bifidobacterium thermophilum ATCC 258662007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID573123Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID528740Antimicrobial activity against penicillin-resistant Streptococcus agalactiae ATCC BAA-611 harboring PBP-2X Q557E mutant gene by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID562369Antimicrobial activity against erythromycin-susceptible Streptococcus Group G clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID557509Displacement of Biocillin FL from Streptococcus pneumoniae 3413 PBP2B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID519067Antibacterial activity against multidrug resistant Streptococcus pneumoniae ATCC 49619 assessed as resistant strains by CLSI microdilution susceptibility testing method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Activity of the Diaminopyrimidine AR-709 against recently collected multidrug-resistant isolates of invasive Streptococcus pneumoniae from North America.
AID524063Binding affinity to methicillin-, vancomycin-resistant, beta-lactamase-positive Staphylococcus aureus 510 PBP3 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID258710Antibacterial activity against gram positive Bacillus subtilis MTCC 4412006Bioorganic & medicinal chemistry letters, Jan-01, Volume: 16, Issue:1
Synthesis and biological evaluation of novel C (7) modified chrysin analogues as antibacterial agents.
AID619771Antibacterial activity against Bacillus subtilis RCMB 000107 at 30 mg/ml after 24 hrs by agar well diffusion method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design and synthesis of some new thiophene, thienopyrimidine and thienothiadiazine derivatives of antipyrine as potential antimicrobial agents.
AID368510Activity of Serratia marcescens SME3 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID609854Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 assessed as growth inhibition after 18 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Unprecedented C-2 arylation of indole with diazonium salts: Syntheses of 2,3-disubstituted indoles and their antimicrobial activity.
AID571188Antibacterial activity against Neisseria gonorrhoeae harboring wild-type penA and DA G101D mutant genes by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID324836Antimicrobial activity against Neisseria gonorrhoeae 188 isolate2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
AID1254312Antibacterial activity against Pseudomonas aeruginosa CCM 1961 after 24 hrs by microdilution broth method2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
AID666781Antifungal activity against Septoria tritici at 0.05 mg by agar diffusion test2012Bioorganic & medicinal chemistry letters, Jul-01, Volume: 22, Issue:13
Bioactive briarane diterpenoids from the South China Sea gorgonian Dichotella gemmacea.
AID1161140Antimicrobial activity against Staphylococcus epidermidis after 24 hrs by broth microdilution method2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
AID278524Antimicrobial activity against Bifidobacterium bifidum BB122007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID332340Antimicrobial activity against methicillin-resistant Staphylococcus aureus 310 after 18 hrs by microbroth dilution method2003Journal of natural products, Feb, Volume: 66, Issue:2
Antibacterial diterpenes from Calceolaria pinifolia.
AID1638899Antimicrobial activity against vancomycin-resistant Enterococcus faecium ATCC 700221 measured after 18 hrs by broth microdilution method2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
AID418562Antibacterial activity against Bacillus cereus ATCC 11778 by NCCLS method2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
AID557468Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae 3665 by CLSI method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID520386Activity at Pseudomonas aeruginosa COL-1 metallo-beta lactamase VIM-2 by spectrometry2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biochemical characterization of metallo-beta-lactamase VIM-11 from a Pseudomonas aeruginosa clinical strain.
AID586081Antimicrobial activity against multidrug-resistant Neisseria gonorrhoeae isolates assessed as resistant isolates by disk susceptibility test2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Characteristics and dissemination of mosaic penicillin-binding protein 2-harboring multidrug-resistant Neisseria gonorrhoeae isolates with reduced cephalosporin susceptibility in northern Taiwan.
AID278523Antimicrobial activity against Bifidobacterium bifidum ATCC 156962007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID1348090Antimicrobial activity against Escherichia coli ATCC 25922 assessed as zone of inhibition at 50 ug per disc after 24 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID1126517Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by two-fold serial dilution method2014Bioorganic & medicinal chemistry, Apr-15, Volume: 22, Issue:8
Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents.
AID438298Inhibition of penicillin-resistant Streptococcus pneumoniae 5204 PBP2X preincubated for 4 hrs before addition of substrate (R)-[2-(benzoylamino)propionylsulfanyl]acetic acid2009Journal of medicinal chemistry, Oct-08, Volume: 52, Issue:19
Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening.
AID524878Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA and ponA mutant gene assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID559707Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus P1369 by microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.
AID1546643Antibacterial activity against Escherichia coli MTCC 443 assessed as diameter of zone of inhibition at 200 ug/ml after 24 hrs by agar well diffusion method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
AID658947Antibacterial activity against Pseudomonas aeruginosa 155250A at 100 mg/ml after 24 hrs by agar-well diffusion technique2012European journal of medicinal chemistry, Jun, Volume: 522-Aminothiophenes as building blocks in heterocyclic synthesis: synthesis and antimicrobial evaluation of a new class of pyrido[1,2-a]thieno[3,2-e]pyrimidine, quinoline and pyridin-2-one derivatives.
AID263104Antibacterial activity against Staphylococcus aureus 849 ATCC 25923 by agar disk diffusion method2006Bioorganic & medicinal chemistry letters, Apr-15, Volume: 16, Issue:8
N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
AID529320Antibacterial activity against Streptococcus pneumoniae serotype 19F URA4087 harboring mutant PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID258711Antibacterial activity against gram positive Bacillus sphaericus (MTCC 11)2006Bioorganic & medicinal chemistry letters, Jan-01, Volume: 16, Issue:1
Synthesis and biological evaluation of novel C (7) modified chrysin analogues as antibacterial agents.
AID557482Displacement of Biocillin FL from Streptococcus pneumoniae 3413 PBP1B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID569255Antimycobacterial activity against Mycobacterium tuberculosis H37Rv2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.
AID531461Antibacterial activity against Streptococcus pneumoniae serotype 22 assessed as percent resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID660263Ratio of MIC for wild type Salmonella typhimurium SH5014 to MIC for Salmonella typhimurium SH7616 harboring missense mutation in acrA/acrB gene by two-fold serial dilution method2012European journal of medicinal chemistry, Jun, Volume: 52Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
AID543277Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 3191 pbp2x and pbp2b genes by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID1546171Antimicrobial activity against Bacillus thuringiensis2019European journal of medicinal chemistry, Dec-15, Volume: 184Current scenario of tetrazole hybrids for antibacterial activity.
AID529325Antibacterial activity against penicillin-resistant Streptococcus pneumoniae serotype 23F URA5391 harboring mutant PBP2B PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID1870134Antibacterial activity against antibiotic resistant Staphylococcus aureus 4788/B assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID773425Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700698 by microdilution technique2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
The synthesis and SAR study of phenylalanine-derived (Z)-5-arylmethylidene rhodanines as anti-methicillin-resistant Staphylococcus aureus (MRSA) compounds.
AID557508Displacement of Biocillin FL from Streptococcus pneumoniae 24 PBP2B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID511535Antimicrobial activity against Streptococcus uberis ATCC 8749 harboring PAP1A A227T/G386R, PBP2B N366I/T402I and PBP2X E381K/D524A/Q554E mutation after 37 passages assessed as inhibition of visible growth broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID533932Antimicrobial activity against linezolid-resistant methicillin-resistant Staphylococcus aureus NRS121 harboring G2576U mutation in peptidyl transferase centre by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID524052Binding affinity to methicillin-, vancomycin-resistant, beta-lactamase-positive Staphylococcus aureus 510 PBP2 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID263112Antibacterial activity against methicillin-resistant Staphylococcus aureus USF657 by agar disk diffusion method2006Bioorganic & medicinal chemistry letters, Apr-15, Volume: 16, Issue:8
N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
AID279185Inhibition of Enterobacter cloacae S3 isolate beta lactamase LAP1 expressed in Escherichia coli DH10B2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Novel Ambler class A beta-lactamase LAP-1 and its association with the plasmid-mediated quinolone resistance determinant QnrS1.
AID417434Antibacterial activity against Staphylococcus aureus after 24 hrs by MTT method2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents.
AID554870Antimicrobial activity against Streptococcus pneumoniae serotype 23F ST 3250 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID546429Activity at Pseudomonas aeruginosa PDC-5 by spectrophotometer2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.
AID559499Antibacterial activity against Listeria monocytogenes assessed as percent susceptible isolates by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID340851Increase in pbp1A gene expression in penicillin-resistant Streptococcus gordonii with penicillin binding protein PR1_2 evolved mutation at 1/8 times MIC assessed as relative luciferase units relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii.
AID171259Concentration of compound in rat liver after intravenous injection of 20 mg/kg benzyl-penicillin after 20 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID278545Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium animalis ATCC 27536 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID503231Ratio of MIC for penicillin-resistant Streptococcus pneumoniae 5204 to MIC for penicillin-sensitive Streptococcus pneumoniae R62007Nature chemical biology, Sep, Volume: 3, Issue:9
Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins.
AID1245116Antimicrobial activity against Escherichia coli ATCC 35218 after 18 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Sep-15, Volume: 23, Issue:18
Design, synthesis and molecular docking of salicylic acid derivatives containing metronidazole as a new class of antimicrobial agents.
AID529317Antibacterial activity against Streptococcus pneumoniae URA2543 harboring mutant PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID568433Antimicrobial activity against Bacillus subtilis MTCC 441 after 24 hrs by broth dilution method2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Stereoselective first total synthesis, confirmation of the absolute configuration and bioevaluation of botryolide-E.
AID1180450Antimicrobial activity against Staphylococcus epidermidis H 6966/08 after 48 hrs by microdilution method2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
AID567283Ratio of Kcat to Km for Acinetobacter baumannii ADC-33 beta-lactamase to Kcat to Km for Acinetobacter baumannii ADC-11 beta-lactamase2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
Extended-spectrum cephalosporinase in Acinetobacter baumannii.
AID1168783Antibacterial against Escherichia coli ATCC 25922 after 24 hrs by two-fold serial dilution method2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Synthesis, molecular docking and biological evaluation of coumarin derivatives containing piperazine skeleton as potential antibacterial agents.
AID577456Inhibition of Bocillin FL binding to PBP2b in Streptococcus pneumoniae isolate 8819 harboring E333G, I361L, E369D, S412P, N422Y, T426K, Q427L, Q438E, L455I, S473T, E476G, S480A, T489A, N538D, D561E, Q564K, and D625G mutant genes2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Affinity of ceftobiprole for penicillin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin.
AID557210Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis assessed as percent intermediate isolates by Etest method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
AID582965Antimicrobial activity against Yersinia enterocolitica Biovar 1B 8081 after 20 hrs by Etest2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Contribution of BlaA and BlaB beta-lactamases to antibiotic susceptibility of Yersinia enterocolitica biovar 1B.
AID269453Antibacterial activity against Escherichia coli ATCC 33475 by agar diffusion assay2006Bioorganic & medicinal chemistry letters, Aug-01, Volume: 16, Issue:15
The synthesis and in vitro testing of structurally novel antibiotics derived from acylnitroso Diels-Alder adducts.
AID1437931Bactericidal activity against Streptococcus mutans ATCC 25175 after 24 hrs2017Journal of natural products, 01-27, Volume: 80, Issue:1
Dibenzofurans and Pseudodepsidones from the Lichen Stereocaulon paschale Collected in Northern Quebec.
AID395343Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 at 10 units after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID533879Antibacterial activity against amoxicillin-resistant Streptococcus pneumoniae assessed as percent susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
AID451355Antimicrobial activity against Candida albicans NBRC1060 after 24 hrs by broth dilution method2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Synthesis and evaluation of bioactive naphthoquinones from the Brazilian medicinal plant, Tabebuia avellanedae.
AID467613Volume of distribution at steady state in human2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
AID394486Ratio of Kcat to Km for Escherichia coli beta-lactamase ACC4 by UV spectrophotometry2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
AID1237606Antibacterial activity against Escherichia coli ATCC25922 assessed as bacterial growth inhibition after 24 hrs by broth dilution method2015European journal of medicinal chemistry, Jul-15, Volume: 100Novel cajaninstilbene acid derivatives as antibacterial agents.
AID573582Antibacterial activity against beta-lactamase producing Bacteroides caccae assessed as susceptible isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID519982Activity of Klebsiella pneumoniae Beta-Lactamase SHV-552008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Biochemical characterization of SHV-55, an extended-spectrum class A beta-lactamase from Klebsiella pneumoniae.
AID571190Antibacterial activity against Neisseria gonorrhoeae harboring wild-type penA and GS A102S mutant genes by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID511448Antimicrobial activity against Streptococcus uberis isolate ALP8092 harboring PAP1A G386R and PBP2X E381K/Q554E mutation assessed as inhibition of visible growth after 24 hrs by broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID1755805Antibacterial activity against Escherichia coli ATCC 35218 incubated for 24 hrs by two fold serial dilution method2021European journal of medicinal chemistry, Jan-15, Volume: 210Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
AID341343Antimicrobial activity against Neisseria meningitidis isolates harboring penA 3 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID558334Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P1093 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID466789Antibacterial activity against Staphylococcus aureus ATCC 65382010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents.
AID575948Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae assessed as resistant isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.
AID490135Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT assay2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis of some N-alkyl substituted urea derivatives as antibacterial and antifungal agents.
AID205985In vitro Minimum inhibitory concentration against Staphylococcus aureus ATCC 6538P (penicillin G sensitive)1981Journal of medicinal chemistry, Oct, Volume: 24, Issue:10
Synthesis and evaluation of ureido- and vinylureidopenicillins as inhibitors of intraruminal lactic acid production.
AID1366163Antibacterial activity against Escherichia coli by agar dilution method2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID588108Antimicrobial activity against Neisseria gonorrhoeae clinical isolates harboring porB G120K, A121D mutant gene, PBP1 L421P mutant gene, PBP2 XXXVIII pattern, insertion of nucleotide T from mtrA promoter, MAST 3158 after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID577442Antimicrobial activity against Staphylococcus aureus USA300 isolate harboring pSK41 plasmid assessed resistant isolates2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States.
AID171247Concentration of compound in rat brain after intravenous injection of 20 mg/kg benzyl-penicillin after 60 min; Below detection limit.1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID431309Antibacterial activity against Staphylococcus epidermidis ATCC 122282009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
AID1546646Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as reduction in microbial growth after 24 hrs by CLSI based microdilution method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
AID1079935Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]
AID511444Antimicrobial activity against Streptococcus uberis ATCC 8749 harboring PAP1A A227T/G386R, PBP2B N366I/T402I and PBP2X E381K/D524A/Q554E mutation after 28 passages assessed as inhibition of visible growth broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID524645Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA and ponA mutant gene assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID171108Concentration of compound in rat blood after intravenous injection of 20 mg/kg benzyl-penicillin after 10 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID431314Antibacterial activity against Bacillus subtilis ATCC 238572009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
AID495733Kcat/Km ratio of Escherichia coli CTX-M-15 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID437459Antimicrobial activity Bacillus subtilis ATCC 6633 by MTT assay2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
AID437463Antimicrobial activity Pseudomonas aeruginosa ATCC 13525 by MTT assay2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
AID528522Antimicrobial activity against Streptococcus pneumoniae ATCC 49619 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID171109Concentration of compound in rat blood after intravenous injection of 20 mg/kg benzyl-penicillin after 20 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID681114TP_TRANSPORTER: inhibition of Gly-Sar uptake (pH6.0) in SKPT cells2005European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, Jan, Volume: 59, Issue:1
Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
AID560705Inhibition of Escherichia coli MC4100 Beta-Lactamase CMY-30 using cephalothin as reporter substrate2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.
AID1759749Binding affinity to Staphylococcus aureus ATCC 43300 50S ribosome assessed as dissociation constant by SPR analysis2021Bioorganic & medicinal chemistry, 05-15, Volume: 38Design, synthesis and biological evaluation of novel pleuromutilin derivatives as potent anti-MRSA agents targeting the 50S ribosome.
AID776442Antibacterial activity against Staphylococcus aureus ATCC 12600 after 24 hrs by microdilution technique2013European journal of medicinal chemistry, Nov, Volume: 69Synthesis, antimicrobial, antioxidant activities of novel 6-aryl-5-cyano thiouracil derivatives.
AID585180Activity of Beta-lactamase GES-13 K104, N170 mutant2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
AID575418Antimicrobial activity against anrB-deficient Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method relative to wild type2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID278527Antimicrobial activity against Bifidobacterium longum ATCC 157072007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID96241In Vitro minimal inhibitory concentration against Klebsiella pneumoniae (NCTC 418)1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
Syntheses of new isodethiaazacephems as potent antibacterial agents.
AID1079948Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]
AID569256Antimycobacterial activity against Mycobacterium bovis BCG str. Tokyo 1722011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.
AID531444Antibacterial activity against Streptococcus pneumoniae serotype 19A assessed as percent susceptible isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID529455Antibacterial activity against multidrug resistant Streptococcus pneumoniae serotype 24F URA5450 harboring mutant PBP2B PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID1720708Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as growth inhibition by micro dilution assay2020Bioorganic & medicinal chemistry letters, 08-15, Volume: 30, Issue:16
Short chain α-pyrones capable of potentiating penicillin G against Pseudomonas aeruginosa.
AID569338Antibacterial activity against Staphylococcus aureus ATCC 25923 by broth micro dilution technique2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
AID420257Inhibition of Enterococcus faecium PBP5fm assessed as residual activity at 100 uM after 16 hrs2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Large ring 1,3-bridged 2-azetidinones: experimental and theoretical studies.
AID529903Antimicrobial activity against Leptospira kirschneri serovar Grippotyphosa isolate 13 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID524033Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 1394 by macrodilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID1126514Antibacterial activity against Bacillus subtilis ATCC 530 after 24 hrs by two-fold serial dilution method2014Bioorganic & medicinal chemistry, Apr-15, Volume: 22, Issue:8
Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents.
AID374676Antimicrobial activity against Escherichia coli AMG1 isolate 24 hrs flow cell-generated biofilms using BacLight staining by CSLM2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
AID1237611Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC425055 assessed as bacterial growth inhibition after 24 hrs by broth dilution method2015European journal of medicinal chemistry, Jul-15, Volume: 100Novel cajaninstilbene acid derivatives as antibacterial agents.
AID287374Antibacterial activity against Bacillus cereus after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID531422Antibacterial activity against Streptococcus pneumoniae serotype 23A by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID529332Antibacterial activity against penicillin-cefotaxime- ceftriaxone-resistant Streptococcus pneumoniae URA6056 harboring mutant PBP2B PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID394489Activity of Hafnia alvei beta-lactamase ACC-12007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
AID420255Inhibition of Actinomadura R39 DD-peptidase assessed as residual activity at 100 uM after 16 hrs2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Large ring 1,3-bridged 2-azetidinones: experimental and theoretical studies.
AID558628Antimicrobial activity against Streptococcus pneumoniae isolate 3681 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID531454Antibacterial activity against Streptococcus pneumoniae serotype 6A/C assessed as percent resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID28949Partition coefficient (logP)1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. Synthesis and properties of some dihydropyridine and dihydroiosquinoline derivatives of benzylpenicillin.
AID542629Antimicrobial activity against streptomycin-resistant Streptococcus pneumoniae R6 harboring PBP2x T338G mutant gene, Janus disruption at PBP1a and aad9 disruption in CiaR gene after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID773426Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC BAA-39 by microdilution technique2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
The synthesis and SAR study of phenylalanine-derived (Z)-5-arylmethylidene rhodanines as anti-methicillin-resistant Staphylococcus aureus (MRSA) compounds.
AID295107Antibacterial activity against Proteus vulgaris ATCC 8427 at 10 ug after 24 hrs by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID592502Antibacterial activity against Legionella pneumophila Corby by microtiter plate assay2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Diversonol and blennolide derivatives from the endophytic fungus Microdiplodia sp.: absolute configuration of diversonol.
AID341535Antimicrobial activity against Neisseria meningitidis isolates harboring penA 33 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID540183Antibacterial activity against Staphylococcus aureus NCIM 2492 after 24 hrs by twofold serial dilution method2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis and anti-tubercular and antimicrobial activities of some 2r,4c-diaryl-3-azabicyclo[3.3.1]nonan-9-one N-isonicotinoylhydrazone derivatives.
AID207806Compound was evaluated for the antibacterial activity against Staphylococcus aureus with the strain 209P1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Dependence of beta-lactamase stability on substructures within beta-lactam antibiotics.
AID562756Ratio of Kcat to Km for Klebsiella pneumoniae AH24-270 CTX-M-71 beta-lactamase2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
New variant of CTX-M-type extended-spectrum beta-lactamases, CTX-M-71, with a Gly238Cys substitution in a Klebsiella pneumoniae isolate from Bulgaria.
AID368523Activity of Enterobacter cloacae 4080 AmpC (P99) assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID665398Antibacterial activity against Pseudomonas aeruginosa MTCC 7952 after 24 hrs by serial dilution technique2012European journal of medicinal chemistry, Jul, Volume: 53Synthesis, characterization, antimicrobial activities and QSAR studies of some 10a-phenylbenzo[b]indeno[1,2-e][1,4]thiazin-11(10aH)-ones.
AID429082Antibacterial activity against penicillin-intermediate resistant Neisseria meningitidis clinical isolates harbouring altered penA gene after 24 hrs by Etest method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Combined real-time PCR and pyrosequencing strategy for objective, sensitive, specific, and high-throughput identification of reduced susceptibility to penicillins in Neisseria meningitidis.
AID569341Antibacterial activity against methicillin-resistant Staphylococcus epidermidis ATCC 12228 by broth micro dilution technique2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
AID524040Antibacterial activity against methicillin-, vancomycin-resistant, beta-lactamase-positive Staphylococcus aureus 510 by macrodilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID495742Kcat/Km ratio of Pseudomonas aeruginosa VIM-2 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID374362Ratio of Kcat to Km of Aeromonas caviae A324R metallo-beta-lactamase IMP-19 expressed in Escherichia coli DH5alpha by computerized microacidimetric method2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
First occurrence of an IMP metallo-beta-lactamase in Aeromonas caviae: IMP-19 in an isolate from France.
AID542623Antimicrobial activity against Streptococcus pneumoniae R6 harboring PBP2x T338P mutant gene, disruption at PBP1a and aad9 disruption in CiaR gene after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID1287894Antimicrobial activity against Chromobacterium violaceum MTCC 2625 after 24 hrs by serial two-fold broth dilution method2016European journal of medicinal chemistry, May-04, Volume: 113Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids.
AID495709Kcat/Km ratio of Pseudomonas aeruginosa OXA-102010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID678786TP_TRANSPORTER: inhibition of PAH uptake in Xenopus laevis oocytes1999The Journal of pharmacology and experimental therapeutics, Aug, Volume: 290, Issue:2
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
AID498372Antimicrobial activity against penicillin- and streptomycin-resistant Streptococcus gordonii Tol1 harboring Tol1 mutation in ptsI after 24 hrs by macrodilution assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.
AID529330Antibacterial activity against multidrug resistant Streptococcus pneumoniae serotype 23F ATCC 51916 harboring mutant PBP2B PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID572286Antimicrobial activity against methicillin-resistant Staphylococcus aureus NB01021 infected in sc dosed BALB/c mouse administered 0, 4, 23 hrs post infection2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models.
AID93879Minimum inhibitory concentration against aerobic organism Klebsiella pneumoniae strain 28821982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
Quaternary heterocyclylamino beta-lactams: a generic alternative to the classical acylamino side chain.
AID368524Activity of Enterobacter cloacae 4080 AmpC (P99) assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID495741Kcat/Km ratio of Serratia marcescens SME-3 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID557510Displacement of Biocillin FL from Streptococcus pneumoniae 2527 PBP2B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID524198Binding affinity to against methicillin-, daptomycin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 25 PBP4 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID495715Kcat/Km ratio of Acinetobacter baumannii OXA-232010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID565812Antimicrobial activity against Neisseria meningitidis assessed as resistant isolate by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
AID1279020Antibacterial activity against ESBL-positive Klebsiella pneumoniae J 14368/08 after 48 hrs by microbroth dilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
AID368539Activity of Pseudomonas aeruginosa 4352 AmpC assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID522388Activity of Aeromonas enteropelogenes Beta-lactamase TRU12010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Genetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenes.
AID324838Antimicrobial activity against Neisseria gonorrhoeae 253 isolate2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
AID1279012Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 48 hrs by microbroth dilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
AID368536Activity of Providencia stuartii AmpC assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID523004Antibacterial activity against uropathogenic Escherichia coli UTI89 assessed as degradation of preexisting biofilm after 24 hrs by microscopy2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
AID340767Induction of pbp2A gene expression in wild type penicillin-susceptible Streptococcus gordonii assessed as relative luciferase units relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii.
AID529579Ratio of Kcat to Km for Legionella gormanii ATCC 33297T beta-Lactamase FEZ-12008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Functional diversity among metallo-beta-lactamases: characterization of the CAR-1 enzyme of Erwinia carotovora.
AID1243285Antimicrobial activity against levofloxacin-resistant Staphylococcus aureus clinical isolates by standard broth microdilution method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.
AID503225Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 4790 by microscopy2007Nature chemical biology, Sep, Volume: 3, Issue:9
Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins.
AID530523Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 8607 expressing multiple copies of wild-type pbp2x by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID301808Antibacterial activity against Bacillus anthracis AMES2007Bioorganic & medicinal chemistry, Dec-01, Volume: 15, Issue:23
Direct diazo-transfer reaction on beta-lactam: synthesis and preliminary biological activities of 6-triazolylpenicillanic acids.
AID447056Antibacterial activity against Bacillus cereus ATCC 7064 at 10 IU after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID1079946Presence of at least one case with successful reintroduction. [column 'REINT' in source]
AID508308Inhibition of PBP6 in wild type Enterococcus faecium D63 membranes assessed as inhibition of fluorescent ampicillin binding after 20 mins at 37 degC2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID525550Antimicrobial activity against ampicillin resistant serotype-e Haemophilus influenzae isolate BB1053 harboring with plasmid pB1000 bearing beta-lactamase ROB-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Haemophilus influenzae clinical isolates with plasmid pB1000 bearing blaROB-1: fitness cost and interspecies dissemination.
AID559702Antimicrobial activity against Staphylococcus aureus AB94004 by microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.
AID404304Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control2008Journal of medicinal chemistry, Jun-12, Volume: 51, Issue:11
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
AID679489TP_TRANSPORTER: inhibition of PAH uptake in Oat1-expressing LLC-PK1 cells2002The Journal of pharmacology and experimental therapeutics, Mar, Volume: 300, Issue:3
Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions.
AID530502Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IA isolate 7490-03 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID660265Antimicrobial activity against wild type Escherichia coli expressing AcrAB-TolC efflux pump2012European journal of medicinal chemistry, Jun, Volume: 52Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
AID428133Antimicrobial activity against wild type Streptococcus gordonii assessed as logarithmic reduction in viability at stationary phase of growth after 70 hrs2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Fitness cost and impaired survival in penicillin-resistant Streptococcus gordonii isolates selected in the laboratory.
AID545512Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1680 by microdilution method2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains.
AID322494Cmax in human term neonates at 15 mg/kg, im administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID558538Antibacterial activity against bla-positive and beta-lactamase-weakly positive Campylobacter coli isolate P1627 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID585182Ratio of Kcat to Km for Beta-lactamase GES-7 K104, G170 mutant2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
AID770974Antibacterial activity against Bacillus subtilis MTCC 441 by broth dilution method2013European journal of medicinal chemistry, Oct, Volume: 68Demonic axe-like conjugated alkynes in combating microbes.
AID528531Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B60 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID301807Antibacterial activity against Streptococcus pneumoniae ATCC 496192007Bioorganic & medicinal chemistry, Dec-01, Volume: 15, Issue:23
Direct diazo-transfer reaction on beta-lactam: synthesis and preliminary biological activities of 6-triazolylpenicillanic acids.
AID368502Activity of Klebsiella pneumoniae TEM26 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID368491Ratio of Kcat to Km of Klebsiella pneumoniae SHV1 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID325448Antibacterial activity against Staphylococcus aureus Mu50 after 14 to 16 hrs by broth dilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Polyamine effects on antibiotic susceptibility in bacteria.
AID495704Kcat/Km ratio of Klebsiella oxytoca Beta-lactamase K12010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID558534Antibacterial activity against bla gene-positive and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni isolate P1699 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID562612Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID557500Displacement of Biocillin FL from Streptococcus pneumoniae 3413 PBP2A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID519634Ratio of Kcat to Km for beta-lactamase FUS1 assessed as compound hydrolysis by spectrophotometry2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
AID1254306Antibacterial activity against Escherichia coli CCM4517 after 24 hrs by microdilution broth method2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
AID625291Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID529576Ratio of Kcat to Km for Erwinia carotovora subsp. atroseptica DSM 30184 beta-Lactamase CAR-12008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Functional diversity among metallo-beta-lactamases: characterization of the CAR-1 enzyme of Erwinia carotovora.
AID715626Antibacterial activity against Escherichia coli MTCC 42 after 24 hrs by serial dilution method2012European journal of medicinal chemistry, Nov, Volume: 57Synthesis, characterization, biological evaluation and QSAR studies of 11-p-substituted phenyl-12-phenyl-11a,12-dihydro-11H-indeno[2,1-c][1,5]benzothiazepines as potential antimicrobial agents.
AID315976Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 24 hrs by broth dilution MIC assay2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Glyconanobiotics: Novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis.
AID521351Antimicrobial activity against Streptococcus pneumoniae isolate k-585 obtained from bronchoalveolar lavage fluid of patient2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20.
AID322503Clearance in human adults at 600 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID535768Antimicrobial activity against penicillin-producing Neisseria gonorrhoeae NGON 08-046 expressing beta-lactamase TEM-1, MLST type ST-1584 and MAST type ST-1478 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Identification of TEM-135 beta-lactamase in penicillinase-producing Neisseria gonorrhoeae strains in Japan.
AID530514Antimicrobial activity against group B Streptococcus sp. 'group B' isolate 4214-03 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID625287Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID368732Ratio of Kcat to Km of Pseudomonas aeruginosa AmpC assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID554875Antimicrobial activity against Streptococcus pneumoniae serotype 18C ST 496 harboring ERY-resistant erm(B) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID522659Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis 003BS by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID531317Activity of Escherichia coli beta-lactamase VIM-1 by spectrophotometry2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
AID573551Antibacterial activity against Bacteroides fragilis assessed as susceptible isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID529661Activity of Pseudomonas aeruginosa 9551 beta-lactamase VIM-15 relative to cephaloridine2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID558607Antimicrobial activity against Streptococcus pneumoniae isolate 1384 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID422495Antimicrobial activity against Escherichia coli BL21 (DE3) harboring pAT514 by E-test2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
AID575078Antimicrobial activity against Streptococcus pneumoniae serotype 35B assessed as percent susceptible isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID539690Antifungal activity against Bacillus subtilis MTCC 441 by broth dilution method2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Indium(III) chloride catalyzed three-component coupling reaction: a novel synthesis of 2-substituted aryl(indolyl)kojic acid derivatives as potent antifungal and antibacterial agents.
AID524062Binding affinity to methicillin-resistant, heteroresistant vancomycin-intermediate, beta-lactamase-negative Staphylococcus aureus 873 PBP3 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID554861Antimicrobial activity against Streptococcus pneumoniae serotype 14 ST 2916 harboring ERY-resistant erm(B) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID1354715Antimicrobial activity against Pasteurella multocida subsp. multocida ATCC 43137 after 24 hrs by serial dilution method
AID715624Antibacterial activity against Bacillus subtilis MTCC 441 after 24 hrs by serial dilution method2012European journal of medicinal chemistry, Nov, Volume: 57Synthesis, characterization, biological evaluation and QSAR studies of 11-p-substituted phenyl-12-phenyl-11a,12-dihydro-11H-indeno[2,1-c][1,5]benzothiazepines as potential antimicrobial agents.
AID341341Antimicrobial activity against Neisseria meningitidis isolates harboring penA 2 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID561102Antibacterial activity against Pasteurella multocida BB1036 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB1005 bearing strA, sul2 genes by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID680321TP_TRANSPORTER: uptake in OATP-B-expressing HEK293 cells2000Biochemical and biophysical research communications, Jun-24, Volume: 273, Issue:1
Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.
AID574169Antibacterial activity against Escherichia coli MG1655 harboring plasmid pBR322 carrying blaTEM-1 and tetA(C) genes grown as planktonic cells after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Induction of multidrug resistance mechanism in Escherichia coli biofilms by interplay between tetracycline and ampicillin resistance genes.
AID658949Antibacterial activity against Bacillus subtilis 154921 at 100 mg/ml after 24 hrs by agar-well diffusion technique2012European journal of medicinal chemistry, Jun, Volume: 522-Aminothiophenes as building blocks in heterocyclic synthesis: synthesis and antimicrobial evaluation of a new class of pyrido[1,2-a]thieno[3,2-e]pyrimidine, quinoline and pyridin-2-one derivatives.
AID1079938Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]
AID368508Ratio of Kcat to Km of Escherichia coli KPC2 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID563973Ratio of Kcat to Km for Klebsiella pneumoniae 05-560 beta-lactamase NDM-12009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
AID773422Antibacterial activity against methicillin-resistant Staphylococcus aureus ST239 HS770 by microdilution technique2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
The synthesis and SAR study of phenylalanine-derived (Z)-5-arylmethylidene rhodanines as anti-methicillin-resistant Staphylococcus aureus (MRSA) compounds.
AID375915Antibacterial activity against methicillin-resistan Staphylococcus epidermidis ATCC 51625 by NCCLS method2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
AID679396TP_TRANSPORTER: inhibition of PAH uptake (PCG: 200 uM) in OAT1-expressing HeLa cells1999The American journal of physiology, 02, Volume: 276, Issue:2
Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C.
AID1347489Antibacterial activity against Serratia marcescens assessed as zone of inhibition after 24 to 48 hrs by well diffusion method2018European journal of medicinal chemistry, Jan-01, Volume: 143Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
AID431317Antibacterial activity against Clostridium perfringens ATCC 103882009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
AID681372TP_TRANSPORTER: inhibition of MTX uptake in OAT3-expressing S2 cells2002The Journal of pharmacology and experimental therapeutics, Aug, Volume: 302, Issue:2
Characterization of methotrexate transport and its drug interactions with human organic anion transporters.
AID557270Antimicrobial activity against Streptococcus pneumoniae 1564 by CLSI method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID447055Antibacterial activity against Klebsiella pneumoniae UC57 at 10 IU after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID418559Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 by NCCLS method2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
AID681426TP_TRANSPORTER: inhibition of E1S uptake (E1S: 40 uM, PCG: 1000 uM) in Xenopus laevis oocytes1999The Journal of biological chemistry, May-07, Volume: 274, Issue:19
Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain.
AID528533Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B502 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID278563Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium longum ATCC 15707 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID529901Antimicrobial activity against Leptospira interrogans serovar Icterohaemorrhagiae isolate 10 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID1870123Antibacterial activity against antibiotic resistant Staphylococcus aureus 4740/B assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID681049TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.05 uM, PCG: 5 uM) in Xenopus laevis oocytes2001Molecular pharmacology, May, Volume: 59, Issue:5
Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney.
AID368527Activity of Enterobacter cloacae 908R AmpC assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID558612Antimicrobial activity against Streptococcus pneumoniae isolate 2617 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID524668Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA and ponA mutant gene assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID381178Antibacterial activity against Pseudomonas aeruginosa after 24 to 72 hrs by disk diffusion method1999Journal of natural products, Sep, Volume: 62, Issue:9
Antimicrobial and antitumor activities of mycosporulone.
AID562341Ratio of Kcat to Km for Chryseobacterium meningosepticum CCUG 4310 beta-lactamase BlaB1 expressed in Escherichia coli DH5alpha by Michaelis-Menten equation2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso.
AID368310Activity of Escherichia coli TEM1 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID562400Antimicrobial activity against erythromycin-susceptible Streptococcus Group F clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID557474Displacement of Biocillin FL from Streptococcus pneumoniae 2527 PBP1A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID558606Antimicrobial activity against Streptococcus pneumoniae isolate 1147 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID531451Antibacterial activity against Streptococcus pneumoniae serotype 33 assessed as percent susceptible isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID278536Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium bifidum BB12 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID529318Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae serotype 14 URA4933 harboring mutant PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID278859Inhibition of metabolic activity in MG63 cells assessed as MTT reduction after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID278528Antimicrobial activity against Bifidobacterium longum ATCC 157082007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID1565591Antibacterial activity against Escherichia coli ATCC 43837 after 18 hrs by CLSI based broth microdilution method2019European journal of medicinal chemistry, Nov-15, Volume: 182Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity.
AID533943Antimicrobial activity against linezolid-resistant Enterococcus faecalis 414 harboring G2576U mutation in peptidyl transferase centre by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID562401Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group F clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID395400Antibacterial activity against Klebsiella pneumoniae TCC 109 at 20 ug after 24 hrs by cup diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis of new series of 5,6-dihydro-4H-1,2-oxazines via hetero Diels-Alder reaction and evaluation of antimicrobial activity.
AID519748Ratio of Kcat to Km for Klebsiella pneumoniae Beta-Lactamase SHV-12008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
AID558619Antimicrobial activity against Streptococcus pneumoniae isolate 3275 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID1180445Antimicrobial activity against Staphylococcus aureus CCM 4516/08 after 24 hrs by microdilution method2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
AID558615Antimicrobial activity against Streptococcus pneumoniae isolate 2874 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID322512Effect on glomerular filtration in human very low birth weight preterm neonates urine assessed as creatinine excretion at 30 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID535349Antimicrobial activity against Streptococcus pneumoniae clinical isolates assessed as susceptible isolates by by based on po dosed broth dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
AID528726Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID554872Antimicrobial activity against Streptococcus pneumoniae serotype 6B ST 3246 harboring ERY-resistant erm(B) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID528525Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B6 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID495913Ratio of Kcat to Km for beta-lactamase VIM-19 expressed in Escherichia coli TOP10 by spectrophotometry2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae.
AID1546642Antibacterial activity against Bacillus subtilis MTCC 441 assessed as diameter of zone of inhibition at 200 ug/ml after 24 hrs by agar well diffusion method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
AID546433Ratio of Kcat to Km for Pseudomonas aeruginosa PDC-5 by spectrophotometer2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.
AID493658Antimicrobial activity against Enterobacter cloacae ATCC 13047 by MTT assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
AID1271948Antibacterial activity against Staphylococcus aureus assessed as growth inhibition at 1 mg/ml by drug sensitive assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel skeleton compound Allomyrinanoid A and two purine alkaloids from the adult of Allomyrina dichotoma L.
AID543279Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 pbp2x, pbp1a and pbp2b genes by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID406549Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition zone diameter at 20 ug after 24 hrs by Kirby-Bauer test2008Bioorganic & medicinal chemistry, Jul-01, Volume: 16, Issue:13
Unsymmetric aryl-alkyl disulfide growth inhibitors of methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
AID522652Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis 02AS-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID531418Antibacterial activity against Streptococcus pneumoniae serotype 6A/C by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID575415Antimicrobial activity against anrB-deficient Listeria monocytogenes EGD-e at 5 ug after 16 hrs by disk diffusion assay2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID529658Ratio of Kcat to Km for Pseudomonas aeruginosa 166301 beta-lactamase VIM-162008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID508303Inhibition of PBP2 in wild type Enterococcus faecium D63 membranes assessed as inhibition of fluorescent ampicillin binding after 20 mins at 37 degC2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID398239Antimicrobial activity against Escherichia coli 442 after 18 hrs by twofold serial microbroth dilution method2003Journal of natural products, Dec, Volume: 66, Issue:12
A novel antibacterial iridoid and triterpene from Caiophora coronata.
AID278676Antibacterial activity against Enterococcus faecalis isolate 57422007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID573596Antibacterial activity against Fusobacterium mortiferum assessed as susceptible isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID561107Antibacterial activity against Pasteurella multocida BB1041 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB9956 bearing tetH gene by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID495740Kcat/Km ratio of Klebsiella pneumoniae KPC-2 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID278553Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium longum ATCC 15708 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID295101Antibacterial activity against Klebsiella pneumoniae UC57 at 10 ug after 24 hrs by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID278683Antibacterial activity against Enterococcus faecalis isolate 57452007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID1129596Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT assay2014European journal of medicinal chemistry, Apr-09, Volume: 76Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents.
AID1765580Antibacterial activity against Acinetobacter baumannii ATCC 19606 incubated for 18 hrs by CLSI based broth dilution method2021Journal of medicinal chemistry, 08-12, Volume: 64, Issue:15
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
AID315975Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth dilution MIC assay2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Glyconanobiotics: Novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis.
AID524876Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA and mtrR mutant gene assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID341340Antimicrobial activity against Neisseria meningitidis isolates harboring penA 5 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID431318Antifungal activity against Candida albicans ATCC 900282009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
AID542612Antimicrobial activity against Streptococcus pneumoniae R6 after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID520398Antibacterial activity against mef-positive Streptococcus pneumoniae isolates assessed as resistance incidence by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).
AID1237610Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC523512 assessed as bacterial growth inhibition after 24 hrs by broth dilution method2015European journal of medicinal chemistry, Jul-15, Volume: 100Novel cajaninstilbene acid derivatives as antibacterial agents.
AID1320835Activity of native signal containing Klebsiella pneumoniae OXA-48 by Michaelis-Menten kinetics assay2016Journal of medicinal chemistry, 06-09, Volume: 59, Issue:11
Screening and Design of Inhibitor Scaffolds for the Antibiotic Resistance Oxacillinase-48 (OXA-48) through Surface Plasmon Resonance Screening.
AID1072985Antimicrobial activity against Bacillus subtilis MB 964 after 20 hrs by 2-fold serial broth dilution method2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Isolation, structure elucidation, and biological activity of altersolanol P using Staphylococcus aureus fitness test based genome-wide screening.
AID494349Antibacterial activity against Pseudomonas aeruginosa by twofold serial dilution method2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis, characterization and antimicrobial studies of 2-(4-methoxy-phenyl)-5-methyl-4-(2-arylsulfanyl-ethyl)-2,4-dihydro-[1,2,4] triazolo-3-ones and their corresponding sulfones.
AID558330Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P316 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID773428Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 34404 by microdilution technique2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
The synthesis and SAR study of phenylalanine-derived (Z)-5-arylmethylidene rhodanines as anti-methicillin-resistant Staphylococcus aureus (MRSA) compounds.
AID322499Cmin in human adults at 600 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID558331Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P338 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID322508AUC (0 to 12) in human very low birth weight preterm neonates at 28 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID562754Activity of Klebsiella pneumoniae AH24-270 CTX-M-71 beta-lactamase2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
New variant of CTX-M-type extended-spectrum beta-lactamases, CTX-M-71, with a Gly238Cys substitution in a Klebsiella pneumoniae isolate from Bulgaria.
AID374680Antimicrobial activity against wild type Escherichia coli K-12 flow cell-generated 24 hrs biofilms at 350 ug/ml after 1 hr using BacLight staining by CSLM2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
AID428135Antimicrobial activity against penicillin-resistant Streptococcus gordonii PR1_2evolved mutant assessed as logarithmic reduction in viability at stationary phase of growth after 70 hrs2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Fitness cost and impaired survival in penicillin-resistant Streptococcus gordonii isolates selected in the laboratory.
AID528710Antibacterial activity against penicillin intermediate Streptococcus pneumoniae clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID519630Antimicrobial activity against Escherichia coli JM83 harboring beta-lactamase OXA-63 after 3 days by Etest2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
AID341533Antimicrobial activity against Neisseria meningitidis isolates harboring penA 81 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID535358Antimicrobial activity against Streptococcus pyogenes clinical isolates assessed as susceptible isolates by broth dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
AID374673Antimicrobial activity against wild type Escherichia coli isolate AMG1 grown as planktonic cells after 24 hrs by spectrophotometric method2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
AID558602Antimicrobial activity against Streptococcus pneumoniae isolate 33 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID171255Concentration of compound in rat kidney after intravenous injection of 20 mg/kg benzyl-penicillin after 60 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID515291Antibacterial activity against Bacillus subtilis MTCC 441 by broth dilution method2010European journal of medicinal chemistry, Oct, Volume: 45, Issue:10
Stereoselective synthesis and biological evaluation of (R)-rugulactone, (6R)-((4R)-hydroxy-6-phenyl-hex-2-enyl)-5,6-dihydro-pyran-2-one and its 4S epimer.
AID1482267Antibacterial activity against Escherichia coli MG1655 measured every 15 mins for 12 hrs2017Journal of medicinal chemistry, 05-11, Volume: 60, Issue:9
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
AID324844Antimicrobial activity against Neisseria gonorrhoeae 67 isolate2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
AID575143Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NRS70 by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
AID562410Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group G clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID324840Antimicrobial activity against Neisseria gonorrhoeae 196 isolate2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
AID609859Antimicrobial activity against Candida albicans ATCC 26555 assessed as growth inhibition after 18 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Unprecedented C-2 arylation of indole with diazonium salts: Syntheses of 2,3-disubstituted indoles and their antimicrobial activity.
AID1236038Antibacterial activity against Staphylococcus aureus assessed as growth inhibition at 200 ug/ml after 24 hrs by paper disk diffusion method2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Bisabolane-Type Sesquiterpenoids from the Whole Plant of Parasenecio rubescens.
AID558622Antimicrobial activity against Streptococcus pneumoniae isolate 3374 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID418556Antibacterial activity against Staphylococcus epidermidis ATCC 12228 by NCCLS method2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
AID535637Antimicrobial activity against Group B streptococcus serotype Ib R3 harboring Q557E, A400V mutations in PBP 2X and T567I, G539E mutations in PBP 2B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID171120Concentration of compound in rat brain after intravenous injection of 20 mg/kg benzyl-penicillin after 3 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID495663Activity at Pseudomonas aeruginosa 51170 beta-lactamase BEL-12010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.
AID571177Antibacterial activity against Neisseria gonorrhoeae assessed as intermediate-resistant isolates by disk agar diffusion method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID558630Antimicrobial activity against Streptococcus pneumoniae isolate 4747 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID557479Displacement of Biocillin FL from Streptococcus pneumoniae 1076 PBP1A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID258715Antibacterial activity against gram negative Chromobacterium violaceum(MTCC 2656)2006Bioorganic & medicinal chemistry letters, Jan-01, Volume: 16, Issue:1
Synthesis and biological evaluation of novel C (7) modified chrysin analogues as antibacterial agents.
AID74713Inhibition of gram negative (resistant) growth.1989Journal of medicinal chemistry, Jun, Volume: 32, Issue:6
Synthesis and antimicrobial properties of substituted beta-aminoxypropionyl penicillins and cephalosporins.
AID295116Antibacterial activity against Listeria monocytogenes ATCC 15313 at 10 ug after 24 hrs by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID1168782Antibacterial against Staphylococcus aureus ATCC 25923 after 24 hrs by two-fold serial dilution method2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Synthesis, molecular docking and biological evaluation of coumarin derivatives containing piperazine skeleton as potential antibacterial agents.
AID524639Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA mutant gene assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID524879Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA, ponA and mtrR mutant gene assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID1054743Antibacterial activity against Staphylococcus aureus ATCC 6538 assessed as growth inhibition after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
Schiff's base derivatives bearing nitroimidazole moiety: new class of antibacterial, anticancer agents and potential EGFR tyrosine kinase inhibitors.
AID324846Antimicrobial activity against Neisseria gonorrhoeae 35 isolate2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
AID495705Kcat/Km ratio of Klebsiella pneumoniae Beta-lactamase TEM-262010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID554863Antimicrobial activity against Streptococcus pneumoniae serotype 19F ST 236 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID533933Antimicrobial activity against linezolid-resistant methicillin-resistant Staphylococcus aureus NRS271 harboring G2576U mutation in peptidyl transferase centre by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID278529Antimicrobial activity against Bifidobacterium longum R01752007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID374674Antimicrobial activity against Escherichia coli isolate AMG1 24 hrs biofilms at 350 ug/ml after 1 hr by microtiter plate count method2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
AID351194Volume of distribution in iv dosed neonates with gestational age of 27 to 40 weeks2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.
AID511439Antimicrobial activity against Streptococcus uberis ATCC 19436 harboring PAP1A A227T, PBP2B N366I/T402I and PBP2X E381K/Q554E mutation after 15 passages assessed as inhibition of visible growth by broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID263111Antibacterial activity against methicillin-resistant Staphylococcus aureus USF656 by agar disk diffusion method2006Bioorganic & medicinal chemistry letters, Apr-15, Volume: 16, Issue:8
N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
AID680337TP_TRANSPORTER: uptake in Xenopus laevis oocytes1999The Journal of pharmacology and experimental therapeutics, Aug, Volume: 290, Issue:2
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
AID569262Antimicrobial activity against Escherichia coli DH5alpha2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.
AID562584Antimicrobial activity against erythromycin-nonsusceptible Streptococcus agalactiae clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID1601846Antibacterial activity against Bacillus subtilis CMCC 63501 measured after 24 hrs by ELISA2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety.
AID1437658Antibacterial activity against Escherichia coli ATCC 25922 after 20 to 24 hrs by two-fold microdilution method
AID534083Antibacterial activity against cefotaxime-resistant Streptococcus pneumoniae assessed as percent susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
AID522868Antibacterial activity against uropathogenic Escherichia coli UTI89 infected in human 5637 cells assessed as decrease in intracellular bacterial level at 600 to 1000 ug/ml after 12 hrs by serial dilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
AID562338Ratio of Kcat to Km for Chryseobacterium indologenes 597 metallo-beta-lactamase IND-6 expressed in Escherichia coli DH5alpha by Michaelis-Menten equation2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso.
AID269449Antibacterial activity against TEM1 beta-lactamase Escherichia coli IV-3-2 by agar diffusion assay2006Bioorganic & medicinal chemistry letters, Aug-01, Volume: 16, Issue:15
The synthesis and in vitro testing of structurally novel antibiotics derived from acylnitroso Diels-Alder adducts.
AID773424Antibacterial activity against methicillin-resistant Staphylococcus aureus CA ATCC BAA-1680 by microdilution technique2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
The synthesis and SAR study of phenylalanine-derived (Z)-5-arylmethylidene rhodanines as anti-methicillin-resistant Staphylococcus aureus (MRSA) compounds.
AID524041Antibacterial activity against methicillin-, linezolid-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 2149A by macrodilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID511292Ratio of Kcat/Km for Pseudomonas aeruginosa GES-13 beta lactamase assessed as hydrolysis by spectrometry2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
AID603190Antibacterial activity against Staphylococcus aureus MTCC 96 by broth microdilution method2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Efficient synthesis, structural characterization and anti-microbial activity of chiral aryl boronate esters of 1,2-O-isopropylidene-α-D-xylofuranose.
AID557505Displacement of Biocillin FL from Streptococcus pneumoniae 3009 PBP2A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID341530Antimicrobial activity against Neisseria meningitidis isolates harboring penA 7 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID508299Inhibition of PBP5 in penicillin-resistant Enterococcus faecium D63r membranes assessed as inhibition of fluorescent ampicillin binding after 20 mins at 37 degC2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID1870132Antibacterial activity against antibiotic resistant Staphylococcus aureus 4515/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID1638904Antimicrobial activity against multidrug-resistant Acinetobacter baumannii ATCC 19606 measured after 18 hrs by broth microdilution method2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
AID368492Activity of Escherichia coli CTX-M-15 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID561110Antibacterial activity against Pasteurella multocida BB1044 harboring plasmid pB1000 bearing blaROB-1 gene, plasmid 1006 bearing tetO gene and plasmid pB1005 bearing strA, sul2 genes by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID374682Antimicrobial activity against wild type Escherichia coli K-12 24 hrs biolflim at 350 ug/ml after 1 hr by microtiter plate count method2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
AID529580Ratio of Kcat to Km for Caulobacter crescentus beta-Lactamase CAU-12008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Functional diversity among metallo-beta-lactamases: characterization of the CAR-1 enzyme of Erwinia carotovora.
AID418558Antibacterial activity against Streptococcus pneumoniae ATCC 6301 by NCCLS method2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
AID606030Antimicrobial activity against Escherichia coli at 100 ug/mL by agar plate diffusion assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Resorcylic acid lactones with cytotoxic and NF-κB inhibitory activities and their structure-activity relationships.
AID557485Displacement of Biocillin FL from Streptococcus pneumoniae 3243 PBP1B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID436378Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT method2009European journal of medicinal chemistry, Oct, Volume: 44, Issue:10
Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents.
AID341537Antimicrobial activity against Neisseria meningitidis isolates harboring penA 18 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID522641Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis Ames by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID495745Kcat/Km ratio of Acinetobacter baumannii OXA-23 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID529582Ratio of Kcat to Km for Bradyrhizobium japonicum beta-Lactamase BJP-12008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Functional diversity among metallo-beta-lactamases: characterization of the CAR-1 enzyme of Erwinia carotovora.
AID495737Kcat/Km ratio of Pseudomonas aeruginosa AmpC relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID558608Antimicrobial activity against Streptococcus pneumoniae isolate 1394 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID543269Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 pbp2x gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID535766Antimicrobial activity against penicillin-producing Neisseria gonorrhoeae NGON 08-043 expressing beta-lactamase TEM-1, MLST type ST-7823 and MAST type ST-1288 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Identification of TEM-135 beta-lactamase in penicillinase-producing Neisseria gonorrhoeae strains in Japan.
AID495798Ratio of Kcat to Km of Pseudomonas fluorescens PF-1 beta-lactamase BIC-1 expressed in Escherichia coli DH10B using nitrocefin hydrolysis2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.
AID543283Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 pbp2x, pbp1a, pbp2b and Streptococcus pneumoniae 3191 murM genes by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID511446Antimicrobial activity against Streptococcus uberis ATCC 9529 harboring PAP1A R273P, PBP2B N366I/T402I and PBP2X E381K/Q554E mutation after 11 passages assessed as inhibition of visible growth by broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID562379Antimicrobial activity against Streptococcus agalactiae clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID532990Antibacterial activity against Klebsiella pneumoniae NCIM 2883 assessed as growth inhibition in presence of 10 mM N-Acetylcysteine2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID571187Antibacterial activity against Neisseria gonorrhoeae harboring wild-type GA and Asp-345a insertion in penA genes by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID522655Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis BA1007 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID545511Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-39 by microdilution method2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains.
AID577460Inhibition of Bocillin FL binding to PBP2b in laboratory-derived Streptococcus pneumoniae isolate R62010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Affinity of ceftobiprole for penicillin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin.
AID368496Activity of Klebsiella oxytoca beta-lactamase K1 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID495719Activity of Klebsiella oxytoca Beta-lactamase K1 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID587974Ratio of Kcat to Km for Escherichia coli beta-lactamase Toho-1 C69A mutant assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID278856Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID219757Minimum protective concentration against beta-lactamase of Xanthomonas maltophilia GN 12873 (CXase-I)2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Design, synthesis, and SAR of novel carbapenem antibiotics with high stability to Xanthomonas maltophilia oxyiminocephalosporinase type II.
AID429081Antibacterial activity against penicillin-intermediate resistant Neisseria meningitidis after 24 hrs by Etest method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Combined real-time PCR and pyrosequencing strategy for objective, sensitive, specific, and high-throughput identification of reduced susceptibility to penicillins in Neisseria meningitidis.
AID1250521Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hr by MTT assay2015European journal of medicinal chemistry, Sep-18, Volume: 102Synthesis and evaluation of new tyrosyl-tRNA synthetase inhibitors as antibacterial agents based on a N2-(arylacetyl)glycinanilide scaffold.
AID1601851Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 measured after 24 hrs by ELISA2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety.
AID573573Antibacterial activity against beta-lactamase producing Bacteroides uniformis assessed as susceptible isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID374684Antimicrobial activity against kanamycin-resistant Escherichia coli U6 deltayhcQ mutant 24 hrs biofilms at 350 ug/ml after 1 hr by microtiter plate count method2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
AID524051Binding affinity to methicillin-resistant, heteroresistant vancomycin-intermediate, beta-lactamase-negative Staphylococcus aureus 873 PBP2 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID546430Ratio of Kcat to Km for Pseudomonas aeruginosa PDC-1 by spectrophotometer2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.
AID573558Antibacterial activity against beta-lactamase producing Bacteroides thetaiotaomicron assessed as resistant isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID356761Antimicrobial activity against Escherichia coli ATCC 25922 after 18 hrs by microbroth dilution method2001Journal of natural products, Jul, Volume: 64, Issue:7
Biological and mechanistic activities of xanthorrizol and 4-(1',5'-dimethylhex-4'-enyl)-2-methylphenol isolated from Iostephane heterophylla.
AID577462Inhibition of Bocillin FL binding to PBP2b Thr446Ala/Ala-619-Gly mutant in laboratory-derived Streptococcus pneumoniae isolate R62010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Affinity of ceftobiprole for penicillin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin.
AID508385Antibacterial activity against Streptococcus pyogenes harboring mutation in L4 ribosomal protein after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID535761Antimicrobial activity against penicillin-producing Neisseria gonorrhoeae NGON 04-025 expressing beta-lactamase TEM-135, MLST type ST-1597 and MAST type ST-1549 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Identification of TEM-135 beta-lactamase in penicillinase-producing Neisseria gonorrhoeae strains in Japan.
AID562608Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID171260Concentration of compound in rat liver after intravenous injection of 20 mg/kg benzyl-penicillin after 3 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID209468In vitro antibacterial activity against the gram-positive bacteria, erythromycin resistant Streptococcus pyogenes; Not determined1999Bioorganic & medicinal chemistry letters, Apr-05, Volume: 9, Issue:7
New N-substituted 7-aminocephalosporanic acid derivatives as potential agents against Streptococcus pneumoniae. Synthesis and in vitro activity.
AID1852754Antibacterial activity against wild type Escherichia coli ATCC 25922 assessed as bacterial growth inhibition by broth microdilution assay2022RSC medicinal chemistry, Sep-21, Volume: 13, Issue:9
Design and evaluation of poly-nitrogenous adjuvants capable of potentiating antibiotics in Gram-negative bacteria.
AID495713Kcat/Km ratio of Pseudomonas aeruginosa IMP-12010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID374678Antimicrobial activity against Escherichia coli isolate AMG1 nylon membrane cultivated 24 hrs biofilms at 350 ug/ml after 1 hr2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
AID575102Antimicrobial activity against Streptococcus pneumoniae serotype 19F assessed as percent susceptible isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID1765577Antibacterial activity against Escherichia coli ATCC 25922 incubated for 18 hrs by CLSI based broth dilution method2021Journal of medicinal chemistry, 08-12, Volume: 64, Issue:15
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
AID448317Antibacterial activity against Pseudomonas aeruginosa MTCC 741 by broth dilution method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, photochemical E (trans)-->Z (cis) isomerization and antimicrobial activity of 2-chloro-5-methylpyridine-3-olefin derivatives.
AID425863Antimicrobial activity against Carnobacterium divergens CIP101029 at 0.5 McFarland inoculum size by E-test2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
AID528702Antibacterial activity against Streptococcus constellatus clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID571184Antibacterial activity against Neisseria gonorrhoeae harboring GS gene by disk agar diffusion method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID559515Antibacterial activity against Streptococcus pyogenes assessed as percent susceptible isolates by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID368499Ratio of Kcat to Km of Klebsiella oxytoca beta-lactamase K1 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID1191521Cytostatic activity against human HepG2 cells after 72 hrs by MTT assay2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID524882Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing beta-lactamase TEM-1 mutant gene assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID356763Antimicrobial activity against Pseudomonas aeruginosa 339 after 18 hrs by microbroth dilution method2001Journal of natural products, Jul, Volume: 64, Issue:7
Biological and mechanistic activities of xanthorrizol and 4-(1',5'-dimethylhex-4'-enyl)-2-methylphenol isolated from Iostephane heterophylla.
AID1347485Antibacterial activity against Klebsiella pneumoniae assessed as zone of inhibition after 24 to 48 hrs by well diffusion method2018European journal of medicinal chemistry, Jan-01, Volume: 143Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
AID524872Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA mutant gene assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID467611Dissociation constant, pKa of the compound2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
AID494348Antibacterial activity against Escherichia coli by twofold serial dilution method2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis, characterization and antimicrobial studies of 2-(4-methoxy-phenyl)-5-methyl-4-(2-arylsulfanyl-ethyl)-2,4-dihydro-[1,2,4] triazolo-3-ones and their corresponding sulfones.
AID535759Antimicrobial activity against penicillin-producing Neisseria gonorrhoeae NGON 00-002 expressing beta-lactamase TEM-1, MLST type ST-1590 and MAST type ST-270 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Identification of TEM-135 beta-lactamase in penicillinase-producing Neisseria gonorrhoeae strains in Japan.
AID524049Binding affinity to against methicillin-, daptomycin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 25 PBP1 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID171118Concentration of compound in rat brain after intravenous injection of 20 mg/kg benzyl-penicillin after 20 min; Below detection limit.1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID617971Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea.
AID620348Antibacterial activity against Pseudomonas aeruginosa RCMB 000102 at 30 ug/ml after 24 hrs by diffusion agar technique2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and anti-microbial activity of some 1- substituted amino-4,6-dimethyl-2-oxo-pyridine-3-carbonitrile derivatives.
AID556155Antimicrobial activity against Streptococcus pneumoniae assessed as resistant isolates broth microdilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
In vitro activity of Iclaprim against respiratory and bacteremic isolates of Streptococcus pneumoniae.
AID1168786Toxicity in human erythrocyte assessed as hemolysis by measuring hemoglobin release after 3 hrs2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Synthesis, molecular docking and biological evaluation of coumarin derivatives containing piperazine skeleton as potential antibacterial agents.
AID1755785Antibacterial activity against Bacillus subtilis ATCC 6633 by MH media dilution method2021European journal of medicinal chemistry, Jan-15, Volume: 210Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
AID278540Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium longum ATCC 15707 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID341520Antimicrobial activity against Neisseria meningitidis isolates harboring penA 25 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID776438Antibacterial activity against Escherichia coli ATCC 11775 after 24 hrs by microdilution technique2013European journal of medicinal chemistry, Nov, Volume: 69Synthesis, antimicrobial, antioxidant activities of novel 6-aryl-5-cyano thiouracil derivatives.
AID356759Antimicrobial activity against Escherichia coli 389 after 18 hrs by microbroth dilution method2001Journal of natural products, Jul, Volume: 64, Issue:7
Biological and mechanistic activities of xanthorrizol and 4-(1',5'-dimethylhex-4'-enyl)-2-methylphenol isolated from Iostephane heterophylla.
AID431307Antibacterial activity against multidrug resistant Staphylococcus aureus BAA-392009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
AID521355Antimicrobial activity against Streptococcus pneumoniae isolate 657 obtained from sputum of patient2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20.
AID524644Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA, penB and mtrR mutant gene assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID301806Antibacterial activity against Escherichia coli ATCC 259222007Bioorganic & medicinal chemistry, Dec-01, Volume: 15, Issue:23
Direct diazo-transfer reaction on beta-lactam: synthesis and preliminary biological activities of 6-triazolylpenicillanic acids.
AID557507Displacement of Biocillin FL from Streptococcus pneumoniae 1077 PBP2A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID431306Antibacterial activity against Staphylococcus aureus ATCC 292132009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
AID425864Antimicrobial activity against Carnobacterium divergens CIP101029 at 3 McFarland inoculum size by E-test2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
AID689075Antifungal activity against Septoria tritici assessed as zone of inhibition at 0.05 mg by agar diffusion method2012Journal of natural products, Sep-28, Volume: 75, Issue:9
Sinularosides A and B, bioactive 9,11-secosteroidal glycosides from the South China Sea soft coral Sinularia humilis Ofwegen.
AID269444Antibacterial activity against wild type Staphylococcus aureus SG 511 by agar diffusion assay2006Bioorganic & medicinal chemistry letters, Aug-01, Volume: 16, Issue:15
The synthesis and in vitro testing of structurally novel antibiotics derived from acylnitroso Diels-Alder adducts.
AID206461In vitro antibacterial activity against the gram-positive bacteria, penicillin sensitive Staphylococcus aureus (663E)1999Bioorganic & medicinal chemistry letters, Apr-05, Volume: 9, Issue:7
New N-substituted 7-aminocephalosporanic acid derivatives as potential agents against Streptococcus pneumoniae. Synthesis and in vitro activity.
AID619678Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 by broth microdilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis, antimicrobial activity and possible mechanism of action of 9-bromo-substituted indolizinoquinoline-5,12-dione derivatives.
AID1437665Antibacterial activity against Enterococcus faecalis ATCC 29212 after 20 to 24 hrs by two-fold microdilution method
AID171256Concentration of compound in rat kidney after intravenous injection of 20 mg/kg benzyl-penicillin after 10 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID1546172Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as zone of inhibition at 100 ug/ml after 24 hrs by disc diffusion method2019European journal of medicinal chemistry, Dec-15, Volume: 184Current scenario of tetrazole hybrids for antibacterial activity.
AID528529Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B12 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID1279010Antibacterial activity against methicillin-resistant Staphylococcus aureus H 5996/08 after 48 hrs by microbroth dilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
AID269456Antifungal activity against Candida albicans BMSY 212 by agar diffusion assay2006Bioorganic & medicinal chemistry letters, Aug-01, Volume: 16, Issue:15
The synthesis and in vitro testing of structurally novel antibiotics derived from acylnitroso Diels-Alder adducts.
AID447058Antibacterial activity against Proteus vulgaris ATCC 8427 at 10 IU after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID541176Antimicrobial activity against multidrug resistant Streptococcus pneumoniae serotype 19F S43 carring erm(B),mef(E) and tet(M) gene2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
New composite genetic element of the Tn916 family with dual macrolide resistance genes in a Streptococcus pneumoniae isolate belonging to clonal complex 271.
AID1348086Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 assessed as zone of inhibition at 50 ug per disc after 24 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID285443Ratio of kcat to Km of Citrobacter gillenii CIP 106783 Beta-lactamase GIL1 expressed in Escherichia coli DH10B relative to benzyl-penicillin2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii.
AID341339Antimicrobial activity against Neisseria meningitidis isolates harboring penA 57 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID1638900Antimicrobial activity against drug-susceptible Enterococcus faecium ATCC 49624 measured after 18 hrs by broth microdilution method2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
AID495696Activity of Serratia marcescens SME-32010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID340910Increase in pbp2B gene expression in penicillin-resistant Streptococcus gordonii with penicillin binding protein PR1_2 evolved mutation assessed as relative luciferase units relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii.
AID1076538Antibacterial activity against Pseudomonas aeruginosa ATCC 13525 after 24 hrs by MTT assay2014European journal of medicinal chemistry, Mar-21, Volume: 75Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
AID466787Antibacterial activity against Bacillus subtilis ATCC 66332010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents.
AID528530Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B40 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID543482Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 murM, pbp2x, pbp2b and Streptococcus pneumoniae 3191 pbp1a genes by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID263110Antibacterial activity against methicillin-resistant Staphylococcus aureus USF655 by agar disk diffusion method2006Bioorganic & medicinal chemistry letters, Apr-15, Volume: 16, Issue:8
N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
AID561104Antibacterial activity against Pasteurella multocida BB1038 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB1005 bearing strA, sul2 genes by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID325449Antibacterial activity against Staphylococcus aureus ATCC 3556 after 14 to 16 hrs by broth dilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Polyamine effects on antibiotic susceptibility in bacteria.
AID285157Antimicrobial susceptibility of tetracycline-resistant Streptococcus pneumoniae from respiratory tract disease patient assessed as percent susceptible isolates2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland.
AID340850Increase in pbp2A gene expression in penicillin-resistant Streptococcus gordonii with penicillin binding protein PR1_2 evolved mutation at 1/2 times MIC assessed as relative luciferase units relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii.
AID524068Binding affinity to methicillin-resistant, heteroresistant vancomycin-intermediate, beta-lactamase-negative Staphylococcus aureus 873 PBP4 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID557490Displacement of Biocillin FL from Streptococcus pneumoniae 24 PBP2X2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID529664Ratio of Kcat to Km for Pseudomonas aeruginosa 166301 beta-lactamase VIM-16 relative to cephaloridine2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID1063967Antibacterial activity against Staphylococcus aureus CCM 4516/08 after 24 hrs by broth microdilution method2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Salicylanilide diethyl phosphates: synthesis, antimicrobial activity and cytotoxicity.
AID1778125Antimicrobial activity against Bacillus anthracis assessed as microbial growth inhibition by CLSI-protocol based broth microdilution assay2021Journal of natural products, 04-23, Volume: 84, Issue:4
Opportunities and Limitations for Assigning Relative Configurations of Antibacterial Bislactones using GIAO NMR Shift Calculations.
AID557472Displacement of Biocillin FL from Streptococcus pneumoniae 24 PBP1A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID559516Antibacterial activity against Streptococcus anginosus assessed as percent susceptible isolates by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID1437664Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 20 to 24 hrs by two-fold microdilution method
AID528527Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B8 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID1348083Antimicrobial activity against Candida parapsilosis ATCC 90018 assessed as zone of inhibition at 50 ug per disc after 48 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID554859Antimicrobial activity against Streptococcus pneumoniae serotype 14 ST 3247 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID545145Ratio of Kcat to Km of CMY-2 by spectrophotometry2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids.
AID442480Antibacterial activity against Escherichia coli MTCC 443 by broth dilution method2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Click chemistry: studies on the synthesis of novel fluorous tagged triazol-4-yl substituted quinazoline derivatives and their biological evaluation--theoretical and experimental validation.
AID531605Activity of Escherichia coli beta-lactamase SHV-112008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.
AID699539Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID431310Antibacterial activity against methicillin-resistant Staphylococcus epidermidis ATCC 516252009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
AID574170Antibacterial activity against Escherichia coli MG1655 grown as biofilms harboring plasmid pBR322 carrying blaTEM-1 and tetA(C) genes after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Induction of multidrug resistance mechanism in Escherichia coli biofilms by interplay between tetracycline and ampicillin resistance genes.
AID562406Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID562340Ratio of Kcat to Km for Chryseobacterium indologenes 597 metallo-beta-lactamase IND-2 expressed in Escherichia coli DH5alpha by Michaelis-Menten equation2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso.
AID587975Ratio of Kcat to Km for Escherichia coli beta-lactamase Toho-1 F160T mutant assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID557513Displacement of Biocillin FL from Streptococcus pneumoniae 3665 PBP2B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID209246Minimum inhibitory concentration against aerobic organisms Streptococcus faecalis strain 28641982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
Quaternary heterocyclylamino beta-lactams: a generic alternative to the classical acylamino side chain.
AID511438Antimicrobial activity against Streptococcus uberis ATCC 19436 assessed as inhibition of visible growth after 24 hrs by broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID524037Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae 1076 by macrodilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID1128828Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by broth microdilution method2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Spiromastixones A-O, antibacterial chlorodepsidones from a deep-sea-derived Spiromastix sp. fungus.
AID341346Antimicrobial activity against Neisseria meningitidis isolates harboring penA 16 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID503230Ratio of MIC for penicillin-resistant Streptococcus pneumoniae 38030509 to MIC for penicillin-sensitive Streptococcus pneumoniae R62007Nature chemical biology, Sep, Volume: 3, Issue:9
Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins.
AID1755799Antibacterial activity against Escherichia coli ATCC 35218 by MH media dilution method2021European journal of medicinal chemistry, Jan-15, Volume: 210Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
AID324850Antimicrobial activity against Neisseria gonorrhoeae 128 isolate2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
AID521346Antimicrobial activity against Streptococcus pneumoniae isolate 2904 obtained from blood of patient2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20.
AID569339Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 by broth micro dilution technique2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
AID1243284Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolates by standard broth microdilution method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.
AID171262Concentration of compound in rat liver after intravenous injection of 20 mg/kg benzyl-penicillin after 5 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID368544Activity of Pseudomonas aeruginosa 18SH AmpC assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID1601842Antibacterial activity against Staphylococcus aureus CMCC 25923 measured after 24 hrs by ELISA2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety.
AID535767Antimicrobial activity against penicillin-producing Neisseria gonorrhoeae NGON 08-044 expressing beta-lactamase TEM-1, MLST type ST-7823 and MAST type ST-1288 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Identification of TEM-135 beta-lactamase in penicillinase-producing Neisseria gonorrhoeae strains in Japan.
AID1079933Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is
AID528536Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B514 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID1112104Antifungal activity against Microbotryum violaceum by agar diffusion test2012Fitoterapia, Apr, Volume: 83, Issue:3
Pyrenocines J-M: four new pyrenocines from the endophytic fungus, Phomopsis sp.
AID529904Antimicrobial activity against Leptospira interrogans serovar Canicola isolate 11 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID428136Antimicrobial activity against penicillin-resistant Streptococcus gordonii PR1_2evolved mutant co-cultured with wild type Streptococcus gordoni assessed as loss of viability at stationary phase of growth at 0.5 ug/mL after 15 hrs2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Fitness cost and impaired survival in penicillin-resistant Streptococcus gordonii isolates selected in the laboratory.
AID561103Antibacterial activity against Pasteurella multocida BB1037 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB1005 bearing strA, sul2 genes by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID1254303Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 48 hrs by microdilution broth method2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
AID428130Antimicrobial activity against penicillin-resistant Streptococcus gordonii PR1_2evolved mutant assessed as generation time at mid-logarithmic phase of growth2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Fitness cost and impaired survival in penicillin-resistant Streptococcus gordonii isolates selected in the laboratory.
AID545509Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 700787 by microdilution method2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains.
AID567282Ratio of Kcat to Km for Acinetobacter baumannii ADC-11 beta-lactamase2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
Extended-spectrum cephalosporinase in Acinetobacter baumannii.
AID1870136Antibacterial activity against antibiotic resistant Staphylococcus aureus 77/CF assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID1882850Binding affinity to Staphylococcus aureus ATCC 43300 50S ribosomal subunit assessed as dissociation constant by surface plasmon resonance analysis
AID263107Antibacterial activity against methicillin-resistant Staphylococcus aureus USF652 by agar disk diffusion method2006Bioorganic & medicinal chemistry letters, Apr-15, Volume: 16, Issue:8
N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
AID524036Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 2527 by macrodilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID1765574Antibacterial activity against Bacillus subtilis ATCC 23857 incubated for 18 hrs by CLSI based broth dilution method2021Journal of medicinal chemistry, 08-12, Volume: 64, Issue:15
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
AID599146Antibacterial activity against Bacillus subtilis after 24 hrs by MTT assay2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Synthesis, crystal structure and antimicrobial activity of deoxybenzoin derivatives from genistein.
AID1546165Antimicrobial activity against Bacillus subtilis assessed as zone of inhibition at 5 mg/ml after 24 to 48 hrs by well diffusion method2019European journal of medicinal chemistry, Dec-15, Volume: 184Current scenario of tetrazole hybrids for antibacterial activity.
AID582266Antimicrobial activity against Bacillus cereus ATCC 4342 by broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax.
AID619769Antibacterial activity against Staphylococcus aureus RCMB 000106 at 30 mg/ml after 24 hrs by agar well diffusion method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design and synthesis of some new thiophene, thienopyrimidine and thienothiadiazine derivatives of antipyrine as potential antimicrobial agents.
AID332338Antimicrobial activity against Bacillus subtilis 327 after 18 hrs by microbroth dilution method2003Journal of natural products, Feb, Volume: 66, Issue:2
Antibacterial diterpenes from Calceolaria pinifolia.
AID559521Antibacterial activity against Streptococcus oralis assessed as percent susceptible isolates by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID335498Antimicrobial activity against Escherichia coli imp 389 after 18 to 20 hrs by standard broth microdilution method2002Journal of natural products, Jun, Volume: 65, Issue:6
New antimicrobial cycloartane triterpenes from Acalypha communis.
AID1546645Antibacterial activity against Klebsiella pneumoniae MTCC 618 assessed as diameter of zone of inhibition at 200 ug/ml after 24 hrs by agar well diffusion method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
AID1870117Antibacterial activity against antibiotic resistant Staphylococcus aureus 4463/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID368537Ratio of Kcat to Km of Providencia stuartii AmpC assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID625288Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID285269Activity of Escherichia coli BL21(DE3) beta-lactamase TEM282007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.
AID588116Antimicrobial activity against Neisseria gonorrhoeae clinical isolates harboring PBP1 L421P mutant gene, PBP2 XXXVII pattern, deletion of nucleotide A from mtrA promoter, MtrR G45D mutant MAST 299 after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID324839Antimicrobial activity against Neisseria gonorrhoeae 273 isolate2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
AID425612Cytotoxicity against mouse J774A1 cells assessed as release of adenylate kinase at 100 ug/ml after 3 hrs by total cell protein assay relative to control2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID495734Kcat/Km ratio of Klebsiella oxytoca Beta-lactamase K1 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID539694Antifungal activity against Pseudomonas aeruginosa MTCC 741 by broth dilution method2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Indium(III) chloride catalyzed three-component coupling reaction: a novel synthesis of 2-substituted aryl(indolyl)kojic acid derivatives as potent antifungal and antibacterial agents.
AID417435Antibacterial activity against Pseudomonas fluorescens after 24 hrs by MTT method2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents.
AID539692Antifungal activity against Staphylococcus epidermidis MTCC 2639 by broth dilution method2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Indium(III) chloride catalyzed three-component coupling reaction: a novel synthesis of 2-substituted aryl(indolyl)kojic acid derivatives as potent antifungal and antibacterial agents.
AID483194Antibacterial activity against Staphylococcus epidermidis ATCC 12228 by microbroth dilution technique2010Bioorganic & medicinal chemistry letters, Jun-15, Volume: 20, Issue:12
Design, synthesis, and antibacterial activity of 2,5-dihydropyrrole formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
AID554857Antimicrobial activity against Streptococcus pneumoniae serotype 14 ST 2918 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID524245Antimicrobial activity against Escherichia coli DH5alpha expressing SHV-12010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain.
AID577455Inhibition of Bocillin FL binding to PBP2b PBP2b 443SSNA mutant in Streptococcus pneumoniae isolate 8009 harboring E333G, N470K, E476G, T489S, E506D, and N538D mutant genes2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Affinity of ceftobiprole for penicillin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin.
AID559705Antimicrobial activity against methicillin-resistant Staphylococcus aureus P1386 by microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.
AID21924Relative Vmax was reported1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Dependence of beta-lactamase stability on substructures within beta-lactam antibiotics.
AID278547Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium bifidum ATCC 15696 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID557517Displacement of Biocillin FL from Streptococcus pneumoniae 24 PBP32009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID269446Antibacterial activity against VRE Enterococcus faecalis 1528 by agar diffusion assay2006Bioorganic & medicinal chemistry letters, Aug-01, Volume: 16, Issue:15
The synthesis and in vitro testing of structurally novel antibiotics derived from acylnitroso Diels-Alder adducts.
AID543272Antimicrobial activity against Streptococcus pneumoniae 72521 by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID171251Concentration of compound in rat kidney after intravenous injection of 20 mg/kg benzyl-penicillin after 20 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID295104Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 at 10 ug after 24 hrs by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID210368In vitro antibacterial activity against the gram-positive bacteria, penicillin sensitive Streptococcus pneumoniae (3512)1999Bioorganic & medicinal chemistry letters, Apr-05, Volume: 9, Issue:7
New N-substituted 7-aminocephalosporanic acid derivatives as potential agents against Streptococcus pneumoniae. Synthesis and in vitro activity.
AID341525Antimicrobial activity against Neisseria meningitidis isolates harboring penA 30 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID375919Antibacterial activity against Bacillus subtilis ATCC 23857 by NCCLS method2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
AID524050Binding affinity to methicillin-, vancomycin-susceptible Staphylococcus aureus ATCC 29213 PBP2 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID171265Concentration of compound in rat lung after intravenous injection of 20 mg/kg benzyl-penicillin after 10 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID625285Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID287378Antibacterial activity against Listeria monocytogenes after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID573140Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID1091744Antibacterial activity against Chromobacterium violaceum MTCC 2656 assessed as inhibition zones at 100 ug/disk at 37 degC for 24 hr2009Chemical & pharmaceutical bulletin, Jul, Volume: 57, Issue:7
Synthesis, nematicidal and antimicrobial properties of Bis-[4-methoxy-3-[3-(4-fluorophenyl)-6-(4-methylphenyl)-2(aryl)-tetrahydro-2H-pyrazolo[3,4-d]thiazol-5-yl]phenyl]methanes.
AID530341Ratio of Kcat to Km for Pseudomonas aeruginosa VIM-1 beta-lactamase2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
AID521345Antimicrobial activity against Streptococcus pneumoniae isolate k-637 obtained from CSF of patient2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20.
AID680174TP_TRANSPORTER: inhibition of MTX uptake (MTX: 1 uM, PCG: 1000 uM) in OAT4-expressing S2 cells2002The Journal of pharmacology and experimental therapeutics, Aug, Volume: 302, Issue:2
Characterization of methotrexate transport and its drug interactions with human organic anion transporters.
AID565817Antimicrobial activity against Neisseria gonorrhoeae isolates by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis.
AID495722Activity of Pseudomonas aeruginosa AmpC relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID559709Antimicrobial activity against penicillin-sensitive Staphylococcus epidermidis P1111 by microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.
AID587973Ratio of Kcat to Km for Escherichia coli beta-lactamase Toho-1 D240A mutant assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID341536Antimicrobial activity against Neisseria meningitidis isolates harboring penA 13 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID535639Antimicrobial activity against Group B streptococcus serotype VI R1 harboring F395L, V405A, R433H, H438Y, and G648A mutations in PBP 2X and T567I mutation in PBP 2B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID495702Kcat/Km ratio of Klebsiella pneumoniae SHV-12010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID557484Displacement of Biocillin FL from Streptococcus pneumoniae 3676 PBP1B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID584847Ratio of Kcat to Km for Aeromonas allosaccharophila AL-1 beta-lactamase PER62010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila.
AID543483Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 3191 pbp2x, pbp2b, pbp1a and Streptococcus pneumoniae 72521 murM genes by broth microdilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
AID70618In vitro antimicrobial activity against Escherichia coli ATCC 39188 was determined2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Design, synthesis, and SAR of novel carbapenem antibiotics with high stability to Xanthomonas maltophilia oxyiminocephalosporinase type II.
AID494346Antibacterial activity against Staphylococcus aureus by twofold serial dilution method2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis, characterization and antimicrobial studies of 2-(4-methoxy-phenyl)-5-methyl-4-(2-arylsulfanyl-ethyl)-2,4-dihydro-[1,2,4] triazolo-3-ones and their corresponding sulfones.
AID171249Concentration of compound in rat kidney after intravenous injection of 20 mg/kg benzyl-penicillin after 1 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID617968Antibacterial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea.
AID278541Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium longum R0175 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID524064Binding affinity to methicillin-, linezolid-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 2149A PBP3 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID524873Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing mtrR mutant gene assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID558605Antimicrobial activity against Streptococcus pneumoniae isolate 1146 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID324843Antimicrobial activity against Neisseria gonorrhoeae 65 isolate2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
AID558322Antibacterial activity against bla gene-positive and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni NCTC 11168 by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID535641Antimicrobial activity against Group B streptococcus serotype V C1 harboring E63K mutation in PBP 2A and L41S mutation in PBP 1B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID340738Ratio of Kcat to Km of Chryseobacterium indologenes metallo-beta-lactamase IND-5 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes.
AID1237607Antibacterial activity against Proteus vulgaris ATCC49101 assessed as bacterial growth inhibition after 24 hrs by broth dilution method2015European journal of medicinal chemistry, Jul-15, Volume: 100Novel cajaninstilbene acid derivatives as antibacterial agents.
AID1254299Antibacterial activity against Staphylococcus aureus CCM 4516/08 after 48 hrs by microdilution broth method2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
AID535350Antimicrobial activity against Streptococcus pneumoniae clinical isolates assessed as resistant isolates by by based on po dosed broth dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
AID557491Displacement of Biocillin FL from Streptococcus pneumoniae 3413 PBP2X2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID1755809Antibacterial activity against Staphylococcus aureus ATCC 6538 by MH media dilution method2021European journal of medicinal chemistry, Jan-15, Volume: 210Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
AID451356Antimicrobial activity against Cryptococcus albidus NBRC0378 after 24 hrs by broth dilution method2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Synthesis and evaluation of bioactive naphthoquinones from the Brazilian medicinal plant, Tabebuia avellanedae.
AID1653058Antibacterial activity against Escherichia coli2019European journal of medicinal chemistry, Feb-15, Volume: 164Isatin derivatives and their anti-bacterial activities.
AID558625Antimicrobial activity against Streptococcus pneumoniae isolate 3458 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID582267Antimicrobial activity against Bacillus cereus ATCC 4342 selected after 20 daily cycles of drug selection followed by 5 days of nonselective growth by broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax.
AID1565595Antibacterial activity against methicillin-resistant Staphylococcus aureus 936 after 18 hrs by CLSI based broth microdilution method2019European journal of medicinal chemistry, Nov-15, Volume: 182Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity.
AID585181Ratio of Kcat to Km for Beta-lactamase GES-1 E104, G170 mutant2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
AID1437928Antibacterial activity against Porphyromonas gingivalis ATCC 33277 after 24 hrs2017Journal of natural products, 01-27, Volume: 80, Issue:1
Dibenzofurans and Pseudodepsidones from the Lichen Stereocaulon paschale Collected in Northern Quebec.
AID476929Human intestinal absorption in po dosed human2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
AID508309Inhibition of Enterococcus faecium low-affinity PBP5fm assessed as rate constant for enzyme acylation by spectrophotometry2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID524666Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA and mtrR mutant gene assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID666780Antifungal activity against Microbotryum violaceum at 0.05 mg by agar diffusion test2012Bioorganic & medicinal chemistry letters, Jul-01, Volume: 22, Issue:13
Bioactive briarane diterpenoids from the South China Sea gorgonian Dichotella gemmacea.
AID1091745Antibacterial activity against Enterobacter aerogenes MTCC 39 assessed as inhibition zones at 100 ug/disk at 37 degC for 24 hr2009Chemical & pharmaceutical bulletin, Jul, Volume: 57, Issue:7
Synthesis, nematicidal and antimicrobial properties of Bis-[4-methoxy-3-[3-(4-fluorophenyl)-6-(4-methylphenyl)-2(aryl)-tetrahydro-2H-pyrazolo[3,4-d]thiazol-5-yl]phenyl]methanes.
AID519749Ratio of Kcat to Km for Klebsiella pneumoniae Beta-Lactamase SHV-722008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
AID542616Antimicrobial activity against Streptococcus pneumoniae R6 harboring PBP2x2349 mutant gene after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID368521Ratio of Kcat to Km of Enterobacter cloacae 4092 AmpC (E2) assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID524067Binding affinity to methicillin-, vancomycin-susceptible Staphylococcus aureus ATCC 29213 PBP4 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID529578Ratio of Kcat to Km for Chryseobacterium meningosepticum beta-Lactamase GOB-12008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Functional diversity among metallo-beta-lactamases: characterization of the CAR-1 enzyme of Erwinia carotovora.
AID575077Antimicrobial activity against Streptococcus pneumoniae serotype 3 assessed as percent susceptible isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID529577Ratio of Kcat to Km for Pseudomonas maltophilia ULA-511 beta-Lactamase L-12008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Functional diversity among metallo-beta-lactamases: characterization of the CAR-1 enzyme of Erwinia carotovora.
AID525549Antimicrobial activity against ampicillin resistant nontypeable Haemophilus influenzae isolate BB1052 harboring with plasmid pB1000 bearing beta-lactamase ROB-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Haemophilus influenzae clinical isolates with plasmid pB1000 bearing blaROB-1: fitness cost and interspecies dissemination.
AID1072981Antimicrobial activity against Candida albicans MY 1055 after 20 hrs by 2-fold serial broth dilution method2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Isolation, structure elucidation, and biological activity of altersolanol P using Staphylococcus aureus fitness test based genome-wide screening.
AID1243283Antimicrobial activity against Staphylococcus aureus ATCC 25923 by standard broth microdilution method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.
AID1243289Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 by standard broth microdilution method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.
AID561112Antibacterial activity against Pasteurella multocida BB1046 harboring plasmid pB1003 bearing blaROB-1 gene and plasmid pB1002 bearing strA, sul2 genes by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID530515Antimicrobial activity against group B Streptococcus sp. 'group B' isolate 6149-03 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID680167TP_TRANSPORTER: inhibition of Ochratoxin A uptake (OTA: 1 uM, PCG: 200 uM) in OAT4-expressing S2 cells2002Biochimica et biophysica acta, Jun-12, Volume: 1590, Issue:1-3
Role of human organic anion transporter 4 in the transport of ochratoxin A.
AID1765575Antibacterial activity against Enterococcus faecalis ATCC 29212 incubated for 18 hrs by CLSI based broth dilution method2021Journal of medicinal chemistry, 08-12, Volume: 64, Issue:15
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
AID374672Antimicrobial activity against tetracycline-resistant Escherichia coli U1 rapA mutant grown as biofilms after 24 hrs by spectrophotometric method2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
AID625279Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID549015Antimicrobial activity against viridans group Streptococcus assessed as percent resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID340770Increase in pbp2A gene expression in penicillin-resistant Streptococcus gordonii with penicillin binding protein PR1_2 evolved mutation assessed as relative luciferase units relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii.
AID245356Minimum inhibitory concentration against Pseudomonas aeruginosa (Gram-negative) by broth dilution method2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Synthesis and antibacterial activity of 2,4,6-tri substituted s-triazines.
AID1601854Antibacterial activity against multidrug-resistant Pseudomonas aeruginosa ATCC BAA-2111 measured after 24 hrs by ELISA2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety.
AID1054725Antibacterial activity against Escherichia coli (Migula) Castellani and Chalmers ATCC 25922 after overnight incubation by broth microdilution method2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
Pahangensin A and B, two new antibacterial diterpenes from the rhizomes of Alpinia pahangensis Ridley.
AID586083Antimicrobial activity against Neisseria gonorrhoeae isolates harboring non-mosaic penicillin-binding protein 2 penA assessed as resistant isolates by disk susceptibility test2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Characteristics and dissemination of mosaic penicillin-binding protein 2-harboring multidrug-resistant Neisseria gonorrhoeae isolates with reduced cephalosporin susceptibility in northern Taiwan.
AID531425Antibacterial activity against Streptococcus pneumoniae serotype 22 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID569347Antibacterial activity against penicillin-resistant Streptococcus pneumoniae by agar dilution method2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
AID311524Oral bioavailability in human2007Bioorganic & medicinal chemistry, Dec-15, Volume: 15, Issue:24
Hologram QSAR model for the prediction of human oral bioavailability.
AID557497Displacement of Biocillin FL from Streptococcus pneumoniae 1076 PBP2X2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID498376Antimicrobial activity against wild type streptomycin-susceptible Streptococcus gordonii harboring P438R mutation in ptsI infected in Wistar rat assessed as decrease in bacterial infection at 300000 U/kg, sc administered 16 hrs after infection every 12 hr2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.
AID557520Displacement of Biocillin FL from Streptococcus pneumoniae 3676 PBP32009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID524070Binding affinity to methicillin-, linezolid-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 2149A PBP4 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID540179Antibacterial activity against Klebsiella pneumoniae after 24 hrs by twofold serial dilution method2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis and anti-tubercular and antimicrobial activities of some 2r,4c-diaryl-3-azabicyclo[3.3.1]nonan-9-one N-isonicotinoylhydrazone derivatives.
AID522664Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis BA1024 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID1870118Antibacterial activity against antibiotic resistant Staphylococcus aureus 4904/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID372640Ratio of Kcat/Km for Escherichia coli DH5alpha beta-lactamase TEM-35 to Kcat/Km for Escherichia coli DH5alpha beta-lactamase TEM-1582007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
AID528739Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B516 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
AID535634Antimicrobial activity against Group B streptococcus serotype VI R6 harboring F395L, V405A, R433H, H438Y, A374V and G648A mutations in PBP 2X and T567I mutation in PBP 2B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID521828Antimicrobial activity against Streptococcus pneumoniae in meningitis patients by broth dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Clonal spread of highly beta-lactam-resistant Streptococcus pneumoniae isolates in Taiwan.
AID542619Antimicrobial activity against streptomycin- resistant Streptococcus pneumoniae R6 harboring PBP2x2349 mutant gene and Janus disruption at PBP1a after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID575103Antimicrobial activity against Streptococcus pneumoniae serotype 23A assessed as percent susceptible isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID520724Activity of Acinetobacter baumannii phenotype 2 beta-lactamase assessed per mg of protein at 100 uM2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97.
AID681115TP_TRANSPORTER: inhibition of Gly-Sar uptake (pH6.0) in Caco-2 cells2005European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, Jan, Volume: 59, Issue:1
Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
AID74700Inhibition of gram negative bacteria growth.1989Journal of medicinal chemistry, Jun, Volume: 32, Issue:6
Synthesis and antimicrobial properties of substituted beta-aminoxypropionyl penicillins and cephalosporins.
AID524874Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penB mutant gene assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID341532Antimicrobial activity against Neisseria meningitidis isolates harboring penA 20 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID530501Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IA isolate 6649-05 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID520727Activity of Escherichia coli TOP10 beta-lactamase OXA-97 assessed as specific activity per mg of protein at 100 uM2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97.
AID405086Ratio of Kcat to Km of Citrobacter freundii PER2 beta lactamase relative to cephalothin2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Biochemical characterization of PER-2 and genetic environment of blaPER-2.
AID592501Antifungal activity against Microbotryum violaceum assessed as zone of inhibition measured as radius at 50 ug by agar diffusion assay2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Diversonol and blennolide derivatives from the endophytic fungus Microdiplodia sp.: absolute configuration of diversonol.
AID524071Binding affinity to methicillin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 1287 PBP4 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID1279015Antibacterial activity against Escherichia coli CCM 4517 after 24 hrs by microbroth dilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
AID1601850Antibacterial activity against Pseudomonas aeruginosa CMCC 10104 measured after 24 hrs by ELISA2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety.
AID368534Ratio of Kcat to Km of Morganella morganii AmpC assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID287377Antibacterial activity against Mycobacterium smegmatis after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID269451Antibacterial activity against PSE1 beta-lactamase Pseudomonas aeruginosa IV-3-13 by agar diffusion assay2006Bioorganic & medicinal chemistry letters, Aug-01, Volume: 16, Issue:15
The synthesis and in vitro testing of structurally novel antibiotics derived from acylnitroso Diels-Alder adducts.
AID511451Antimicrobial activity against Streptococcus uberis isolate 1.11 harboring PAP1A G386R, PBP2B T593I and PBP2X E381K/Q554E mutation assessed as inhibition of visible growth after 24 hrs by broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID1168784Antibacterial against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by two-fold serial dilution method2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Synthesis, molecular docking and biological evaluation of coumarin derivatives containing piperazine skeleton as potential antibacterial agents.
AID1254308Antibacterial activity against Klebsiella pneumoniae D 11750/08 after 24 hrs by microdilution broth method2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
AID287372Antibacterial activity against Staphylococcus aureus after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID587976Ratio of Kcat to Km for Escherichia coli beta-lactamase Toho-1 G232A mutant assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID206459In vitro antibacterial activity against the gram-positive bacteria, penicillin sensitive Staphylococcus aureus (3072)1999Bioorganic & medicinal chemistry letters, Apr-05, Volume: 9, Issue:7
New N-substituted 7-aminocephalosporanic acid derivatives as potential agents against Streptococcus pneumoniae. Synthesis and in vitro activity.
AID519629Antimicrobial activity against Escherichia coli JM83 without producing beta-lactamase OXA-63 after 3 days by Etest2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
AID603194Antibacterial activity against Klebsiella pneumoniae MTCC 618 by broth microdilution method2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Efficient synthesis, structural characterization and anti-microbial activity of chiral aryl boronate esters of 1,2-O-isopropylidene-α-D-xylofuranose.
AID278531Antimicrobial activity against Bifidobacterium pseudolongum ATCC 255622007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID263114Antibacterial activity against methicillin-resistant Staphylococcus aureus USF659 by agar disk diffusion method2006Bioorganic & medicinal chemistry letters, Apr-15, Volume: 16, Issue:8
N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
AID558629Antimicrobial activity against Streptococcus pneumoniae isolate 3791 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID522657Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis V770 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID557496Displacement of Biocillin FL from Streptococcus pneumoniae 3009 PBP2X2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID562373Antimicrobial activity against Streptococcus Group C clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID562367Antimicrobial activity against Streptococcus Group F clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID1180458Selectivity index, ratio of IC50 for human HepG2 cells to MIC for methicillin-resistant Staphylococcus aureus H 5996/082014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
AID577459Antimicrobial activity against laboratory-derived Streptococcus pneumoniae isolate R6 harboring Thr446Ala/Ala-619-Gly mutant gene by broth microdilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Affinity of ceftobiprole for penicillin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin.
AID532982Antibacterial activity against Escherichia coli W3110 in presence of 10 mM N-Acetylcysteine2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID418554Antibacterial activity against multidrug-resistant Staphylococcus aureus BAA-39 by NCCLS method2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
AID1638901Antimicrobial activity against Enterococcus faecalis ATCC 29212 measured after 18 hrs by broth microdilution method2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
AID562581Antimicrobial activity against erythromycin-nonsusceptible Streptococcus pyogenes clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID573565Antibacterial activity against beta-lactamase producing Bacteroides vulgatus assessed as resistant isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID524669Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA, ponA and mtrR mutant gene assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID372641Ratio of Kcat/Km for Escherichia coli DH5alpha beta-lactamase TEM-1 to Kcat/Km for Escherichia coli DH5alpha beta-lactamase TEM-1582007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
AID542624Antimicrobial activity against Streptococcus pneumoniae R6 harboring PBP2x T338G mutant gene, disruption at PBP1a and aad9 disruption in CiaR gene after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID561105Antibacterial activity against Pasteurella multocida BB1039 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB9956 bearing tetH gene by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID1565592Antibacterial activity against Klebsiella pneumoniae ATCC 700603 after 18 hrs by CLSI based broth microdilution method2019European journal of medicinal chemistry, Nov-15, Volume: 182Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity.
AID521349Antimicrobial activity against Streptococcus pneumoniae isolate 909 obtained from bronchoalveolar lavage fluid of patient2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20.
AID207928Compound was evaluated for the antibacterial activity against Staphylococcus aureus with the strains beta-Lactamase-positive (LAC+)/ beta-Lactamase-negative (LAC-); 64/0.031984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Dependence of beta-lactamase stability on substructures within beta-lactam antibiotics.
AID1870130Antibacterial activity against antibiotic resistant Staphylococcus aureus 4679/B assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID521830Antimicrobial activity against Streptococcus pneumoniae isolated from meningitis patient assessed as percent susceptible isolates by CLSI method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Clonal spread of highly beta-lactam-resistant Streptococcus pneumoniae isolates in Taiwan.
AID1454339Antibacterial activity Klebsiella pneumoniae MTCC 618 by agar well method2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Synthesis and biological evaluation of 5-fatty-acylamido-1, 3, 4-thiadiazole-2-thioglycosides.
AID495728Activity of Pseudomonas aeruginosa IMP-1 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID562413Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group C clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID1546169Antimicrobial activity against Proteus mirabilis2019European journal of medicinal chemistry, Dec-15, Volume: 184Current scenario of tetrazole hybrids for antibacterial activity.
AID1079934Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]
AID584848Ratio of Kcat to Km for Aeromonas allosaccharophila AL-1 beta-lactamase PER22010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila.
AID588117Antimicrobial activity against Neisseria gonorrhoeae clinical isolates harboring porB G120K, A121D mutant gene, PBP1 L421P mutant gene, PBP2 XXXVIII pattern, deletion of nucleotide A from mtrA promoter, MAST 3570 after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID521829Antimicrobial activity against Streptococcus pneumoniae in non-meningitis patients by broth dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Clonal spread of highly beta-lactam-resistant Streptococcus pneumoniae isolates in Taiwan.
AID582966Antimicrobial activity against beta-lactamase A-deficient Yersinia enterocolitica GY5717 after 20 hrs by Etest2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Contribution of BlaA and BlaB beta-lactamases to antibiotic susceptibility of Yersinia enterocolitica biovar 1B.
AID524877Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA, penB and mtrR mutant gene assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID368494Ratio of Kcat to Km of Escherichia coli CTX-M-15 assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID1601848Antibacterial activity against Escherichia coli CMCC 44568 measured after 24 hrs by ELISA2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety.
AID341338Antimicrobial activity against Neisseria meningitidis isolates harboring penA 11 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID1870133Antibacterial activity against antibiotic resistant Staphylococcus aureus 5079/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
AID522393Ratio of Kcat Km for Aeromonas caviae Beta-lactamase CAV12010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Genetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenes.
AID524034Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 24 by macrodilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID381179Antibacterial activity against penicillin-resistant Staphylococcus aureus after 24 to 72 hrs by disk diffusion method1999Journal of natural products, Sep, Volume: 62, Issue:9
Antimicrobial and antitumor activities of mycosporulone.
AID520389Ratio of Kcat to Km for Pseudomonas aeruginosa COL-1 metallo-beta lactamase VIM-2 over Kcat to Km for Pseudomonas aeruginosa M5109 metallo-beta-lactamase VIM-112008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biochemical characterization of metallo-beta-lactamase VIM-11 from a Pseudomonas aeruginosa clinical strain.
AID210366In vitro antibacterial activity against the gram-positive bacteria, penicillin sensitive Streptococcus pneumoniae (3272)1999Bioorganic & medicinal chemistry letters, Apr-05, Volume: 9, Issue:7
New N-substituted 7-aminocephalosporanic acid derivatives as potential agents against Streptococcus pneumoniae. Synthesis and in vitro activity.
AID558335Antibacterial activity against Campylobacter jejuni isolate P1093 harboring blaOXA-61::cat gene by NCCLS agar doubling dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
AID530499Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IA isolate 3047-05 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID451353Antimicrobial activity against Pseudomonas aeruginosa NBRC13275 after 24 hrs by broth dilution method2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Synthesis and evaluation of bioactive naphthoquinones from the Brazilian medicinal plant, Tabebuia avellanedae.
AID524035Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 3413 by macrodilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID495840Hydrolytic activity of beta-lactamase VIM-1 in Escherichia coli DH5alpha expressing pBCLL/39H by microacidimetric method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
AID528707Antibacterial activity against Streptococcus pyogenes group A clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID1706284Half life of compound2020European journal of medicinal chemistry, Dec-15, Volume: 208β-lactam antibiotics: An overview from a medicinal chemistry perspective.
AID533937Antimicrobial activity against linezolid-resistant Staphylococcus aureus ATCC 29213 by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID562370Antimicrobial activity against Streptococcus Group G clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID619543Antibacterial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT assay2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Tyrosyl-tRNA synthetase inhibitors as antibacterial agents: synthesis, molecular docking and structure-activity relationship analysis of 3-aryl-4-arylaminofuran-2(5H)-ones.
AID1072984Antimicrobial activity against wild-type Escherichia coli MB 2884 after 20 hrs by 2-fold serial broth dilution method2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Isolation, structure elucidation, and biological activity of altersolanol P using Staphylococcus aureus fitness test based genome-wide screening.
AID1243287Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates by standard broth microdilution method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.
AID447057Antibacterial activity against Micrococcus luteus La 2971 at 10 IU after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID523001Cytotoxicity against human 5637 cells assessed as mild induction of cell death by trypan blue exclusion assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
AID1437930Bactericidal activity against Porphyromonas gingivalis ATCC 33277 after 24 hrs2017Journal of natural products, 01-27, Volume: 80, Issue:1
Dibenzofurans and Pseudodepsidones from the Lichen Stereocaulon paschale Collected in Northern Quebec.
AID529323Antibacterial activity against penicillin-resistant Streptococcus pneumoniae serotype 19A URA3635 harboring mutant PBP2B PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID562757Ratio of Kcat to Km for Klebsiella pneumoniae AH27 CTX-M-15 beta-lactamase2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
New variant of CTX-M-type extended-spectrum beta-lactamases, CTX-M-71, with a Gly238Cys substitution in a Klebsiella pneumoniae isolate from Bulgaria.
AID495900Activity of Pseudomonas aeruginosa VIM-2 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID322495Cmax in human adults at 600 mg/kg, iv administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID557473Displacement of Biocillin FL from Streptococcus pneumoniae 3413 PBP1A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID1079943Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]
AID541023Ratio of Kcat to Km for Burkholderia cenocepacia 07-34 beta-lactamase PenB1 expressed in Escherichia coli Top102009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex.
AID1778127Antimicrobial activity against Staphylococcus aureus assessed as microbial growth inhibition by CLSI-protocol based broth microdilution assay2021Journal of natural products, 04-23, Volume: 84, Issue:4
Opportunities and Limitations for Assigning Relative Configurations of Antibacterial Bislactones using GIAO NMR Shift Calculations.
AID535354Antimicrobial activity against Streptococcus pneumoniae clinical isolates assessed as resistant isolates by by based on parenterally dosed broth dilution method in presence of beta-lactamase inhibitor clavulanic acid2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
AID1428252Antibacterial activity against Staphylococcus aureus RCMB 000108 assessed as zone of inhibition at 30 ug/ml2017European journal of medicinal chemistry, Jan-27, Volume: 126An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.
AID340852Effect on pbp2B gene expression in penicillin-resistant Streptococcus gordonii with penicillin binding protein PR1_2 evolved mutation assessed as relative luciferase units relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii.
AID524670Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA, penB and ponA mutant gene assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID508306Inhibition of PBP5 in wild type Enterococcus faecium D63 membranes assessed as inhibition of fluorescent ampicillin binding after 20 mins at 37 degC2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID573145Antibacterial activity against penicillin-susceptible Streptococcus viridans assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID1209734Inhibition of mouse OAT1 expressed in CHO cells assessed as inhibition of fluorescein uptake at 500 uM over 20 mins relative to untreated-control2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
AID368516Ratio of Kcat to Km of Pseudomonas aeruginosa IMP1 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID558604Antimicrobial activity against Streptococcus pneumoniae isolate 1055 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID28560Concentration of compound in human brain tissues after intravenous administration of 2 g dose1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. Synthesis and properties of some dihydropyridine and dihydroiosquinoline derivatives of benzylpenicillin.
AID532676Antimicrobial activity against ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates assessed as susceptible isolates by agar dilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
AID368522Ratio of Kcat to Km of Enterobacter cloacae 4092 AmpC (E2) assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID1149039Antibacterial activity against Salmonella schottmuelleri assessed as growth inhibition incubated for 24 hrs using mixed anhydride1976Journal of medicinal chemistry, Feb, Volume: 19, Issue:2
Beta-lactam antibiotics with N-oxide side chains. 1. Quinoxaline N-oxides.
AID1079932Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]
AID495706Kcat/Km ratio of Escherichia coli CMY-22010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID70752In vitro Minimum inhibitory concentration against Escherichia coli ATCC 259221981Journal of medicinal chemistry, Oct, Volume: 24, Issue:10
Synthesis and evaluation of ureido- and vinylureidopenicillins as inhibitors of intraruminal lactic acid production.
AID417436Antibacterial activity against Escherichia coli after 24 hrs by MTT method2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents.
AID278558Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium animalis ATCC 27536 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID575083Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F assessed as percent susceptible isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID340764Antibacterial activity against penicillin-resistant Streptococcus gordonii with penicillin binding protein PR1_2 evolved mutation2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii.
AID341344Antimicrobial activity against Neisseria meningitidis isolates harboring penA 27 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID373216Ratio of Kcat for Bacillus cereus beta-lactamase BcI to Kcat for Bacillus clausii NR beta-lactamase BCL12007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
AID394487Activity of Escherichia coli beta-lactamase ACC4 by UV spectrophotometry2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
AID539691Antifungal activity against Staphylococcus aureus MTCC 96 by broth dilution method2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Indium(III) chloride catalyzed three-component coupling reaction: a novel synthesis of 2-substituted aryl(indolyl)kojic acid derivatives as potent antifungal and antibacterial agents.
AID495732Kcat/Km ratio of Klebsiella pneumoniae SHV-1 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID521356Antimicrobial activity against Streptococcus pneumoniae isolate 2907 obtained from sinusitis of patient2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20.
AID210367In vitro antibacterial activity against the gram-positive bacteria, penicillin sensitive Streptococcus pneumoniae (3273)1999Bioorganic & medicinal chemistry letters, Apr-05, Volume: 9, Issue:7
New N-substituted 7-aminocephalosporanic acid derivatives as potential agents against Streptococcus pneumoniae. Synthesis and in vitro activity.
AID540210Clearance in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID588115Antimicrobial activity against Neisseria gonorrhoeae clinical isolates harboring PBP2 XXXVIII pattern, deletion of nucleotide A from mtrA promoter, MAST 3553 after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID679175TP_TRANSPORTER: inhibition of Pravastatin uptake in Oat3-expressing LLC-PK1 cells2002The Journal of pharmacology and experimental therapeutics, Mar, Volume: 300, Issue:3
Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions.
AID341524Antimicrobial activity against Neisseria meningitidis isolates harboring penA 12 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID530513Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IV isolate 3454-03 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID372620Ratio of Kcat to Km for Escherichia coli DH5alpha beta-lactamase TEM-12007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
AID573598Antibacterial activity against Fusobacterium varium assessed as resistant isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID575099Antimicrobial activity against Streptococcus pneumoniae serotype 15A assessed as percent susceptible isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID1546649Antibacterial activity against Escherichia coli MTCC 443 assessed as reduction in microbial growth after 24 hrs by CLSI based microdilution method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
AID1755800Antibacterial activity against Pseudomonas aeruginosa ATCC 13525 by MH media dilution method2021European journal of medicinal chemistry, Jan-15, Volume: 210Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
AID322510AUC (0 to 12) in human term neonates at 15 mg/kg, im administered every 12 hrs after 24 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID557493Displacement of Biocillin FL from Streptococcus pneumoniae 3676 PBP2X2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID530342Ratio of Kcat to Km for Pseudomonas aeruginosa VIM-13 beta-lactamase2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
AID278546Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium bifidum R0071 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID1072990Bactericidal activity against Streptococcus mutans ATCC 35668 after 3 days2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Pyrano-isoflavans from Glycyrrhiza uralensis with antibacterial activity against Streptococcus mutans and Porphyromonas gingivalis.
AID557486Displacement of Biocillin FL from Streptococcus pneumoniae 3665 PBP1B2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID395346Antibacterial activity against Mycobacterium smegmatis CCM 2067 at 10 units after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID531417Antibacterial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID495797Activity at Pseudomonas fluorescens PF-1 beta-lactamase BIC-1 expressed in Escherichia coli DH10B carrying pSau12010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.
AID1279014Antibacterial activity against Enterococcus sp. J 14365/08 after 48 hrs by microbroth dilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
AID508301Inhibition of PBP6 in penicillin-resistant Enterococcus faecium D63r membranes assessed as inhibition of fluorescent ampicillin binding after 20 mins at 37 degC2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID557525Displacement of Biocillin FL from Streptococcus pneumoniae 1077 PBP32009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID163788In vitro antimicrobial activity against Pseudomonas aeruginosa 1101-75 was determined2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Design, synthesis, and SAR of novel carbapenem antibiotics with high stability to Xanthomonas maltophilia oxyiminocephalosporinase type II.
AID1254300Antibacterial activity against methicillin-resistant Staphylococcus aureus H 5996/08 after 24 hrs by microdilution broth method2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
AID368495Ratio of Kcat to Km of Escherichia coli CTX-M-15 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID1474167Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID522660Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis BA1086 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID568434Antimicrobial activity against Staphylococcus epidermidis MTCC 437 after 24 hrs by broth dilution method2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Stereoselective first total synthesis, confirmation of the absolute configuration and bioevaluation of botryolide-E.
AID1454341Antibacterial activity Staphylococcus aureus MTCC 96 by agar well method2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Synthesis and biological evaluation of 5-fatty-acylamido-1, 3, 4-thiadiazole-2-thioglycosides.
AID571183Antibacterial activity against Neisseria gonorrhoeae harboring wild-type ponA gene by disk agar diffusion method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID522644Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis SK57 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID554860Antimicrobial activity against Streptococcus pneumoniae serotype 14 ST 143 harboring ERY-resistant erm(B) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID530521Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 8607-03 expressing pbp2x Q557E mutant and harboring empty vector by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID375912Antibacterial activity against multi-drug resistant Staphylococcus aureus BAA-39 by NCCLS method2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
AID524672Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing beta-lactamase TEM-1 mutant gene assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID533927Antimicrobial activity against Staphylococcus aureus 1651 harboring G2576U mutation in peptidyl transferase centre by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID210365In vitro antibacterial activity against the gram-positive bacteria, penicillin resistant Streptococcus pneumoniae (4636)1999Bioorganic & medicinal chemistry letters, Apr-05, Volume: 9, Issue:7
New N-substituted 7-aminocephalosporanic acid derivatives as potential agents against Streptococcus pneumoniae. Synthesis and in vitro activity.
AID495725Activity of Klebsiella pneumoniae KPC-2 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID770970Antibacterial activity against Pseudomonas aeruginosa MTCC 741 by broth dilution method2013European journal of medicinal chemistry, Oct, Volume: 68Demonic axe-like conjugated alkynes in combating microbes.
AID524643Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA and mtrR mutant gene assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID1091747Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as inhibition zones at 100 ug/disc at 37 degC for 24 hr2009Chemical & pharmaceutical bulletin, Jul, Volume: 57, Issue:7
Synthesis, nematicidal and antimicrobial properties of Bis-[4-methoxy-3-[3-(4-fluorophenyl)-6-(4-methylphenyl)-2(aryl)-tetrahydro-2H-pyrazolo[3,4-d]thiazol-5-yl]phenyl]methanes.
AID520384Antimicrobial activity Escherichia coli DH5alpha expressing beta lactamase VIM-2 by agar macrodilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biochemical characterization of metallo-beta-lactamase VIM-11 from a Pseudomonas aeruginosa clinical strain.
AID665397Antibacterial activity against Escherichia coli MTCC 42 after 24 hrs by serial dilution technique2012European journal of medicinal chemistry, Jul, Volume: 53Synthesis, characterization, antimicrobial activities and QSAR studies of some 10a-phenylbenzo[b]indeno[1,2-e][1,4]thiazin-11(10aH)-ones.
AID1254298Antibacterial activity against Staphylococcus aureus CCM 4516/08 after 24 hrs by microdilution broth method2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
AID278522Antimicrobial activity against Bifidobacterium bifidum R00712007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID295113Antibacterial activity against Mycobacterium smegmatis CCM 2067 at 10 ug after 24 hrs by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID559701Antimicrobial activity against Bacillus subtilis AB91021 by microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.
AID372898Antibacterial activity against sPseudomonas aeruginosa ATCC 13525 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID540213Half life in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID529660Ratio of Kcat to Km for Pseudomonas aeruginosa COL-1 beta-lactamase VIM-22008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID535645Antimicrobial activity against Group B Streptococcus serotype Ia N1 harboring E63K mutation in PBP 2A and L41S mutation in PBP 1B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID573795Antibacterial activity against Prevotella buccae assessed as susceptible isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID625281Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID524058Binding affinity to methicillin-, linezolid-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 2149A PBP2a by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID1653047Antibacterial activity against Staphylococcus aureus2019European journal of medicinal chemistry, Feb-15, Volume: 164Isatin derivatives and their anti-bacterial activities.
AID511445Antimicrobial activity against Streptococcus uberis ATCC 9529 harboring PBP2B N366I/T402I and PBP2X E381K/Q554E mutation assessed as inhibition of visible growth by broth macrodilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
AID258713Antibacterial activity against gram negative Pseudomonas aeruginosa (MTCC 741)2006Bioorganic & medicinal chemistry letters, Jan-01, Volume: 16, Issue:1
Synthesis and biological evaluation of novel C (7) modified chrysin analogues as antibacterial agents.
AID562580Antimicrobial activity against Streptococcus Group C clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID398238Antimicrobial activity against vancomycin-resistant Enterococcus faecium 379 after 18 hrs by twofold serial microbroth dilution method2003Journal of natural products, Dec, Volume: 66, Issue:12
A novel antibacterial iridoid and triterpene from Caiophora coronata.
AID495707Kcat/Km ratio of Pseudomonas aeruginosa AmpC2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID562585Antimicrobial activity against erythromycin-susceptible Streptococcus agalactiae clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID587970Ratio of Kcat to Km for Escherichia coli beta-lactamase Toho-1 N104D mutant assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID1454340Antibacterial activity Bacillus subtilis MTCC 441 by agar well method2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Synthesis and biological evaluation of 5-fatty-acylamido-1, 3, 4-thiadiazole-2-thioglycosides.
AID278682Antibacterial activity against Enterococcus faecium isolate 57532007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID1546651Antibacterial activity against Klebsiella pneumoniae MTCC 618 assessed as reduction in microbial growth after 24 hrs by CLSI based microdilution method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
AID588106Antimicrobial activity against Neisseria gonorrhoeae clinical isolates harboring porB A121S mutant gene, PBP1 L421P mutant gene, PBP2 XXXVIII pattern, deletion of nucleotide A from mtrA promoter, MAST 3116 after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID307355Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 24 hrs by broth dilution assay2007Bioorganic & medicinal chemistry letters, Jun-15, Volume: 17, Issue:12
Penicillin-bound polyacrylate nanoparticles: restoring the activity of beta-lactam antibiotics against MRSA.
AID498367Antimicrobial activity against wild type streptomycin-susceptible Streptococcus gordonii assessed as bacterial count at 2 ug/ml after 24 hrs by macrodilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.
AID1054722Antibacterial activity against Bacillus cereus Frankland and Frankland ATCC 11778 after overnight incubation by broth microdilution method2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
Pahangensin A and B, two new antibacterial diterpenes from the rhizomes of Alpinia pahangensis Ridley.
AID498370Antimicrobial activity against erythromycin- and streptomycin-resistant Streptococcus gordonii Tol1 harboring R483P mutation in ptsI assessed as bacterial count at 2 ug/ml after 24 hrs by macrodilution technique2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.
AID1237603Antibacterial activity against Staphylococcus aureus ATCC25923 assessed as bacterial growth inhibition after 24 hrs by broth dilution method2015European journal of medicinal chemistry, Jul-15, Volume: 100Novel cajaninstilbene acid derivatives as antibacterial agents.
AID341349Antimicrobial activity against Neisseria meningitidis isolates harboring penA 111 allele encoding PBP2 P551 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID206811In vitro Minimum inhibitory concentration against Staphylococcus penicillin G resistant)1981Journal of medicinal chemistry, Oct, Volume: 24, Issue:10
Synthesis and evaluation of ureido- and vinylureidopenicillins as inhibitors of intraruminal lactic acid production.
AID405085Ratio of Kcat to Km of Citrobacter freundii PER2 beta lactamase2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Biochemical characterization of PER-2 and genetic environment of blaPER-2.
AID1064522Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 24 hrs by microdilution broth method2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Alkylamino derivatives of pyrazinamide: synthesis and antimycobacterial evaluation.
AID532989Antibacterial activity against Klebsiella aerogenes NCIM 2281 in presence of 10 mM N-Acetylcysteine2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID1079936Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]
AID1191522Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID351192Elimination half life in preterm neonates with septicemia or invasive infections with gestational age of less than 32 weeks at 50000 U/kg, iv administered every 12 hrs2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.
AID375916Antibacterial activity against Streptococcus pneumoniae ATCC 6301 by NCCLS method2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
AID573151Antibacterial activity against vancomycin-susceptible Enterococcus faecalis assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID171122Concentration of compound in rat brain after intravenous injection of 20 mg/kg benzyl-penicillin after 40 min; Below detection limit.1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID351191Volume of distribution at steady state in preterm neonates with septicemia or invasive infections with gestational age of less than 32 weeks at 50000 U/kg, iv administered every 12 hrs2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.
AID378413Antimicrobial activity against Penicillium griseofulvum DSM 847 after 24 hrs2006Journal of natural products, Aug, Volume: 69, Issue:8
Carneic acids A and B, chemotaxonomically significant antimicrobial agents from the xylariaceous ascomycete Hypoxylon carneum.
AID530520Antimicrobial activity against group B Streptococcus sp. 'group B' serotype V isolate 9171-03 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID1079945Animal toxicity known. [column 'TOXIC' in source]
AID530522Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 8607-03 expressing pbp2x Q557E mutant and harboring plasmid expressing wild-type pbp2x by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID561252Antibacterial activity against Streptococcus pneumoniae assessed as resistant isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID1778129Antimicrobial activity against Pseudomonas aeruginosa assessed as microbial growth inhibition by CLSI-protocol based broth microdilution assay2021Journal of natural products, 04-23, Volume: 84, Issue:4
Opportunities and Limitations for Assigning Relative Configurations of Antibacterial Bislactones using GIAO NMR Shift Calculations.
AID530511Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 7507-03 expressing pbp2x Q557E mutant and multilocus sequence type ST19 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID293928Growth inhibition against penicillin-susceptible Staphylococcus ATCC 25923 aureus after 24 hrs2007Bioorganic & medicinal chemistry, Mar-15, Volume: 15, Issue:6
N-thiolated beta-lactams: Studies on the mode of action and identification of a primary cellular target in Staphylococcus aureus.
AID625531Antimicrobial activity against Klebsiella pneumoniae MTCC 618 by broth dilution method2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Iodine-catalyzed conjugate addition of indoles onto en-1,4-dione: a novel synthesis of 3-(1-(1H-indol-3-yl)-2-oxo-2-phenylethyl)indolin-2-ones as antibacterial and antifungal agents.
AID495743Kcat/Km ratio of Pseudomonas aeruginosa IMP-1 relative to Cephaloridine2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID560701Ratio of Kcat to Km for Escherichia coli MC4100 Beta-Lactamase CMY-30 harboring Val211?Gly211 mutation2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.
AID575080Antimicrobial activity against Streptococcus pneumoniae serotype 11A assessed as percent susceptible isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
AID1474166Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID634234Antibacterial activity against Prevotella intermedia ATCC 25611 assessed as growth inhibition at 0.00625 to 2.5 ug/ml ug/ml after 24 hrs by microplate dilution assay2011Journal of natural products, Dec-27, Volume: 74, Issue:12
Isoflavonoids and coumarins from Glycyrrhiza uralensis: antibacterial activity against oral pathogens and conversion of isoflavans into isoflavan-quinones during purification.
AID529902Antimicrobial activity against Leptospira interrogans serovar Pomona isolate 12 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID533944Antimicrobial activity against linezolid-resistant Enterococcus faecalis 1172 harboring G2576U mutation in peptidyl transferase centre by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
AID524060Binding affinity to against methicillin-, daptomycin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 25 PBP2a by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID395342Antibacterial activity against Klebsiella pneumoniae UC57 at 10 units after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID278533Antimicrobial activity against Bifidobacterium breve R00702007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID525545Antimicrobial activity against Haemophilus influenzae Rd KW20 by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Haemophilus influenzae clinical isolates with plasmid pB1000 bearing blaROB-1: fitness cost and interspecies dissemination.
AID535644Antimicrobial activity against Group B streptococcus serotype Ib N2 harboring E63K mutation in PBP 2A and L41S mutation in PBP 1B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID617970Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea.
AID1765573Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 18 hrs by CLSI based broth dilution method2021Journal of medicinal chemistry, 08-12, Volume: 64, Issue:15
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
AID524649Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing beta-lactamase TEM-1 mutant gene assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID573147Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID1243292Antimicrobial activity against ciprofloxacin-resistant Escherichia coli clinical isolates by standard broth microdilution method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.
AID530516Antimicrobial activity against group B Streptococcus sp. 'group B' isolate 7368-04 by broth dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
AID587972Ratio of Kcat to Km for Escherichia coli beta-lactamase Toho-1 D240S mutant assessed as compound hydrolysis by spectrophotometry2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
AID368726Activity of Serratia marcescens AmpC assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID521344Antimicrobial activity against Streptococcus pneumoniae ATCC BAA-3432008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20.
AID519746Activity of Klebsiella pneumoniae Beta-Lactamase SHV-12008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
AID542620Antimicrobial activity against streptomycin-resistant Streptococcus pneumoniae R6 harboring PBP2x T338G mutant gene and Janus disruption at PBP1a after 48 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
AID1755806Antibacterial activity against Pseudomonas aeruginosa ATCC 13525 incubated for 24 hrs by two fold serial dilution method2021European journal of medicinal chemistry, Jan-15, Volume: 210Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
AID490133Antibacterial activity against Pseudomonas aeruginosa ATCC 13525 after 24 hrs by MTT assay2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis of some N-alkyl substituted urea derivatives as antibacterial and antifungal agents.
AID448316Antibacterial activity against Escherichia coli by broth dilution method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, photochemical E (trans)-->Z (cis) isomerization and antimicrobial activity of 2-chloro-5-methylpyridine-3-olefin derivatives.
AID546209Antimicrobial activity against Staphylococcus aureus 2171 by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
Identification of the novel dfrK-carrying transposon Tn559 in a porcine methicillin-susceptible Staphylococcus aureus ST398 strain.
AID611679Antibacterial activity against Bacillus megaterium at 0.05 mg by agar diffusion method2011Journal of natural products, Jul-22, Volume: 74, Issue:7
Bioactive 11,20-epoxy-3,5(16)-diene briarane diterpenoids from the South China Sea gorgonian Dichotella gemmacea.
AID1161137Antimicrobial activity against Staphylococcus aureus after 24 hrs by broth microdilution method2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
AID356757Antimicrobial activity against Enterococcus faecium 436 after 18 hrs by microbroth dilution method2001Journal of natural products, Jul, Volume: 64, Issue:7
Biological and mechanistic activities of xanthorrizol and 4-(1',5'-dimethylhex-4'-enyl)-2-methylphenol isolated from Iostephane heterophylla.
AID43582Inhibition constant (Ki) for TEM-1 beta-lactamase1988Journal of medicinal chemistry, Feb, Volume: 31, Issue:2
N-aryl 3-halogenated azetidin-2-ones and benzocarbacephems, inhibitors of beta-lactamases.
AID508305Inhibition of PBP4 in wild type Enterococcus faecium D63 membranes assessed as inhibition of fluorescent ampicillin binding after 20 mins at 37 degC2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID1638897Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC BAA-41 measured after 18 hrs by broth microdilution method2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
AID528708Antibacterial activity against multidrug-resistant Streptococcus pneumoniae clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID171124Concentration of compound in rat brain after intravenous injection of 20 mg/kg benzyl-penicillin after 5 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID374683Antimicrobial activity against kanamycin-resistant Escherichia coli K-12 M1 W3110 deltarapA mutant 24 hrs biolflim at 350 ug/ml after 1 hr by microtiter plate count method2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
AID431308Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 335912009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
AID368535Activity of Providencia stuartii AmpC assessed as drug hydrolysis by spectrophotometry2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID529333Antibacterial activity against penicillin-cefotaxime- ceftriaxone-resistant Streptococcus pneumoniae serotype 14 URA3043 harboring mutant PBP2B PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID588114Antimicrobial activity against Neisseria gonorrhoeae clinical isolates assessed as percent susceptible isolates after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID603191Antibacterial activity against Staphylococcus epidermidis MTCC 2639 by broth microdilution method2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Efficient synthesis, structural characterization and anti-microbial activity of chiral aryl boronate esters of 1,2-O-isopropylidene-α-D-xylofuranose.
AID558623Antimicrobial activity against Streptococcus pneumoniae isolate 3412 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID563975Ratio of Kcat to Km for Klebsiella pneumoniae 05-560 beta-lactamase IMP12009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
AID1348088Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 assessed as zone of inhibition at 50 ug per disc after 24 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID1180446Antimicrobial activity against Staphylococcus aureus CCM 4516/08 after 48 hrs by microdilution method2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
AID1309201Antibacterial activity against Agrobacterium tumefaciens by broth microdilution assay2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Four new minor brominated indole related alkaloids with antibacterial activities from Laurencia similis.
AID508296Inhibition of PBP2 in penicillin-resistant Enterococcus faecium D63r membranes assessed as inhibition of fluorescent ampicillin binding after 20 mins at 37 degC2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID558601Antimicrobial activity against Streptococcus pneumoniae isolate 24 by agar dilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Comparative antipneumococcal activities of sulopenem and other drugs.
AID577454Inhibition of Streptococcus pneumoniae isolate 8882 Bocillin FL binding to PBP2b 443SSNA mutant2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Affinity of ceftobiprole for penicillin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin.
AID546432Ratio of Kcat to Km for Pseudomonas aeruginosa PDC-3 by spectrophotometer2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.
AID681390TP_TRANSPORTER: uptake in Oat3-expressing LLC-PK1 cells2002Molecular pharmacology, May, Volume: 61, Issue:5
Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus.
AID418561Antibacterial activity against Bacillus subtilis ATCC 23857 by NCCLS method2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
AID524055Binding affinity to against methicillin-, daptomycin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 25 PBP2 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID678811TP_TRANSPORTER: uptake in Xenopus laevis oocytes1999The Journal of pharmacology and experimental therapeutics, May, Volume: 289, Issue:2
Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations.
AID375922Antibacterial activity against Clostridium perfringens ATCC 10388 by NCCLS method2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
AID689077Antibacterial activity against Bacillus megaterium assessed as zone of inhibition at 0.05 mg by agar diffusion method2012Journal of natural products, Sep-28, Volume: 75, Issue:9
Sinularosides A and B, bioactive 9,11-secosteroidal glycosides from the South China Sea soft coral Sinularia humilis Ofwegen.
AID451359Antimicrobial activity against Penicillium expansum NBRC8800 after 24 hrs by broth dilution method2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Synthesis and evaluation of bioactive naphthoquinones from the Brazilian medicinal plant, Tabebuia avellanedae.
AID1437659Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 25923 after 20 to 24 hrs by two-fold microdilution method
AID563977Ratio of Kcat to Km for Klebsiella pneumoniae 05-560 beta-lactamase VIM22009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
AID495695Activity of Klebsiella pneumoniae KPC-22010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
AID573601Antibacterial activity against Fusobacterium necrophorum assessed as resistant isolates by CLSI agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
AID773427Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700787 by microdilution technique2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
The synthesis and SAR study of phenylalanine-derived (Z)-5-arylmethylidene rhodanines as anti-methicillin-resistant Staphylococcus aureus (MRSA) compounds.
AID442477Antibacterial activity against Bacillus subtilis MTCC 441 by broth dilution method2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Click chemistry: studies on the synthesis of novel fluorous tagged triazol-4-yl substituted quinazoline derivatives and their biological evaluation--theoretical and experimental validation.
AID428127Antimicrobial activity against penicillin-resistant Streptococcus gordonii PR1_2 mutant2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Fitness cost and impaired survival in penicillin-resistant Streptococcus gordonii isolates selected in the laboratory.
AID528706Antibacterial activity against Streptococcus agalactiae group B clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID529322Antibacterial activity against Streptococcus pneumoniae serotype 22 URA2542 harboring PBP2B harboring mutant PBP2B PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID520399Antibacterial activity against mef and erm(B) positive Streptococcus pneumoniae isolates assessed as resistance incidence by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).
AID447061Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 at 10 IU after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID592681Apparent permeability across human Caco2 cell membrane after 2 hrs by LC-MS/MS analysis2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
QSAR-based permeability model for drug-like compounds.
AID406550Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition zone diameter at 20 ug after 2 hrs by Kirby-Bauer test2008Bioorganic & medicinal chemistry, Jul-01, Volume: 16, Issue:13
Unsymmetric aryl-alkyl disulfide growth inhibitors of methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
AID278564Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium longum ATCC 15708 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID561250Antibacterial activity against Streptococcus pneumoniae assessed as susceptible isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID571176Antibacterial activity against Neisseria gonorrhoeae by disk agar diffusion method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility.
AID559512Antibacterial activity against Lancefield Streptococcus sp. 'group G' assessed as percent susceptible isolates by CLSI M100-S18 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
AID425652Total body clearance in human2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Physicochemical determinants of human renal clearance.
AID508297Inhibition of PBP3 in penicillin-resistant Enterococcus faecium D63r membranes assessed as inhibition of fluorescent ampicillin binding after 20 mins at 37 degC2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID203340Minimum inhibitory concentration against aerobic organism Shigella species strain 28801982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
Quaternary heterocyclylamino beta-lactams: a generic alternative to the classical acylamino side chain.
AID1759750Binding affinity to Staphylococcus aureus ATCC 43300 50S ribosome assessed as dissociation rate constant by SPR analysis2021Bioorganic & medicinal chemistry, 05-15, Volume: 38Design, synthesis and biological evaluation of novel pleuromutilin derivatives as potent anti-MRSA agents targeting the 50S ribosome.
AID1321392Antibacterial activity against Staphylococcus aureus ATCC 29213 by broth microdilution method2016Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19
The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases.
AID689078Antimicrobial activity against Chlorella fusca assessed as zone of inhibition at 0.05 mg by agar diffusion method2012Journal of natural products, Sep-28, Volume: 75, Issue:9
Sinularosides A and B, bioactive 9,11-secosteroidal glycosides from the South China Sea soft coral Sinularia humilis Ofwegen.
AID572272Antimicrobial activity against Streptococcus pneumoniae ATCC 6301 by broth microdilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models.
AID1638905Antimicrobial activity against NDM1 beta-lactamase expressing Klebsiella pneumoniae ATCC BAA-2470 measured after 18 hrs by broth microdilution method2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
AID557503Displacement of Biocillin FL from Streptococcus pneumoniae 3243 PBP2A2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
AID609858Antimicrobial activity against Acinetobacter baumannii ATCC 15151 assessed as growth inhibition after 18 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Unprecedented C-2 arylation of indole with diazonium salts: Syntheses of 2,3-disubstituted indoles and their antimicrobial activity.
AID1348087Antimicrobial activity against Staphylococcus aureus subsp. aureus ATCC 25923 assessed as zone of inhibition at 50 ug per disc after 24 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID1237615Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC52056 assessed as bacterial growth inhibition after 24 hrs by broth dilution method2015European journal of medicinal chemistry, Jul-15, Volume: 100Novel cajaninstilbene acid derivatives as antibacterial agents.
AID1209730Inhibition of mouse OAT3 expressed in CHO cells assessed as inhibition of fluorescein uptake over 20 mins2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
AID368504Ratio of Kcat to Km of Klebsiella pneumoniae TEM26 assessed as drug hydrolysis by spectrophotometry relative to cephaloridine2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
AID494347Antibacterial activity against Staphylococcus epidermidis by twofold serial dilution method2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis, characterization and antimicrobial studies of 2-(4-methoxy-phenyl)-5-methyl-4-(2-arylsulfanyl-ethyl)-2,4-dihydro-[1,2,4] triazolo-3-ones and their corresponding sulfones.
AID575145Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NRS71 by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
AID524069Binding affinity to methicillin-, vancomycin-resistant, beta-lactamase-positive Staphylococcus aureus 510 PBP4 by competitive binding assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
AID575420Antimicrobial activity against anrB-deficient Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID495915Ratio of Kcat to Km for beta-lactamase VIM-1 expressed in Escherichia coli TOP10 by spectrophotometry2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae.
AID560706Inhibition of Escherichia coli MC4100 Beta-Lactamase CMY-2 using cephalothin as reporter substrate2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.
AID1243290Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolates by standard broth microdilution method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.
AID375917Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 by NCCLS method2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
AID278544Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium thermophilum ATCC 25866 after 18 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
AID1209735Inhibition of mouse OAT3 expressed in CHO cells assessed as inhibition of fluorescein uptake at 500 uM over 20 mins relative to untreated-control2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
AID522666Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis Texas 2 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID529656Ratio of Kcat to Km for Pseudomonas aeruginosa 9551 beta-lactamase VIM-152008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID559703Antimicrobial activity against Escherichia coli AB94012 by microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.
AID521826Antimicrobial activity against Streptococcus pneumoniae isolated from patient with bacterial infection by broth dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Clonal spread of highly beta-lactam-resistant Streptococcus pneumoniae isolates in Taiwan.
AID1505254Antibacterial activity against Staphylococcus aureus 155554A incubated for 16 hrs by microdilution assay2018ACS medicinal chemistry letters, Jan-11, Volume: 9, Issue:1
Disconnecting the Estrogen Receptor Binding Properties and Antimicrobial Properties of Parabens through 3,5-Substitution.
AID1347488Antibacterial activity against Staphylococcus aureus assessed as zone of inhibition after 24 to 48 hrs by well diffusion method2018European journal of medicinal chemistry, Jan-01, Volume: 143Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
AID322504Volume of distribution at steady state in human very low birth weight preterm neonates at 28 mg/kg, iv2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.
AID503229Ratio of MIC for penicillin-resistant Streptococcus pneumoniae 4790 to MIC for penicillin-sensitive Streptococcus pneumoniae R62007Nature chemical biology, Sep, Volume: 3, Issue:9
Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins.
AID425865Antimicrobial activity against Carnobacterium divergens BM4489 expressing beta-lactamase CAD1 at 0.5 McFarland inoculum size by E-test2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
AID662528Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 20 hrs by spectrophotometry2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Discovery of potent antimicrobial peptide analogs of Ixosin-B.
AID532980Antibacterial activity against Escherichia coli DH5alpha in presence of 10 mM N-Acetylcysteine2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID531607Ratio of Kcat to Km for Escherichia coli beta-lactamase SHV-112008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.
AID562408Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID522642Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis Vollum 1B by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID508371Antibacterial activity against Streptococcus pneumoniae harboring erm(A) gene after overnight incubation by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
AID531606Ratio of Kcat to Km for Escherichia coli Inhibitor-resistant beta-lactamase SHV-562008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.
AID554878Antimicrobial activity against Streptococcus pneumoniae serotype 10 ST 461 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID1348084Antimicrobial activity against Candida albicans ATCC 10231 assessed as zone of inhibition at 50 ug per disc after 48 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID171264Concentration of compound in rat lung after intravenous injection of 20 mg/kg benzyl-penicillin after 1 min1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
AID529329Antibacterial activity against multidrug resistant Streptococcus pneumoniae serotype 19A URA5805 harboring mutant PBP2B PBP2X and PBP1A2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.
AID341531Antimicrobial activity against Neisseria meningitidis isolates harboring penA 17 allele encoding PBP2 mutant2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
AID508307Inhibition of low-affinity PBP5fm in wild type Enterococcus faecium D63 membranes assessed as inhibition of fluorescent ampicillin binding after 20 mins at 37 degC2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
AID1320836Activity of native signal containing Klebsiella pneumoniae OXA-48 assessed as ratio of Kcat to Km by Michaelis-Menten kinetics assay2016Journal of medicinal chemistry, 06-09, Volume: 59, Issue:11
Screening and Design of Inhibitor Scaffolds for the Antibiotic Resistance Oxacillinase-48 (OXA-48) through Surface Plasmon Resonance Screening.
AID1546650Antibacterial activity against Pseudomonas aeruginosa MTCC 741 assessed as reduction in microbial growth after 24 hrs by CLSI based microdilution method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
AID539695Antifungal activity against Klebsiella pneumoniae MTCC 618 by broth dilution method2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Indium(III) chloride catalyzed three-component coupling reaction: a novel synthesis of 2-substituted aryl(indolyl)kojic acid derivatives as potent antifungal and antibacterial agents.
AID681152TP_TRANSPORTER: uptake in Xenopus laevis oocytes2002Drug metabolism and pharmacokinetics, , Volume: 17, Issue:4
Transporter-mediated Drug Interactions.
AID531420Antibacterial activity against Streptococcus pneumoniae serotype 19F by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1802450Oatp1d1 Transport Assay from Article 10.1074/jbc.M113.518506: \\Molecular characterization of zebrafish Oatp1d1 (Slco1d1), a novel organic anion-transporting polypeptide.\\2013The Journal of biological chemistry, Nov-22, Volume: 288, Issue:47
Molecular characterization of zebrafish Oatp1d1 (Slco1d1), a novel organic anion-transporting polypeptide.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8,965)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905986 (66.77)18.7374
1990's1051 (11.72)18.2507
2000's914 (10.20)29.6817
2010's868 (9.68)24.3611
2020's146 (1.63)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 88.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index88.91 (24.57)
Research Supply Index9.20 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index166.71 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (88.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials353 (3.70%)5.53%
Reviews397 (4.16%)6.00%
Case Studies1,459 (15.30%)4.05%
Observational10 (0.10%)0.25%
Other7,316 (76.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (36)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Follow-up Study for Patients Who Participated in the GOAL Trial (GOAL-Post) [NCT05211024]1,102 participants (Anticipated)Observational2022-01-28Active, not recruiting
Treatment of Pharyngitis Study (TOPS): A Randomized Equivalence Trial of Intramuscular Penicillin G vs. Oral Amoxicillin Antibiotics for the Treatment of Streptococcal Pharyngitis in Children in Developing Countries [NCT01156740]558 participants (Actual)Interventional2001-08-31Completed
Trial Evaluating the Clinical Efficacy of Cefixime for Treatment of Early Syphilis in Non-pregnant Women [NCT03752112]Phase 1/Phase 2180 participants (Anticipated)Interventional2019-11-22Recruiting
Single-dose Azithromycin Versus Penicillin G Benzathine for the Treatment of Yaws in Children [NCT01382004]Phase 3255 participants (Actual)Interventional2010-09-30Completed
Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis [NCT04958122]Phase 3400 participants (Anticipated)Interventional2021-06-20Recruiting
Prospective Randomized Study to Compare Clinical Outcomes in Patients With Osteomyelitis Treated With Intravenous Antibiotics Versus Intravenous Antibiotics With an Early Switch to Oral Antibiotics [NCT02099240]Early Phase 111 participants (Actual)Interventional2014-03-06Terminated(stopped due to Not enough patient enrollment and lack of staffing)
First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition [NCT03174236]Phase 32,000 participants (Anticipated)Interventional2017-09-04Active, not recruiting
A Phase 1, Open-label Study To Investigate The Pharmacokinetics And Safety Of A Single Intramuscular Injection Of Benzathine Benzylpenicillin In Japanese Healthy Subjects [NCT03612557]Phase 18 participants (Actual)Interventional2018-08-20Completed
Treatment Responses of Early Syphilis to Single-dose Ceftriaxone Plus Doxycycline Versus Single-dose Benzathine Penicillin G Plus Doxycycline in PLWH [NCT05980871]Phase 4300 participants (Anticipated)Interventional2023-03-10Recruiting
Therapeutic Drug Monitoring and Continuous Infusion of Beta-lactam Antibiotics in Patients With Bacteraemia [NCT03108690]Phase 40 participants (Actual)Interventional2017-10-01Withdrawn(stopped due to Logistics)
[NCT02871505]Phase 4150 participants (Anticipated)Interventional2016-08-31Recruiting
A Multi-centre Study to Define Novel Individualised Dosing Regimens to Maximise Antibiotic Effectiveness for Treatment of Pneumonia in Intensive Care Units [NCT04986254]80 participants (Anticipated)Observational2019-10-17Recruiting
Closed-loop Control of Penicillin Delivery Integrating Electrochemical Biosensor Technology [NCT04053140]Phase 120 participants (Anticipated)Interventional2019-11-05Recruiting
Clinical Trial Evaluating the Clinical Efficacy of Cefixime for Treatment of Early Syphilis [NCT03660488]Phase 258 participants (Actual)Interventional2018-09-03Completed
Comparison of Intravenous Co-amoxiclav Versus Benzyl Penicillin in Children With Severe Tonsillitis [NCT04215770]310 participants (Actual)Interventional2018-01-01Completed
Once-daily Therapy for Streptococcal Pharyngitis [NCT01310361]Phase 10 participants Interventional2004-01-31Completed
Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections. Can Measurement of Procalcitonin Reduce the Use of Antibiotics? [NCT02171338]Phase 455 participants (Anticipated)Interventional2013-10-31Active, not recruiting
Simplified Antibiotic Regimens for the Management of Sepsis in Young Infants in First-level Facilities: Randomized Controlled Trial [NCT01027429]Phase 32,543 participants (Actual)Interventional2009-12-31Completed
Supportive Care and Antibiotics for Severe Pneumonia Among Hospitalized Children [NCT04041791]Phase 34,392 participants (Anticipated)Interventional2019-08-19Recruiting
Doctor of Medicine [NCT02857959]Phase 4150 participants (Anticipated)Interventional2016-08-31Recruiting
Randomized Controlled Trial of Intramuscular Ceftriaxone Versus Procaine Penicillin Versus Cotrimoxazole and Gentamicin for Management of Serious Bacterial Infections in Young Infants in Community Settings [NCT00189384]Phase 3426 participants Interventional2003-11-30Active, not recruiting
Validate an Easy to Administer Algorithm to Define Penicillin (PCN-B-lactam) Allergy Status in Sexually Transmitted Disease (STD) Clinic Outpatients [NCT04620746]Phase 4284 participants (Actual)Interventional2021-06-01Completed
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus (Relais Oral Dans le Traitement Des Endocardites à Streptocoques Multi-sensibles) [NCT02701595]Phase 3324 participants (Anticipated)Interventional2016-02-29Recruiting
Randomized, Clinical Trial to Compare the Serological Response Rates of Serofast Early Syphilis Cases Retreated With Three Doses Benzathine Penicillin and Absence of Any Retreatment [NCT02884115]Phase 4150 participants (Anticipated)Interventional2016-08-31Recruiting
A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals [NCT00000648]100 participants InterventionalCompleted
Comparisons of Treatment Responses of Early Syphilis to 2.4 Milliunits (MU) Single-dose Benzathine Penicillin G With or Without Doxycycline in People Living With HIV [NCT06069141]688 participants (Anticipated)Interventional2023-10-31Not yet recruiting
A Phase 4 Comparative Trial of Benzathine Penicillin G 2.4 Million Units Administered as a Single Dose Versus Three Successive Weekly Doses for Treatment of Early Syphilis in Subjects With or Without HIV Infection [NCT03637660]Phase 4249 participants (Actual)Interventional2018-10-31Completed
A Phase III Equivalence Trial of Azithromycin vs. Benzathine Penicillin for the Treatment of Early Syphilis [NCT00031499]Phase 3593 participants (Actual)Interventional2000-06-30Completed
Pilot Randomised Controlled Trial of Penicillin Versus Flucloxacillin for Definitive Treatment of Invasive Penicillin Susceptible Staphylococcus Aureus [NCT03632642]Phase 40 participants (Actual)Interventional2019-07-01Withdrawn(stopped due to Study never commenced)
CHOICE UTI - Clinical Efficacy of Single Dose (Daily) IV Antibiotics Followed by 2 Days Oral Antibiotics Compared to 3 Doses (Daily) IV Antibiotics for Children With Complicated Urinary Tract Infections: a Multicentre Randomised Trial [NCT04876131]Phase 4452 participants (Anticipated)Interventional2022-05-30Recruiting
Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A Non-inferiority Randomized Trial [NCT05693545]Phase 21,004 participants (Anticipated)Interventional2023-09-01Recruiting
Syphilis Response to Higher Penicillin Dosage in HIV Co-Infected Patients [NCT02611765]Phase 464 participants (Actual)Interventional2008-09-30Completed
Amoxicillin Versus Benzyl Penicillin for Severe Childhood Pneumonia Amongst Inpatients: An Open Label Randomised Controlled Non-inferiority Trial [NCT01399723]Phase 3561 participants (Actual)Interventional2011-09-30Completed
Staphylococcus Aureus Network Adaptive Platform Trial [NCT05137119]Phase 46,000 participants (Anticipated)Interventional2022-02-16Recruiting
Confirmatory Study to Examine Negative Predictive Value (NPV) and Safety of Skin Testing With PRE-PEN, a Minor Determinant MIxture (MDM) of Penicillin Antigens, and Amoxicillin Reagent Against an Oral Challenge With Amoxicillin [NCT01818336]Phase 3481 participants (Actual)Interventional2012-12-31Completed
The GOAL (GwokO Adunu pa Lutino) Trial: Determining the Impact of Penicillin on Latent Rheumatic Heart Disease: A Randomized Controlled Trial in Uganda [NCT03346525]Phase 2807 participants (Actual)Interventional2018-06-26Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT01399723 (3) [back to overview]Outcome (Death/Readmission) at 14 Days as Determined by Telephone or Direct Interview
NCT01399723 (3) [back to overview]Treatment Failure at 48 Hours (Two Full Days After Enrollment)
NCT01399723 (3) [back to overview]Treatment Failure at or Before Discharge / Day 5 Post Enrollment (Whichever Occurs First)
NCT01818336 (1) [back to overview]Negative Predictive Value
NCT02611765 (1) [back to overview]Treatment Success Defined as a Decrease in Rapid Plasma Reagin (RPR) Titer of >= 2 Dilutions (4-fold)
NCT03637660 (12) [back to overview]The Number of Participants Who Receive All Assigned Doses Within the Assigned Visit Windows
NCT03637660 (12) [back to overview]The Number of Participants Who Report Jarisch-Herxheimer Reaction Manifestations
NCT03637660 (12) [back to overview]The Number of Participants With a Serological Response by Month 6.
NCT03637660 (12) [back to overview]Continuous Descriptive Statistics of Participant Baseline Demographics Collected Via a Study-specific Questionnaire
NCT03637660 (12) [back to overview]Continuous Descriptive Statistics of Sexual History at Baseline Collected Via a Study-specific Questionnaire
NCT03637660 (12) [back to overview]Continuous Descriptive Statistics of Sexual History at Baseline Collected Via a Study-specific Questionnaire
NCT03637660 (12) [back to overview]Continuous Descriptive Statistics of Sexual History at Baseline Collected Via a Study-specific Questionnaire
NCT03637660 (12) [back to overview]Continuous Descriptive Statistics of Socio-epidemiologic Characterictics at Baseline Collected Via a Study-specific Questionnaire
NCT03637660 (12) [back to overview]Number of Participants With Serological Response by Month 6 Among Participants With or Without HIV Infection
NCT03637660 (12) [back to overview]Categorical Descriptive Statistics of Participant Baseline Demographics Collected Via a Study-specific Questionnaire
NCT03637660 (12) [back to overview]Categorical Descriptive Statistics of Sexual History at Baseline Collected Via a Study-specific Questionnaire
NCT03637660 (12) [back to overview]Categorical Descriptive Statistics of Socio-epidemiologic Characteristics at Baseline Collected Via a Study-specific Questionnaire
NCT03660488 (1) [back to overview]Treatment Response
NCT04620746 (4) [back to overview]Number of Respondents Who Responded YES to Any Question Defining High Risk Penicillin Allergy Using Questionnaire Developed by the Study
NCT04620746 (4) [back to overview]Patient Acceptability of PCN Testing/Oral Challenge Assessed by a Study Team Developed Questionnaire
NCT04620746 (4) [back to overview]Provider Assessment of Feasibility of Allergy Evaluation at the End of Study
NCT04620746 (4) [back to overview]Safety of Direct Oral Challenge Defined by Number of Subjects Who Did Not Have Pre-defined Changes in Vital Signs or Pre-defined Emergence of New Respiratory or Skin Symptoms After Oral Challenge

Outcome (Death/Readmission) at 14 Days as Determined by Telephone or Direct Interview

Definition of death as described in third secondary outcome measure. (NCT01399723)
Timeframe: Day 14

Interventionparticipants (Number)
Amoxicillin33
Penicillin42

[back to top]

Treatment Failure at 48 Hours (Two Full Days After Enrollment)

Development of any signs of very severe pneumonia at any time Hypoxemia defined as SpO2 <85% or <80% for altitude < or ≥1500m respectively measured after minimum of 3 minutes on ambient air Persistent vomiting (occurring within 30 minutes of administration of amoxicillin with failure to retain drug after 3 successive attempts at administration) at any time Clinical diagnosis of new bacterial co-morbid condition requiring revision of antibiotic treatment at any time Lower chest wall indrawing Temperature ≥38◦C Respiratory rate ≥5bpm of admission rate if above age-adjusted normal upper limit (NCT01399723)
Timeframe: 48 hours

Interventionparticipants (Number)
Amoxicillin20
Penicillin21

[back to top]

Treatment Failure at or Before Discharge / Day 5 Post Enrollment (Whichever Occurs First)

Treatment failure as defined in the primary outcome measure. (NCT01399723)
Timeframe: Patients will be followed up from the day of hospitalisation (day 0) until the day of medical discharge (average duration of 3 days) or until day 5 of hospitalisation (whichever occurs first).

Interventionparticipants (Number)
Amoxicillin30
Penicillin29

[back to top]

Negative Predictive Value

The primary endpoint was the negative predictive value (NPV), which was estimated as p = percentage of n history-positive subjects with negative skin tests from the Penicillin Allergy Skin Test Kit (as confirmed with an overall negative result for the skin puncture/intradermal testing) who do not experience an IgE-dependent hypersensitivity reaction within 72 hours of the oral amoxicillin challenge. (NCT01818336)
Timeframe: 72 hours

Interventionpercentage of participants (Number)
Intent-to-Treat Population98.0

[back to top]

Treatment Success Defined as a Decrease in Rapid Plasma Reagin (RPR) Titer of >= 2 Dilutions (4-fold)

Number of participants who achieve treatment success. Loss to follow-up was assumed to be a failure. (NCT02611765)
Timeframe: 12 months

Interventionparticipants (Number)
Enhanced Therapy27
Standard Therapy28

[back to top]

The Number of Participants Who Receive All Assigned Doses Within the Assigned Visit Windows

Compliance with study product will be defined as the participant received all assigned doses within the assigned visit windows. A participant is not adherent to study product if they miss at least one dose or receive at least one dose out of the visit window. (NCT03637660)
Timeframe: Through Month 12

InterventionParticipants (Count of Participants)
One Dose BPG 2.4 MU124
Three Doses BPG 2.4 MU97

[back to top]

The Number of Participants Who Report Jarisch-Herxheimer Reaction Manifestations

Approximately 24 hours after Visit 1, participants were contacted and evaluated for symptoms of a JHR, which included fever, chills, myalgia, weakness, flushing, worsening of skin rash, tachycardia, heart palpitations, arthralgia, nausea, headache, and dizziness, including time of onset and time of resolution of each symptom reported. (NCT03637660)
Timeframe: Day 1 through Day 2

InterventionParticipants (Count of Participants)
One Dose BPG 2.4 MU27
Three Doses BPG 2.4 MU32

[back to top]

The Number of Participants With a Serological Response by Month 6.

"Serological response to therapy by Month 6 was defined as follows, where available rapid plasma reagin (RPR) results from all visits prior to the end of the Month 6 visit window (i.e., scheduled visits up to and including the Month 6 visit, early termination visit, or any unscheduled visit that occurred prior to the end of month 6 visit window) were evaluated:~4-fold or greater decline in RPR titer at any visit prior to the end of the Month 6 visit window compared to baseline, OR~RPR-negative at any visit prior to the end of the Month 6 visit window (i.e., seroreversion)." (NCT03637660)
Timeframe: Day 1 to Day 180

InterventionParticipants (Count of Participants)
One Dose BPG 2.4 MU94
Three Doses BPG 2.4 MU87

[back to top]

Continuous Descriptive Statistics of Participant Baseline Demographics Collected Via a Study-specific Questionnaire

Age (NCT03637660)
Timeframe: Day 1

,
Interventionyears (Mean)
HIV-infectedHIV-uninfected
One Dose BPG 2.4 MU37.533.4
Three Doses BPG 2.4 MU36.530.1

[back to top]

Continuous Descriptive Statistics of Sexual History at Baseline Collected Via a Study-specific Questionnaire

Sex history in last 60 days (NCT03637660)
Timeframe: Day 1

,
Interventioncount of partners (Mean)
Total number of partners in the past 60 days (HIV-infected)Total number of partners in the past 60 days (HIV-uninfected)Number of new partners (HIV-infected)Number of new partners (HIV-uninfected)Number of regular partners (HIV-infected)Number of regular partners (HIV-uninfected)Number of occasional partners (HIV-infected)Number of occasional partners (HIV-uninfected)Number of male partners (HIV-infected)Number of male partners (HIV-uninfected)Number of female partners (HIV-infected)Number of female partners (HIV-uninfected)
One Dose BPG 2.4 MU4.63.92.02.12.01.50.70.84.43.30.10.6
Three Doses BPG 2.4 MU3.56.11.72.81.41.50.61.93.45.70.10.4

[back to top]

Continuous Descriptive Statistics of Sexual History at Baseline Collected Via a Study-specific Questionnaire

Sex history in last 60 days (NCT03637660)
Timeframe: Day 1

Interventiondays (Mean)
Days since last had sexual intercourse in the past 60 days (HIV-infected)Days since last had sexual intercourse in the past 60 days (HIV-uninfected)Days since last diagnosed with gonorrhea in the past 60 days (HIV-infected)Days since last diagnosed with gonorrhea in the past 60 days (HIV-uninfected)Days since last diagnosed with chlamydia in the past 60 days (HIV-infected)Days since last diagnosed with any other STI in the past 60 days (HIV-infected)
One Dose BPG 2.4 MU14.316.81.07.53.43.3

[back to top]

Continuous Descriptive Statistics of Sexual History at Baseline Collected Via a Study-specific Questionnaire

Sex history in last 60 days (NCT03637660)
Timeframe: Day 1

Interventiondays (Mean)
Days since last had sexual intercourse in the past 60 days (HIV-infected)Days since last had sexual intercourse in the past 60 days (HIV-uninfected)Days since last diagnosed with gonorrhea in the past 60 days (HIV-infected)Days since last diagnosed with gonorrhea in the past 60 days (HIV-uninfected)Days since last diagnosed with chlamydia in the past 60 days (HIV-infected)Days since last diagnosed with chlamydia in the past 60 days (HIV-uninfected)
Three Doses BPG 2.4 MU13.012.624.713.012.713.0

[back to top]

Continuous Descriptive Statistics of Socio-epidemiologic Characterictics at Baseline Collected Via a Study-specific Questionnaire

Years of formal education (NCT03637660)
Timeframe: Day 1

,
Interventionyears (Mean)
HIV-infectedHIV-uninfected
One Dose BPG 2.4 MU37.533.4
Three Doses BPG 2.4 MU36.530.1

[back to top]

Number of Participants With Serological Response by Month 6 Among Participants With or Without HIV Infection

"Serological response to therapy by Month 6 was defined as follows, where available rapid plasma reagin (RPR) results from all visits prior to the end of the Month 6 visit window (i.e., scheduled visits up to and including the Month 6 visit, early termination visit, or any unscheduled visit that occurred prior to the end of month 6 visit window) were evaluated:~4-fold or greater decline in RPR titer at any visit prior to the end of the Month 6 visit window compared to baseline, OR~RPR-negative at any visit prior to the end of the Month 6 visit window (i.e., seroreversion).~Serological response to therapy by Month 6 was examined among participants with and without HIV infection," (NCT03637660)
Timeframe: Day 1 to Day 180

,
InterventionParticipants (Count of Participants)
HIV-infectedHIV-uninfected
One Dose BPG 2.4 MU5339
Three Doses BPG 2.4 MU5928

[back to top]

Categorical Descriptive Statistics of Participant Baseline Demographics Collected Via a Study-specific Questionnaire

Sex, Ethnicity, Race (NCT03637660)
Timeframe: Day 1

InterventionParticipants (Count of Participants)
Sex: Male72284253Sex: Male72284254Sex: Female72284253Sex: Female72284254Ethnicity: Not Hispanic or Latino72284254Ethnicity: Not Hispanic or Latino72284253Ethnicity: Hispanic or Latino72284253Ethnicity: Hispanic or Latino72284254Ethnicity: Not Reported72284253Ethnicity: Not Reported72284254Race: American Indian or Alaskan Native72284254Race: American Indian or Alaskan Native72284253Race: Asian72284254Race: Asian72284253Race: Native Hawaiian or Other Pacific Islander72284253Race: Native Hawaiian or Other Pacific Islander72284254Race: Black or African American72284253Race: Black or African American72284254Race: White72284253Race: White72284254Race: Multi-Racial72284253Race: Multi-Racial72284254Race: Unknown72284253Race: Unknown72284254
HIV-infectedHIV-uninfectedUnknown HIV status
One Dose BPG 2.4 MU68
Three Doses BPG 2.4 MU83
One Dose BPG 2.4 MU48
One Dose BPG 2.4 MU2
One Dose BPG 2.4 MU3
One Dose BPG 2.4 MU64
Three Doses BPG 2.4 MU80
One Dose BPG 2.4 MU49
Three Doses BPG 2.4 MU38
Three Doses BPG 2.4 MU2
One Dose BPG 2.4 MU6
Three Doses BPG 2.4 MU0
Three Doses BPG 2.4 MU1
One Dose BPG 2.4 MU0
One Dose BPG 2.4 MU1
One Dose BPG 2.4 MU40
Three Doses BPG 2.4 MU57
One Dose BPG 2.4 MU32
Three Doses BPG 2.4 MU22
One Dose BPG 2.4 MU20
One Dose BPG 2.4 MU15
Three Doses BPG 2.4 MU14
One Dose BPG 2.4 MU7
Three Doses BPG 2.4 MU11
One Dose BPG 2.4 MU4

[back to top]

Categorical Descriptive Statistics of Sexual History at Baseline Collected Via a Study-specific Questionnaire

Gender identity, sexual orientation, sexual partner, sex history in last 60 days (NCT03637660)
Timeframe: Day 1

InterventionParticipants (Count of Participants)
Gender Identity : Man72284253Gender Identity : Man72284254Gender Identity : Woman72284253Gender Identity : Woman72284254Gender Identity : Trans male / trans man72284253Gender Identity : Trans male / trans man72284254Gender Identity : Trans female / trans woman72284253Gender Identity : Trans female / trans woman72284254Gender Identity : Genderqueer / gender non-conforming72284253Gender Identity : Genderqueer / gender non-conforming72284254Gender Identity : Multiple72284254Gender Identity : Multiple72284253Gender Identity : Non-binary72284253Gender Identity : Non-binary72284254Gender Identity : Other72284253Gender Identity : Other72284254Gender Identity : Declined to respond72284254Gender Identity : Declined to respond72284253Sexual Orientation : Heterosexual / straight72284253Sexual Orientation : Heterosexual / straight72284254Sexual Orientation : Homosexual / gay / lesbian72284253Sexual Orientation : Homosexual / gay / lesbian72284254Sexual Orientation: Bisexual72284253Sexual Orientation: Bisexual72284254Sexual Orientation : Other72284253Sexual Orientation : Other72284254Sexual Orientation : Declined to respond72284253Sexual Orientation : Declined to respond72284254Sexual Partner: Men72284253Sexual Partner: Men72284254Sexual Partner: Women72284253Sexual Partner: Women72284254Sexual Partner: Trans male/ trans man72284253Sexual Partner: Trans male/ trans man72284254Sexual Partner: Trans female/ trans woman72284253Sexual Partner: Trans female/ trans woman72284254Sexual Partner: Multiple72284253Sexual Partner: Multiple72284254Sexual Partner: Other72284253Sexual Partner: Other72284254Sexual Partner: Declined to respond72284253Sexual Partner: Declined to respond72284254Sexual intercourse in past 60 days: Yes72284253Sexual intercourse in past 60 days: Yes72284254Sexual intercourse in past 60 days: No72284253Sexual intercourse in past 60 days: No72284254Sexual intercourse in past 60 days: Unknown72284253Sexual intercourse in past 60 days: Unknown72284254If yes to sexual intercourse in past 60 days, Sites of exposure: Oral receptive72284254If yes to sexual intercourse in past 60 days, Sites of exposure: Oral receptive72284253If yes to sexual intercourse in past 60 days, Sites of exposure: Oral active72284253If yes to sexual intercourse in past 60 days, Sites of exposure: Oral active72284254If yes to sexual intercourse in past 60 days, Sites of exposure: Rectal receptive72284253If yes to sexual intercourse in past 60 days, Sites of exposure: Rectal receptive72284254If yes to sexual intercourse in past 60 days, Sites of exposure: Rectal insertive72284253If yes to sexual intercourse in past 60 days, Sites of exposure: Rectal insertive72284254If yes to sexual intercourse in past 60 days, Sites of exposure: Genital/vaginal72284254If yes to sexual intercourse in past 60 days, Sites of exposure: Genital/vaginal72284253If yes to sexual intercourse in past 60 days, condom or barrier for protection: Always72284253If yes to sexual intercourse in past 60 days, condom or barrier for protection: Always72284254If yes to sexual intercourse in past 60 days, condom or barrier for protection: Sometimes72284254If yes to sexual intercourse in past 60 days, condom or barrier for protection: Sometimes72284253If yes to sexual intercourse in past 60 days, condom or barrier for protection: Never72284254If yes to sexual intercourse in past 60 days, condom or barrier for protection: Never72284253Any known exposures to an STD in the past 60 days: Yes72284254Any known exposures to an STD in the past 60 days: Yes72284253Any known exposures to an STD in the past 60 days: No72284253Any known exposures to an STD in the past 60 days: No72284254Any known exposures to an STD in the past 60 days: Unknown72284254Any known exposures to an STD in the past 60 days: Unknown72284253Diagnosed with gonorrhea in the past 60 days: Yes72284253Diagnosed with gonorrhea in the past 60 days: Yes72284254Diagnosed with gonorrhea in the past 60 days: No72284254Diagnosed with gonorrhea in the past 60 days: No72284253Tested for gonorrhea in the past 14 days: Yes72284254Tested for gonorrhea in the past 14 days: Yes72284253Tested for gonorrhea in the past 14 days: No72284253Tested for gonorrhea in the past 14 days: No72284254If tested for gonorrhea in past 14 days, Test results: Positive72284253If tested for gonorrhea in past 14 days, Test results: Positive72284254If tested for gonorrhea in past 14 days, Test results: Negative72284253If tested for gonorrhea in past 14 days, Test results: Negative72284254Diagnosed with chlamydia in the past 60 days: Yes72284253Diagnosed with chlamydia in the past 60 days: Yes72284254Diagnosed with chlamydia in the past 60 days: No72284254Diagnosed with chlamydia in the past 60 days: No72284253Tested for chlamydia in the past 14 days: Yes72284253Tested for chlamydia in the past 14 days: Yes72284254Tested for chlamydia in the past 14 days: No72284253Tested for chlamydia in the past 14 days: No72284254If tested for chlamydia in the past 14 days, Test results: Positive72284253If tested for chlamydia in the past 14 days, Test results: Positive72284254If tested for chlamydia in the past 14 days, Test results: Negative72284253If tested for chlamydia in the past 14 days, Test results: Negative72284254Diagnosed with any other STI in the past 60 days: Yes72284254Diagnosed with any other STI in the past 60 days: Yes72284253Diagnosed with any other STI in the past 60 days: No72284253Diagnosed with any other STI in the past 60 days: No72284254
Non HIV-infectedUnknown HIV statusHIV-infected
One Dose BPG 2.4 MU67
Three Doses BPG 2.4 MU81
One Dose BPG 2.4 MU46
Three Doses BPG 2.4 MU37
Three Doses BPG 2.4 MU2
Three Doses BPG 2.4 MU1
Three Doses BPG 2.4 MU0
One Dose BPG 2.4 MU58
Three Doses BPG 2.4 MU69
One Dose BPG 2.4 MU7
One Dose BPG 2.4 MU59
Three Doses BPG 2.4 MU71
One Dose BPG 2.4 MU29
Three Doses BPG 2.4 MU27
One Dose BPG 2.4 MU3
One Dose BPG 2.4 MU10
Three Doses BPG 2.4 MU8
One Dose BPG 2.4 MU0
One Dose BPG 2.4 MU9
One Dose BPG 2.4 MU12
One Dose BPG 2.4 MU57
Three Doses BPG 2.4 MU72
One Dose BPG 2.4 MU47
Three Doses BPG 2.4 MU36
One Dose BPG 2.4 MU13
One Dose BPG 2.4 MU4
One Dose BPG 2.4 MU43
Three Doses BPG 2.4 MU66
Three Doses BPG 2.4 MU31
One Dose BPG 2.4 MU45
Three Doses BPG 2.4 MU58
One Dose BPG 2.4 MU35
One Dose BPG 2.4 MU41
Three Doses BPG 2.4 MU55
One Dose BPG 2.4 MU21
Three Doses BPG 2.4 MU23
One Dose BPG 2.4 MU38
Three Doses BPG 2.4 MU38
One Dose BPG 2.4 MU22
Three Doses BPG 2.4 MU15
One Dose BPG 2.4 MU6
Three Doses BPG 2.4 MU4
One Dose BPG 2.4 MU5
One Dose BPG 2.4 MU33
One Dose BPG 2.4 MU28
Three Doses BPG 2.4 MU20
One Dose BPG 2.4 MU14
Three Doses BPG 2.4 MU28
Three Doses BPG 2.4 MU12
Three Doses BPG 2.4 MU13
Three Doses BPG 2.4 MU7
One Dose BPG 2.4 MU54
Three Doses BPG 2.4 MU53
One Dose BPG 2.4 MU37
Three Doses BPG 2.4 MU29
Three Doses BPG 2.4 MU6
One Dose BPG 2.4 MU69
One Dose BPG 2.4 MU49
One Dose BPG 2.4 MU30
Three Doses BPG 2.4 MU42
One Dose BPG 2.4 MU15
Three Doses BPG 2.4 MU10
One Dose BPG 2.4 MU1
One Dose BPG 2.4 MU40
Three Doses BPG 2.4 MU41
One Dose BPG 2.4 MU36
Three Doses BPG 2.4 MU30
One Dose BPG 2.4 MU2
Three Doses BPG 2.4 MU3
Three Doses BPG 2.4 MU39
One Dose BPG 2.4 MU63
Three Doses BPG 2.4 MU77
Three Doses BPG 2.4 MU5
One Dose BPG 2.4 MU23
Three Doses BPG 2.4 MU9
One Dose BPG 2.4 MU66
Three Doses BPG 2.4 MU83
One Dose BPG 2.4 MU51
Three Doses BPG 2.4 MU40

[back to top]

Categorical Descriptive Statistics of Socio-epidemiologic Characteristics at Baseline Collected Via a Study-specific Questionnaire

Highest level of education completed, stage of syphilis, prior syphilis history (NCT03637660)
Timeframe: Day 1

InterventionParticipants (Count of Participants)
Highest level of education completed: Did not complete high school72284253Highest level of education completed: Did not complete high school72284254Highest level of education completed: Completed high school72284253Highest level of education completed: Completed high school72284254Highest level of education completed: Completed junior college72284253Highest level of education completed: Completed junior college72284254Highest level of education completed: Completed Completed college (undergraduate degree)72284253Highest level of education completed: Completed Completed college (undergraduate degree)72284254Completed graduate degree72284253Completed graduate degree72284254Stage of syphilis: Early latent syphilis72284254Stage of syphilis: Early latent syphilis72284253Stage of syphilis: Primary syphilis72284253Stage of syphilis: Primary syphilis72284254Stage of syphilis: Secondary syphilis72284254Stage of syphilis: Secondary syphilis72284253Prior syphilis history: Yes72284253Prior syphilis history: Yes72284254
HIV-infectedHIV-uninfectedUnknown HIV status
One Dose BPG 2.4 MU3
Three Doses BPG 2.4 MU5
Three Doses BPG 2.4 MU0
One Dose BPG 2.4 MU40
Three Doses BPG 2.4 MU52
One Dose BPG 2.4 MU31
Three Doses BPG 2.4 MU23
One Dose BPG 2.4 MU6
One Dose BPG 2.4 MU9
Three Doses BPG 2.4 MU4
Three Doses BPG 2.4 MU24
Three Doses BPG 2.4 MU10
One Dose BPG 2.4 MU7
Three Doses BPG 2.4 MU1
One Dose BPG 2.4 MU5
Three Doses BPG 2.4 MU3
One Dose BPG 2.4 MU25
Three Doses BPG 2.4 MU31
Three Doses BPG 2.4 MU9
One Dose BPG 2.4 MU2
One Dose BPG 2.4 MU10
Three Doses BPG 2.4 MU12
One Dose BPG 2.4 MU14
One Dose BPG 2.4 MU1
One Dose BPG 2.4 MU35
Three Doses BPG 2.4 MU39
One Dose BPG 2.4 MU23
Three Doses BPG 2.4 MU20
One Dose BPG 2.4 MU0
Three Doses BPG 2.4 MU11
One Dose BPG 2.4 MU4
Three Doses BPG 2.4 MU2

[back to top]

Treatment Response

subjects who have a 4-fold decrease (from study entry Rapid plasma reagin) in Rapid plasma reagintiters from baseline at 3 or 6 months will be considered a positive treatment response. (NCT03660488)
Timeframe: 3 or 6 months after treatment completion

InterventionParticipants (Count of Participants)
Benzathine Penicillin G14
Cefixime Group13

[back to top]

Number of Respondents Who Responded YES to Any Question Defining High Risk Penicillin Allergy Using Questionnaire Developed by the Study

Used yes/no questionnaire designed by study team. Any positive response on the high-risk history was grounds for exclusion from randomization to allergy testing arm (NCT04620746)
Timeframe: Baseline

InterventionParticipants (Count of Participants)
Skin Testing Arm36
Direct Oral Challenge36

[back to top]

Patient Acceptability of PCN Testing/Oral Challenge Assessed by a Study Team Developed Questionnaire

Brief Acceptabilty Questionnaire to subjects on acceptability of PCN allergy testing in the STD clinic setting. Reported as number of participants who found testing acceptable. Questionnaire asked subjects whether they found the process helpful and whether they would return for this type of testing. Using a 1-5 scale, with 1 defined as extremely helpful and 5 defined as not helpful. (NCT04620746)
Timeframe: Immediately after intervention

InterventionParticipants (Count of Participants)
Skin Testing Arm99
Direct Oral Challenge89

[back to top]

Provider Assessment of Feasibility of Allergy Evaluation at the End of Study

Provider assessment of feasibility of providing PCN testing in the STD clinic setting. This was based on a team-developed questionnaire using Likert scale questions that asked about feasibility and self-efficacy in performing the assessments. Feasibility defined by 1-5 scale, with 1= highly feasible and 5=not feasible. Reported as number of providers who found PCN testing feasible. (NCT04620746)
Timeframe: 18 months

InterventionParticipants (Count of Participants)
Providers11

[back to top]

Safety of Direct Oral Challenge Defined by Number of Subjects Who Did Not Have Pre-defined Changes in Vital Signs or Pre-defined Emergence of New Respiratory or Skin Symptoms After Oral Challenge

Safety was determined by the presence or absence of adverse reactions. Symptoms assessed included pruritis, flushing, shortness of breath. Physical examination included vital signs, blood pressure, pulse, respiratory rate and peak expiratory flow (NCT04620746)
Timeframe: 30 minutes after intervention

InterventionParticipants (Count of Participants)
Skin Testing Arm96
Direct Oral Challenge95

[back to top]